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Introduction: Health research with children – finding the balance
between competing interests
1.1 Introduction
This thesis is a critical evaluation of South Africa’s ethical-legal framework for regulating
health research with children.1 It describes the evolution of the ethical-legal framework, sets
out the current institutional and normative obligations for health research, and critiques the
extent to which they protect child participants, facilitate child participation in research-
related decisions and promote appropriate health research with children. It concludes with
proposals for law and policy reform.
This thesis is premised on the notion that there are conflicting interests in research
regulation, particularly research involving children, and that an ethical-legal framework is
required to find a way of balancing these competing interests. It argues that this can be
achieved by using the principles underlying children’s rights and ethical guidelines to develop
specific research-related legal norms which ensure child protection, child participation and
research towards the improvement of health care products and services for children.
This particular chapter sets out the background to the thesis, it describes the importance of
health research and of involving children in such research, discusses the competing interests
that need to be balanced during the regulation of research, identifies key legal complexities
regulating research with children, gives a brief overview of the evolution of the current
ethical-legal framework and describes the specific objectives, research questions, premise
and structure of this dissertation.
1
The scope of this thesis is limited to an investigation into the regulation of clinical trials and social science
studies.
17
1.1.1 The importance of health research in improving the quality of health care services
Medicine and the provision of health care play a central role in ensuring that individuals have
an adequate standard of living. The Preamble to the Constitution reflects the importance of
socio-economic rights by stating that one of the purposes of the Constitution is to improve
quality of life.2 Section 27 reflects this principle as a right, stating that ‘(1) (e)veryone has the
right to have access to . . . health care services, including reproductive health care; (2) The
state must take reasonable legislative and other measures, within its available resources, to
achieve the progressive realisation of each of these rights.’3 Section 28(1)(c) provides further
that children4 are entitled to ‘basic nutrition, shelter, basic health care services and social
services’.5
Given the societal interest in high quality health care, great value has been attached to the
development and improvement of health services through research. Accordingly, it has been
argued that evidence-based medicine is a critical tool for physicians in clinical decision-
making.6 The mission statement of the national Health Research Policy in South Africa
reflects this approach by stating that we must ‘promote research that contributes towards
the improvement of human health and welfare in South Africa.’7 General Comment Number
2




Any person under the age of 18, s 28(3) ibid. The Children’s Act also provides that children are persons under
the age of 18, s 17 Children’s Act 38 of 2005.
5
There are also references to the right to health rights in a number of other places in the Constitution (note 2
above) including, s 12 the right to bodily integrity, s 24 the right to an environment that is not harmful to a
person’s health, s 27(3) the right not to be denied emergency care and s 35(2)(e) the rights of all arrested,
detained and accused person’s to adequate medical treatment.
6
JP Burns ‘Research in children’ (2003) 31(3) Crit Care Med 127, 131.
7
Department of Health, Health Research Policy in South Africa, (2001) available from
http://www.doh.gov.za/docs/index.html [Accessed: 25 August 2008]. This policy is based on the principles
established in the Department of Health’s White Paper for the Transformation of the Health System in South
Africa, available from http://www.nhrc.org.za/ [Accessed: 8 February 2012]. The White Paper’s stated aim was
to address the transformation of South Africa’s health services by reducing the high levels of social inequality in
18
Five of the Committee on the Convention on the Rights of the Child also requires that
member states collect ‘sufficient and reliable’ data on children as part of national
programmes.8 Furthermore benefiting from health research can be regarded as a right in
international law given that Article 15 of the International Convention on Economic, Social
and Cultural Rights (ICESCRs) states that everyone has the right to ‘enjoy the benefits of
scientific progress and its applications’.9
1.1.2 The importance of involving children in health research
Traditionally in order to protect children from harm, they have been excluded from
participating in health research. This exclusionary approach was largely in response to public
concerns regarding research abuses including, amongst others, the inappropriate research
on institutionalised children.10 Given the absence of adequate controls establishing when
and how children could participate in research, the exclusionary approach was seen as the
only way in which children could be protected from research-related harm. The other
argument for the exclusion of children from research was founded on a restrictive
interpretation of the Nuremburg Code which requires a research participant to have legal
capacity to consent to research. It was argued that in terms of this Code a person without
the capacity to consent, such as a child or someone who was mentally disabled, was
ineligible to volunteer as a research participant.11
health. It recognised the importance of knowledge, information and evidence by stating that health research
must be linked and integrated into planning, policies, programming and implementation.
8
http://www.unhcr.org/refworld/category,LEGAL,CRC,,,4538834f11,0.html [Accessed: 13 February 2009].
9
http://www.unhchr.ch/html/menu3/b/a_cescr.htm [Accessed: 29 August 2008]. However no similar right is
included within our Bill of Rights (note 2 above).
10
Burns (note 6 above).Also see R Gandhi ‘Research involving children: Regulations, Review Boards and Reform’
(2005) 8:2 Journal of Health Law and Policy 265; JA Singh ‘Research and legal liability’ (2009) 1125 Acta Tropica
s 72, s 74 andChapter Two for a more detailed discussion of these points.
11
Ibid Gandhi 268. The first principle of the Nuremburg Code states ‘The voluntary consent of the human
subject is absolutely essential. This means that the person involved should have legal capacity to give consent;
should be so situated as to be able to exercise free power of choice without the intervention of any element of
force, fraud, deceit, duress, over-reaching, or other ulterior form of constraint or coercion; and should have
sufficient knowledge and comprehension of the elements of the subject matter involved as to enable him to
make an understanding and enlightened decision. This latter element requires that before the acceptance of an
19
This traditional exclusionary approach to protecting child research participants was never
formally made part of our law in South Africa. In other words, laws did not expressly prohibit
children from participating in health research. However elements of this protective approach
were found within the Medical Research Council’s (MRC’s) Ethical Guidelines as they
provided that parents could give proxy consent for non-therapeutic research with their
children only if the study was observational in nature and did not pose more than a
negligible risk of harm to the child.12 A number of legal academics also argued that proxy
consent for research which did not hold out the possibility of direct benefit to the
participants was lawful only in very limited circumstances.13 This approach excluded children
from participating in virtually all clinical trials.14
affirmative decision by the experimental subject there should be made known to him the nature, duration, and
purpose of the experiment; the method and means by which it is to be conducted; all inconveniences and
hazards reasonably to be expected; and the effects upon his health or person which may possibly come from
his participation in the experiment. The duty and responsibility for ascertaining the quality of the consent rests
upon each individual who initiates, directs or engages in the experiment. It is a personal duty and responsibility
which may not be delegated to another with impunity.’ Nuremburg Code available from
http://ohsr.od.nih.gov/guidelines/nuremberg.html [Accessed: 18 March 2011].
12
Guidelines on Ethics for Medical Research: General Principles (Book One) Medical Research Council (1993)
available from http://www.mrc.ac.za/ethics/ethicsbook1.pdf [Accessed: 3 February 2011].
13
C Van Wyk ‘HIV preventative vaccine research on children: Is this possible in terms of South African law and
research guidelines?’ (2005) Vol 68,35 THRHR 42, 46. Also see the earlier articles of RC Smit ‘Clinical trials,
children and the law’ (1977) No. 2 South African Medical Journal 155 and J Burchell ‘Non-Therapeutic Medical
Research on Children’ (1978) Vol 95 South African Law Journal 193. Non-therapeutic research has been defined as
‘research that does not hold out the prospect of direct benefit to the participant but holds out the prospect of
generalisable knowledge’, Regulation 1, Regulations relating to research on human subjects Government
Gazette No. 29637 23 February 2007 available from
http://www.doh.gov.za/docs/regulations/2007/reg0135.pdf [Accessed: 6 December 2012]. After the
completion of this thesis on 1 May 2013 draft Regulations Relating to Research with Human Subjects were
published for public comment in the Government Gazette No. R 378 Gazette No. 365083 dated 29 May 2013.
These draft regulations are not dealt with in this thesis however a full explanation of their content and possible
implications for future regulation of health research with children is set out in an addendum to this
dissertation.
14
However, it is not clear to what extent this approach was actually followed in practice by the MRC which
conducted a number of non-therapeutic clinical trials with children during this period, for example, a
microbicide study was completed which enrolled adolescents from 16, given that the study tested a vaginal
microbicide it was clearly not observational or non-interventional, L van Damme, G Ramjee M Alary,
B Vuysteke, V Chamndeying, H Rees, P Sirvongrangson, L Mukenge-Tshibakwa, V Ettiegne-Traore,
20
The extreme measure of protecting children through excluding them from health research
has been increasingly criticised. It has been argued that, ironically, this approach undermines
rather than protects children’s health, as excluding any group from research impedes
medical progress for that sector of the population.15 Furthermore this blanket exclusion of
children has the unintended consequence of ineffective and even harmful interventions
being used on them as no evidence exists of, for example, drug efficacy or dosage with this
age group.16 The WHO has reported that as a result of children being excluded from drug
trials limited information is available on the efficacy and safety of many medicines commonly
used for children. 17 Given that children’s bodies differ from adults and that they metabolise
medicines differently, they may need different dosages.18 There is also a wide range of
weight and physical conditions that exists within children as a class, making these types of
extrapolations difficult without child-specific information.19 Without research data collected
from children, physicians have had to use assumptions and extrapolate from adult data to
develop paediatric dosages.20 The lack of child-based evidence also means that interventions
which have been found to be effective in adult populations only benefit children many years
after they have been made available to adults, thus hindering access to care for this group.21
Finally, an overly protective approach fails to recognise that children have evolving capacity
C Uaheowitchai, S Abdool-Karim, B Masse, J Perriens & M Laga ‘Effectiveness of COL-1492, a nonoxynol-9
vaginal gel, on HIV-1 transmission in female sex workers: a randomized control study’ (2002) Vol 360 The Lancet
971, 972.
15




http://www.who.int/childmedicines/questions/en/ [Accessed: 7 April 2009].
18
HB Jaspen, CR Cunningham, TJP Tucker, PF Wright, SG Selt, RL Sheets, AS Rogers, LG Bekker, CM Wilson, A
Duerr, JN Wasswerheit and the Vaccines Adolescent Trials Working Group ‘Inclusion of adolescents in
preventative HIV vaccine trials: Public policy and research design at a crossroads’ (2004) Vol 47(1) Acquired




Ibid. It has been argued by Jaspen et al that influential regulatory bodies such as the US Food and Drug
Regulatory Authority now require all package inserts on drugs to be based on data obtained from clinical trials
carried out on individuals similar to the proposed end users. Accordingly, they argue that child specific data is
required to be obtained from clinical trials before drugs can be registered and prescribed for children.
21
Burns (note 6 above) 131.
21
and that certain children have the capacity to participate in decision-making. Accordingly, in
recent decades there has been a global shift back towards facilitating the inclusion of
children in health research. This is based on the recognition of the importance of allowing
children to participate and benefit from health research because:22
(i) The number and severity of diseases that affect children is growing. Furthermore
most of these diseases are either preventable or treatable.23 According to the
United Nations Children’s Fund (UNICEF) over nine million children under the age of
five die each year from preventable diseases.24 For example, over 1 700 children die
every day of malaria25 and 30 000 South African children (under the age of five) die
every year of AIDS-related illnesses. 26
(ii) Some disorders occur only in children or are far more common in children, for
example, cystic fibrosis and lymphoid interstitial pneumonitis;27
(iii) Certain medication has a different impact on children as opposed to adults, for
example, thalidomide causes phocomelia in unborn children;28
22
DG Hirtz & LG Fitzsimmons ‘Regulatory and ethical issues in the conduct of clinical research involving
children’ (2002) 14 Current opinion in Pediatrics 600, 609.
23
South Africa’s Children: A Review of Equality and Child Rights (2011) South African Human Rights Commission,
UNICEF and the Department of Women, Children and People with Disabilities 32.
24
See Chapter Four for further discussion on the leading diseases and causes of death amongst children in
South Africa and how they should drive the research agenda.
25
World Health Organisation (note 17 above).
26
South Africa’s Children (note 23 above) 36. Furthermore, 60 per cent of all HIV positive adults in South Africa
were infected before the age of 25. The Department of Health’s 2010 antenatal HIV prevalence survey showed
that 14 per cent of pregnant girls between the ages of 15–19 were HIV positive, Q Abdool Karim, ABM Khamny,
JA Frohlich, L Werner, M Mlotshwa, BT Madlala & SS Abdool Karim ‘HIV incidence in young girls in KwaZulu
Natal South Africa – Public Health Imperative for the inclusion in HIV biomedical intervention trials’ (2012)
published online 23 May 2012 AIDS Behav.
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Ibid. Likewise children may be a greater risk of certain disorders for example, Abdool Karim et al ibid argue
that young women in South Africa are at high risk of HIV infection yet many are unable to abstain from sex,
negotiate the use of safer sex practices or rely on consistent condom use. As a result they have very few
options in reducing their risk to HIV infection. Accordingly, the authors argue that new female controlled HIV
prevention technologies are urgently needed for this group. These can only be developed through research
with the affected population – female adolescents.
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(iv) Children have different biokinetics,29 metabolism,30 physiology,31 and immunology32
to adults;
(v) There is a developing trend against allowing the licensing of drugs, vaccines and
other interventions for children, before testing their safety and efficacy in this age
group. There is also concern regarding the ‘off label’ use of medicines for children.33
Arguments have been made regarding the inappropriateness of children being given
drugs and treatments that have not been tested on them;34 and
(vi) Using the results from clinical trials on children has resulted in significant health
benefits,35 for example, the survival rate for children with lymphoblastic leukaemia
increased from 25 per cent to more than 70 per cent following clinical trials into
new forms of cancer treatment.36
Increasingly, arguments are put forward for the active inclusion of children in health research
from social scientists using rights-based language:
29
Biokinetics is defined as ‘the science of the movements within organisms’, Free On-line Dictionary, available
from http://medical-dictionary.thefreedictionary.com/biokinetics [Accessed: 14 February 2012].
30
Metabolism is defined as the ‘whole range of biochemical processes that occur within an organism.
Metabolism consists both of anabolism and catabolism (the buildup and breakdown of substances,
respectively). The term is commonly used to refer specifically to the breakdown of food and its transformation
into energy’ Medicine.Net.comm available from
http://www.medterms.com/script/main/art.asp?articlekey=4359 [Accessed: 14 February 2012].
31
Physiology is defined as the ‘biological study of the functions of living organisms and their parts’ Free On-Line
Dictionary, available from http://www.thefreedictionary.com/physiology [Accessed: 14 February 2012].
32
Immunology is defined as the ‘branch of biomedicine that is concerned with the structure and function of the
immune system, innate and acquired immunity, and laboratory techniques involving the interaction of antigens
with antibodies’ Free On-Line Dictionary, available from http://medical-
dictionary.thefreedictionary.com/immunology [Accessed: 14 February 2012].
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persons in their own right and as worthy of recognition, respect and voice. Their participation
in research is akin to respecting and promoting their entitlement to have their opinions
heard. It assumes that they are persons of value, their experiences are of interest to
themselves, and to others, and that they have a valuable contribution to make to social and
political life.37
This approach which is becoming increasingly common in social science research is based on
‘an effort to move beyond constructing and reconstructing children’s experiences based
upon adult-centred ideals’.38 It aims at obtaining the views of children directly on health
interventions being designed for them:
We cannot hope to devise strategies or solutions that will address their concerns and will
constantly be struggling to make sense of the world without some of the vital information
that we need.39
1.2 The complexities of conducting health research with children
There are pressing public health and human rights rationales for involving children in health
research; however, there are three key complexities which impact on ethical-legal
frameworks regulating health research with children. These are: the competing interests of
the various stakeholders in the research relationship; the nature of health research itself;
and various legal complexities relating to the children not having full legal capacity until
adulthood.
37
A Graham & R Fitzgerald ‘Children’s participation in research: some possibilities and constraints in the current
Australian research environment’ (2012) Vol 46(2) Journal of Sociology 133, 135. Also see the similar views
expressed in G Clacherty & D Donald ‘Child participation in research: reflections on ethical challenges in the
Southern African context’ (2007) 6(2) African Journal of AIDS Research 145, 147 and J Cashmore ‘Ethical issues
concerning obtaining children’s consent to reports on their experience of violence’ (2006) Vol 30 Child Abuse &
Neglect 969, 969.
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R Balen, E Blyth, H Calabretto, C Fraser, C Horricocks & M Manby ‘Involving children in health and social
research: “human becomings” or “active beings”’? (2006) 13(1) Childhood 29, 31.
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1.2.1 Complexities flowing from the competing interests in health research with children
There are competing interests in research. Health research frequently requires the use of
human volunteers who may bear some risk in order to generate new knowledge. Their
interests are pitted against the interests of science which renders balancing the protection of
human subjects with the facilitation of research, a complex issue.40
A central concern in the regulation of health research is ensuring that the interests of society
and of science do not override the individual interests of research participants.41 The
individual interests of research participants include protecting their autonomy, the freedom
to enter into contracts, ensuring respect for amongst others their rights to dignity, privacy
and equality.42 The interests of science, on the other hand, include the freedom to research
and develop knowledge to improve efficiency in medical care and public administration.43
There are also numerous other competing interests such as:
(a) Many researchers are health professionals and may face conflicts between their duty
of care, and their sense of responsibility to public health concerns that could be
addressed through research;
40
F Fisher Medical Ethics Today its Practice and Philosophy (1993) 195.
41
Ibid. The World Medical Association in the Helsinki Declaration states that ‘medical progress is based on
research which ultimately must rest in part on experimentation involving human subjects . . . in medical
research on human subjects, considerations related to the well-being of the human subject should take
precedence over the interests of science and society’: Declaration of Helsinki,
http://www.wma.net/e/policy/b3.htm [Accessed: 19 August 2008]. See Chapter Two for a more detailed
discussion on this point.
42
L Nielsen ‘From bioethics to biolaw’ in CM Mazzoni (ed) A legal framework for bioethics (1998) 39, 40.
43
Fisher (note 40 above) 196 refers to a number of authors who discuss the moral imperative on scientists to
peruse the goals of science.
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(b) Researchers may face conflicts between their personal interests, such as obtaining
postgraduate degrees, enhancing their publication records and securing opportunities
for promotion at work versus the interests of research participants;44
(c) Different interest groups may have specific research interests which are linked to
political or other objectives, for example, under apartheid considerable government
funding was invested in genomic research which was aimed at establishing a scientific
rationale for the state’s racial segregation policy;45
(d) The community at large has an interest in maintaining the public’s confidence in
research to ensure continuing medical advances;46 and
(e) The profit motives of powerful corporate institutions, such as the pharmaceutical
industry and health insurance companies.47
These tensions between the interests of individuals and the interests of science are
heightened when children are to be enrolled as research participants. Children’s rights
ideology posits that decision-makers act in the best interests of the child.48 This requires
society to protect children from their youth and inexperience whilst promoting participation
by respecting their emerging autonomy and views.49 It also requires that children benefit
44
M Heywood ‘Health research and ethical principles’ in A Hassim, M Heywood, J Berger (eds) Health and
democracy (2007) 393, 394.
45
JA Singh & AE Strode ‘An analysis of South Africa’s health systems and research regulation schemes’ (2004)
unpublished (on file with author). Singh & Strode illustrate this point with a quote from the political leader
Hofmeyr who stated that research ought to aim at establishing ‘the lines along which white and coloured races
can best live together in harmony and to their common advantage.’ JH Hofmeyr ‘Africa and Science’. In: British
Medical Association for the Advancement of Science. Report of the 97
th
Meeting, South Africa, 1929 (1930) 7.
46
Fisher (note 40 above) 202.
47
HDC Roscam Abbing ‘Medical research involving incapacitated persons: What are the standards?’ (1994) Vol
1 European Journal of Health Law 140, 147. These interests may impact directly on the research relationship if
the researcher receives a grant or other forms of funding from industry.
48
Article 3, Convention on the Rights of the Child (, available from
http://www.unhchr.ch/html/menu3/b/k2crc.htm [Accessed: 13 April 2009] and Section 28 Constitution of the
Republic of South Africa (note 2 above).
49
RA Jordaan & CJ Davel Law of Persons 4 ed (2005) 52–53 and C Slack, A Strode & M Mamashela ‘Ethical-legal
challenges in adolescent HIV vaccine trials’ 2007) Vol (2) Southern African Journal of HIV Medicine 12, 12.
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from scientific progress. These competing rights and duties (of parents, children, researchers
and the state) can create disharmony within the context of health research. Table 1 below
contrasts the interests that must be balanced in health research with children.
Table 1: Competing interests in health research with children
Individual interests Scientific interests Other interests




Freedom to enter into
contracts;
Protection of the rights






Doctor’s duty of care to













Child specific interests Protection from harm;








Roscam Abbing argues that individually, each of these interests may be legitimate but taken
collectively they can easily conflict with one another. It is this conflict and the need to
protect the dignity and integrity of research participants that has led to the introduction of
27
legislation in this field.50 Resultantly, this thesis argues that establishing when concerns
relating to the well-being of individuals ought to take priority over the interests of science is
an issue that must be managed by an ethical-legal framework.51 Furthermore, based on the
precedence principle which is a well-established ethical concept requiring a consideration of
context when resolving ethical dilemmas,52 this thesis argues that an ethical-legal framework
regulating research with children should be cognisant of balancing the following contextual
principles, namely the:
 Protection of children;
 Participation of children by recognising their evolving capacity; and
 Facilitation of appropriate health research.
1.2.2 Complexities posed by the nature of health research involving children
A wide range of health research occurs with children. This dissertation has confined itself to
clinical and social science research, since these two major categories cover most forms of
health research. Some authors divide health research into therapeutic and non-therapeutic
research and this language is also used in some ethical guidelines and the NHA. Therapeutic
research is defined as research on sick persons which aims to develop generalisable
information by providing medically beneficial therapy to individuals.53 Non-therapeutic
research is undertaken with healthy volunteers and has been defined as seeking
generalisable knowledge, but not by providing therapy to benefit the individuals directly.54
However in recent years, this approach of classifying studies into either therapeutic or non-
50
Roscam Abbing HDC ‘Medical research involving incapacitated persons: What are the standards?’ (1994) Vol
1 European Journal of Health Law 140, 148.
51
I Kennedy & A Grubb Medical Law 3 ed (2000) 1667–1668.
52
See http://www.answers.com/topic/ethics-of-public-health [Accessed: 16 August 2012] for a detailed
explanation of this concept. The authors suggest that in using this principle ethical tensions are ‘resolved by
taking the overall context of the issue of concern into consideration. Above all, an ethical analysis is not
conducted against a checklist. Rather, it is a thoughtful appraisal of all related concerns, paying due cognizance
to the broader social context that gave rise to the tension in the first place’ ibid.
53
Ibid. For example, a study into whether a new cancer drug can assist persons with lung cancer.
54
Ibid. For example, a study into whether a candidate HIV vaccine can prevent new HIV infections amongst
persons at risk but not infected with HIV.
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therapeutic has been criticised as many forms of research do not fall neatly into either
category.55 This thesis uses the terms ‘therapeutic’ and ‘non-therapeutic’ when they are the
terms used in legislation or ethical guidelines. In all other instances it refers to either
research which holds out the prospect of direct benefit or research which does not hold out
the prospect of direct benefit as these are the terms used in the national ethical guidelines
issued by the National Health Research Ethics Council (NHREC).56
The National Health Act (the NHA) defines a clinical trial as ‘a systematic study, involving
human subjects that aims to answer specific questions about the safety or efficacy of a
medicine or method of treatment’.57 The Good Clinical Practice Guidelines define a clinical
trial as a pre-planned, usually controlled clinical study to determine the safety, efficacy or
optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or
prophylactic drugs, devices or interventions in humans selected according to predetermined
criteria of eligibility.58 Clinical trials can take various forms and occur in a number of different
phases. They are generally interventionist in nature, for example, testing a new drug which
volunteers must use as prescribed. The stages within clinical trials ensure that the research
progresses along a continuum from safety to efficacy studies. Stobie, Strode and Slack
describe how such phases would work in relation to adolescent HIV vaccine trials. It is
submitted that the phases that would be followed in moving an HIV vaccine from concept to
a product ready for registration, are similar to those that would be followed in any other
clinical trial involving an investigational drug or new therapy:
55
C Slack & M Kruger ‘The South African Medical Research Council’s Guidelines on Ethics for Medical Research
– implications for HIV preventative vaccine trials with children’ (2005) Vol 95(4) South African Medical Journal
269, 269. Many authors now refer to research holding out the possibility of direct benefit (therapeutic
research) or research not holding out the possibility of direct benefit (non-therapeutic research). See Chapter
Six for further discussion on these criticisms.
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Ethics in Health Research: Principles, Structures and Processes, Department of Health (2004)
http://www.doh.gov.za/docs/factsheets/guidelines/ethnics/editors.pdf [Accessed: 8 March 2012].
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S 72(7) National Health Act 61 of 2003.
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Guidelines for Good Clinical Practice in the Conduct of Clinical, Department of Health (2006) 56 available from
www.doh.gov.za [Accessed: 1 February 2011].
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Phase I clinical trials include a small group of humans, to determine toxicity, safety and
immunogenicity. Phase I trial participants do not have to be at high risk of HIV infection, as
efficacy is not being tested. Phase II and III trials are conducted on larger scales, including trial
participants who are at somewhat higher risk of HIV infection, to determine efficacy and
ongoing safety. Phase II and III trial participants should be at somewhat higher risk of HIV
infection, in order for efficacy to be tested. Results of the third phase are hoped to show that
the vaccine has succeeded in stimulating an immune response to the HI virus that can
prevent HIV infection or disease progression. In addition to these three phases, bridging trials
can take place, to answer specific questions not asked in the previous three phases, building
on from the knowledge gained in the previous trial. Children may well be involved in such
bridging trials. Phase IV entails post-licensing monitoring of the efficacy and side-effects of
the drug.59
Within each phase of the trial the research may be made up of a range of different health
interventions, not all of which are research related. For example, within HIV prevention
research it is likely that at least some of the following interventions would form part of the
protocol and be provided to participants:
 General physical examinations and medical history-taking;
 Assessment of HIV risk factors including personal questions about sex and substance
use;
 Personalised risk reduction counselling;
 Administration of the experimental HIV vaccine or placebo via injection;
 Blood draws for safety testing; and
 Regular testing for HIV infection.60
59
M Stobie, A Strode & C Slack ‘The dilemma of enrolling children in HIV vaccine research in South Africa: what
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In other words, the research may be made up of numerous types of health interventions,
some of which may benefit the research participants directly, for example, treatment of
sexually transmitted infections. Other interventions, such as the administration of an
experimental vaccine, may be of no direct benefit to the child.61
Social science research, which spans a wide range of disciplines including sociology,
psychology, anthropology, economics, political science, and history, is defined in the Human
Sciences Research Council Act as ‘the generation, preservation, augmentation and
improvement of knowledge by means of scientific investigation and methods in the field of
the human sciences’.62
Like clinical trials, social science research can also take many forms and use different
methodologies, including questionnaires, key informant interviews and focus group
discussions. For example, the Birth to Twenty Project is an on-going longitudinal study of the
health and well-being of urban South African children.63 It aims at understanding the holistic
determination of child and adolescent health and development in Johannesburg and
Soweto.64 In other words, it uses certain key health outcomes to measure whether children
are getting healthier as we move further into our democracy. Child participants in this study
are offered a range of health care and counselling services.65
Social science research can also include observation studies, for example, the care of sick
children in South Africa in the context of the AIDS pandemic, was an observational study
61
The different interventions within a study have consent implications. In Chapter Five it is argued that some
children have the capacity to consent to certain health interventions independently, such as HIV testing, even
though their parents or legal guardian may be providing over-arching consent for them to participate in the
research.
62









undertaken by the Human Sciences Research Council (HSRC). It ‘examined psychosocial care
approaches to improve the care of children in over-burdened hospital conditions. A
situational analysis using observational methodology involved nurses, children and care-
givers in identifying challenges and priorities for interventions. Naturalistic observations
captured spontaneous care strategies indicating opportunities for feasible low cost
interventions’.66
The complexities posed by the nature of health research with children are: firstly, the
research can take many forms with differing risks from non-invasive, observational studies to
highly invasive clinical trials. Secondly, some health research includes a number of
interventions some of which may provide direct therapeutic benefits to child participants.
Thirdly, some studies offer no direct therapeutic benefit and require healthy children to act
altruistically for the benefit of others.
1.2.3 Legal complexities of research involving children
Although compelling scientific arguments can be made for including children in health
research, regulating such research is legally complex for a number of reasons.
Firstly, there is an over-arching constitutional obligation to act in the best interests of
children.67 This requires a wide range of factors to be considered to promote a child’s
physical, moral, emotional and spiritual welfare during decision-making affecting the child.68
This principle limits the autonomy of parents and other decision-makers as the ‘best
interests’ approach has both subjective and objective elements.69 Accordingly, decisions on,
for example, how schools should discipline children must be guided by standards established
66
http://www.hsrc.ac.za/Research_Project-752.phtml [Accessed: 25 March 2011].
67
S 28(2) Constitution of the Republic of South Africa (note 2 above).
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McCall v McCall 1994 (3) SA 201 (C) 204, s 28(2).
69 In the Marriage of Homan (1976) FLC 90-024 .
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by the Constitution rather than solely on a parent’s religious beliefs.70 The implications of
this for research are that public policy considerations may limit the autonomy of parents or
guardians to enrol their children in certain forms of research.71 It can also mean that the
person giving proxy consent, ie the parent, is under an obligation to protect the interests of
children and does not therefore have the capacity to consent to enrol them in certain forms
of research, such as research with unacceptable risk levels. 72
Secondly, there is a constitutional obligation on parents and the state to protect children
from harm because of their vulnerability resulting from their lack of knowledge and
experience.73 Protection is achieved through numerous legal mechanisms including limiting
their legal capacity and ensuring children have legal guardians able to act on their behalf.74
This results in several implications for the regulation of research. It introduces additional
parties into the research relationship making it an alliance between the state (as the overall
regulator), researchers, parents or proxy consenters and the child, all of whom could have
potentially different interests. Ethical principles require that even if adults give consent,
children should assent to participation and must be able to withdraw from the research with
or without parental approval.75 In practice however, the power disparities between children
and adults make managing this process difficult, especially in societies which place a high
70
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social value on obedience.76 In addition, obtaining proxy consent from parents may be
complex as oftentimes children are not living with their biological parents and there is a high
proportion of illiterate care-givers, especially in rural areas.77 In some instances parental
consent is not attainable as the parents are deceased.78 Furthermore, given the involvement
of parents or guardians in the research relationship, maintaining a child’s right to privacy
may prove difficult. Even where parents have no right to the research information provided
by their children, they may expect access. For example, adolescents in HIV prevention trials
may disclose information about high risk behaviours such as underage sex or drug-taking to
researchers, and parents who have provided consent for enrolment into the trial may have
an expectation that they will be provided with this information.79 The potential disclosure of
private information to parents may also act as a deterrent to the enrolment of adolescents in
research.80
Thirdly, whilst there is an obligation on the parents and the state to protect children the law
also recognises their evolving autonomy. The obligation to protect children means that steps
must be taken to ensure that children do not face physical or psychological harm during
research.81 Children evolve through distinct developmental stages, including infancy (0–6
years), middle childhood (6–10 years), early adolescence (10–14 years) and late adolescence
76
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(14–18 years).82 A child’s evolving capacity is linked to these developmental stages as their
cognitive and physical abilities evolve. This has implications for, amongst others, the point at
which children have the capacity to consent independently to research. Table 2 below shows
the ages at which children can consent independently to various health interventions.
Debates abound regarding when children possess sufficient cognitive capacity to consent
independently to health research.83
Table 2: Age at which children can consent independently to health interventions
Intervention Age of consent Source
Medical treatment 12, if the child has ‘sufficient
maturity’ and the mental
capacity to make the decision
S 129, Children’s Act, No. 38 of
2005
HIV testing 12 S 130, Children’s Act
Contraceptives and contraceptive
advice
12 S 134, Children’s Act
Male circumcision 16 S 12(9), Children’s Act
Operations 12, if the child has ‘sufficient
maturity’ and the mental
capacity to make the decision
and is ’assisted’ by his/her
parents
S 129 Children’s Act
Research 18 S 71, National Health Act, No. 61
of 2003
Terminations of pregnancy Any age S 1 and 5, Choice of Termination
of Pregnancy Act, No. 92 of 1996
The implications are that whilst parents or legal guardians may provide consent for their
children to participate in health research, older adolescents may have the capacity to
82
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consent independently to various health procedures and interventions offered within a
study.84 This is particularly relevant within clinical trials where a range of health services may
be provided alongside the research intervention. The complexity of having various ages of
consent is that researchers must be cognisant of the age of consent of each of these
individual health interventions and of any corresponding privacy obligation. For example,
children can independently obtain contraceptives from the age of 12 and they have the right
to privacy regarding their use of such services.85
Fourthly, these legal complexities are heightened by structural problems within ethical-legal
frameworks which have failed to deal adequately with the participation of children within
health research. In many instances, legal frameworks are inappropriate or inconsistent. For
example, many African countries do not have dedicated research laws which set the norms
for research participation and this means that general principles of the law, particularly
those relating to medical treatment, have to be applied to a research context.86 Resultantly,
in many instances, the legal position is unclear. For example, recent research undertaken by
the African AIDS Vaccine Initiative in Botswana, Ethiopia, Kenya, Tanzania and Uganda
concluded that it could not be established definitively when and how children could
participate in HIV vaccine trials.87
Fifthly, there are a range of non-research specific laws that may impact on the way in which
research with children is conducted, for example, the age of consent to sex or the obligations
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on certain adults (such as medical practitioners) to report abuse.88 Applying these laws to
health research adds a further layer of legal complexities.
1.3 The regulation of health research with children in South Africa
The need for an ethical-legal framework to regulate health research and to ensure that
competing interests are managed is internationally recognised.89 It is argued that research
regulation ought to balance the competing interests described above. However, few
frameworks have been able to achieve this with any real success. Glantz argues that the
balance ought to be created by procedural protections by the very adults who control
research and ensure that children are not exploited.90 Friedman Ross refers to this issue as
the access versus protection dilemma, in which legal and policy frameworks have acted as a
pendulum swinging between over-protection resulting in the exclusion of children from
research, and access resulting in the inappropriate use of children in research.91
1.3.1 The development of the ethical-legal framework for regulating health research with
children in South Africa
South Africa’s ethical-legal framework has evolved through three distinct phases.92 In the
first phase there was no formal, legally established ethical-legal framework. There were
however a limited number of institutions to regulate research, and some legally binding
88
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norms and standards.93 In this phase the focus was on self-regulation with many forms of
research not being required by statute to, for example, obtain ethical approval.94
The second stage of the ethical-legal framework came into being with the partial
implementation of the NHA in 2005.95 This created a formal ethical-legal system consisting of
a number of key institutions able to set the policy agenda, establish norms and standards,
and review and/or regulate individual studies. Legally enforceable norms in ethical guidelines
could be established to set substantive and procedural ethical guidelines for health research,
including research with children.96 Monitoring and enforcement through, amongst others,
Research Ethics Committees (RECs) and the National Health Research Ethics Council (NHREC)
were also introduced. However the framework did not include comprehensive legal norms
regulating research with children.
The third or current stage of the ethical-legal framework came into being on 1 March 2012
with the implementation of sections 11 and 71 of the NHA.97 This completed the
introduction of a comprehensive ethical-legal framework by operationalising the legal norms
in the NHA on how and when research with human subjects may be conducted, and included
specific provisions on research with minors.98
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which were issued by the MRC, Guidelines on ethics for medical research: General Principles (note 13 above).
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1.3.2 Problems with the way in which health research with children was regulated in the past
Previously the legal provisions regulating health research, where they existed, were
contained in different pieces of legislation.99 For example, the Constitution provides in
s 12(2(c), in respect of the right to freedom and security of the person that ‘(E)veryone has
the right to bodily and psychological integrity, which includes the right . . . not to be
subjected to medical or scientific experiments without their informed consent.’100 On the
other hand, the nature of ethical review was set out in the NHA which provided that
institutions undertaking health research must have access to an REC.101 There was no child-
specific research legislation.102
Given this vacuum, researchers and RECs had to be guided by the general legal principles
particularly those relating to medical treatment, and the provisions in ethical guidelines.103
For example, in using the principles relating to consent to medical treatment, certain RECs
allowed children to consent to so-called therapeutic research at 12 years of age as they have
the capacity to consent to medical treatment at this age in terms of section 129 of the
Children’s Act.104 In a similar vein, some RECs used the principles in ethical guidelines to
establish norms for, amongst others, appropriate risk standards.105 For example, the national
ethical guidelines, Ethics in Health Research: Principles, Structures and Processes, provide
that research with children which poses greater than minimal risk, and does not hold out the
99
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100
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39
prospect of direct benefit to child participants, should only be approved by an REC if there is
a high probability of generating significantly generalisable knowledge. Furthermore, the risks
of the study should not exceed a minor increase over minimal risk. The term ‘minimal risk’ is
defined as being the risks of daily life or of routine medical or psychological examinations.106
The previous framework with its lack of clear legal guidance was fraught with
implementation problems.107 Firstly, in many instances given that it was left to either RECs or
the Medicines Control Council (MCC) to interpret general legal principles or apply ethical
guidelines, inconsistencies occurred between committees and institutions. Often
inconsistencies arose in relation to, for example, the age at which children could consent
independently to research. Using the different guidelines, RECs adopted divergent
approaches, for example, one REC allowed adolescents of 16 years and older to participate
independently in clinical trials testing a microbicide,108 whilst another required a socio-
behavioural study as part of the South African Studies on HIV in Adolescents Project to
obtain consent from parents or guardians.109 Secondly, as the research relationship is
different in its nature and objective to a therapeutic one, applying the principles relating to
medical treatment has in some instances resulted in anomalies; for example, it is difficult to
equate so-called non-therapeutic research to any form of medical treatment and thus there
was little guidance on when children could consent independently to this form of health
research. Thirdly, there was a lack of harmonisation amongst the three key sets of ethical
guidelines, particularly with regard to the permissible risk level for research which does not
106
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Personal communication, Dr Melissa Wallace, SASHA study, 4 February 2009. This study used the licensed
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adolescents in HIV prevention trials http://www.desmondtutuhivcentre.org.za/en/article/research/adolescent-
prevention/sasha.html [Accessed: 24 May 2009].
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hold out the prospect of direct benefit to the participants.110 Thus RECs, depending on the
ethical guidelines they were consulting, applied different risk standards. For example, Van
Wyk argued that adolescents would not be able to participate in HIV vaccine trials as the
MRC’s Ethical Guidelines allowed non-therapeutic research with minors only if the research
was classified as being observational in nature, and not posing more than a minor increase
over minimal risk.111 Given that HIV vaccine trials will in all likelihood involve the injection of
a vaccine they clearly cannot be considered observational research.112 On the other hand
Smit submitted that minors could participate in such studies provided the risks of
participation did not exceed a minor increase over minimal risk, which is allowed by the
national ethical guidelines issued by the NHREC and the Good Clinical Practice Guidelines.113
In other words, this lack of harmonisation meant that these two discrete positions adopted
by RECs were both justifiable depending on which ethical guidelines were being applied.
Overall, the previous ethical-legal frameworks failed as they did not adequately protect child
research participants or sufficiently promote child participation. They were however
facilitative of health research.
1.3.3 Overview of the current ethical-legal framework for regulating research with children
The legislature has attempted to resolve this lack of normative guidance within the ethical-
legal framework by inserting child specific provisions into the research chapter of the NHA.114
Sections 11 and 71 of the NHA were operationalised on 1 March 2012 by a notice in the
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Government Gazette.115 This has completed the inauguration of a comprehensive ethical-
legal framework by establishing norms for the manner in which health research ought to be
conducted, including research involving children. These provisions are important as they deal
with the lacuna in our law vis-à-vis the participation of children in health research.
1.3.4 Problems with the current approach to regulating research with children
Many shortcomings have been identified with regulation of health research by the NHA. For
example, the protections are based on the controversial notion of classifying research into
therapeutic and non-therapeutic research,116 it focuses on consent as the primary protection
for participants117 and it is inconsistent with many of the principles in the Children’s Act and
national ethical guidelines.118 Furthermore, the NHA raises a range of new issues, such as
adding an additional administrative burden on researchers by requiring ministerial consent
for all non-therapeutic research involving minors.119 Finally, given that it was brought into
operation without the proclamation of accompanying regulations, it is argued that some of
its provisions, such as the obligation to obtain ministerial consent for non-therapeutic
research with minors, are not implementable.120
At a macro level it has been argued that the current system is overly protectionist through its
very restrictive consent norms. For example, requiring consent from parents or legal
guardians and not care-givers for all forms of health research with minors will halt some
forms of low risk, school-based research as many children are sent away from home to
115
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relatives or others in order to be educated.121 The system also fails to adequately recognise
the importance of child participation in decisions which they have the capacity to undertake.
Whilst the Children’s Act clearly describes the ages at which children may consent to various
health interventions, such as HIV testing and medical treatment, the NHA only allows
independent consent to health research at 18.122 In other words the NHA fails to recognise
that children may have the capacity to consent to some forms of health research below the
age of 18.123 Finally, the overly protective approach hinders health research with children
and, as a result, a number of universities and research institutions have notices on their
websites indicating that they will not be implementing these sections until further clarity is
obtained.124
1.4 Objectives, research question, premise and structure of this thesis
1.4.1 Objectives of this thesis
This thesis aims to contribute to the current discourse on the development of an ethical-legal
framework that protects child research participants, recognises and enables children’s participation
in studies, and facilitates appropriate health research.125 It attempts to do so by describing the
institutional and normative foundations of an ideal ethical-legal framework,126 setting out the
current ethical-legal framework and how it has evolved over the last 50 years, identifying key
problems with the current framework, and making proposals for law and policy reform based on a
conceptual model of protection, participation and research promotion. Accordingly, the primary
aims of this thesis are to:
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43
(i) Describe and critique the current ethical-legal framework for health research with
children in order to inform law and policy reform proposals;
(ii) Develop a theoretical model which can be used to develop norms which balance
the need to protect children, facilitate their involvement in research-related
decisions and promote health research which benefits them; and
(iii) Contribute towards the development of a more effective ethical-legal framework
for health research with children in South Africa through the development of law
and policy reform proposals based on both ethical principles and children’s rights
as articulated in the CRC, the Constitution and the Children’s Act.
It should be noted that, as stated above, this thesis has limited its focus to health research
which can be classified as either a clinical trial or a social science study.
1.4.2 The research questions
This thesis investigates two key research questions. The first is: to what extent does the
current ethical-legal framework meet the needs of protecting research participants, enabling
child participation in accordance with the child’s evolving capacity and the facilitating of
appropriate health research? This question is answered through a critique of the current
ethical-legal framework. The critique is grounded in (a) an examination of the extent to
which the ethical-legal framework meets the international standards, and (b) an evaluation
of the extent to which it is able to balance the three principles which underpin this thesis.
The second research question: is how can the three principles of protection, participation
and promotion be used to establish the key legal norms that ought to inform the
development of laws regulating health research with children? Accordingly, this thesis
attempts to investigate whether the principles underlying children’s rights can be used to
develop a framework for legislation regulating health research when linked to well-
established ethical norms. This thesis attempts to answer this second research question by
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describing these principles and demonstrating how balancing them can result in the
development of a framework which is protective, participatory and facilitative. It makes
specific recommendations to show how these principles could be operationalised in South
Africa through the introduction of law and policy reform.
1.4.3 Central premise of this thesis
Walking the tightrope between protecting child research participants, empowering them
through child participation according to their evolving capacity, and facilitating appropriate
research with them, is the central theme of this thesis. It concerns not only when but also
under what circumstances children ought to participate in health research in South Africa.
The term ‘child protection’ is a broad one referring to the obligation to protect children from
harm in various ways. Section 28 of the Constitution127 places obligations on parents and the
state to protect children by providing them with, amongst others, a right to family or
alternative care, requiring them to be protected from ‘maltreatment, neglect, abuse, or
degradation’, and prohibiting child labour.128
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S 28(1) ‘Every child has the right –
(a) to a name and a nationality from birth; (b) to family care or parental care, or to appropriate alternative care
when removed from the family environment; (c) to basic nutrition, shelter, basic health care services, and social
services; (d) to be protected from maltreatment, neglect, abuse, or degradation; (e) to be protected from
exploitative labour practices; (f) not to be required or permitted to perform work or provide services that –
(i) are inappropriate for a person of that child’s age; or (ii) place at risk the child’s well-being, education,
physical or mental health, or spiritual, moral, or social development; (g) not to be detained except as a measure
of last resort, in which case, in addition to the rights a child enjoys under sections 12 and 35, the child may be
detained only for the shortest appropriate period of time, and has the right to be – (i) kept separately from
detained persons over the age of 18 years, and (ii) treated in a manner, and kept in conditions, that take
account of the child’s age; (h) to have a legal practitioner assigned to the child by the state, and at state
expense, in civil proceedings affecting the child, if substantial injustice would otherwise result; and (i) not to be
used directly in armed conflict, and to be protected in times of armed conflict.
(2) A child’s best interests are of paramount importance in every matter concerning the child.
(3) In this section, “child” means a person under the age of 18 years’, Constitution of the Republic of South




The Children’s Act has also been drafted with due consideration to the principles contained
in both the CRC and section 28 of the Constitution. Section 6 sets out some general principles
to guide the interpretation and implementation of the Children’s Act. These principles
include a strong focus on protection by providing for the importance of respect for children’s
rights, respect for a child’s dignity, treating children fairly and equitably, and protection from
unfair discrimination.129 The obligation to protect children also flows from the concept of
parental responsibilities and rights. These are duties owed by certain persons, such as
parents to children, and include an obligation to care for the child and to act as guardian of
the child.130 The Children’s Act also contains special obligations for interventions where there
is a possibility that a child is in need of care or protection. This includes mandatory reporting
obligations if children are being abused, neglected or are in need of care and protection.131
These principles recognise the vulnerability of children and the need for special measures to
ensure that their best interests are promoted.
It is submitted that in the context of research, the term child protection means there are
special obligations on researchers and regulators to ensure that children are not harmed
physically or psychologically by participating in the study.132 This can be achieved for
example, through measures such as requiring parental, guardian or care-giver consent for
research participation involving children under the age of 12, or by setting upper limits on
the risks that children may be subjected to during health research.133
The term ‘child participation’ refers to the involvement of children in decision-making
according to their evolving capacity. The principle is one of the four fundamental pillars
129
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underlying the CRC134 which recognises that children are the bearers of rights and, as such,
ought to participate in decisions that affect them in accordance with their evolving
capacity.135 This requires a consideration of how children can be involved in decision-making,
both when they have capacity and in circumstances where they require assistance.136 The
principle has been formally recognised in section 10 of the Children’s Act which provides that
every ‘child that is of such an age, maturity and stage of development as to be able to
participate in any matter concerning that child has the right to participate in an appropriate
way and views expressed by the child must be given due consideration’.137
This thesis argues that child participation in research decision-making is particularly
important given the shift within the context of medical relationships away from paternalism
to patient autonomy.138 In the context of research it is submitted that this means involving
children in deciding whether to participate in the study, obtaining their consent or assent,
and ensuring respect for their wishes should they wish to withdraw at any point.
The third and final principle underpinning this thesis is research facilitation. It is based on an
acceptance that children have a right to benefit from scientific progress. However, they can
only do so if appropriate child research takes place. The thesis argues that this principle
requires an ethical-legal framework which provides that children have a right to participate
in research and to benefit from its outcomes. In other words, structures and norms are
needed which do not exclude children from research participation, but rather facilitate their
134
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involvement in a protective manner.139 Nevertheless, this must be research which can be
justified on objective, scientific grounds.
It is argued that balancing competing interests when regulating research with children is
complex, as greater emphasis must be placed on protecting children, particularly those who
are required to act altruistically, whilst nevertheless facilitating health research.
Furthermore, protections must be balanced with the recognition of a child’s evolving
capacity and the need to involve and empower older or more mature children to act
independently. In this tightrope walk, protectionist and empowering measures need to be
found which do not exclude children but rather protect and promote their rights and welfare
during research. This approach is aptly described by the WHO/UNAIDS/AAVP Expert Group:
Children and adolescents represent vulnerable individuals who must be afforded special
protections. At the same time, epidemiological data show that sexually active adolescents are
especially affected by the HIV epidemic, both biologically and behaviourally. As with all
medical regulatory decision making, risks should be weighed against potential benefits for
specific target populations. Clinical research involving healthy minors should thus be
considered and balanced against the moral obligation to protect adolescents from disease, if
possible through vaccination. Therefore, consideration should be given to the consequences
of overly protective laws and regulations that limit the participation in HIV vaccine-related
research and clinical trials of those groups who are precisely more likely to benefit from a
successful HIV vaccine.140
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This is not an approach unique to research regulation. In recent years there has been a shift
within the children’s rights’ discourse from protection to autonomy, from nurturing to self-
determination, and from welfare to justice.141 This thesis argues that such a shift ought to be
reflected in legislation regulating the participation of children in research. The three
principles of autonomy, self-determination and justice, when combined with the others
underlying the CRC, the constitutional provisions on children, and those articulated in the
Children’s Act, can help create a framework for the development of a set of norms which
inform legislation regulating health research with children.142
1.4.4 Overview of the structure of this thesis
This thesis draws on work done by the author in a series of articles written over the last 12
years on a range of issues relating to the participation of children in health research, with a
special focus on the participation of adolescents in HIV prevention research.143 It develops
this work into a more cohesive and comprehensive discussion on how an ethical-legal
141
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framework can protect children, promote their participation in research-related decisions
and facilitate appropriate health research.
In this thesis, Chapter One deals with the background to this thesis, includes a discussion of
the three strands that ought to underpin research regulation with children and describes a
children’s rights framework. Chapter Two sets out the ethical-legal norms for regulating
health research as established in international law and ethical codes. Chapter Three
describes the evolution of the ethical-legal framework from an informal and largely voluntary
system to a highly regulated framework created by law. Chapter Four sets out the current
institutional framework regulating research in South Africa. Chapter Five describes the
current normative framework regulating research with children. Chapter Six is a critique of
the extent to which the current ethical-legal framework protects children, promotes child
participation and facilitates research with children. Chapter Seven describes the principles
that ought to inform law reform and how they can be used to create a legislative framework
which protects children, enables them to participate in research-related decisions and
enables appropriate research to take place with this population. It provides details of the
proposed law and policy reform proposals. Chapter Eight concludes this dissertation by
setting out the broad conclusions of this study.
1.5 Conclusion
It is clear that children need to participate in health research in order to develop and
enhance provision of health care services designed for them. However, involving children in
research is legally complex and many competing interests need to be balanced. The
limitation of an exclusionary approach is that it undermines the future development of child
health, while an overly inclusionary approach may compromise children’s rights.
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In this context, this study argues that it is an oversimplification to view this as an ‘access
versus protection’ dilemma. Rather, it is important to develop a standard which
accommodates the three competing interests of protection, child participation and research
facilitation. An ethical-legal framework is required to achieve the balance described above if
it is to be in the best interests of children. It does not argue that a perfect equilibrium must
be found, but rather a system which strives as far as possible to balance these interests,
under the over-arching principle of the best interests of the child.
In South Africa, neither the previous nor current ethical-legal frameworks have protected




The institutional and normative framework for regulating health
research with children as established by international law and
ethical codes
In the preceding chapter, the background to this thesis was presented. It described the
importance of health research in developing evidence-based interventions and of involving
children in such research; discussed the competing interests that need to be balanced during
the regulation of research; identified the key legal complexities with regulating research with
children; and gave an overview of the current ethical-legal framework for regulating research
in South Africa. The chapter concluded by arguing that in South Africa, neither the previous
nor the current ethical-legal frameworks have protected under-age participants adequately,
facilitated child participation or promoted research with this population. Accordingly, law
and policy reform is required to serve the interests of both children and science. Thus law
and policy reform must be grounded in the well-established principles described in
international law and ethical codes.
This chapter describes: the historical context which has informed the development of the
international ethical-legal framework; the interface between ethics and law; and the
rationales used to justify the regulation of health research. The most significant documents
in international humanitarian and human rights law and ethical codes for the regulation of
research, the key characteristics of well-functioning ethical-legal frameworks (institutions
and norms) and a model for classifying ethical-legal systems are also described. The chapter
concludes with comments on the nature of the protections found within the institutional and
normative framework in international law and ethical guidelines and how they can be used
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to inform the critique of our current ethical-legal framework, and the development of law
reform proposals.
2.1 Introduction
At the international level there are well-established institutional and normative principles
setting out how countries and institutions should review, regulate and enforce health
research standards.
2.1.1 Historical context
The legal regulation of research has had a relatively short history. Prior to the Nuremburg
Code in 1946, legal restraints on health research were almost non-existent.144 The regulation
of research with children has an even shorter history, the Nuremburg Code, for example,
being silent on this issue.145 Regulation has been introduced largely as a result of public
pressure on legislatures following the exposure of high profile human rights abuses.
Resultantly, in the last century governments have responded by developing ethical-legal
frameworks that regulate health research through substantive and procedural protections
for research participants.146
Two of the most high profile abuses of the rights of research participants in clinical trials
were the experiments conducted on Nazi prisoners-of-war, and the Tuskegee syphilis study
in the United States of America.
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During the Second World War, Nazi doctors undertook widespread medical experimentation
on prisoners-of-war. For example, the so-called ‘freezing experiments’ were performed to
find the most effective way of resuscitating German pilots who had to parachute into the
North Sea. Prisoners-of-war (research participants) were forced to remain outside in sub-
zero conditions for nine to 14 hours, or they were coerced into tanks of ice water for up to
three hours at a time. Re-warming occurred by placing them in a hot bath, or between two
naked gypsy women. Many prisoners died during these resuscitation processes.147
In the Tuskegee trial, the US Public Health Service recruited poor African-American men
between 1932 and 1972 into a study and allowed them to die of untreated syphilis, in order
to facilitate research into the natural progression of the disease.148 Even when penicillin was
found to be a cheap and effective treatment for syphilis, the researchers failed to offer this
treatment or disclose this information to participants.149 The denial of a known therapy to
research participants was exposed in the media in 1972, leading to public outrage and a
series of public hearings. Ultimately, it resulted in pressure being placed on the United States
government to pass the National Research Act of 1974 and federal regulations dealing with
research.150
There have also been a number of high profile abuses in clinical trials involving children. For
example, the infamous Nazi doctor, Josef Mengele undertook extensive medical
experimentation on hundreds of sets of twins at Aushwitz concentration camp in Germany
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worse than animals . . . The victims of these crimes are numbered among the anonymous millions who met
death at the hands of the Nazis’ ibid 67.
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during the Second World War.151 Dr Mengele was particularly interested in genomics and
investigating which characteristics twins were born with and which they developed as a
result of their environment,152 In the US, the longitudinal hepatitis study that took place at
Willowbrook State School in the USA from the 1950s until the 1970s is regarded as having
abused the rights of a highly vulnerable group even though parental consent was
obtained.153 Children at this school for the mentally disabled were injected with a hepatitis
virus in order to allow researchers to study the natural course of the disease. Parents wishing
to enroll their children in the school (very few of such schools existed at the time) were
required to agree that their child would participate in the study. The research was only
stopped after a public outcry.154 More recently, it was alleged that research into Trovan, a
meningitis drug which was being tested on children living in Nigeria, was undertaken without
appropriate consent and it resulted in 12 deaths and many more children suffering brain
damage, paralysis or slurred speech.155
Research abuses have not been confined to clinical research, in recent decades a number of
social science studies which have violated participants rights have been exposed in the
media and academic journals.156 For example, Wassenaar and Mamotte describe a study on
the sexual practices of gay men undertaken during the 1970s. This was done by observing
covert meetings of men in a public park. Photographs were taken of their car registrations
and this information was used to trace their physical addresses in order to recruit them into
151
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the study. Potential participants were visited at home and invited to be interviewed about
their sexual behavior or practices.157
Wassenaar and Mamotte argue that this study violated ethical principles through its
unjustified ‘intrusive monitoring of public and private behaviour’, and using this as an entry
to coercive recruitment practices.158
There have also been a number of research-related scandals in South Africa. These include:
the failure of an academic from the University of Witwatersrand to obtain ethical approval
for breast-cancer studies that compared conventional and high doses of chemotherapy
involving women who were at risk of breast cancer;159 and the so-called ‘Virdodene affair’ in
which researchers from the University of Pretoria conducted clinical trials with an industrial
solvent which they claimed ‘cured AIDS’. Following a public outcry, an investigation
established that the researchers had proceeded without the requisite permission being
obtained from either the ethics committee or the MCC.160
More recent examples of research abuses have been more complex and less overt
transgressions of ethical or regulatory obligations. For example, in the late 1990s there was
an international debate on whether Prevention of Mother to Child Transmission (PMTC)
studies, which included a placebo arm, were ethical given that data already existed which
showed that a short course in azidothymidine (AZT) reduced the possibility of HIV
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that AZT could reduce the possibility of HIV being transmitted to the child during pregnancy
and birth, and that it had been registered as a drug for this particular use, was it ethical to
deny female research participants in the placebo group the possibility of preventing mother
to child transmission by using AZT? Subsequently a number of on-going trials were either
stopped or re-designed.161
These abuses of procedural protections and substantive rights have demonstrated that
firstly, health research must be regulated by external institutions and not simply by scientists
themselves. Secondly, norms and standards must be put in place in both ethical guidelines
and laws, ensuring basic protections for human subjects. Thirdly, enforcement mechanisms
need to be in place to ensure that rights are complied with and obligations met.
2.1.2 The two faces of research regulation – the inter-relationship between law and ethics
The link between law and ethics in the context of health research is complex. However, for
the most part, it is a symbiotic relationship. While laws impose enforceable norms, it has
been argued that bioethics aims at establishing ‘morally defensible’ practices.162
Nevertheless both ethics and law have the common goal of providing rules or norms for the
regulation of human conduct with regard to health research.
In the field of health research, law and ethics provide an interwoven set of norms. Firstly,
where there is no clear legal rule dealing with the issue, ethical guidelines can be used to
establish the obligations on researchers. Harm emanating from a failure to adhere to ethical
guidelines could be actionable.163 Secondly, ethics may inform policy-making and underpin
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the approach taken by statutory institutions, for example, the MCC requires that applications
to undertake clinical trials include a signed statement that the investigators will comply with
the ethical norms in the Good Clinical Practice Guidelines (GCP) issued by the Department of
Health and obtain ethical approval by a recognised REC.164 Thirdly, in some instances ethical
norms have become legal obligations, for example, the long-standing ethical rule of
submitting research to an REC for review has become a legal obligation in terms of section 73
of the NHA which requires that all institutions undertaking health research establish or have
access to an REC.165
2.2 Rationales for regulating research
Traditionally, legislatures have resisted regulating research as they have preferred not to
interfere in the special relationship between doctors and patients, encroach on academic
freedom, or infringe on the autonomy rights of individuals.166 Accordingly, the law has played
a relatively minor role in regulating health research.167 However health research frequently
requires the use of human volunteers who may bear some risk. Furthermore, as described
above, the potential for abuse or exploitation of such volunteers may exist, particularly if
regulatory systems are under-developed, lack resources or are ineffective.168 Accordingly, it
has been recognised increasingly that an effective ethical-legal framework is required for
research regulation.
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In this context it has been argued that the regulation of research is important for two
reasons. Firstly, in order to safeguard participants from harm, ensuring that their autonomy
is protected, and that they participate only with their or a proxy’s informed consent.169 And
secondly, in order to ensure that the interests of society and of science do not outweigh the
individual interests of research participants.170 The Helsinki Declaration recognises that
although medical progress requires research which may entail experimentation involving
human subjects, the well-being of human subjects should take precedence over the interests
of science and society.171 Chima postulates the other purpose of research regulation as being
the guidance it provides on, amongst others, the role of local RECs, informed consent
procedures, standards of care, and compensation for harm.172
Nielsen, on the other hand, identifies three different functions that are served by regulating
research. They are, firstly, a norm-setting function. This declares certain interests as worthy
of protection against infringement, for example, the need for informed consent (or proxy
consent) from all research participants. Secondly, a protective function, which balances the
protected values against other interests, for example, ensuring appropriate risk standards
exist in research even where the study may generate important outcomes such as a possible
HIV vaccine. Thirdly, a declarative function, which establishes clarity in dealing with
controversial issues, for example, setting out the position that ought to be adopted regarding
research into human cloning.173
2.3 The International framework for research regulation
In the post-Nuremburg period, the ethical-legal regulation of research has been an issue of
concern for the international community, which has developed a number of international
169
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and regional statements establishing norms and standards.174 There has also been the
adoption of, amongst others, the four Geneva Conventions,175 the International Covenant on
Civil and Political Rights (ICCPRs),176 the ICESCRS, 177 and the Universal Declaration on the
Human Genome and Human Rights (UDHGHRs),178 all of which make some reference to
research. There has also been one regional convention, the Convention on Human Rights and
Biomedicine, which was adopted by the European Union.179 Finally, although the CRC is silent
on the issue of the participation of children in health research, the Committee on the Rights
of the Child has issued two General Comments both of which deal in some way with the
participation of children in research.180
Several international ethical codes have also been issued in recent years, including, the
World Medical Association’s Helsinki Declaration,181 the Council for the International
Organisations of Medical Sciences (CIOMS) International Ethical Guidelines for Biomedical
Research involving Human Subjects,182 the World Health Organisation’s Guidelines for Good
Clinical Practice for Trials on Pharmaceutical Products,183 and the Good Clinical Practice
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Guidelines issued by the International Conference on Harmonisation of Technical
Requirements for Registration of Pharmaceuticals for Human Use.184
Andanda posits that these international guidelines can be divided into three broad
categories, those found in international:
(i) Humanitarian law;
(ii) Human rights law; or
(iii) Ethical documents issued by the medical profession.185
2.3.1 Protections described in international humanitarian law
The four Geneva Conventions all make various references to research. They deal primarily
with ensuring that research occurs only in limited circumstances, and with the informed
consent of participants. Thus, for example, Article 12 of the First and Second Geneva
Conventions provides that members of the armed forces may not be subjected to biological
experiments:
Members of the armed forces and other persons mentioned in the following Article . . . shall
be respected and protected in all circumstances . . . Such persons shall be treated humanely
and cared for by the Parties to the conflict in whose power they may be, without any adverse
distinction founded on sex, race, nationality, religion, political opinions, or any other similar
criteria. Any attempts upon their lives, or violence to their persons, shall be strictly
prohibited; in particular, they shall not be murdered or exterminated, subjected to torture or
to biological experiments.186
184
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These provisions, by their very nature, have limited application as they apply only to armed
conflicts.187 Furthermore, the Geneva Conventions do not deal expressly with the
participation of child soldiers in research, given that children under the age of 15 are
prohibited from fighting in armed conflicts.188
2.3.2 Protections found in international human rights law
There are several documents which form part of international human rights law, which make
reference to research. They establish a limited number of substantive norms and do not
create any procedural obligations relating to the need, for example, to undertake ethical
review. The international legal framework also does not deal in any detail with the
participation of children in health research.
(i) The Nuremburg Code
One of the most critical issues facing the court in the so-called ‘doctor’s trial’ was the lack of
established ethical and legal standards for research involving human subjects.189 Given this
lacuna in international guidance the judges responded by issuing the Nuremburg Code.190
This Code, based on the theory of natural law,191 protects the rights of research participants
primarily through the doctrine of informed consent. Two of the 10 principles reflect the
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rights of research participants192 and the other eight require researchers to promote the
welfare of research participants during research.193 The Code also requires the research
process to promote the welfare of participants before consent is secured.194 The 10
principles articulated in the Nuremburg Code are as follows:
1. The voluntary consent of the human subject is absolutely essential. This means that the
person involved should have legal capacity to give consent; should be so situated as to be
able to exercise free power of choice without the intervention of any element of force, fraud,
deceit, duress, over-reaching, or other ulterior form of constraint or coercion; and should
have sufficient knowledge and comprehension of the elements of the subject matter involved
as to enable him to make an understanding and enlightened decision. This latter element
requires that before the acceptance of an affirmative decision by the experimental subject
there should be made known to him the nature, duration, and purpose of the experiment;
the method and means by which it is to be conducted; all inconveniences and hazards
reasonably to be expected; and the effects upon his health or person which may possibly
come from his participation in the experiment. The duty and responsibility for ascertaining
the quality of the consent rests upon each individual who initiates, directs or engages in the
experiment. It is a personal duty and responsibility which may not be delegated to another
with impunity.
2. The experiment should be such as to yield fruitful results for the good of society,
unprocurable by other methods or means of study, and not random and unnecessary in
nature.
3. The experiment should be so designed and based on the results of animal experimentation
and a knowledge of the natural history of the disease or other problem under study that the
anticipated results will justify the performance of the experiment.
192
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4. The experiment should be so conducted as to avoid all unnecessary physical and mental
suffering and injury.
5. No experiment should be conducted where there is an a priori reason to believe that death
or disabling injury will occur; except, perhaps, in those experiments where the experimental
physicians also serve as subjects.
6. The degree of risk to be taken should never exceed that determined by the humanitarian
importance of the problem to be solved by the experiment.
7. Proper preparations should be made and adequate facilities provided to protect the
experimental subject against even remote possibilities of injury, disability, or death.
8. The experiment should be conducted only by scientifically qualified persons. The highest
degree of skill and care should be required through all stages of the experiment of those who
conduct or engage in the experiment.
9. During the course of the experiment the human subject should be at liberty to bring the
experiment to an end if he has reached the physical or mental state where continuation of
the experiment seems to him to be impossible.
10. During the course of the experiment the scientist in charge must be prepared to
terminate the experiment at any stage, if he has probable cause to believe, in the exercise of
the good faith, superior skill and careful judgment required of him that a continuation of the
experiment is likely to result in injury, disability, or death to the experimental subject.195
The Code is regarded as significant for several reasons. Firstly, it was the first international
code of practice establishing principles for the regulation of health research.196 Secondly, it
has been the impetus for the development of other international codes dealing with health
research, such as the Geneva Conventions and the Helsinki Declaration issued by the World
Medical Association.197 Thirdly, it has been argued that its provisions are so widely accepted
195
Nuremburg Code (note 11 above).
196
CM Bassiouni, TG Baffes & JT Evrard ‘An appraisal of human experimentation in international law and
practice’ (1981) The Journal of Criminal Law and Criminology 1639, 1641.
197
S Perley, SS Fluss, Z Bankowski & F Simon The Nuremburg Code: An international overview in GJ Annas &
MA Grodin (eds) The Nazi doctors and the Nuremburg Code: Human rights in human experimentation (1992)
149, 152–154.
64
that they have become part of international customary law and may be applied in both civil
and criminal courts.198
Nevertheless, the Code has been criticised on a number of grounds, including: it was
developed as a human rights document by judges in a criminal trial; it is silent on research
involving children, healthy volunteers or mentally disabled persons;199 and it makes no
mention of the need for ethical review of research.200 There have also been criticisms of
numerous specific principles, for example, principle three, as researchers are not generally
able to guarantee success.201 So too with principle five, as the willingness of researchers to
expose themselves to risk cannot justify an otherwise unethical study.202 Finally, principle six
can be faulted for requiring an evaluation of one’s own research which is contrary to the
more modern focus on independent ethical review.203
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(ii) The International Convention on Civil and Political Rights
The ICCPRs was adopted by the United Nations in 1966 and came into operation in 1976.204
The Preamble to the Convention states ‘the ideal of free human beings enjoying civil and
political freedom and freedom from fear and want can only be achieved if conditions are
created whereby everyone may enjoy his civil and political rights.’205 The 53 articles deal with
amongst others: equality between men and women,206 the right to liberty and security of the
person,207 and the right to freedom of thought, conscience and religion.208 Notably, the
Convention does not deal with issues relating specifically to children.209
Only one article in this Covenant deals directly with research. Article 7 provides that ‘no one
shall be subjected without his free consent to medical or scientific experimentation’.210
Although there is no other specific reference to research, many of the provisions in the
Convention are broad and could apply indirectly to health research. For example, Article 17
deals with the right to privacy and provides that ‘(N)o one shall be subjected to arbitrary or
unlawful interference with his privacy, family, home or correspondence, nor to unlawful
attacks on his honour and reputation.’ This article could be applied to a research relationship
to ensure that participants’ rights are protected from the arbitrary disclosure of research
information. Other rights that could be applicable to a research relationship include the right
not to be subjected to torture, cruel or inhuman treatment, and the right to physical
integrity, dignity and equality.211 Furthermore, rights protecting vulnerable groups such as
204
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women or children could also assist in ensuring that such populations are not harmed during
research.212
South Africa ratified this Convention in 1998.213
There has been criticism of the way in which Article 7 of the ICCPRs has been worded with
some arguing that the use of the words ‘without his free consent’ implies that proxy consent
for health research is not permissible as only the individual participants themselves may give
consent.214 This argument excludes children and other groups who do not have the capacity
to consent from participating in some forms of research, such as clinical trials. However it
could also be argued, using a purposive approach to interpretation, that this phrase simply
means that research without consent (from the individual or an authorised representative) is
not permitted.215
(iii) International Covenant on Economic, Social and Cultural Rights
The ICESCRs was adopted by the United Nations in 1966 and came into operation in 1976.216
It deals with socio-economic and cultural rights. Its preamble states that ‘the ideal of free
human beings enjoying freedom from fear and want can only be achieved if conditions are
created whereby everyone may enjoy his economic, social and cultural rights, as well as his
civil and political rights.’217 States are required to take steps to the maximum of their
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Covenant.218 The 31 articles in the Covenant deal with, amongst others, the right to just
working conditions,219 social security220 and the enjoyment of the highest attainable
standard of physical and mental health.221 The Covenant does not deal with issues relating
specifically to children.222
The Covenant deals directly with research in only one provision, Article 15, which states that
everyone has the right to ‘enjoy the benefits of scientific progress and its applications.’223 As
in the case of the ICCPRS, many of its non-specific provisions could nevertheless be applied
to health research. For example, Article 12 outlines the right of every person to the ‘highest
attainable standard of physical and mental health’ and it is argued that this could be
interpreted as placing an obligation on the state to ensure that participants in clinical trials
receive adequate care during and after the study.224
South Africa signed this Covenant in 1994 but has not ratified it as yet.225
(iv) Universal Declaration on the Human Genome and Human Rights
The UDHGHRs was adopted by the General Conference of the United Nations Educational,
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deals with the human rights issues relating specifically to genomic research and not health
research generally.
The Declaration deals with amongst others: the right of everyone to respect for their dignity
and rights, regardless of their genetic characteristics;227 ensuring the rights of all persons are
protected, including, for example, obtaining consent before research;228 outlawing
discrimination due to genetic characteristics;229 ensuring human rights prevail over research
interests;230 outlawing practices which are contrary to human dignity such as human
cloning;231 and encouraging states to foster genomic research whilst nevertheless
considering the ethical, legal, social and economic considerations.232
This is a declaration and not a convention and is therefore not legally binding on member
states of the United Nations. However it does describe the obligations that ought to be
imposed on states in implementing safeguards which balance respect for human rights with
the fundamental freedom to engage in genomics research.233
Despite not being legally binding, the Declaration is regarded as significant for a number of
reasons including that it is the first international document which links the language of
















YM Barilan & M Brusa ‘Human rights and bioethics’ (2008) Vol 34 J Med Ethics 379, 379.
69
(v) Convention on the Rights of the Child
The CRC was adopted by the United Nations in 1989 and has established children’s rights a
core element of international law.235 Wolfson argues that its significance lies in its attempt to
articulate the practical implications of the best interests of the child standard.236 It does this
by focusing on four key principles which underlie the Convention. They are: non-
discrimination; the best interests of the child; the right to life, survival and development; and
respect for the views of the child.237
The CRC contains 54 articles and two Optional Protocols.238 It does not specifically mention
the rights of child research participants. However, it is argued that, as has been stated above
in relation to the ICCPRs and the ICESCRs, many of its provisions are broad enough to permit
their application to health research. For example, it includes the right to non-
discrimination,239 consideration of the best interests of children during decision-making,240
survival and development,241 of children to express their views if they are capable of doing
so,242 privacy,243 access to information,244 protection from violence or abuse,245 the highest
attainable standard of health,246 play,247 and not to be subjected to torture or cruel and
inhuman treatment.248
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South Africa ratified the CRC on 16 June 1995.249
Although the CRC does not itself refer to research with children, General Comment No. 3
(2003) on HIV/AIDS and the rights of the child issued by the Committee on the Rights of the
Child250 takes a very restrictive approach to the participation of children in research. It states
in point 29:
Consistent with article 24 of the Convention, States parties must ensure that HIV/AIDS
research programmes include specific studies that contribute to effective prevention, care,
treatment and impact reduction for children. States parties must, nonetheless, ensure that
children do not serve as research subjects until an intervention has already been thoroughly
tested on adults. Rights and ethical concerns have arisen in relation to HIV/AIDS biomedical
research, HIV/ADS operations, and social, cultural and behavioural research. Children have
been subjected to unnecessary or inappropriately designed research with little or no voice to
either refuse or consent to participation. In line with the child’s evolving capacities, consent
of the child should be sought and consent may be sought from parents or guardians if
necessary, but in all cases consent must be based on full disclosure of the risks and benefits
of research to the child. States parties are further reminded to ensure that the privacy rights
of children, in line with their obligations under article 16 of the Convention, are not
inadvertently violated through the research process and that personal information about
children, which is accessed through research, is, under no circumstances, used for purposes
other than that for which consent was given. States parties must make every effort to ensure
that children and, according to their evolving capacities, their parents and/or their guardians
participate in decisions on research priorities and that a supportive environment is created
for children who participate in such research.251
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The main criticisms of this General Comment are threefold. Firstly, it focuses on HIV research
instead of health research more broadly. It is important to have international guidance on
health research with children and while much of the current focus is on HIV, it is not the only
significant health problem facing children.252 Secondly, it is unclear what is meant by the
provision that children may only participate in research after interventions have been
‘thoroughly tested on adults’. For example, in a clinical trial context, it is uncertain whether
this means that children may participate only after sufficient adult data has been obtained to
ensure registration of the product, or at an earlier point. This is of concern as there have
been numerous calls for the earlier introduction of children into clinical trials in order to
ensure that they benefit from new interventions or drugs.253 Thirdly, the General Comment
refers only to parents or legal guardians providing proxy consent for children to participate in
research. Given the social context of orphanhood in many children’s lives, particularly those
in sub-Saharan Africa, this could have the unintended consequence of excluding such
children from health research, if they are, for example, living with care-givers rather than
parents.254
The Committee on the Rights of the Child has also made research recommendations in
General Comment No. 5 of 2003.255 This General Comment recommends that all states
undertake research with children in order to ensure information is available on the
implementation of the CRC and to allow for the ‘identification of discrimination and/or
disparities in the realization of rights’.256 The Committee promotes the participation of
children in this research process:
252
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The Committee emphasizes that, in many cases, only children themselves are in a position to
indicate whether their rights are being fully recognized and realized. Interviewing children
and using children as researchers (with appropriate safeguards) is likely to be an important
way of finding out, for example, to what extent their civil rights, including the crucial right set
out in article 12, to have their views heard and given due consideration, are respected within
the family, in schools and so on.
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(vi) Convention for the Protection of Human Rights and Dignity of Human Beings with regard
to the application of Biology and Medicine: Convention on Human Rights and Biomedicine
The Convention for the Protection of Human Rights and Dignity of Human Beings with regard
to the application of Biology and Medicine: Convention on Human Rights and Biomedicine is
a regional convention adopted by the Council of Europe in 1997 (‘the Convention on Human
Rights and Biomedicine’).258 This is the only existing regional convention which deals directly
with research and human rights.
The Convention on Human Rights and Biomedicine links the importance of on-going scientific
developments in the fields of biology and medicine to existing human rights obligations in
documents such as the ICCPRs.259 It deals with, amongst others, the rights of all research
participants to non-discrimination,260 the primacy of human rights over science,261 the right
to privacy in research262 and the freedom to undertake research.263
The Convention on Human Rights and Biomedicine refers to minors and persons who do not
















demonstrated that such persons are indispensible to the research.264 Furthermore, persons
lacking legal competency may participate in research only if it will be of direct benefit to
them.265 The Convention on Human Rights and Biomedicine promotes child participation in
decision-making by requiring the minor’s opinion to be taken into consideration.266
The Convention on Human Rights and Biomedicine could be criticised for failing to specify
when persons would lack competence to provide consent to research. Its approach to
research which does not hold out the prospect of direct benefit is also unclear. Under Article
6, research which does not hold out the prospect of direct benefit to participants is
prohibited with persons who cannot provide their own consent. However, under Article
17(2) such research may take place provided that, firstly, it will contribute knowledge which
will help to understand the minor’s condition, disease or disorder.267 Secondly, if the
research poses no more than a minimal risk to, and burden for, the participant.
The Convention on Human Rights and Biomedicine is binding only on countries of the Council
of Europe who have signed and ratified the Convention.
2.3.3 International ethical codes issued by the medical profession
There are a number of international ethical codes which deal with the regulation of health
research. Although none of the ethical codes is legally binding, they create an extensive
framework of accepted norms and standards for the conduct of health research with human
subjects. In particular, within this framework, ethical review of all research protocols is
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including standards on the manner and circumstances in which children can participate in
research. Finally, within this framework, there is a focus on harmonising and standardising
norms for clinical trials across the globe, through the issuing of the WHO’s Good Clinical
Practice Guidelines268 and the Good Clinical Practice Guidelines issued by the International
Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals
for Human Use.269
(i) Declaration of Helsinki
The Nuremburg Code was followed several decades later by the adoption of the Declaration
of Helsinki (the Helsinki Declaration) by the General Assembly of the World Medical
Assembly in 1964.270 This Declaration has been revised several times and currently the 2008
revision is in force.271 Dhai and McQuoid-Mason argue that it is an expansion of the
principles articulated in the Nuremberg Code. 272 They submit that the Helsinki Declaration
makes it clear that a physician’s primary duty extends beyond the obtaining of informed
consent to ensuring the well-being of the patient under his or her care.273
The stated aims of the Helsinki Declaration are to act as a common statement of key ethical
principles for medical research involving human subjects, including research on identifiable
human material and data.274 Although the Helsinki Declaration is an ethical code it also refers
to the importance of protecting the legal rights of human subjects.275 Given that this is a
declaration issued by the General Assembly of the World Medical Association, it is binding
268
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D Human & SS Fluss ‘The World Medical Association’s Declaration of Helsinki’ available from
http://www.wma.net/e/ethicsunit/helsinki.htm [Accessed: 26 June 2009].
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only on its members. Nevertheless, its significance is that it is the most widely accepted
international ethical guide on medical research involving human subjects. Furthermore,
given its broad acceptance throughout the global medical and research communities it is
possible to argue that it forms part of international customary law.276 Andanda argues
further that the Helsinki Declaration’s significance lies in the influence that it has had globally
on research legislation at a regional and national level.277
The Helsinki Declaration deals with both procedural obligations and substantive ethical
norms. For example, it provides that there is a need to develop a research protocol and
submit this for ethical review.278 It also stresses the importance of complying with ethical
norms and safeguards,279 including respect for domestic legal and regulatory obligations.280
The Helsinki Declaration also requires:
 Special protection of vulnerable groups which may participate in research;281
 Research to have an appropriate risk-benefit ratio;282
 Privacy rights to be protected;283 and
 Voluntary informed consent to be obtained from research participants.284
Finally, as stated above, the Helsinki Declaration requires researchers to be aware of the
local ethical, legal and regulatory requirements for research on human subjects in their own
countries, as well as of any applicable international requirements. Furthermore national
276
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ethical, legal or regulatory requirements should not be allowed to reduce or eliminate any of
the protections for human subjects set out in the Declaration.285
The Helsinki Declaration has been criticised for not dealing directly with the participation of
children in research. However, guidance points 17, 27 and 28 all refer to the protections that
ought to be in place when the research subject does not have the capacity to give either
consent or assent to the research, a provision which would obviously include certain children
who lack the capacity to provide independent consent.286
(ii) Council for International Organisations of Medical Sciences (CIOMS) Guidelines
CIOMS is a non-governmental organisation that was established in 1949 by the WHO and the
United Nations Educational, Scientific and Cultural Organisation (UNESCO). It has produced
the International Ethical Guidelines for Biomedical Research Involving Human Subjects (the
CIOMS Guidelines).287 These Guidelines were first published in 1993. They are in essence a
commentary on the Helsinki Declaration.288 They were the first attempt to address ethical
concerns that could arise in relation to the so-called ‘internationalisation of research’.289
The CIOMS Guidelines deal with, amongst others: the special limitations on the level of risk
that persons who are not competent to consent, are able to be subjected to during bio-
medical research,290 and the equitable distribution of the burden and the benefits of
research.291 The Guidelines are not legally binding but their stated aim is to ensure that the
principles established in the Helsinki Declaration are of use to developing countries ‘in
defining national policies on the ethics of biomedical research involving human subjects,
285
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applying ethical standards in local circumstances, and establishing or improving ethical
review mechanisms’.292 They are also more broadly applicable to the wide range of persons
who may participate in health research, unlike the Helsinki Declaration which is directed at
medical doctors. Andanda argues that the CIOMS Guidelines create a framework that ought
to inform the development of a modern ethical-legal regulatory system at domestic level.293
The CIOMS Guidelines deal specifically with the participation of children in research in
Guideline 14. This Guideline provides that:
Before undertaking research involving children, the investigator must ensure that: the
research might not equally well be carried out with adults; the purpose of the research is to
obtain knowledge relevant to the health needs of children; a parent or legal representative of
each child has given permission; the agreement (assent) of each child has been obtained to
the extent of the child’s capabilities; and, a child’s refusal to participate or continue in the
research will be respected.294
The strength of the approach taken in the CIOMS Guidelines is that, firstly, it requires
researchers to justify the inclusion of children in research. Secondly, it recognises that proxy
consent may be given by more than just parents or legal guardians through the use of the
words ‘legal representative’. It is submitted that this is a broad concept which could include
for example, care-givers.295 Thirdly, it recognises the principle of child participation through
its specific reference to obtaining assent from children and its focus on the rights of children








See Chapters Five and Six for more detailed discussion on who ought to have the authority to provide proxy
consent for health research involving children in South Africa.
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The CIOMS Guidelines have been criticised for failing to make provision for more specific
issues such as sample sizes in studies, or when research ought to be undertaken.296
(iii) World Health Organisation’s Guidelines on Good Clinical Practice (WHO GCP)
The WHO’s GCP is a set of ethical guidelines regulating clinical trials. Its objective is to set
globally-applicable standards for the conduct of biomedical research on human participants,
and to ensure established ethical and scientific quality standards exist for the design,
conduct, recording and reporting of clinical research involving the participation of human
participants.297 These guidelines ought to be followed by all members of the WHO.298
The WHO Guidelines state that the use of the WHO’s GCP in clinical trials promotes public
confidence in research, as communities are assured that the rights, safety, and well-being of
research participants will be protected and respected throughout the world. At the same
time, the scientific integrity of clinical research data is maintained.299
These Guidelines deal with, amongst others: requiring countries undertaking clinical trials to
have an appropriate regulatory framework;300 protocols to be submitted for ethical
review;301 and ensuring that research participants have safe and adequate medical care
during the trial.302 The Guidelines are not binding but in the introduction, it is recommended
that countries use and adapt them into binding national standards.303
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Ibid. See Chapter Four for further discussion on the way in which South Africa has adopted and adapted
these Guidelines.
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The WHO’s GCP has been criticised for failing to deal expressly with the participation of
children in clinical trials, with the exception of the section on informed consent which refers
briefly to children.304
(iv) The International Conference on Harmonisation of Technical Requirements for
Registration of Pharmaceuticals for Human Use (ICH) Guidelines
In 1997 the ICH brought together regulators of clinical trials, from the US, Japan and Europe
to develop international norms for the conduct of clinical trials .305 These Guidelines, entitled
the Guidelines for Good Clinical Practice E6(R1) have resulted in greater standardisation on
the minimum requirements for clinical trials. Many countries have adopted and/or adapted
these guidelines into local norms.306 The Guidelines pay some attention to the use of
children in research.307 They are only of persuasive value in respect of research that can be
defined as a clinical trial.308
Recently there has been some criticism of the ICH Guidelines with suggestions that they are a
bronze, rather than a gold standard for clinical research.309 Criticisms include:
(i) The references to good clinical practice are misleading as they focus on the way in
which trials are conducted;
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above). The 2
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ed of the SA GCP specifically provides that the principles based in the document are based on
those articulated in amongst others by the ICH. Furthermore, one of the purposes of the SA GCP has been to
ensure that the general principles contained in documents such as those produced by ICH are adapted for the
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(iii) There are no identified authors;
(iv) They have not been updated for more than 15 years; and
(v) Compliance with the Guidelines entails enormous costs but no research has been
conducted on whether such costs are justified.310
2.4 Key characteristics of effective ethical-legal frameworks
2.4.1 Overview
The well-established international ethical-legal norms and standards have informed the
development of a number of institutions, laws, policies, guidelines and enforcement
mechanisms at a domestic level. Nevertheless there are multiple views on what the key
characteristics of an ideal domestic ethical-legal framework are. Elster and Hoffman argue
that effective systems are based on four fundamental tenets: firstly, ethical review by an
independent body; secondly, voluntary and informed consent to enrolment by participants;
thirdly, protection of the privacy of participants; and fourthly, institutional assurances of
compliance with regulations.311 Following a more normative approach, Annas argues that
effective ethical-legal frameworks are those that protect the dignity and rights of
participants and promote their welfare.312
The 1997 Convention on Human Rights and Biomedicine also provides a good summary of
the key elements of an effective ethical-legal framework. This Convention states that
research with human participants should take place only if:
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ii. the risks which may be incurred by that person are not disproportionate to the potential
benefits of the research;
iii. the research project has been approved by the competent body after independent
examination of its scientific merit, including assessment of the importance of the aim of
the research, and multidisciplinary review of its ethical acceptability;
iv. the persons undergoing research have been informed of their rights and the safeguards
prescribed by law for their protection;
v. the necessary consent as provided for under Article 5 has been given expressly,
specifically and is documented. Such consent may be freely withdrawn at any time.313
Importantly, there has been a shift in the international norms away from a narrow focus on
informed consent as reflected in the Nuremburg Code. Although consent remains one of the
most important rights of research participants, an extra layer of protection has been added
through the ethical-legal obligation that researchers must obtain ethical approval.314 Fisher
argues that this is a natural progression within the evolution of research regulation. Initially
doctors were required to satisfy only themselves as to whether their research was
acceptable. Following the Nuremburg Code, this responsibility shifted to individuals through
the doctrine of informed consent, and has finally has been placed largely in the hands of
RECs.315 It is argued that this signifies a move towards a broader public policy approach in
which it must be demonstrated that research is both scientifically valid and ethically
acceptable, before individuals are approached and invited to be research participants. For
example, it requires ethics committees to consider whether a study into a potential HIV
313
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Fisher (note 40 above) 195–196. Also see for example, JH Jones Bad blood: The Tuskagee syphilis experiment
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the hands of scientists failed to protect research participants as they could place the interests of science over
those of participants. Jones argues that in the Tuskagee case ‘the consensus was that the experiment was
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vaccine which enrols adolescents, is scientifically justified and ethical before approaching the
community and inviting participants to consider volunteering. It also reflects an acceptance
of both the complexities and limitations of informed consent in a context in which research
participants may be influenced by a range of external factors such as gender dynamics,
limited access to health care or the proposed compensation offered for participation.316
It is suggested that, although expressed differently, there is significant consensus amongst
these writers and within the international law framework regarding the core elements of an
ethical-legal framework. In essence, this thesis argues that effective ethical-legal frameworks
require, firstly, institutions which are able to (a) create policy guidance on the most
appropriate forms of research that ought to be undertaken, (b) review and regulate research
(scientifically and ethically), and issue ethical norms and standards dealing with both
procedural and substantive matters, (c) liaise with and involve the community, and (d)
implement effective enforcement mechanisms.317 Secondly, they require legally established
norms which establish minimum standards for conduct of research.
2.4.2 Ethical-legal institutions to regulate health research
A range of institutional structures is required to regulate health research. At the most basic
level these are primarily, a policy formulation body, a national drug regulatory authority,
research ethics committees, community advisory structures, and various bodies to monitor
and enforce rights.
Although the range of institutions that are required to regulate research is broadly accepted,
there is lesser consensus on a number of other issues. The first is the inter-relationship
316
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desire to be ‘good patients’. See Chapter One for a definition of therapeutic research.
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between the ethical-legal institutions and how to manage tensions that may exist between
them, when carrying out their respective functions.318 The second is managing overlapping
roles between institutions, for example, the scientific validity of a clinical trial is a concern for
both national drug regulatory authorities and RECs. The third is strengthening the
independence of institutions which are required to review and approve research.319
(i) Research policy formulation
An institution is required to set the framework for research policy so as to ensure that
appropriate research, which will benefit local communities and focus on priority health
problems, is undertaken.320 Delineating the role such institutions should play, and finding a
balance between oversight and interference in the research agenda, is a complex issue.
Although there is no specific right to academic freedom in international law, this remains a
key human rights issue. Research should be justified for objective scientific reasons, such as
addressing a key health concern for a particular population. Nevertheless the line separating
science and political policy-making can become blurred. For example, in South Africa during
the Mbeki era, scientific arguments were used to promote a particular AIDS denialist agenda
resulting in the government denying women early access to prophylaxis which could have
prevented mother to child transmission of HIV.321 This approach was in part based on
318
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arguments that insufficient operational research had been conducted on implementing
PMTC programmes.322
Many writers have attempted to articulate the parameters of acceptable research. For
example, it has been argued that research should not be allowed if it is likely to result in the
discovery of knowledge that is inappropriate for human beings to process. Or, when such
knowledge may be misused in human hands, for example, if it could be used to develop or
perfect instruments for killing or injuring human beings. Alternatively, if the research is not
being conducted properly, is unfair to participants, or the risks are so great that they
outweigh the benefits to participants or society.323 In a similar vein, Shapiro and Spece
suggest that certain scientific questions should not be explored as the knowledge gained by
the research may present serious social dilemmas, could be put to improper use, the
technology developed may have harmful effects or the new knowledge may threaten our
existing values and way of life.324 These remain on-going debates. Although a number of
countries have legislated on some of these issues through, for example, prohibitions on
human cloning,325 in many instances it remains the prerogative of bodies setting the research
policy agenda, research priorities or RECs to establish whether such research will in the
circumstances be ethical.
This thesis argues that there ought to be an ethical-legal institution which sets research
policy and that this body should engage with a range of stakeholders in policy formulation.
Holman and Dutton suggest that the public ought to participate in the development of
epidemic’ (2006) 1 Stell LR 38, 44 for a discussion of the scientific arguments raised by AIDS denialists which
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research policies as it has a democratic right to participate in social policy formulation, its
participation ensures that the public interest is reflected in the research agenda, and that
public participation is essential to the practice and development of modern science.326 Such
institutions should therefore have mandates to involve the public broadly in developing
research policies.
(ii) National drug regulatory authorities
A national drug regulatory structure which has the over-arching function of regulating the
registration and use of medicines. It ought to, amongst others, regulate clinical trials
researching medicines intended for use on humans or animals. Such a body should: evaluate
the scientific quality of the proposed research, approve research in conjunction with ethics
review bodies, monitor such research and intervene should deviations from the approved
protocol occur.327
There is a complex inter-relationship between national drug regulatory authorities and ethics
committees. Although it is submitted that ideally national drug regulatory authorities ought
to work with ethics committees in regulating health research and in particular clinical trials,
the WHO has identified three different models of the way in which they operate in practice.
328 The first approach is one in which the regulation of clinical trials is undertaken solely by
the national drug regulatory authority.329 For example, in Uganda, the National Drug
Authority is established by the National Drug Policy and Authority Act of 1993 and its
functions, as per section 5, include dealing with the development and regulation of
pharmacies and drugs in the country (which includes approving new drugs) and preparations
326
HR Holman & DB Dutton ‘A case for public participation in science policy formulation and practice’ ((1978)
Vol 51 Southern Californian Law Review 1505, 1508.
327
For example, the Tanzania Food and Drugs Authority is responsible for regulating clinical trials of drugs in
Tanzania. CJ Grant (note 86 above).
328
S Ratanawijitrasin and E Wondemagegnehu (2002) Effective drug regulation: A multi-country study World




for inclusion on the national formulary of drugs, granting certificates of approval for clinical
trials on drugs, approving the national list of essential drugs and supervising revisions of the
list in a manner approved by the Minister, establishing and revising professional guidelines
and disseminating information to health professionals and the public, and providing advice
and guidance to the Minister and bodies concerned with drugs on the implementation of the
national drug policy.330
The second model is one in which the regulation of clinical trials is done by both a national
drug regulatory authority and an ethics committee.331 For example, in South Africa the MCC
can only approve a clinical trial that has already received ethical approval by a local ethics
committee.332 In terms of the third model clinical trials are regulated solely by local ethics
committees. 333 For example, in the Netherlands an ethics committee at the trial site
regulates the conduct of the research.334
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(iii) Research ethics committees
Ethical review bodies should exist within research and other institutions with the capacity to
review protocols.335 Ethics committees should provide third party review of research
protocols in order to minimise possible conflicts of interests, protect research participants
and avoid the exploitation of vulnerable individuals or communities.336 O’Grady argues that
research ethics committees (or institutional review boards as they are called in the US) are at
the ‘core’ of the system for protecting research participants’ rights.337 They were established
by institutions to provide independent review of research conducted by that institution in
order to assess whether it was ethical and whether researchers faced any conflicts of
interests in conducting the proposed study.338 One of the most important functions of RECs
is to protect human research participants.339
It is argued that such bodies should operate within a national framework in which
standardised procedures govern review and the composition of ethics committees; where an
accreditation mechanism exists, and a national body monitors their composition, training,
review process and reporting requirements.340 Finally, such bodies should be aware of the
335
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local context and appreciate the potential vulnerability of proposed research volunteers in
light of local socio-economic and cultural factors.341
It has been argued that ethics in research was ‘… born in scandal and reared in
protectionism’.342 Many attribute the development of the norm requiring review by an REC
to the outcry created by an article written by an American academic Henry Beecher, who
exposed human rights abuses in 22 scientific experiments being undertaken with human
participants in the USA at the time.343 In his seminal 1966 article published in the New
England Journal of Medicine herecommended that institutions undertaking health research
set up committees to review proposed research in order to address these types of abuses of
research participants.344
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(iv) Community advisory structures
Growing attention is being paid to the importance of community advisory boards in health
research.345 There is also increasing international debate on the nature of public
participation in science.346 Consequently, it is becoming an international norm that in large
community-based studies, some form of structure is established to facilitate engagement
between researchers and the communities in which they will be conducting the study.
It has been argued that community participation is important as ‘consultation, collaboration,
and dynamic interaction between communities and researchers are seen as key to increasing
participants’ and communities’ sense of ownership of research, commitment to research
success, and to implementation of research-based programmes’.347 Much of this relatively
new focus on community participation was initiated following a recommendation by the
National Institute of General Medical Sciences in the United States that researchers obtain
community input into all phases of research.348 This includes the involvement of the
community in all levels of ethical decision-making.349 This approach is in addition to the
recommendation that research ethics committees include community members or lay
persons on their committees.350
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See for example, s 4.1 GCP (note 58 above).which provides that an ethics committee must be ‘representative
of the communities it serves’. Furthermore such committees should have ‘at least two lay persons, who have
no affiliation to the institution, are not currently involved in medical, scientific or legal work and are preferably
from the community n which the research is to take place’.
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Reddy et al argue that historically, communities were involved in research for three distinct
reasons.351 Firstly, social scientists pioneered ‘participatory action research’ which aimed at
using community engagement through research to achieve social change. In this approach
community engagement was used to develop more effective interventions.352 Secondly,
following strong advocacy from HIV-related interests groups, community advisory boards
were set up to liaise between researchers and the community in HIV treatment research in
the USA.353 These community groups played a strong role in monitoring the research
process. Thirdly, there has been a move towards establishing community advisory boards in
order to protect participants by involving the community in the consent processes, amongst
others:
community participation ensures that communities are not exploited . . . this ethical
requirement entails: developing partnerships among researchers, policy makers and the
community; involving community partners in identifying health problems; assessing the value
of the research; planning, conducting, and overseeing the research; integrating the results
into the health care system; respecting the community’s values, culture, and social practices;
and ensuring that communities benefit from the research. Thus CABs are perceived primarily
in an ethical role.354
It has been suggested that community organisations could play six distinct roles in
biomedical research. These are: acting as an interface between the researchers and the
community; facilitating access to vulnerable communities who may ordinarily be included in
research; acting as collaborators with the research team; acting as a check to ensure the
research is being planned and implemented in a manner that serves the best interests of the
local community; acting as advocates for the adoption of research findings as local policy;
351








and acting as a distribution channel to assist researchers with the delivery of effective
interventions.355
Ensuring that community advisory structures achieve these roles is difficult, and key issues
include ensuring representivity, and addressing non-sectarianism, financial and other
agendas within the structure. Bhan et al allude to these and other issues facing community
liaison structures including possible conflicts of interests between the community
organisations and the researchers, accountability of the structure to the broader community,
relationships with elected local government officials and maintaining transparency.356 Similar
views are expressed by Swartz and Kagee who argue that one of the complexities of the
notion of community participation is the assumption that if there are high levels of
awareness amongst communities, and opportunities to be involved in the study, this will
increase the numbers of persons who volunteer to participate in the trial. They submit that
given this context community participation is not just driven by a social good of encouraging
active engagement in research but also aims at improving research objectives such as the
recruitment and retention of participants in the study.357
While good science is needed to contribute to building human rights, in order to achieve the
best in both fields, we need to recognize some potential contradictions along the way.358
(v) Monitoring and enforcement mechanisms
Ideally, a range of monitoring and enforcement mechanisms needs to exist. This should
include a structure with the ability to issue ethical codes, namely a national ethics structure
and a national regulatory body to regulate research on new medical products.
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Paragraph 15 of the Helsinki Declaration states that RECs should monitor ongoing studies,
and it places an obligation on the researchers to provide monitoring information to the
committee, and in particular, information about any serious adverse events. Monitoring of
research is important because ethical approval cannot on its own ensure the protection of
research participants. Klitzman argues that an REC can monitor research through, firstly, the
review of applications for renewal of ethical approval at regular points.359 Secondly,
monitoring informed consent processes.360 Thirdly, examinations of whether there has been
adherence to protocols and, fourthly, investigations into unapproved activities.361
Civil and criminal laws should also be available to enforce research participants’ rights. Singh
argues that we need to see enforcement mechanisms broadly; they are not merely to
enforce the rights of research participants, but they can also be a ‘useful mechanism to
reverse irrational ideology-driven science policy and decision-making’.362
Criminal law could be used to remedy a situation where participants have not given their
consent, or where they have been induced by fraudulent means to enter the study.363 For
example, charges of assault could be laid if a researcher wilfully failed to obtain consent, or
fraud if they deliberately misled a potential participant.364 Nevertheless, the criminal law can
generally only be used in very restrictive circumstances where there is proof beyond a
359
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reasonable doubt that a researcher intentionally harmed a participant.365 The 1946 trial of 23
German doctors charged with war crimes and crimes against humanity, for the
experimentation carried out on prisoners-of-war during the Second World War, is to date the
most high profile criminal trial regarding research abuses. It resulted in the documentation
one of the most extreme examples of the role doctors can play in research abuses and
criminal activity.366 At the conclusion of the trial, 15 defendants were found guilty and seven
were executed.367 No criminal charges were laid against researchers in the Tuskegee clinical
trial.368 Given the nature of modern research regulation in terms of which researchers must
obtain ethical and other forms of approval, it can be argued that the possibility of intentional
harm to research participants has been reduced.
There are a number of different ways in which civil law could be used to hold a researcher
liable for wrongful acts during research. Firstly, contract law can be used to ensure that
investigators meet all their obligations to the participant as set out in the informed consent
form.369 It is also possible that contract law could be used to compel researchers to continue
to supply a research participant with a particular therapy. In other words an interdict could
be applied for to order them to act positively if they are failing to comply with obligations in
the informed consent document (the contract). Secondly, the law of delict could also be
utilised to enable participants to claim damages should they suffer harm or an injury as a
result of the negligent actions of researchers, for example, the inappropriate disclosure of








Kennedy & Grubb (note 51 above) 1715.
369
See also Singh (note 10 above) s 72.
370
See for example, NM and Others v Smith and Others (Freedom of Expression Institute as Amicus Curiae) 2007
(5) SA 250 (CC) in which three women claimed their rights to privacy and dignity had been infringed when their
names were published in a biography of a prominent politician, Ms Patricia de Lille. The women had been
assisted by De Lille in making a complaint to the ethics committee at the University of Pretoria when they had
safety concerns about a clinical trial they were participating in which was being run at the University’s academic
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successfully used the civil law to sue the Public Health Service for compensation.371 Singh
argues that the civil law could be used to sue researchers for amongst others, a lack of
informed consent, and breaches of confidentiality, emotional distress, fraud, and faulty-
product liability.372 He argues further that the civil law has been used to hold a wide range of
parties to the research relationship liable including researchers, institutions373 which host the
research, RECs,374 consultants advising the study375 and sponsors of the research.376 Thirdly,
complaints to professional associations should be possible, for example, if researchers are
doctors it should be possible to report them to the appropriate governing body.377
Finally, besides laws placing obligations on researchers and sponsors of research, ethical-
legal institutions are required to enable participants to enforce their rights. These should
include amongst others, institutions with a mandate to regulate research such as RECs, or
drug regulatory authorities, as well other statutory bodies such as human rights
hospital. This assistance offered by Ms De Lille in resolving their ethical complaint about the study was used as
an example of her HIV activism in the book. The Constitutional Court held at para 45 that the women had an
expectation of privacy in this situation and that there was no compelling public interest in the disclosure of
their names and HIV status. Furthermore, this amounted to a wrongful publication of a private fact which
resulted in a breach of their right to privacy, para 67. The women were each awarded R35 000 in damages, para
82. See also Singh ibid where several examples of civil claims against researchers are described.
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For example, the Tanzanian Medical Association has the power to discipline any of its members who
contravene its code of ethics. Grant (note 87 above) argues that this means that medical doctors undertaking
research in Tanzania could be disciplined if they acted unethically.
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commissions. These bodies should have the power for example, to order that researchers
discontinue the trial if there are significant adverse effects resulting from the study.
2.4.3 Ethical-legal norms and standards dealing with procedural and substantive issues
Both ethical and legal norms are required in order to regulate research. Our Good Clinical
Practice Guidelines provide the following rationale for having such norms and standards:
The purpose of these guidelines is to ensure that clinical trials conducted on human
participants are designed and conducted according to sound scientific and ethical standards
within the framework of good ethical practice. Compliance with these standards provides the
public with assurance that the rights, safety and well-being of participants are protected and
that the clinical trial data are credible.378
In the post Nuremberg Code era, ethical guidelines governing research have been considered
an essential component of the package of safeguards that should exist to protect research
participants.379 Building on the principles articulated in the Nuremburg Code the Helsinki
Declaration provides that researchers should be aware of the ethical, legal and regulatory
requirements for research on human subjects in their own countries as well as applicable
international requirements.380 Furthermore, no national ethical, legal or regulatory
requirement should be allowed to reduce or eliminate any of the protections for human
subjects set out in the Declaration.381
Ethical standards should also be developed to regulate the ethical conduct of the researchers
by national research ethics bodies, ministries of health or professional bodies regulating
health care workers and researchers. Nielsen argues that codes of conduct describing key
378
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379
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ethical standards for health professionals can be an important protection that promotes a
high scientific standard.382 However, given that not all health researchers or members of a
research team may be registered with a professional council, for example, field workers
collecting data cannot be disciplined by such bodies if they are not registered health
professionals, there are limitations to this approach.383 Nevertheless, it is argued that to
ensure consistency ethical guidelines should be utilised by all bodies that review research.
Furthermore, national guidelines should be based on accepted international ethical norms
regarding research as well as be cognisant of the local context. Recent research in Botswana,
Ethiopia, Kenya, Tanzania and Uganda found that all five countries had norms and standards
setting out the process for ethical review. However, there was less information on the extent
to which committees follow this guidance. 384
Nienaber argues that as in most cases ethical guidelines are not legally enforceable, they
should be supported by the introduction of domestic laws dealing with research. 385
Accordingly, it is argued that an ideal legal framework should have laws describing the rights
of research participants, and the obligations on the state, researchers and sponsors to
protect these rights. The preceding section has described many of the rights of research
participants which are recognised in international law.386 If countries do not have research-
specific laws, Nienaber submits that research participants could use the rights in their
domestic constitutions which protect for example, rights to equality, privacy and dignity:387
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self-evidently, the goal of clinical research is the promotion of human health and human well-
being. Human rights, as embodied in domestic human rights instruments, define and advance
human well-being; a rights-based approach to research participation delivers a conceptual
and a practical framework by which to assess the process.388
If constitutional or statutory protection does not exist, then, at a minimum, countries should
utilise common law protections that preclude research participants being involved in
research without informed consent, amongst other rights. Research within the Southern and
East African region has found that there are very limited examples of research-specific laws
setting norms and standards for health research, and protecting the rights of research
participants. In such contexts the rights of research participants are generally drawn from
laws and policies conferring broad rights, such as the right to security of the person and the
right to privacy.389 This approach has obvious disadvantages including a lack of clarity as to
how such a general principle applies to research.390 Furthermore, research-specific issues
such as the setting of appropriate levels of risk that participants, particularly vulnerable
groups such as children, can be exposed to are not found in general legal principles of the
law or in laws relating to medical treatment.
There are, however, many examples of research-specific legislation in developed countries.
Many of these establish key ethical norms as legal obligations. An example is the Code of
Federal Regulations (Title 45, Part 46: Protection of Human Subjects) in the United States
which deals with research with human subjects.391 This Code sets minimum standards for
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researchers must obtain informed consent from the participants or their legally authorised
representative.393
(i) Informed consent
Informed consent is based on the principle of respect for a person’s autonomy.394 Its
historical roots are in the Nuremburg Code and the subsequent Helsinki Declaration.395 The
central role that it plays in protecting research participants has been described in the
preceding section detailing research rights in international law.396 Wendler and Grady
describe the over-arching purpose of informed consent as being:
(i)nformed consent serves at least two purposes. First, the requirement for informed consent
allows competent individuals to decide whether participation in research is consistent with
their interests. This goal implies that individuals should understand the information they
need to determine whether participation in a given study is consistent with their interests.
Second, informed consent allows individuals to decide for themselves whether they will
enroll in the study in question. For this purpose, potential participants should be provided
with the information they want to decide whether to enroll in the study.397
Informed consent is widely accepted as a process rather than an event.398 As such, there are
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consent for research to be both ethical and legal. It has been argued that the threshold
elements of consent include the ability to consent and voluntariness.399
The ICH Good Clinical Practices guidelines list 20 items of information that research
participants ought to be informed of during the consent process, including the risks,
potential benefits, expenses and duration of the study.400 These Guidelines highlight, by
making it the first item, the importance of potential volunteers being aware that they are
participating in research.401 The CIOMS guidelines list 26 factors that must be covered in the
informed consent process. Again, the first item is that individuals must understand they are
being invited to volunteer to participate in research.402
In some types of research, there are specific complexities regarding consent, for example,
with focus group discussions. Tolich argues that obtaining informed consent may be complex
as the group discussion could generate new questions or discussion points which were not
part of the research plan and accordingly, consent would not have been given for these
aspects of the group discussion.403 In order for the consent to be comprehensive, researchers
must be aware of the nature of the study and address such possibilities in the consent
process.
399
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Ibid. Wendler and Grady argue that there is an obligation to ensure that participants understand that they
are part of a study therefore ‘potential participants should understand: that they are being invited to contribute
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Where children do not have the capacity to consent to research they should nevertheless
provide assent to it. Lee et al argue that assent from children shows respect for them and
enables them to be given information on their illness and to start developing the capacity to
consent which they will require as adults.404 The American Academy of Pediatrics published a
position paper on assent in 1995. It states that there are four elements to assent, namely,
helping children reach an age-appropriate understanding of their illness, ensuring there is
awareness of the nature of the proposed treatment, assessing the child’s level of
understanding, and ascertaining whether they give their agreement to the procedure.405
(ii) Privacy, confidentiality, dignity and equality
International law provides that everyone has a right to privacy with Article 17 of the ICCPRs
stating that ‘(n)o one shall be subjected to arbitrary or unlawful interference with his privacy,
family, home or correspondence, nor to unlawful attacks on his honour and reputation’.406
Although this is not specific to health research it is submitted that it would protect research
participants from unlawful disclosures of confidential information. Furthermore, a number of
international ethical codes provide that research participants are entitled to privacy when
they participate in research.407
It is argued that the right to privacy in the context of health research means the participants
are entitled to (a) any information which they disclose during the research process or the
fact that they participated in the study to be kept confidential. This includes ensuring that
any results from the study are not directly linkable to the research participants even after
their death.408
404
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In some research contexts, there are specific issues regarding confidentiality, for example,
within a focus group discussion, researchers cannot guarantee that other participants will
keep information private even if urged to do so:
Researchers may promise participants confidentiality without acknowledging how difficult it
may be in practice to achieve this when there are few formal restrictions on (focus) group
members divulging information mentioned inside the group to others outside the group. 409
Accordingly, the consent form should specify that although researchers can guarantee that
they will not divulge personal information about the research participant, they cannot
provide this same guarantee on behalf of other members of the focus group.410 The leading
foreign case regarding the limitations of confidentiality within a medical relationship is
Tarasoff v Regents of the University of California.411 In this matter the court held that a
psychologist was negligent for failing to warn a third party at risk of harm.412 It could be
argued that based on the principles established in the Tarasoff case the right to privacy
within research may be limited in some situations.413
The rights to dignity and equality are also well established in international law.414 However,
fewer documents link these rights to research participation. The right to dignity is referred to
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right was only recently recognised with the adoption of the International Declaration on the
Human Genome and Human Rights.416 It is argued that the right to dignity within the context
of health research means the right to be treated with respect and not simply as a means to a
scientific end.
None of the key international ethical codes refer directly to the right to equality.
However, it is argued that it is indirectly recognised through it being a core element of the
ethical principle of justice. It is argued that the right to equality within research means that
(a) participants may not be unfairly excluded from research on arbitrary grounds such as race
or gender, and (b) certain populations being recruited into studies should not
disproportionately bear the burdens of research.
(iii) Risk standards
Research to improve the health and well-being of individuals and society often requires
research participants to be exposed to some risks or burdens that they would not otherwise
face in their daily lives.417 Although research participants accept these risks through the
informed consent process, it is an international ethical norm dictated by public policy
considerations that requires the risks to be appropriate given that in many instances
participants will accept them altruistically for the benefit of others.418 Weijer submits that
risk standards serve two purposes, firstly they enable ethics committees to establish which
protocols will require greater scrutiny and secondly, they establish an upper limit of risk that
they may not be exceeded.419
416
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Despite agreement on this basic principle Nelson et al submit that there are four key areas of
divergence. These are: (a) the permissible level of risk, as this varies according to different
legal jurisdictions; (b) identifying common terms that can be used to describe the
permissible level of risk, for example minimal risk or negliglible risk; (c) agreeing on how
these terms are interpreted420 and (d) establishing whether research which does not provide
a direct benefit to the child but will develop generalisable knowledge is to be permitted.421
2.5 Classifying ethical-legal frameworks
Classifying ethical-legal frameworks is important as it enables comparisons of various
systems or models for regulating health research. This in turn enables the identification of
the key characteristics of various systems including the extent to which they protect
participants, promote participation and facilitate research. It also illustrates the advantages
and disadvantages of using the law to regulate health research.
Nielsen argues that there are four possible forms of ethical-legal frameworks. These range
from those with low levels of regulation or self-regulation, to highly regulated systems in
which legislation establishes substantive protections and procedural obligations.
Nielsen’s first form of an ethical-legal framework is the individual control model or the
private ordering approach. This model is based on self-regulation. There is no legal
regulation of health research in this model. In terms of this model, responsible persons and
institutions make autonomous choices. This leaves the protection of participants in their own
hands. The obvious limitation of this approach, identified by Nielsen, is that it leaves
420
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vulnerable participants open to abuse as it may be difficult for them to understand the long-
term consequences of their choices, especially in cases of urgent health needs. Furthermore,
in this model there are no norm-setting guidelines.422 Leenen argues further that self-
regulation absolves the state of its responsibilities to protect the fundamental rights of its
citizens by requiring private rule-making.423 In summary, this model offers low levels of
protection, but it facilitates research.
The second model is the professional control model or the professional ordering approach.
In terms of this model regulation occurs primarily through professional councils; in other
words, this approach is based on regulation by peers who monitor whether researchers are
acting in accordance with their professional code of ethics. Again, in terms of this model
there is no direct regulation of research by the law. This model emphasises ethical
procedures and norm setting.424 A problem with this model is that in many instances, not all
researchers or members of the research team are required to register with professional
councils. Thus should research participants wish to lay a complaint regarding the conduct of
a non-professional member of the research team they would have to complain to the
institution hosting the study.425 In some instances there have also been complaints of
professional associations showing bias towards their members when resolving disputes
regarding professional malpractice, given their vested interests in protecting the profession
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the large funders of health research such as the National Institutes of Health in the US could
also be seen as a form of professional ordering as this is a form of control exercised by a
state or an international organisation.427 Obligations imposed by funders would have to be
met alongside any local obligations in the country where the health research was being
conducted.428 Whilst the funders of research would not have the power to discipline
researchers they could stop or withdraw funding for a project and thus exert considerable
power over researchers. The second model offers some protection and remains facilitative of
research.
The third model is the cautious regulatory approach. This is a model in which there is a level
of legal regulation by the state within the ethical-legal framework. This model envisages laws
and policies issued by the state which regulate certain normative aspects of health research,
as well as laws establishing an institutional framework such as ethical committees which are
tasked with approving and monitoring research. This model is protective of participants and
does not prevent research that meets the normative standards set by the state. This
approach is generally regarded as the ideal approach.
The final model is one which takes a prohibitive approach. This model is an extension of the
cautious regulatory approach. It is a system in which there is a high level of regulation by the
state through legislation which not only sets norms and establishes regulatory institutions
but prohibits certain kinds of research. This model also includes penalties for non-
compliance.429 Although it has many strengths in that it creates an ethical-legal framework
that the South African Health Professions Council has been ineffective in disciplining its members. See Chapter
Six for further discussion on this issue.
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enforced by law, its weakness is that it may fall into the danger of over-regulating research,
thus impinging on academic freedom and the discovery of new knowledge.430 In summary,
this model is highly protective but is also obstructive of research.
2.6 Conclusion
There are some criticisms of the value of the international ethical-legal framework. Nienaber
argues that it provides very little protection as it is not directly enforceable.431 Furthermore,
compliance is dependent on professional sanction and other non-legal enforcement
measures.432 Resultantly, she submits that other than ‘a refusal to fund or a refusal to
publish unethical research, there is little to guard against unethical research conducted by
unscrupulous agencies’.433 Furthermore, Annas and Grodin have articulated three lessons
from the Nuremburg trials of Nazi doctors, which can also be considered to be a broader
critique of the current international ethical-legal framework. They posit that:
(i) Ethical guidelines are in many instances not enforceable;
(ii) Violations of human rights do occur in human experimentation; and
(iii) There is no effective international mechanism for promulgating and enforcing
basic medical ethics and human rights principles.434
In conclusion, however, this thesis argues that despite the fragility of the international
framework as a system of law in itself, it nevertheless provides a framework which can be
used to describe and develop the key elements of effective systems for regulating health
research at domestic level. The international ethical-legal framework sets out a number of
key institutions which ought to exist in order to ensure that an appropriate research agenda
430
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is established, the scientific quality of research is assured, ethical review of protocols takes
place, there is community engagement, and rights are enforced. At a normative level, the
international guidance clearly establishes norms regarding consent, privacy, dignity, enjoying
the benefits of research, and protection against unfair discrimination. There are also well-
established ethical norms regarding the participation of children within health research.
The international framework has evolved over the last 60 years, with the role of ethical-legal
institutions becoming more prominent of late. In particular, there has been a shift from a
purely normative focus to one in which there is now a significant role for drug regulatory
authorities and ethics committees. Simultaneously, institutions that will be necessary to
ensure public participation in research and setting the research agenda are emerging. The
international ethical-legal framework is incomplete with many gaps. It also faces key
challenges as scientific knowledge develops exponentially, raising new and more complex
issues for regulatory frameworks. Advocacy is needed to promote an international covenant
protecting the rights of research participants. Nevertheless, the international framework is of
value in regulating health research with children as it provides guidance (albeit in a limited




The development of the current South African ethical-legal
framework for regulating health research with children
The preceding Chapter discussed the institutional and normative framework for regulating
health research, which has been established by the international community. It
contextualised the international norms for research regulation by briefly discussing the
history of research regulation, including two key events which prompted the development of
protective research norms, namely, the exposure of medical experimentation on prisoners of
war by Nazi doctors and the Tuskegee syphilis trial in the USA. The ethical-legal norms that
have been established through international humanitarian and human rights law and ethical
codes were set out. Based on these norms the preceding Chapter argued that the key
characteristics of well-functioning ethical-legal frameworks are firstly, institutions which are
able to (a) create a policy framework, (b) review and regulate research, (c) issue ethical
norms and standards dealing with both procedural and substantive issues, (d) liaise with the
community and (d) enforce research participants' rights. Secondly, it submitted that effective
ethical-legal frameworks have legally established norms which create minimum standards for
conducting health research. The Chapter concluded with a theoretical model of how ethical-
legal frameworks can be classified.
This Chapter describes the evolution of the South African ethical-legal framework through
three distinct legislative phases, namely, the situation:
(i) Prior to the adoption of the NHA (first phase);435
(ii) Following the partial implementation of the NHA (second phase); and
(iii) Currently, following the full implementation of the NHA (third phase).
435
National Health Act (note 57 above).
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Using the key institutional and normative characteristics of well-functioning ethical-legal
frameworks described in Chapter Two as benchmarks, this Chapter briefly describes and
critiques the first two phases of the ethical-legal framework for regulating health research in
South Africa.436 It does this by describing the key institutions, setting out any ethical-legal
norms and classifying the frameworks in terms of Nielsen’s model.437 Both phases are
critiqued using the three themes underlying this thesis, namely, the extent to which they
protect child research participants, promote child participation and facilitate health
research.438 The Chapter concludes with general comments on the nature of the evolution of
the ethical-legal framework and its implications for research with children.
3.1 Introduction439
Medical research in South Africa dates back to the 1860s.440 Early scientific work was
conducted primarily by the Veterinary Research Institute, in Onderstepoort and the South
African Association for the Advancement of Science.441 The first academic journal dealing
with medical issues was the South African Medical Record which published original scientific
articles between 1903 and 1926.442 During the twentieth century the state began to invest
more funding in medical research and established, amongst others, the South African
Institute of Medical Research, the MRC and HSRC.443
436
The current phase of the ethical-legal framework is described in Chapters Four (institutional aspects) and
Five (normative elements). It is critiqued in Chapter Six.
437
Nielsen’s model is described in more detail in Chapter Two.
438
See Chapter One for a full description of these three concepts.
439
This Chapter is based to a limited extent on previous work by the author in Strode, Slack & Mushariwa (note
94 above) 598–601. In this article, Strode, as the first author prepared the first draft of the article and her co-
authors provided inputs on that version when assisting in completing the piece.
440
BJ Barker ‘A Short General History of the MRC’ available from http://www.mrc.ac.za/history/history.pdf
[Accessed: 18 June 2012].
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It has been submitted that during the Apartheid era state-funded health research aimed at
achieving:
two primary considerations: (a) the desire to improve the health of white citizens; and (b) the
desire to improve the health of non-white citizens, but primarily only in so far as their health
posed a threat to white citizens, or threatened to undermine the national economy. As such,
health research in the country was motivated by economic considerations and not
humanitarian ones.444
Initially, research was unregulated. However, in the last 50 years the ethical-legal framework
has evolved through three phases from high levels of self-regulation to a highly
sophisticated, institutional and normative framework which describes procedural and
substantive protections for research participants.
3.2 The ethical-legal framework prior to the National Health Act
3.2.1 Overview
Prior to the NHA there was no formal, legally established ethical-legal framework for
regulating health research.445 In essence, in this first phase of the development of the
ethical-legal framework the focus was on self-regulation, with many researchers and
research institutions not being under any statutory obligation to, for example, submit
research for ethical review, unless they were undertaking clinical trials or the research was
conducted by or on behalf of the MRC.446
3.2.2 Institutional framework
The only two institutions established by law which dealt with ethical-legal matters related to
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Related Substances Act447 (the ‘Medicines Act’), and the MRC’s REC. 448 There were, however,
a number of other statutory institutions which played a varying degree of roles in the
informal ethical-legal framework as is illustrated by Table 3 below. These included the HSRC
as the largest statutory body undertaking social science research,449 the South African
Medical and Dental Council which had the authority to regulate and discipline its members
(medical practitioners) undertaking health research450 and the courts. Finally, although they
were not specifically required to do so by statute, a number of institutionally based RECs
were voluntarily established.451



















Medicines and Related Substances Act 101 of 1965, s 35(1)(xxxix) read with the General Regulations (note
164 above) Government Gazette, 10 April 2003, No. 24727, R510 and Act 58 of 1991.
448
The MRC was established by the South African Medical Research Council Act 19 of 1969 and later by the
Medical Research Council Act 58 of 1991.
449
Human Sciences Research Act (note 62 above). The objectives of the HSRC were to promote research and
the development of knowledge in the field of human sciences, s 2A and 3 ibid. See Chapter One for the
definition of social science research as contained in the current Human Sciences Research Council Act ibid. The
HSRC does not have a regulatory function as is evident from s 2 of its Act, which describes its objectives as
being, amongst others, to ‘(a) initiate, undertake and foster strategic basic research and applied research in
human sciences, and to gather, analyse and publish data relevant to developmental challenges in the Republic,
elsewhere in Africa and in the rest of the world, especially by means of projects linked to public sector oriented
collaborative programmes; (b) inform the effective formulation and monitoring of policy and to evaluate the
implementation of policy; (c) stimulate public debate through the effective dissemination of fact-based results
of research; (d) help build research capacity and infrastructure for the human sciences in the Republic and
elsewhere in Africa; (e) foster and support research collaboration, networks and institutional linkages within
the human sciences research community: (f) respond to the needs of vulnerable and marginalised groups in
society by researching and analysing developmental problems, thereby contributing to the improvement of the
quality of their lives; and (g) develop and make publicly available new data sets to underpin research, policy
development and public discussion of the key issues of development, and to develop new and improved
methodologies for use in their development’.
450
Health Professions Act 56 of 1974.
451
The first University to create an REC was the University of Witwatersrand which did so in 1966 K Moodley &
M Landon ‘Health research ethics committees in South Africa: 12 years into democracy’ (2007) Vol 8(1) BMC


















(i) Institutions establishing research priorities
In the first phase of the ethical-legal framework there was no statutory body with the
express mandate of setting national research priorities for all forms of health research in
South Africa. However, both the HSRC and the MRC were required to advise their respective
ministers of research priorities in their fields of research. The HSRC was required to advise
the Minister of National Education on ‘research priorities’ relating to human sciences452
whilst the MRC was required to advise the minister assigned to this function of ‘the
determination of policy and national priorities regarding research’ and on the ‘development,
promotion, implementation and co-ordination of research on a national basis’.453
(ii) Institutions reviewing and regulating health research
The only regulatory bodies in this first phase of the ethical-legal framework were the MCC,
the MRC’s REC and other institutional RECs.
One of the primary functions of the MCC was to provide for the registration of medicines and
related substances.454 Although the Medicines Act didn’t deal directly with the conduct of
clinical trials it was given the authority to register medicines only if it was satisfied with their
application for registration following ‘any investigation or enquiry which it may consider
452
S 2A(b) Human Sciences Research Act (note 62 above).
453
S 20 Medical Research Council Act (note 448 above).
454
Preamble, Medicines and Related Substances Act (note 447 above).
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necessary’.455 It is argued therefore that the broad mandate of the MCC included the
regulation of clinical trials which preceded the registration of a medicine or medical
product.456 In this context it is submitted that one of the regulatory functions of the MCC was
to ensure that clinical trials were scientifically valid given the stipulations that were set out in
the General Regulations accompanying the Medicines Act.457
No RECs were expressly required to be established by law although the MRC, a statutory
body established to use ‘research, development and technology transfer, to promote the
improvement of the health and the quality of life of the population of the Republic’458 was
required to ‘establish ethical directives’ and ‘ensure that they were complied with by MRC
staff’.459 It could be argued that this placed an obligation on the MRC Board to ensure that
research or experimentation with humans or animals undertaken by MRC staff or persons on
behalf of the MRC was regulated and controlled. Thus although not expressly provided for, it
appears that the MRC was under an indirect statutory obligation to establish an REC.460
Furthermore, even though no other research institutions were required to set up RECs, many
were obliged to if they wished to conduct clinical trials because in order to register a clinical
trial with the MCC, ethical approval was required from a recognised REC.461 Accordingly,
many institutions voluntarily established RECs for both clinical trials and social science
studies and required researchers (employees or contractors) conducting research on their
455
General Regulations, Medicines and Related Substances Act, Regulation 15(3)(a) (note 164 above).
456
Strode, Slack & Mushariwa (note 94 above) 599.
457
Ibid. Although see also below, regarding the requirement in the General Regulations, Medicines and Related
Substances Act that researchers obtain ethical approval before approaching the MCC (note 164 above).
458




The MRC complied with this obligation by establishing an REC in 1970. Furthermore in its Guidelines on
ethics for medical research: General Principles (Book 1), which was first issued in 1977, it provided that
research on healthy volunteers and patients must be subject to independent ethical review by an REC (note 12
above).
461
Regulation 34(2), General Regulations issued in terms of the Medicines and Related Substances Act (note
164 above).
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behalf to obtain ethical clearance.462 Far fewer social science research institutions
established RECs or required researchers to obtain ethical approval for studies with human
participants with, for example, the HSRC did not require ethical approval for all its work until
after the partial implementation of the NHA.463
(iii) Institutions to issue ethical norms and standards
Both the MCC and the MRC had the statutory authority to issue norms and standards
regulating health research.464 The MRC issued ethical guidelines in 1977, 1987, 1993 and
2003.465 The most recent, the Guidelines on ethics for medical research: General Principles
(Book One), were informally regarded as national ethical guidelines as no other widely used
set of ethical guidelines issued by a statutory body existed.466
A similar statutory duty was placed on the Medical and Dental Council in terms of the Health
Professions Act which empowered the Council to, amongst others, issue ethical codes to
guide the professional conduct of their members.467 Any registered doctor, dentist or
psychologist undertaking research would be required to comply with such ethical codes.468
Unlike the MRC, the HSRC’s empowering legislation did not require it to establish an ethics
462
Moodley & Landon (note 451 above) 1.
463
The HSRC only established an REC in 2003, personal communication, Professor Wassenaar, Chair, HSRC
Research Ethics Committee, 14 May 2012.
464
The General Regulations accompanying the Medicines and Related Substances Act (note 164 above)
described in some detail the obligations on researchers conducting clinical trials. This included for example, in
Regulation 34(2) that the application to the MCC must include: the trial protocol; the investigator’s brochure
which includes the background information on the product to be tested; the curriculum vitae of all
investigators; a signed statement by all investigators that they will comply with the Good Clinical Practice
Guidelines (GCP) issued by the Department of Health; a copy of the informed consent document; and ethical
approval by a recognised REC. The first set of GCP guidelines was issued by the Department of Health in 2000.
An updated version was completed and issued in 2006, Guidelines for Good Clinical Practice in the Conduct of
Clinical Trials with Human Participants in South Africa (note 58 above).Whilst s 17 of the MRC Act (note 448
above) required the MRC to ‘establish ethical directives’ which it did by developing ethical guidelines.
465
Medical Research Council (2003) Guidelines on ethics for medical research: General Principles (Book 1) (note
12 above).
466
Van Oosten (note 104 above) 7–8.
467




committee, to issue ethical directives for social science research or to ensure that ethical
standards were enforced.469
(iv) Institutions to facilitate communication between researchers and the community
No institutions were required to be established to provide a forum for liaison between
researchers and the community during this phase of the ethical-legal framework, and none
were voluntarily set up.
(v) Institutions to enforce research participants rights
A number of both research-specific and other institutions existed which could potentially be
used to enforce research participants’ rights including:
(a) The MCC could act against researchers who failed to comply with the obligations
set out in the General Regulations;470
(b) The MRC REC was able to act against researchers either employed by it or those
undertaking work on its behalf, for failing to comply with its ethical guidelines;471
(c) Any institutionally-based REC could act against its employees who failed to
comply with their ethical guidelines. They could also refer the matter to the
institution for further disciplinary steps;472
(d) The Medical and Dental Council could act against any of its members for
unprofessional or unethical conduct during research;473 and
(e) Courts could adjudicate on any criminal or civil complaint regarding the unethical
or illegal conduct of a researcher.474
469
S 2A(a) provided for example, that the HSRC was required to ‘promote, support and co-ordinate research’
(note 67 above). It is submitted that this cannot be interpreted as implying a regulatory function on the HSRC.
470
General Regulations accompanying the Medicines and Related Substances Act (note 164 above).
471
S 17 MRC Act (note 4480 above).
472
It is possible to argue that the failure to comply with ethical guidelines was a breach of a workplace rule and
accordingly was a form of misconduct for which an employee could be dismissed in terms of s 188(1)(a)(i) of the
Labour Relations Act 66 of 1995.
473
Health Professions Act (note 450 above).
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There was only one statutory obligation regarding the monitoring of research in order to
protect research participants’ rights, namely, researchers conducting clinical trials had to
submit regular progress reports to the MCC.475 The MRC Guidelines did not require progress
reports but clearly indicated that the REC had an on-going oversight role for the duration of
the research.476 Furthermore, although not required by law, many institutional ethical
guidelines required RECs to monitor research that they had approved.477
Obligations also existed in the MRC and GCP Guidelines regarding research-related injuries.
Both provided that if research participants were harmed as a direct result of research
participation they were entitled to compensation.478
Finally, there were a number of institutions which did not have a research-specific mandate
but which could have been used to enforce research participants’ rights. This included, for
example, the Medical and Dental Council which had disciplinary powers over its members
(doctors, dentists and psychologists).479
474
See Chapter Four for a more detailed discussion on the circumstances in which the criminal or civil law could
be used to hold a researcher liable for inappropriate or harmful conduct relating to research.
475
Regulation 34(5)–(6) General Regulations (note 164 above).
476
10.3 MRC Book One (note 12 above).
477
For example, the MRC’s ethical guidelines on Ethics for Medical Research (Book 1) provide in 10.2 that
research ethics committees have a critical role to play in monitoring research and that their responsibilities
‘continue whilst the research is in progress’ ibid. However, outside of research conducted by the MRC this was
not a legal requirement.
478
The MRC’s Book One ibid provided in point 10.6 that participants should be compensated if they were
injured during the research. They recommended that researchers obtain professional indemnity insurance to
cover this possibility. Furthermore, if a participant suffered a ‘significant injury’ they would be entitled to
compensation regardless of whether or not there was negligence or legal liability on the part of the
researchers, 10.6.2.2 ibid. The GCP Guidelines in point 4.11 (note 58 above) provide that researchers must
obtain comprehensive insurance to cover any possible research-related injuries. Furthermore ‘compensation
should be paid when, on the balance of probabilities, the injury was attributable to the administration of a
medicinal product under a trial or any clinical intervention or procedure provided for by the protocol that
would not have occurred but for the inclusion of the patient in the trial’.
479
Health Professions Act (note 450 above).
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3.2.3 Normative framework
There was no comprehensive normative framework for regulating research in the first phase
of the ethical-legal framework. However, there were some limited references to research
norms contained in a number of different statutes. None of these norms dealt expressly with
the participation of children in health research. The laws included the:
(i) Medicines Act which described the regulation of clinical trials;480
(ii) South African Medical Research Council Act which contained some norms
regarding research undertaken by the MRC;481
(iii) Human Tissues Act482 which regulated the removal, use of and import/export of
human bodies, blood, tissues and gametes from living or deceased persons,
including research on such material;483 and
(iv) The common law relating to everyone’s personality rights which could be applied
to research.484
It can be argued that these legal norms required, firstly, that informed consent be obtained
from research participants before enrolment in a study.485 Secondly, ethical approval had to
be obtained for all clinical trials and research conducted by the MRC. Thirdly, authorisation
was required from the MCC for clinical trials.486 Figure 1 below shows the procedural
obligations prior to the NHA.
480
Medicines and Related Substances Act (note 429 above).
481
Medical Research Council Act (note 450 above).
482
Act 65 of 1983. This Act has been repealed by the NHA (note 57 above).
483
Ibid s 18, 19, 24 and 25.
484
Stobie, Strode & Slack (note 59 above) 194.
485
Before 1996 this was not an express requirement in our law. S 12 of the Constitution of the Republic of
South Africa (note 2 above) was the first general obligation to ensure that consent was obtained before health
research. See Chapters One and Five for further discussion on this point. However, s 18(b) Human Tissues Act65
of 1983 required consent to any research on blood, human tissues or gametes. Nevertheless it is argued that
given the fundamental right to autonomy in terms of the common law, researchers would be required to obtain
consent from potential participants.
486
General Regulations accompanying the Medicines and Related Substances Act (note 164 above) and the
MRC Act (note 450 above).
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Figure 1: The ethical-legal framework prior to the implementation of the National Health
Act
Fourthly, MRC researchers were required to comply with the ethical guidelines issued by the
MRC.487 These dealt expressly with the participation of children in health research.488
Researchers conducting clinical trials were required to comply with the GCP issued by the
Department of Health which included research participant protections.489 It has been argued
that these requirements indirectly resulted in some ethical norms being legally
487
S 17(1) Medical Research Council Act ibid. There are currently five MRC books dealing with ethical issues
(note 9 above) they include; Book 1: Guidelines for medical research: General Principles, Book 2: Guidelines on
ethics for medical research: Reproductive biology and genetic research, Book 3: Guidelines on ethics for
medical research: use of animals in research, Book 4: Guidelines on Ethics for Medical Research: use of
Biohazards and Radiation, Book 5: Guidelines on Ethics for Medical Research: HIV Vaccine Trials, available from
www.mrc.ac.za [Accessed: 2 June 2008].
487
Before 1996 this was not an express requirement in our law. S 12 of the Constitution of the Republic of
South Africa (note 2 above) was the first general obligation to ensure that consent was obtained before health
research. See Chapters One and Five for further discussion on this point. However, s 18(b) Human Tissues Act
(note 467 above) required consent to conduct any research on blood, human tissues or gametes. Nevertheless
it is argued that given the fundamental right to autonomy in terms of the common law, researchers would be
required to obtain consent from potential participants.
487
General Regulations accompanying the Medicines and Related Substances Act (note 164 above).
488
MRC Book One (note 12 above).
489
Regulation 34(2) Medicines and Related Substances Act (note 164 above). The GCP Guidelines were
developed to provide clear, appropriate and locally relevant standards of good clinical practice in research and
to ensure that research with human participants takes place with thin the framework of sound scientific and
ethical standards (note 58 above).
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enforceable.490 Fifthly, only authorised institutions who had obtained permits were allowed
to import or export any blood, blood product or gamete for research purposes.491
Child-specific ethical norms were established in the GCP Guidelines of 2000 and Book One
issued by the MRC. These focused on consent, risk standards and limiting the nature of
research or trials in which children could participate. Differing approaches were taken by
both sets of guidelines on all three issues. Firstly, with regard to consent, the GCP Guidelines
did not provide for independent consent by children in any circumstances whilst the MRC
allowed independent consent by children over 14 in therapeutic research (this could include
clinical trials) (See Table 4 below).492
Table 4: Comparison between the approach taken by GCP and the MRC (Book One) on
consent to research participation in research by children
GCP (2000) MRC Book One
Consent Consent from parents or
legal guardians and
assent from children
Consent from parents for non-therapeutic research
Consent from the child over the age of 14 for therapeutic
research, parental consent if below 14
Assent from children if unable to consent
Secondly, in terms of risk standards the GCP Guidelines (2000) specified no express limit on
the permissible level of risk in research which holds out the possibility of direct benefit to
490
In essence this approach argued that the courts would look to ethical guidelines to establish the standard of
behaviour expected from health professionals, see for example, Jansen van Vuuren and Another NNO v Kruger
(note 157 above) 854G–H where the Appellate Division held that patients had a right to expect that their
doctors would abide by the ethical guidelines issued by their professional body. Given that this meant that
health professionals could be held delictually liable for failing to comply with ethical guidelines it has been
argued that these ethical codes were indirectly legally enforceable.
491
Ss 24 and 25 Human Tissue Act (note 487 above).
492
The MRC justified this approach by providing that therapeutic research could be equated to medical
treatment and as children could consent independently to medical treatment from the age of 14 in terms of s
39(4) of the Child Care Act 74 of 1983, they could in turn also consent to therapeutic research from the age of
14, point 5.3.1.2.1, MRC Book One (note 12 above).
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child participants. However, if the study posed more than a minor increase over minimal risk,
then the risks had to be justified by the benefits to participants.493 In research which did not
hold out the prospect of direct benefit a study could not pose more than a minor increase
over minimal risk. Furthermore, the risks had to be justified by the generalisable knowledge
that would be generated by the study.494 On the other hand, the MRC’s Book One provided
that so-called therapeutic research could not pose any more than an everyday risk for
children.495 In other words, it could not pose more than small chance of a ‘trivial reaction,
remote chance or serious injury/death’.496 With so called non-therapeutic research it could
not pose more than a negligible risk of harm (See Table 5 below).497
Table 5: Comparison between the approach taken by GCP and the MRC (Book One) on the
issue of risks standards in research involving children
Therapeutic research Non-therapeutic research
GCP (2000) No express limit on the allowable level
of risk
If the study posed more than a minor
increase over minimal risks to be
justified by the benefits to participants
A study could not pose more than a
minor increase over minimal risk
Risks to be justified by the generalisable
knowledge generated by the study
MRC (Book One) Express limit on allowable level of risk
– no more than the everyday risk of
harm
Express limit on allowable level of harm –
no risks or no more than negligible risk
Finally, the two sets of guidelines differed with regard to the nature of the research that
children could participate in, with the MRC limiting so-called therapeutic research to studies
493








Ibid. See Chapter Two for a more detailed discussion on the international debates on the meaning of the
term minimal risk.
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which took the form of treatment, and so-called non-therapeutic research to observational
and non-intervention research.498
3.2.4 Classifying the ethical-legal framework prior to the adoption of the National Health Act
Using Nielsen’s approach, as described in Chapter Two, on the classification of ethical-legal
frameworks499 it is argued that given the lack of a comprehensive institutional or normative
ethical-legal framework, South Africa’s ethical-legal regime prior to the NHA could be
regarded as falling between the professional control model and the cautious regulatory
approach. The system had elements of the professional control model as bodies like the
Medical and Dental Council which regulated doctors, dentists and psychologists could have
been used to discipline the unethical conduct of health professionals conducting health
research. On the other hand elements of the cautious regulatory approach existed as both
the MCC and the MRC had certain statutory obligations to regulate research, issue norms
and standards and ensure compliance with them. However, given that these norms applied
only to some forms of health research, the framework also did not completely fit into the
cautious regulatory approach (See Table 6 below).
Table 6: Applying Nielsen’s model to South Africa’s ethical-legal framework prior to the
National Health Act
Model Key elements Application to South Africa
Professional control model Regulation of researchers by
professional bodies
The Medical and Dental Council
and other similar bodies had the
authority to discipline members
who acted unethically in health
research
Cautious regulatory approach Legal regulation of research
through institutions such as RECs





See Chapter Two for a detailed description of Nielsen’s model.
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MRC RECs had the authority to
regulate MRC research
Institutional ethical guidelines
existed and limited legal
provisions
3.2.5 Critique of the ethical-legal framework prior to the adoption of the National Health Act
The ethical-legal framework before the adoption of the NHA was limited, fragmented and
inconsistent in its approach to children. Elements of the framework were overly protective
and, for example, certain ethical guidelines excluded almost all clinical trials with children.500
Other parts of the framework were very permissive as the lack of legal regulation meant, for
example, that social science studies did not require ethical approval. Overall, protection was
weak as ethical norms were not directly enforceable and did not apply to all studies. There
were no special obligations regarding health research involving children, except for those
established in ethical guidelines.501 Child participation was recognised in ethical guidelines
which required assent from children without the capacity to consent, and independent
consent from children in certain circumstances.
500
See the above discussion on the MRC’s Book One (note 12 above) which prohibited all forms of non-
therapeutic research with children which were interventional in nature. Very few clinical trials are not
interventional as generally they are testing a new drug, intervention or therapy. See the definitions of a clinical
trial in Chapter One.
501
Stobie, Strode & Slack (note 59 above) 196.
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Table 7: The extent to which the first phase of the ethical-legal framework protected and
promoted child participation whilst facilitating research with children
Protection Child participation Research facilitation
Weak Recognised as a principle through
assent and consent procedures
Ranged between excluding research with
children and allowing research in any
circumstances
(i) Institutional framework
In first stage of the development of our ethical-legal framework, the institutional
arrangement for regulating research was weak. Firstly, the framework lacked key institutions
to set research policy, to provide ethical review, issue ethical standards or to facilitate
community engagement in research. Secondly, it focused largely on regulating a narrow
sector of health research, namely, clinical trials.502 The flagship institution in the ethical-legal
framework was the MCC which was primarily responsible for setting the scientific standards
in clinical research.503 A key social science institution, the HSRC was not required to regulate
social science research.504 Thirdly, there was some overlap between the respective
regulatory roles of RECs and the MCC on ethical issues which resulted in some uncertainty.
For example, the scientific validity of a clinical trial was clearly a concern for the MCC, which
had to be satisfied that the research was methodologically valid and would produce reliable
data.505 Likewise it is a key ethical principle that research must be scientifically valid. In the
past the MCC’s approach of encroaching on ethical policy standards as part of its review of
clinical trials caused conflict, for example, many researchers were outraged when it required
that phase one HIV vaccine trial participants had to have 12 years education in order to be
eligible to participate in such a study.506 This was also contrary to the MRC ethical guidelines
which required research participants to have understanding as part of the consent process
502




HSRC Act (note 62 above).
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S 35(i)(xxxix) Medicines and Related Substances Act (note 429 above).
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Personal communication, Dr Efthyhia Vardas, 5 February 2004.
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but did not stipulate that they had to have a particular educational standard.507 Fourthly, the
institutional framework was fragmented in the sense that there was no mechanism to co-
ordinate the work of the MCC, RECs, MRC and the HSRC.
Finally, monitoring and enforcement mechanisms were generally weak as few institutions
had a legal mandate to protect and promote the rights of research participants.508 Where
mechanisms did exist, they focused on, for example, the submission of reports to the MCC.
Furthermore, given that ethical review was not required for many forms of social science
research, not all research was scrutinised or monitored. This meant, for example, that
participants had to use the civil law if they wished to bring an action against researchers who
had conducted health research illegally by not obtaining consent for participation, as the
ethical guidelines only provided for compensation for harm where a physical injury occurred.
(ii) Normative framework
Prior to the adoption of the NHA the norms and standards regulating research were limited,
with almost no statute on this issue and no national ethical guidelines.509 Furthermore,
where legal norms did exist most were not established in research-specific laws.510
Nevertheless, research participants did have protections such as the right to informed
consent, privacy and protection from harm. The implications of this limited legal framework
was firstly, there was no legal obligation on researchers who were not conducting clinical
trials or performing work for the MRC to obtain ethical approval.511 Thus, for example, a
507
Strode, Slack & Mushariwa (note 94 above) 600. Ironically, this would mean for example, that President




Although as stated above, some writers such as Van Oosten (note 104 above) argued that the MRC
Guidelines ought to be regarded as national ethical guidelines 7.
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Strode, Slack, Grant & Mushariwa (note 114 above) 225 and Stobie, Strode & Slack (note 59 above) 194.
See Chapter Four for a more detailed discussion on this point.
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S 17 Medicines and Related Substances Act (note 429 above). Regulations accompanying the Act provide
that an application to the MCC for approval of a clinical trial must include a copy of ethical approval by an REC.
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qualitative study into the experiences of children growing up in child-headed households was
not required by law to obtain ethical approval even though it could pose some risk for
participants. Secondly, given the lack of explicit legal provisions, academic writers and RECs
often had to apply the general principles relating to medical treatment or the norms
established in ethical guidelines to a research context.512 There were two problems with this.
One, the research relationship is different in its nature and objectives to a therapeutic one,
for example, it is difficult to equate so-called non-therapeutic research to medical treatment.
Two, ethical guidance had not been completely harmonised.513 Furthermore, this
inconsistent approach resulted in RECs taking divergent approaches to key issues, such as the
age at which children could consent independently to participation in health research.
3.3 The ethical-legal framework following the partial implementation of the National
Health Act
3.3.1 Overview
The second stage of the development of the ethical-legal framework commenced with the
implementation of parts of the NHA.514 Chapter Nine of the NHA created a formal ethical-
legal framework for the first time in South Africa. The parts of this Chapter which came into
operation on 2 May 2005 included:515
(i) A number of key institutions, which set the policy agenda, establish norms and
standards, review and regulate individual studies;
Although there was no legal obligation to obtain ethical approval, many institutions and sponsors of research
required the research protocol to be reviewed.
512
Strode, Slack & Mushariwa (note 94 above) 600.
513
In particular there was a lack of harmonisation around the issue of the permissible level of risk in non-
therapeutic research. Also see Stobie, Strode & Slack (note 59 above) 194 and Chapter One for an example of
the different approaches by RECs on the issue of independent consent by adolescents.
514




(ii) Legally enforceable norms in ethical guidelines which established substantive and
procedural guidelines for the conducting of health research;516 and
(iii) Monitoring and enforcement mechanisms through RECs and the NHREC.
Significantly, the new ethical-legal framework was inclusive as it regulated both clinical trials
and social science studies. The second stage of the development of the ethical-legal
framework did not however include the implementation of legal norms regulating when and
how health research with children may be conducted. This was the case despite the
promulgation of the Children’s Act which made provision for numerous health rights for
children, but did not address the rights of child research participants.517
3.3.2 Institutional framework
The NHA created a number of new institutions to regulate and support health research,
including the National Health Research Committee (NHRC), the National Health Research
Ethics Council (NHREC) and RECs. These institutions together with the pre-existing MCC
create a comprehensive institutional framework for health research. The institutional
framework introduced in 2005 is our current ethical-legal framework as no significant
changes having been introduced in the last seven years. Accordingly, it is discussed in detail
in Chapter Four of this thesis which describes the current institutional framework for
regulating health research.
3.3.3 Normative framework
The normative framework changed between the first and second stages of the development
of the ethical-legal framework in two significant ways. Firstly, the Bill of Rights in the final
Constitution contained a specific provision on consent to research.518 The nature of this right
516
See Chapter 5 for a detailed description of these legal norms.
517
Strode, Slack & Essack (note 143 above) 247.
518
S 12(2)(c) Constitution of the Republic of South Africa (note 2 above).
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is discussed in Chapter Five. Secondly, the NHA gave the newly-created NHREC the power to
issue national ethical guidelines which RECs and researchers were obliged to follow.519 This
ushered in a new era in which national ethical norms and standards could be developed by
the NHREC.
Section 72 of the NHA creates a national system of ethical review by providing for the
establishment of the NHREC.520 One of the key functions of the NHREC is norm setting. The
Council is required to issue guidelines on both the functioning of ethics committees as well
as ethical norms and standards for health research.521 Acting in terms of this function the
NHREC issued national ethical guidelines entitled Ethics in Health Research: Principles,
Structures and Processes.522 The Guidelines require researchers to be mindful of four key
ethical principles; respect for human beings, beneficence, non-malfeasance and justice.523
The Guidelines have a dedicated section on minors and children which details, amongst
others, the appropriate risk levels and consent requirements.524 Furthermore, they instruct
RECs to pay special attention when approving research with vulnerable groups such as
children.525
The section below only discusses the norms established by the national ethical guidelines
issued by the NHREC in 2004 and the 2006 revised version of the GCP Guidelines.526 It does
not deal with the constitutional principles or any other part of the normative framework
which remains in place today as these are set out in detail in Chapter Five. This section
simply articulates the norms that governed informed consent to child research during the
519
S 72(5)(2) National Health Act (note 57 above).
520
Ibid. See Chapter Four for a detailed description of the NHREC’s role and functions.
521
S 72(6)(a) and (c) ibid.
522
NHREC Guidelines (note 56 above). It recommends that the Guidelines be used by ‘investigators, ethical
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second stage of the ethical-legal framework, which have now been replaced, through the
implementation of sections 11, 16 and 71 of the NHA.527
During this period, given the state’s failure to implement explicit legal guidance on consent
to health research, the key legislative and common law principles relating to informed
consent to medical treatment and the principles established in ethical guidelines were used
as a framework for determining when consent to health research would be lawful.528
Informed consent has a positive element, the recognition of the rights of individuals to act as
autonomous agents.529 This ensures that a patient’s or research participant’s rights to self-
determination and freedom of choice are respected and it encourages rational decision-
making through enabling them to weigh and balance the various options.530 Consent also has
a negative element in the sense that it can operate as a defence for health care providers or
researchers, as persons who willingly consent to a harmful act or activity cannot claim that a
delict has been committed against them.531 If the principle is to operate as a defence the
following must exist, namely, the patient or research participant should:
(i) Have knowledge of the nature and extent of the harm or risk involved;532
(ii) Appreciate and understand the nature of the harm or risk;533 and
527
The current normative framework established by ss 11, 16 and 71 of the National Health Act (note 57 above)
is set out in Chapter Five.
528
The NHREC is required to set norms and standards for conducting research on humans and animals. Acting in
terms of this section the NHREC has issued national ethical guidelines (note 56 above). The Guidelines also
apply to the military and national research institutions. Furthermore given that s 73 of the NHA provides that
RECs must approve health research that meets the ethical standards of their committee it has been argued by
Smit that this is a reference to the standards established in the national ethical guidelines: Smit (note 34
above). It is submitted that this makes ethical guidelines indirectly legally enforceable.
529
G Lindegger & L Richter ‘HIV vaccine trials: critical issues in informed consent’ (2000) Vol (96) South African
Journal of Science 313, 315. The doctrine of informed consent was introduced into South African law in the case
of Castell v de Greef reflecting a shift from medical paternalism to patient autonomy (note 142 above) 426B.
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P Carstens & D Permain Foundational principles of South African Medical Law (2007) Butterworths: Durban,
South Africa 875.
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(iii) Voluntarily consent to the harm or assume the risk.534
Furthermore the person consenting must have legal capacity.535 These four requirements for
valid consent to medical treatment are used as a framework for the discussion below.
(i) Provide research participants with knowledge of the nature and extent of the risks
involved in the research
The common law required the patient to have knowledge of the nature and extent of the
risks involved in the procedure for the consent to be valid.536 However, there was no express
legal guidance on the nature and extent of the information that ought to be provided to
research participants. In applying this principle relating to medical treatment to health
research, Van Oosten argued that it placed an obligation on researchers to inform
participants or persons consenting, in layperson’s language, of the nature, scope,
consequences, risks, dangers, complications, benefits, disadvantages and prognosis as well
as any alternatives.537
The NHREC’s national ethical guidelines listed the information that should be given to
research participants. It required participants to be informed of, amongst others:
 The investigators’ qualifications;
 Their responsibilities as participants;
 The foreseeable risks or discomforts;
 The benefits to the participants or to others (during and after the research);
 Alternative procedures or courses of treatment;
 The extent to which confidentiality will be maintained;
534
Esterhuizen v Administrator, Transvaal 1957 (3) SA 710 (T) 722.
535




Van Oosten (note 104 above) 6 and C van Wyk (note 13 above) ‘Clinical trials, medical research and cloning
in South Africa’ 7.
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 Whether the research has been approved by an REC;
 Contact details of the REC;
 Whether compensation will be given for research-related injuries;
 The consequences of any injury, including medical treatments that will be provided;
and
 Who to contact in the event of a research-related injury. 538
Similar requirements were contained in the GCP Guidelines regulating clinical trials.539 Both
the GCP and the NHREC Guidelines required the information to be provided in a culturally
sensitive manner.540 With regard to social science research the HSRC ethical guidelines did
not deal specifically with the nature of the information that ought to be provided to research
participants.541
(ii) Appreciating and understanding the risks of the research
It is argued that research participants had to appreciate and understand the nature of the
harm or risk associated with research participation.542 Ethical guidelines were silent on this
point. However, the courts have viewed knowledge and understanding as inter-twined but
distinct concepts:
(I)t must be clearly shown that the risk was known, that it was realised, and that it was
voluntarily undertaken. Knowledge, appreciation, consent – these are the essential elements;
538
NHREC Guidelines (note 56 above) 4–5.
539
Guidelines for Good Clinical Practice (note 58 above).
540
Ibid 11 and NHREC Guidelines (note 56 above) 4.
541
Code of Research Ethics, Human Sciences Research Council, available from www.hsrc.ac.za [Accessed: 9
February 2010].
542
Waring & Gillow Ltd v Sherborne 1904 TS 340 at 344 cited with approval in Christian Lawyers Association v
Minister of Health and Others (Reproductive Health Alliance as Amicus Curiae) 2005 (1) SA 509 (TDP) 515G–H.
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but knowledge does not invariably imply appreciation, and both together are not necessarily
equivalent to consent.543
The requirement of ‘appreciation’ implies more than mere knowledge ….. (the patient) must
also comprehend and understand the nature and extent of the harm or risk.544
Courts take a factual approach to establishing whether appreciation exists.545 With regard to
children they consider subjective and objective factors including age, knowledge, experience,
judgment and personal circumstances.546 Nevertheless, establishing whether a research
participant appreciates the risks associated with research is clearly a complex issue, as
Lindegger and Richter describe:
understanding is an elusive concept, and it is not a simple matter to gauge the nature and
level of understanding that someone has of a concept, an event or process. While it may be
relatively easy to evaluate the adequacy of information disclosed (eg, showing information
on a videotape) it is far more difficult to assess how the information and its implications are
truly understood.547
In practice, clinical trials invariably assess understanding by requiring research participants






For example, in C v Minister of Correctional Services (note 533 above) the court found that a prisoner had
been aware that he was to be tested for HIV and that he had a right to refuse the test yet, nevertheless,
appreciation did not exist as required by the Department of Correctional Services’ own norms regarding
consent to HIV testing. Relevant factors included: the prisoner had been given information on the test in a
group whilst waiting in a line in the passage way; he had not been given an opportunity to consider and reflect
on the information; the right to refuse the test was not expressed to him individually; and the information was
not provided by a person who had been trained in pre-test counseling, 300E–F and 304A–E. Likewise the
criminal courts in assessing, for example, whether children may be held responsible for criminal conduct (as
they have criminal capacity) have required that the child show an appreciation of wrongfulness and an ability to
act in accordance with that appreciation, J Burchell & J Milton Principles of Criminal Law 3 ed (2005) 368 .
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Burchell & Milton ibid.
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Lindegger & Richter (note 511 above) 315.
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statements are, for example, true or false.548 There has been considerable debate about the
most appropriate method of assessing understanding549 and it has been submitted that this
approach of testing how much information has been retained does not establish
understanding but is instead an assessment of short-term memory of technical and
product-related information.550
(iii) Express agreement to the risk of research participation
Van Oosten has submitted that research participants have to clearly express their intention
to participate in the study, and their consent has to extend to all aspects of the research and
its consequences.551 The NHREC Guidelines provided that generally consent is required
however it may be given, verbally or in writing. In certain limited circumstances consent does
not need to be obtained, However, prior approval of the REC must be obtained for research
where consent is to be waived.552 GCP required informed consent but did not specify
whether this should always be in writing.553
Consent was required to be given freely and voluntarily. Ethical guidelines required careful
consideration of subtle coercive factors that may influence voluntariness, particularly in the
case of children who may be more vulnerable due to their youth and inexperience.554
548
G Lindegger, C Milford, C Slack, X Xaba & M Quayle ‘Assessing understanding for HIV vaccine trial
participation in South Africa’ (2006) Vol 43 Acquired Immune Deficiency Syndrome 560, 560.
549
Ibid 560. It appears that less of a focus has been placed on assessing the understanding of participants in
social science research. This may be due to the lower levels of risk that it often poses.
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Van Oosten (note 104 above) 30.
552
NHREC Guidelines (note 56 above) 4.
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There may be many factors that could impact on voluntariness, for example, Lindegger & Richter (note 511
above) 314 refer to social desirably which is the tendency for research participants to behave and respond in a
manner in which they think is expected of them. They will therefore try to be a ‘good’ research subject by
complying with researcher demands. Social desirability clearly impacts on the ability of the research participant
to act autonomously.
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Furthermore, both the NHREC Guidelines and GCP state that participants should not be
prejudiced by their refusal to participate in, or continue with, a study.555
(iv) Capacity
Consent had to be given by a person who is legally capable of consenting.556 The capacity of
minors to participate in legal transactions is limited, in order to protect them from their lack
of intellectual or cognitive ability, inexperience and social or emotional immaturity.557
In the second phase of the development of the ethical-legal framework there was a wide
divergence of views of when, if ever, children had the capacity to consent independently to
health research and in the event that they did not have the capacity, who could provide
proxy consent on their behalf.558 In this phase children become legal majors at the age of 18
rather than 21559 and from this point onwards the law provided them with the ability to
make legally-binding decisions.560
There were three uncertainties regarding consent in this phase of the ethical-legal
framework: firstly, when did children have the capacity to consent independently to health
research? Secondly, if children did not have the capacity to consent, who could consent on
their behalf? Thirdly, if children did not have the capacity to consent, when did they have the
capacity to assent?
(a) Capacity to consent independently to health research
555
NHREC Guidelines (note 56 above) 5 and GCP (note 58 above) 11.
556
Van Oosten (note 104 above) 14. Carstens and Permain argue that legal capacity refers to competence and
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The ethical guidelines, generally, provided a flexible approach as to when children would
have the capacity to consent independently to all health research except clinical trials. The
NHREC Guidelines stated that consent for children to participate in health research must be
obtained from the parents or legal guardian in all but exceptional circumstances. However,
where children are ‘competent to make the decision’ they may consent alongside their
parents.561 Adopting a similar approach, the HSRC Guidelines on the participation of children
in research provided that consent for children over the age of 12 should be obtained from
the parents or legal guardian ‘wherever possible’.562 GCP did not allow independent consent
by children.563 A more restrictive approach to independent consent was taken by the MRC’s
ethical guidelines, as described above.564 Nevertheless, the role of the MRC Guidelines was
less important during this period given that the NHREC Guidelines were regarded as the
national ethical guidelines.565
A number of academic authors explored the issue of ‘exceptional circumstances’ and
articulated arguments for when children could independently consent to research (See Table
8 below). Some applied the principles relating to the capacity to consent to medical
treatment to therapeutic health research. 566 Accordingly, they argued that children from the
561
NHREC Guidelines (note 56 above) 5.2.
562
Points 1.3–1.4 HSRC’s Code of Research Ethics (note 541 above). The guidelines provide where the child is
under the age of 12 proxy consent is mandatory.
563
GCP (note 58 above) 17.
564
See s 3.2.3 above for a more detailed discussion of the content of the MRC’s Book One. This approach
sparked debate on the issue of whether proxy consent may be given for children to participate in non-
therapeutic health research. Arguments have been made that proxy consent to so-called non-therapeutic
research is contra bonos mores as parents do not have the capacity to consent to children participating in
research which holds no direct benefit for them. This approach has been discredited in recent years. See
Chapter One for more discussion on this point.
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See for example, Andanda (note 166 above) 79–80 where she argues that the MRC Guidelines were
subservient to the NHREC ones during this period. See also Smit (note 34 above) who argues that the ethical
standards referred to in the NHA are those issued by the NHREC 15.
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Van Wyk (note 13 above) 40–41. The NHREC Guidelines define therapeutic research as ‘interventions
directed to the wellbeing of the individual or community involved’ and non-therapeutic research is defined as
‘interventions not directed to the benefit of the individual but rather towards improving scientific knowledge or
technical application’ (note 56 above).
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age of 14 who had the capacity to consent to medical treatment in terms of the Child Care
Act could consent to so-called therapeutic research without assistance.567 Others used a
competence argument as a way of establishing the ability of older children to act unassisted.
This was supported by the NHREC Guidelines which provided that children may consent
independently when they are ‘competent to make the decision’.568 The NHREC Guidelines
also allow children who have reached puberty to consent independently if (a) the research
poses no more than minimal risk for the child participants, (b) the REC is convinced that it is
unlikely that parents, guardians or the community from which the children are drawn would
object to independent consent, and (c) this exceptional approach has been justified in the
protocol.569 Finally, arguments have been made for independent consent on the basis of the
level of risk in the study, it being submitted that research which does not hold out the
prospect of direct benefit but which carries no risk at all should be an exceptional
circumstance, and children should be able to participate without parental consent.570
Table 8: Independent consent from children for health research in the second phase of the
ethical-legal framework
Research to which children cannot consent to
independently
Research to which children may consent
independently
Clinical trials
Research where the REC does find ‘exceptional
circumstances’ exist
Social science research with children under 12
All other forms of health research provided:
 Research found to fall within ‘exceptional
circumstances’ by an REC. The child is
competent and the
o Research poses no more than
minimal risk
o Notion of independent informed
567
Ibid. This approach was reflected in the MRC’s Book One (note 12 above). During the second phase of the
ethical-legal framework the Children’s Act (note 4 above) came into operation and as a result the age of
consent to medical treatment dropped to 12 provided the child had ‘sufficient maturity’, see s 129 Children’s
Act. This did not in any way change the nature of this argument just the age of consent to medical treatment
and accordingly the age of consent to therapeutic research.
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NHREC Guidelines (note 56 above) 5.2.
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Van Oosten (note 104 above) 19. Pope (note 93 above) 170 submits, albeit within the context of HIV
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136
consent is acceptable within the
community
o This approach has been justified
 The child is over the age of 12 or can be
classified as an adolescent for the
purposes of social science research
 Study is classified as therapeutic and the
child is over 14
 The research is non-therapeutic in nature
and poses no risks
The ethical guidelines also dealt with the issue of children refusing to consent or participate
in health research, the general principle being that no children should be forced into
research participation and their refusal must be respected.571 Furthermore, like adults,
children may withdraw from the research at any point.572 In a slightly different approach,
Van Oosten argued that where the child did not wish to participate despite parental consent,
the overriding consideration would be the best interests of the child.573
(b) Proxy consent for child participation in research
Ethical guidelines take different approaches to proxy consent for research participation. The
NHREC Guidelines require proxy consent from parents or legal guardians,574 while GCP
requires consent from a parent or guardian, failing which a care-giver providing long-term
care for the child may provide consent.575 Pope suggests that where adolescents do not have
parents or legal guardians the High Court as the upper guardian of all minors should be
approached to provide consent if this is in the best interests of the minor.576
(c) Assent for child participation in research
571
Point 5.2 NHREC Guidelines (note 56 above).
572
Points 1.3 and 1.4 HSRC Code of Research Ethics (note 541 above).
573
Van Oosten (note 104 above) 19–20.
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Pope (note 93 above) 170.
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Assenting to health research is an important way in which children, even those without
capacity, can participate in research-related decisions. Ethical guidelines require assent from
children who do not have the capacity to consent independently. In other words, even when
children do not have the capacity to consent they nevertheless need to be involved in the
consent process through researchers obtaining their assent to the research.577 The NHREC
Guidelines provide that where RECs are of the view that child participants are capable, their
assent to the research should be obtained.578 GCP similarly also require assent from children
participating in clinical trials.579 This reflects the principle of child participation as set out in
section 10 of the Children’s Act.580
3.3.4 Classifying the ethical-legal framework following the partial implementation of the
National Health Act
The ethical-legal framework following the partial implementation of the NHA was one in
which there was a strong institutional framework. These institutions ensured:
(i) A policy framework mandating research within priority areas is undertaken in the
public sector;
(ii) Research was regulated by institutions with the power to review and approve
research on ethical and scientific grounds; and
(iii) Norms and standards for research were established.
However, the normative framework was less developed as norms and standards existed but
largely in ethical guidelines rather than in law. There were also a range of monitoring and
enforcement mechanisms. In this context it is possible to argue that South Africa’s ethical-
legal framework could be classified as falling within the cautious community control model
577
This is a reflection of the principle of child participation. See Chapters One and Five for further discussion on
this point.
578
NHREC Guidelines (note 56 above) 5.2.1.
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580
See Chapter One for a more detailed discussion on the principle of child participation.
138
as described by Nielsen (See Table 9 below).581 In terms of this model research was
regulated, RECs had statutory authority and research participants were protected by some
non-research specific laws and ethical guidelines.
Table 9: Applying Nielsen’s model to South Africa’s ethical-legal framework with the partial
implementation of the National Health Act
Model Key elements Application to South Africa
Cautious regulatory approach Legal regulation of research
through institutions such as RECs
The NHA created a policy
framework for ensuring relevant
health research
NHREC given the responsibility of
creating a national framework for
RECs and ethical review
The MCC and RECs were required
to regulate all health research
Norms and standards were
established in ethical guidelines
and to a lesser extent in general
laws
3.3.5 Critique of the ethical-legal framework following the partial implementation of the
National Health Act
There were a number of problems with the ethical-legal framework which existed whilst the
NHA was only partially implemented, including: firstly, the provisions relating to research
were contained in various different pieces of legislation.582 Secondly, there was no child-
specific research legislation in operation.583 This was despite the introduction of the new
Children’s Act during this period which described a number of other children’s health
rights.584 Thirdly, there were inconsistent approaches to applying general legal principles to
research particularly in areas in which the general principles to medical treatment could not
581
See Chapter Two for a full discussion of the nature of Nielsen’s model.
582
Strode, Slack & Mushariwa (note 94 above) 600.
583
Pope (note 93 above) 168. S 71 of the National Health Act (note 57 above) does deal directly with the
participation of ‘minors’ in health research, see Chapter Five. See Chapter Six for further discussion on the
conflict between the NHA and the Children’s Act (note 4 above).
584
See Chapter Five for a full discussion on the relevant provisions in the Children’s Act.
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be applied easily.585 Fourthly, although the ethical guidelines586 deal expressly with the
participation of children in research by describing the circumstances and the manner in
which children may participate, these are not completely harmonised.587
Finally, during the second phase, the ethical-legal framework became more protective of
child research participants as the new institutional framework strengthened the regulation
and enforcement of research participants’ rights. Nevertheless, it also continued to facilitate
research as the norms established in ethical guidelines were flexible enough to ensure that
the merits of each study could be individually considered by an REC. The system however
failed to adequately recognise the importance of child participation according to their
evolving capacity as, whilst the Children’s Act clearly described the ages at which children
may consent to various health interventions such as HIV testing and medical treatment, it
was silent on consent to health research.588 The ethical principles regarding obtaining
consent or assent from children did however enable them to participate in the informed
consent process.
Table 10: The extent to which the second phase of the ethical-legal framework protected
and promoted child participation whilst facilitating research with children
Protection Child participation Research facilitation
Strong Strong through consent and assent
processes but undermined by a




Stobie, Strode & Slack (note 59 above) 194. For example, the general principles relating to medical
treatment could not be easily applied to so-called non-therapeutic research.
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NHREC Guidelines (note 56 above). GCP (note 58 above) and MRC Book One (note 12 above).
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risk standards when the research involves children.
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Children’s Act (note 4 above). See Chapters Five and Six for more discussion on these issues.
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3.4 The current ethical-legal framework following the full implementation of the National
Health Act
3.4.1 Overview
In the third stage of the development of the ethical-legal framework, sections 11 and 71 of
the NHA were operationalised on 1 March 2012 by a notice in the Government Gazette.589
This completed the development of a comprehensive ethical-legal framework for regulating
health research in South Africa. This was done through the NHA describing a number of
norms for the way in which health research ought to be conducted, including health research
with minors. Although draft regulations to accompany this section were published for public
comment in 2007 and again in 2013, to date they have not been finalised.590 The
operationalisation of section 71 in particular reflects a shift in the ethical-legal framework to
a particularly restrictive approach to research regulation in which the discretion is removed
from RECs and the focus is on the protection of research participants, especially minors, by
limiting the circumstances in which minors can participate in research.591
3.4.2 Institutional framework
The current institutional framework is described in detail in Chapter Four. This institutional
framework creates three layers of control within the ethical-legal framework. Firstly, policy
controls through the NHRC which ensures that research focuses on our priority health
problems. Secondly, regulatory controls by the MCC, the NHREC and institutionally-based
RECs which ensure that research is reviewed and approved by appropriate, independent
589
Government Gazette No. 35081 (note 95 above).
590
Regulation No. R135, 23 (note 13 above). A further set of regulations, presumably based on the public
comments and dated 2009 are available on the NHREC website, see http://www.nhrec.org.za/wp-
content/uploads/2009/09/human.pdf. No record could be found of these draft regulations having been
finalised and published in the Government Gazette. A further revision of the draft regulations was published on
the 29 May 2013 for public comment (note 13 above).
591
S 71 National Health Act (note 57 above) uses the term ‘minors’ rather than children. More detailed
discussion on the implications of the use of this term is contained in Chapter Five. A critique of this approach is
contained in Chapter Six.
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bodies. Thirdly, community liaison, albeit more informally, through community advisory
groups or bodies.
3.4.3 Normative framework
The current normative framework was created by amongst others, section 12 of the
Constitution,592 sections 11, 16 and 71 of the NHA and various sections of the Children’s
Act.593 It is set out in Chapter Five of this study. The new normative framework is highly
restrictive and even though children or minors are not excluded per se from participating in
health research, there is a strong focus on protection through restriction of circumstances in
which children may participate in research.
3.4.4 Classifying the current ethical-legal framework
Using Nielsen’s model for classifying ethical-legal frameworks, it is submitted that the
current ethical-legal framework falls within the community control model - prohibitive
approach as all elements of this model exist. 594 Firstly, there is a high level of regulation of
health research through statutory bodies.595 Secondly, highly restrictive legal norms exist
which prohibit certain forms of health research, such as so-called non-therapeutic research,
with minors unless ministerial consent is obtained.596 Thirdly, the legal norms are in direct
conflict with well-established ethical norms. And fourthly, penalties exist for non-compliance
with the legal norms597 (See Table 11 below).
592
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Table 11: Applying Nielsen’s model to South Africa’s current ethical-legal framework
Model Key elements Application to South Africa
Community control model or
prohibitive approach





for regulating research through
policy controls, ethical and
scientific review and
enforcement mechanisms
Highly restrictive legal norms in
place
3.5 Conclusions
In the three stages of the evolution of the ethical-legal framework, South Africa has moved
from a very low level of regulation (professional control model) to a highly restrictive and
overly regulated approach (the community control model) in a period of approximately 30
years (See Table 12 below).
Table 12: Development of the current ethical-legal framework
Ethical-legal framework prior to
the NHA
Ethical-legal framework following
the partial implementation of the
NHA
Current ethical-legal framework
following the full implementation
of the NHA
Framework lacked institutions and
legally binding norms
A strong institutional framework
created and enabled the
development of legally binding
ethical norms
Strong institutional framework and
legal norms for when and how
research with children is to take
place
Stage One: professional control
model
Stage Two: professional control
model and cautious regulatory
model
Stage Three: community control
model prohibitive approach
In the first phase of the ethical-legal framework there were low levels of protection as a
formal ethical-legal framework for regulating all forms of health research was non-existent in
South Africa. There were, however, obligations on researchers conducting clinical trials and
those working for or on behalf of the MRC. With all other forms of health research the
system was largely based on voluntary compliance with institutional guidelines and the
personal integrity of researchers. In the absence of a range of statutory institutions or well-
set for the conduct of research in terms of the Act’. Subsection (e) allows the NHREC to refer any violation of an
ethical rule to a statutory body it is argued that this is an enforcement mechanism for non-compliance with the
norms in the ethical-legal framework. See Chapter Four for a more detailed discussion on this issue.
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established ethical-legal norms, research participants were vulnerable to exploitation. In this
phase there was also uncertainty regarding the legality of the participation of children in so-
called non-therapeutic research. In this period children were involved to some extent in
research decision-making as ethical guidelines provided for their participation in the
informed consent process. Given the lack of regulation, there was a strong focus on research
facilitation.
With the partial implementation of the NHA the system became more formalised and
protective as statutory institutions were established with the power to regulate health
research. Child participation continued through the ethical norms on consent and assent
and, given the flexible nature of ethical norms, research with children was facilitated.
With the third phase of the ethical-legal framework since the full introduction of the NHA,
the framework has been completed and formalised. It has become highly protective,
particularly of child research participants. However, it is of real concern that the norms in the
NHA are so highly protective that they are out of step with other legislation and the
principles in ethical guidelines. 598 The new norms undermine child participation by requiring
mandatory parental consent and act as a barrier to the conduct of child research. It appears
that the pendulum has thus swung from being under-protective to being over-protective.599
598
For example, s 129 Children’s Act (note 4 above) allows proxy consent to be provided by a care-giver for
medical treatment rather than limiting this authority to parents or guardians. See Chapter Six for a more
detailed critique of this approach.
599
Friedman Ross (note 91 above) 2–3. The author argues that few countries have managed to maintain a
balance between protection of participants and the facilitation of research.
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Chapter Four:
The current institutional framework for regulating health research
with children
The preceding Chapter examined the evolution of our ethical-legal framework through three
distinct legislative phases. It described how prior to the adoption of the NHA the ethical-legal
framework was predominantly based on the principle of self-regulation. There were a few
institutions tasked with regulating research and norms, and where they existed, were
enabled by a range of different laws which did not have general application. The system
could not be neatly classified in terms of Nielsen’s framework and thus it was argued that it
straddled both the professional control and the cautious regulatory systems. The protection
of child research participants was generally weak. There was however some scope for child
participation through older children providing informed consent unassisted and assent being
obtained from children whose parents or guardians were providing proxy consent. Research
was facilitated under this system due to the low levels of formal regulation.
The Chapter also set out how in the second phase of the development of the ethical-legal
framework the institutional framework was strengthened through partial implementation of
the NHA and the creation of the NHRC and NHREC as statutory bodies. Obligations were also
placed on all institutions conducting health research to establish or have access to an REC. In
this phase the NHREC was given the statutory authority to issue ethical guidelines, which it
did and these dealt specifically with participation of children in health research. This
enhanced the normative framework by establishing national ethical standards on when and
how children could participate in health research. The Chapter argued that this second phase
of the ethical-legal framework could be classified as falling into the cautious regulatory
system as described by Nielsen in her models. In this phase the ethical-legal framework was
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more protective of child research participants however, it also continued to facilitate both
child participation and health research.
Chapter Three also touched on the third phase of the development of the ethical-legal
framework by giving an overview of the current system regulating health research with
children. In this third phase legal norms setting standards for when and how research with
children can be conducted were introduced through operationalisation of sections 11 and 71
of the NHA. This completes the ethical-legal framework as both institutions and norms are
now in place.
The Chapter concluded with comments on how South Africa has moved from low-level
regulation to a highly restrictive and overly regulated approach to health research. It argued
that this occurred behind the scenes and without proper public discourse on the issue.
This Chapter contains a detailed description of the current institutional arrangements within
the ethical-legal framework. Based on the arguments made in Chapter Two that effective
ethical-legal systems require firstly, institutions and secondly, norms and standards in order
to regulate health research, this Chapter reviews the current institutional framework while
Chapter Five examines the current normative framework established by both law and ethical
guidelines.
The Chapter looks at the institutions which are able to (a) create a policy framework, (b)
establish a national system for regulating research ethics, (c) undertake ethical review at an
institutional level, (d) engage with the community, and (e) implement effective monitoring
and enforcement mechanisms. Accordingly, it begins with the parameters of the current
ethical-legal framework for regulating health research, examining the types of health
research that are subject to regulation. Then follows a description of the role and functions
of each institution, namely, the NHRC, the MCC, the NHREC, RECs and CAGs. It also discusses
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the range of bodies that are tasked with monitoring research as well as those capable of
enforcing research-related rights. It concludes with a description of the procedural
obligations placed on key research stakeholders. It also makes provisional comments on both
the strengths and weaknesses of the institutional framework for regulating health research
in South Africa.
4.1 Introduction
Prior to the adoption of the NHA, given that there was no overall ethical-legal framework for
regulating health research, there were no formal legislative parameters setting out what
types of health research ought to be regulated. There were however some specific
obligations in the Medicines Act applicable to clinical trials, and others in the MRC Act
relating to research undertaken or funded by the MRC.600 These did not however effectively
describe health research and the obligations that ought to be placed on the various research
stakeholders.
The parameters of the current ethical-legal framework for health research are set by three
key concepts used in the NHA. These concepts delineate (a) what forms of health research fit
within the ethical-legal framework, and (b) under which circumstances researchers must
meet obligations described in the NHA.
Firstly, the term ‘health research’ is defined in section 1 of the NHA. This is an exceptionally
wide term and creates the over-arching framework for the type of activities to be regulated
by the ethical-legal system. Section 1 defines health research as research which contributes
to knowledge in various health-related fields:
(A)ny research which contributes to knowledge of – (a) biological, clinical, psychological or
social processes in human beings; (b) improved methods for the provision, of health care
600
This point is discussed in detail in Chapter Three.
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services; (c) human pathology, (d) the cause of disease, (e) the effects of the environment on
the human body, (f) the development or new application of pharmaceuticals, medicines and
related substances, and (g) the development of new applications of human technology.601
It is submitted that there are two key elements to this definition. Firstly, the research activity
must aim at knowledge production. The NHA does not define ‘research which contributes to
knowledge’ but the national ethical guidelines issued by the NHREC define it as a ‘systematic
investigation to establish facts, principles or knowledge’:602
A research project generally is described in a protocol that sets forth explicit objectives and
formal procedures designed to reach those objectives. The protocol may include therapeutic
and other activities intended to benefit the subjects as well as procedures to evaluate such
activities. Research objectives range from understanding normal and abnormal physiological
or psychological functions or social phenomena, to evaluating diagnostic, therapeutic or
preventive interventions and variations in services or practices. The activities or procedures
involved in research may be invasive or non-intrusive and include surgical interventions;
removal of body tissues or fluids; administration of chemical substances or forms of energy;
modifications of diet; daily routine or service delivery; alteration of environment;
observation, administration of questions or tests; randomisation; review of records etc.603
Secondly, the research must fit within the ambit of one of the fields mentioned in (a)–(g) of
the definition. The listed areas seem to cover most aspects of health research except
possibly studies into human rights or health law.
601
S 1 National Health Act (note 57 above). A similar definition of research is found in s 1 of the Human Sciences
Research Council Act (note 62 above). This Act describes research as ‘the generation, preservation,
augmentation and improvement of knowledge by means of scientific investigation and methods in the field of
the human sciences’.
602
NHREC Guidelines (note 56 above).
603
This definition of health research is set out in the US National Commission for the Protection of Human
Subjects; it is quoted with approval in the NHREC Guidelines ibid.
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The manner in which health research is defined with the focus on contributing knowledge
towards our understanding of various aspects of health means that even studies involving
the broader social aspects of health, such as the TV-watching habits of teenagers, could be
included. It is argued that given the wide definition of ‘health research’ it includes studies
without the direct involvement of living participants.604 The term is used in the following
sections of the NHA which deal with research regulation:
(i) Sections 69 and 70 which require the NHRC to determine the health research
priorities for public sector or state-funded research;
(ii) Section 72 which describes the role and functions of the NHREC vis-à-vis the
ethical issues involved in health research; and
(iii) Section 73 which places obligations on institutions conducting health research
establish or have access to an REC.
This very broad definition of health research means that the legislature intended most forms
of health research to (a) fall within national research priorities, (b) be regulated by the
NHREC, and (c) be submitted for ethical review.605
The second key term which defines some of the obligations in the ethical-legal framework is
‘research or experimentation on a living person’. This is a particular form of health research
which requires additional scrutiny or protection. This phrase is used in section 71 of the NHA
and it limits the norms contained in that section to research on or with human subjects. The
NHA does not define this phrase. However, the NHREC ethical guidelines describe a research
participant as ‘a living individual or group of individuals about whom a researcher conducting




The only exception being record reviews by health care providers at health care establishments as these do
not require ethical approval s 16(2) National Health Act (note 57 above). See Chapter Six for further discussion
on this point.
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private data’.606 Given that this definition of the phrase refers to research involving an
interaction with a living person it excludes epidemiological research or bio-medical research
on tissue or blood samples as such do not involve an ‘intervention or interaction with the
person’. The obligations on researchers conducting health research on human subjects are:
(a) Obtaining written consent from the participants;
(b) Complying with prescribed norms;
(c) Therapeutic research with minors must be in their best interests, consent must be
obtained from their parents/legal guardians, and from the minors if they have
understanding; and
(d) Non-therapeutic research with minors must obtain consent from their
parents/legal guardians, from the minors if they have understanding, and the
Minister of Health.607
By limiting these norms to studies which involve ‘living persons’ the legislature did not intend
to impose these additional obligations on, for example, record reviews or the annual HIV
prevalence study on pregnant women. However, this has the unintended consequence of
excluding this type of research from certain participant protections such as requiring
researchers to ensure that privacy is maintained regarding all information collected during
the study.
The third key phrase setting the parameters of the ethical-legal framework within the NHA
refers to a ‘health service for research or experimental purposes’.608 Again, this is a particular
type of health research, namely, research into an experimental health service. Health service
is defined in section 1 of the NHA as ‘(a) health care services, including reproductive health
care and emergency medical treatment, contemplated in section 27 of the Constitution; (b)
606
NHREC Guidelines (note 56 above) 59.
607
S 71 National Health Act (note 57 above).
608
S 11 ibid. S 16(2) provides that if the information on a user is anonymous written consent is not required.
See Chapter Five for a more detailed discussion of this point.
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basic nutrition and basic health care services contemplated in section 28(l)(c) of the
Constitution; (c) medical treatment contemplated in section 35(2)(e) of the Constitution; and
(d) municipal health services’. The phrase is, amongst others, used in Chapter Two of the
NHA and it delineates when special steps must be taken to protect users609 of health services
because the health service they are receiving is experimental in nature or forms part of a
study. Thus again, it requires additional protection due to the nature of and the place where
the research is being conducted. There is some overlap between a health service which is
experimental and research or experimentation on a living person. In other words, in many
instances the obligations in section 71 and those in Chapter Two of the NHA would apply to a
study. Table 13 below shows the obligations in the NHA which flow from each term and how
they cascade downwards, with health research which forms part of a health service having to
comply with the most obligations.610
609
The drafters of the National Health Act elected to use the term ‘user’ rather than patient. A user is defined
in s 1 as ‘the person receiving treatment in a health establishment, including those receiving blood or blood
products, or using a health service, and if the person receiving treatment or using a health service is– (a) below
the age contemplated in section 39(4) of the Child Care Act, 1983 (Act No. 74 of 1983), “user” includes the
person’s parent or guardian or another person authorised by law to act on the first mentioned person’s behalf;
or (b) incapable of taking decisions, “user” includes the person’s spouse or partner or, in the absence of such
spouse or partner, the person’s parent, grandparent, adult child or brother or sister, or another person
authorised by law to act on the first mentioned person’s behalf’ ibid.
610
There are a number of other instances in which the NHA refers to obligations on researchers and institutions
regarding specific forms of health research however, it is argued that these provisions are specific in nature and
do not help delineate the parameters of the ethical-legal framework.For example, s 16 ibid refers to the
circumstances in which record reviews for research purposes may be undertaken by health care providers.
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Table 13: The parameters of the ethical-legal framework for health research and the
corresponding obligations on researchers in terms of the NHA
Health research – research which contributes to knowledge in various health-related fields
All health research must:
 Fit within national health research priorities (if undertaken by the public sector)
 Comply with obligations set by the NHREC
 Be submitted for ethical review
Health research which includes ‘research or
experimentation on a living person’
Health research which forms part of a ‘health service
for research or experimental purposes’
All health research with human subjects must be
with:
 Written consent
 Adherence to prescribed obligations
If the health research is considered therapeutic and it
enrols minors it must:
 Be in their best interests
 Obtain consent from their parent/guardian
and the minors themselves if they have
understanding
If the health research is considered non-therapeutic
and it enrols minors it must:
 Obtain consent from the Minister of Health
 Obtain consent from the minors’
parents/guardians, and the minors
themselves if they have understanding
All health research which forms part of a health
service can only be undertaken if:
 The user is informed that the health service
is experimental
 Consent has been obtained from the user,
their health care provider, the head of the
health establishment and the REC
4.2 The institutional framework for regulating research
The current ethical-legal framework consists of a wide range of statutory and non-statutory
institutions all of which play a role in regulating health research.
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Figure 2: The current ethical-legal framework
4.2.1 Policy making bodies: the National Health Research Committee
Prior to the implementation of Chapter Nine of the NHA there was no statutory body
mandated to develop national health research priorities. However, the two national
statutory research institutions, the HSRC and the MRC, were required by their empowering
legislation to advise government of an appropriate research agenda in their respective
fields.611
611
The HSRC was required to advise the Minister of National Education on ‘research priorities’ relating to the
human sciences s 2A(b) Human Sciences Research Act (note 62 above) and the MRC was required to advise the
minister assigned to this function of ‘the determination of policy and national priorities regarding research’ and
on the ‘development, promotion, implementation and co-ordination of research on a national basis’: s 20
Medical Research Council Act (note 448 above).
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The NHA changed this situation with the establishment of the National Health Research
Committee (NHRC).612 This is a committee appointed by the Minister of Health after
consulting with the National Health Council.613 The NHA defines the role of the NHRC as
being to:
(a) determine the health research to be carried out by public health authorities;
(b) ensure that health research agendas and research resources focus on priority health
problems;
(c) develop and advise the Minister on the application and implementation of an integrated
national strategy for health research; and
(d) co-ordinate the research activities of public health authorities.614
The NHA provides the Committee with a wide mandate to ensure that public health
authorities undertake research on priority health problems and that research activities are
co-ordinated. However, health research undertaken by the private sector is not required to
conform with the policy framework established by the NHRC.615
612
S 69 National Health Act (note 57 above).
613
Established in terms of s 70 of the National Health Act ibid. The NHRC’s role as the over-arching body
required to set the research agenda must be seen in relation to the on-going role of the HSRC in terms of
s 4(1)(b) of the HSRC Act (note 62 above) to advise the Minister of Science and Technology on various issues
relating to social science research. It should be noted that the term social science research is broader than that





Although private sector research agencies do not need to focus their research on the priority areas identified
by the NHRC they must comply with other regulatory obligations such as obtaining ethical approval. In Chapter
Six it is argued that the ethical principle of justice which requires ‘fairness in the treatment of individuals and
communities and the equitable distribution of the burdens and benefits of research’ requires RECs to ensure
that their research will be relevant to the participants and their communities: GB Tangwa ‘Ethical principles in
health research and review process’ (2009) Vol 1125 Acta Tropica 52, 56. It is argued that this indirectly
requires the private sector to work in priority research areas.
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The composition and functioning of the NHRC is detailed in its Regulations.616 Regulation 3(1)
provides that the NHRC is to be made up of at least four persons including; one person with
‘extensive experience and knowledge of health research’, a person representing the
Department of Health, an individual representing the community and someone with
knowledge of the law.617 The NHRC must meet at least four times a year618 and make
decisions on the basis of a simple majority.619 Persons aggrieved with decisions made by the
Committee may appeal to the Minister of Health620 who is required to establish an appeals
committee to deal with the matter.621
In terms of the NHRC’s core mandate of establishing research priorities, section 70 of the
NHA requires it to take into account five factors when developing a national research
agenda. These include:
(a) the burden of disease;
(b) the cost-effectiveness of interventions aimed at reducing the burden of
disease;
(c) the availability of human and institutional resources for the implementation of
an intervention at the level closest to the affected communities;
(d) the health needs of vulnerable groups such as women, older persons, children and people
with disabilities; and
(e) the health needs of communities.622
616
Regulations relating to the Establishment of the National Health Research Committee, Government Gazette






Regulation 7(1) ibid. An appeal must be lodged within 60 days of the person having become aware of the




Regulation 10(3) ibid. The Appeals Committee must consist of at least three members of the NHRC. It must
be chaired by a person with knowledge of the law and at least two other members both with expertise in
research ethics.
622
S 70(2) National Health Act (note 57 above).
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In 2001 an interim body, which preceded the Committee, produced the Health Research
Policy in South Africa which was intended to be a preliminary document articulating some of
the policy principles which ought to underpin the development of research priorities. 623 To
date, the 2001 Health Research Policy in South Africa has not been revised or replaced.624
This policy aims at ensuring that all stakeholders ‘promote research that contributes to the
improvement of human health and welfare in South Africa.’625 Accordingly, its goals are to:
(i) Develop a national health research system that contributes to equitable health
development;
(ii) Promote innovation in health and health-related service delivery;
(iii) Through research, advance knowledge that underpins health and equitable, quality
health care;
(iv) Develop a co-ordinated, well-funded agenda for research;
(v) Nurture talent and develop capacity to conduct research and utilise its findings; and
(vi) Encourage uptake of research-based knowledge into the health care system.626
The Policy requires all government-funded health research bodies to provide the NHRC with
annual business plans and reports. These should state how their work fits in with national
research priorities. The policy identified the NHRC’s role as being to use this information to
advise government on the gaps, synergies and overlaps that exist as well as on the
appropriateness of the work, budget, achievements and emphases.627 The Policy proposes
further that Provincial Health Research Committees should be established to co-ordinate
public sector research, manage the setting of research priorities and review research reports
623
Department of Health Research Policy in South Africa (note 7 above).
624
2011 National Health Summit Report, Department of Health available from








within provinces.628 Read with the NHA this policy document has created a framework for
the establishment of research priorities in South Africa. However, recently there have been
calls for the development of a white paper on health research which could be used as the
basis for broader consultations on the revision of the 2001 policy.629
Since 1994 the Department of Health has facilitated four national conferences with
stakeholders to develop research priorities.630 These conferences have identified national
research priorities, applying an Essential National Health Research Model (ENHR).631 Using
this model, the leading causes of Disability Adjusted Life Years (DALYs) were identified in
2002 and 2006.632 Table 14 below identifies some of the leading health problems affecting
children, extrapolated from the ranking of all priority health problems in South Africa (with
their overall ranking reflected).
628
Ibid para 3.3.3. This appears to have been done in some provinces at least: see for example, the Terms of
Reference for the Provincial Health Research Committee of the Department of Health, KwaZulu-Natal, available
from http://www.kznhealth.gov.za/research/tor.pdf [Accessed: 19 August 2012]. It should be noted that
research conducted by the Department of Health must also obtain approval in accordance with the Department
of Health Policy Framework for the Ethics Approval and Endorsement of Health Research by National
Department of Health (2012) available from http://www.doh.gov.za/docs/policy/2012/researchethics.pdf
[Accessed: 18 February 2013].
629
2011 National Health Summit Report (note 624 above).
630
Conferences were held in 1996, 2002, 2006 and 2011 Department of Health, 2006. 2
nd
National Conference
on Priority Setting for Health Research, available from http://www.nhrc.org.za/wp-
content/uploads/2009/08/2ndNatConferenceonPrioritySettingsaddlestitch.pdf [Accessed: 6 March 2012] and
2011 National Health Summit Report (note 624 above).
631
This model promotes the development of research priorities following (a) a review of key health concerns
and the identification of Disability Adjusted Life Years (DALYs), (b) stakeholder consultation and (c) analysis of
this data ibid.
632
The most significant DALYs affecting children in 2006 were (in order of significance); HIV and AIDS, homicide
and violence, TB, road traffic accidents, diarrhoea, disease, low birth weight and protein energy malnutrition
ibid,
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Table 14: Leading conditions affecting child health extrapolated from the leading causes of
DALYs: 2006633
Condition Ranking
HIV and AIDS 1
Injuries (all causes) 2
Diarrhoea 4
Peri-natal and neonatal mortality 5
Nutrition 6
Orphans and child-headed households 9
Malaria 13
Source: Adapted from Department of Health (2006)
This data, amongst others, was used to develop the 2006 South African Research
Prioritisation Framework.634 Within the broad areas targeted by the framework, four areas
impact on child health, namely, nutrition, child health, reproduction (including teenage
pregnancy, contraception and abortions) and infections/immunity.635 The framework
recommends that research be carried out on these key issues from the perspective of basic
science, clinical, social science, health systems, public health and policy reform.636 The most
recent conference was held in 2011, and like the previous conferences it aimed to identify
the research priorities to support national health outcomes.637 One of the four key national
health outcomes was child specific, that of reducing maternal and child mortality rates.638
Several research priorities supporting this objective were adopted by the summit.639
633
The numbering in this table is not consecutive as the data on children has been extrapolated from the








2011 National Health Summit Report (note 624 above). The four national health outcomes the state wanted
to achieve were increasing life expectancy, reducing maternal and child mortality rates, combating HIV/AIDS




The summit agreed that priority should be given to research that (a) generates a better understanding of
neonatal infections, (b) ascertains the HIV profile in children under the age of five, (c) determines the impact of
vaccines on promoting child health, and (d) instigates why 40 per cent of child deaths occur outside of
healthcare facilities ibid.
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4.2.2 Regulatory bodies: National drug regulatory authority: the Medicines Control Council
In terms of section 2(1) of the Medicines and Related Substances Act640 (the Medicines Act)
the MCC is established as a statutory body.641 It is given the authority to exercise powers and
perform functions conferred upon or assigned to it by the Medicines Act.642 One of the
primary functions of the MCC is to ‘provide for the registration of medicines and related
substances, intended for human and animal use’.643
The MCC is to be made up of not more than 24 members who are appointed by the Minister
of Health for a five-year term.644 The Minister of Health designates one member to be the
Chairperson of the Council and another to be its Vice-Chairperson.645 A majority of its
members must be present at each meeting for there to be a quorum.646 A decision of the
MCC is lawful if a majority of the members present at the meeting vote in favour of that
decision.647
The MCC has a statutory obligation to ensure that drugs available in South Africa are safe,
efficacious and of good quality. Furthermore, the decision to register a drug must be in the
interests of the public.648 The Medicines Act does not deal directly with the conduct of
640
Medicines and Related Substances Act (note 429 above).
641




Preamble ibid. Accordingly, no person may sell medicines that are not registered s 14(1) ibid.
644
Ss 3–4 ibid. In terms of s 4(2) of the Medicines Act (note 164 above) it is possible for members to serve two






S 8(3) ibid. This seems to imply that the decision requires a majority of those present provided that there is a
quorum. If there is no clear majority the Chairperson of the meeting is given the deciding vote, ibid.
648
Ibid s 15(3)(a). The process that must be followed in registering a medicine is set out in s 15. This provides
that an application for registration must be made to the registrar of the MCC in the prescribed manner. This
application is submitted to the MCC for consideration. If the MCC approves the registration of the medicine
then the registrar is required to register it. Section 15(2)(b) allows for an expedited registration process if a
medicine is on the Essential Drugs List or ‘if it is in the opinion of the Minister essential for national health’ ibid.
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clinical trials,649but the MCC is given the authority to register medicines if it is satisfied with
the application for registration, following ‘any investigation or enquiry which it may consider
necessary’.650 In other words, it is submitted that the broad mandate of the MCC to register
medicines includes the regulation of clinical trials which may precede the registration of a
medicine or medical product.651 In this regard the MCC’s role is to ensure that clinical trials
are scientifically valid and provide the information necessary for establishing valid
registration of the product for use in South Africa.
Regulations accompanying the Medicines Act detail the obligations on sponsors and principal
investigators regarding the control and conduct of clinical trials. They provide:
(i) Application for authorisation to conduct a clinical trial must be made to the MCC
on a standard form;652
(ii) The application must include: the trial protocol; the investigator’s brochure which
includes the background information on the product to be tested; the curriculum
vitae of all investigators; a signed statement by all investigators that they will
comply with the GCP Guidelines issued by the Department of Health; a copy of
the informed consent document; and ethical approval by a recognised REC;653
(iii) The trial protocol must at a minimum set out the number of human subjects to be
involved in the trial, the name of the principal investigator, who must be an
649
NHREC Guidelines (note 56 above) 56. These Guidelines define a clinical trial as a preplanned, usually
controlled clinical study to determine the safety, efficacy or optimum dosage schedule (if appropriate) of one or
more diagnostic, therapeutic, or prophylactic drugs, devices or interventions in humans selected according to
predetermined criteria of eligibility. Also see Chapter One for further definitions of a clinical trial.
650
General Regulations, Medicines and Related Substances Act, Regulation 15(3)(a) (note 158 above).
651
S 35(1)(xxxix) Medicines and Related Substances Act (note 429 above).
652
Regulation 34(1) General Regulations, Medicines and Related Substances Act (note 164 above).
653
Regulation 34(2) ibid. The GCP Guidelines have been developed to provide clear, appropriate and locally
relevant standards of good clinical practice in research and to ensure that research with human participants
takes place with thin the framework of sound scientific and ethical standards. Guidelines for Good Clinical
Practice in the Conduct of Clinical Trials with Human Participants in South Africa 2 ed (note 57 above).
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appropriately qualified person who is resident in South Africa, and any other
information required by the MCC;654
(iv) Clinical trials must be conducted in accordance with good clinical practice
guidelines issued by the MCC from time to time;655
(v) Reports must be submitted to the MCC every six months, and 30 days after the
completion of the clinical trial;656
(vi) The MCC may request additional information, inspect a clinical trial site, and
withdraw authorisation for a trial if it believes that the safety of trial subjects is
compromised, or the scientific reasons for conducting the trial have changed;657
and
(vii) Medicines used in the clinical trial must be properly labelled so that it is clear to
participants that the drugs are experimental and not registered with the Council.
658
Associated to the role of the MCC in regulating clinical trials is the South African National
Clinical Trials Register (SANCTR). Sponsors or principal investigators are required to register
clinical trials with SANCTR. This is a database of all clinical trials managed by the Department
of Health. Application for a unique identifying number for the trial must be made after
obtaining ethical approval. Clinical trials may not commence without registration on
SANCTR.659. The register aims to provide the public with information on current clinical trials
with human participants. The register describes a trial’s purpose, who can participate, where
the trial is located, and contact details of staff. The Department of Health maintains that the
benefits of a clinical trial register include: that it serves to promote collaboration among
654










http://www.sanctr.gov.za [Accessed: 19 May 2008]. This is regardless of whether they are trials funded by
the state or the private sector.
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researchers, the private sector and the community through the sharing of research
information; it assists people to identify clinical trials that they can volunteer for; it reduces
duplication of research efforts, promotes the best use of limited funds, and contributes to
global efforts to reduce disease.660
Although there is nothing specific to children in the Medicines Act or its accompanying
regulations, the GCP Guidelines refer to the manner and circumstances in which children
may be enrolled in clinical trials.661 The GCP Guidelines provide that proxy consent is
required for clinical trial participation by children.662 Proxy consent can be provided by a
parent or guardian, failing which a ‘care-giver providing long term care for the child’ can act
on their behalf.663 The GCP Guidelines do not place any explicit limits on the permissible level
of risk in so-called therapeutic research with children. However, if the study poses more than
a minor increase over minimal risk, then the risks must be justified by the benefits to
participants.664 In so-called non-therapeutic research a study should not pose more than a
minor increase over minimal risk. Furthermore, the risks have to be justified by the
generalisable knowledge that would be generated by the study.665
4.2.3 Regulatory and norm setting bodies: National Health Research Ethics Council (NHREC)
Prior to the promulgation of the NHA there was no national framework for regulating RECs.
Section 72 of the NHA has changed this by ensuring that local RECs form part of a national




GCP (note 58 above) 2.3.1. See Chapter Five for a comparison of the different approaches taken in GCP and
the NHREC ethical guidelines regarding the participation of children in research. It should be noted, as stated
above, that the Principal Investigator in a clinical trial is required to sign a declaration that they will comply with
the principles established in the GCP in their application for approval for the study by the MCC. This makes the






Stobie, Strode & Slack (note 59 above) 206–207.
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Ibid. See Chapter Five for further discussion on this issue as these norms have now been superseded by s 71
of the National Health Act (note 57 above).
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Health is authorised by the NHA to appoint not more than 15 persons to the NHREC after
consulting with the National Health Council.666 Regulations relating to the NHREC provide
more detail on the composition of the Council by stating in Regulation 2 that at least nine (of
the 15 members) must be persons who have ‘extensive experience and knowledge in health
research ethics’.667 There should also be at least one representative from: the community,
the Department of Health, the pharmaceutical industry, the MCC, the animal health research
field and the legal profession.668 There is a public process of appointing members to the
NHREC. However, if an insufficient number of nominations is received through such process,
the Minister of Health may appoint members to the Council.669 The regulations provide that
the NHREC must meet at least four times a year.670
The Council was first formally established in September 2006.671 Its role is described in
section 72(6) of the NHA as being to:
(a) determine guidelines for the functioning of health research ethics committees;
(b) register and audit health research ethics committees;
(c) set norms and standards for conducting research on humans and animals including norms
and standards for the conducting of clinical trials;
(d) adjudicate complaints about the functioning of health research ethics committees and
hear any complaint by researchers who believe that they have been discriminated against by
a health research ethics committee;
666
S 72(2) ibid. This section provides further that members of the NHREC will have a three-year term of office.
However they may be re-appointed by the Minister of Health for one or more terms after this initial term: s
72(3) ibid.
667









Report for the National Health Research Ethics Council, 2010/2011, available from
http://www.nhrec.org.za/wp-content/uploads/2011/report2011.pdf [Accessed: 12 March 2012].
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(e) refer to the relevant statutory health professions council, matters involving the violation
or potential violation of an ethical or professional rule by a health care provider;
(f) institute such disciplinary action as may be prescribed, against any person found in
violation of any norms and standards, or guidelines set for the conduct of research in terms
of the Act; and
(g) advise the national department and provincial departments on any ethical issues
concerning research.
It is submitted that the NHA creates four distinct roles for the NREC. Firstly, norm setting in
that the Council is required to issue guidelines on both the functioning of ethics committees
and on ethical norms and standards for health research.672 Secondly, oversight over RECs,
ensuring they perform their statutory mandate and are competent to undertake ethical
review.673 Thirdly, enforcing ethical norms and standards by adjudicating complaints,
referring ethical violations to relevant professional councils and instituting disciplinary action
against persons violating ethical norms.674 Fourthly, advising the national and provincial
departments of health on ethical issues.675
With regard to its first role, that of norm setting, previously, there were no national ethical
guidelines.676 The NHA changed this scenario by providing that one of the functions of the
672








However it has been argued that the GCP Guidelines could be considered national ethical guidelines in the
sense that they applied to all institutions but were only binding on clinical trials. See Chapter Three for more
discussion on the role played by the GCP prior to the establishment of the NHREC. Furthermore, it was argued
by Van Oosten that the MRC ethical guidelines which applied to both clinical trials and social science research
ought to be used by institutions without their own institutional ethical guidelines. Even thought strictly
speaking they only governed the work of MRC staff or research undertaken on its behalf s 17(1) Medical
Research Council Act (note 448 above). Van Oosten (note 104 above) 8–9 argued that as the MRC ethical
guidelines were issued by the only statutory body required to issue ethical guidelines they should have been
followed as national ethical guidelines in the absence of other guidance. Similar views have been expressed by
Andanda (note 166 above) 78–79. See Chapter Three for further discussion on this point.
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NHREC is to set norms and standards for health research on humans and animals.677 Acting in
terms of this section the NHREC has issued national ethical guidelines, namely, Ethics in
Health Research: Principles, Structures and Processes which apply to all health-related
research involving animals or humans, including research undertaken by the military and
national research institutions.678 Accordingly, it is submitted that these guidelines apply to
clinical trials, social science research and studies undertaken by the MRC.679 The NHREC
Guidelines have been given further legal force through section 73 of the NHA which states
that RECs must approve health research that meets the ethical standards of the Committee.
Given the obligation on the NHREC to produce national ethical norms and standards the
‘ethical standards of that committee’ would in fact be the standards established by the
NHREC.680
The NHREC Guidelines deal specifically with child research by providing that children should
participate in health research only when they are indispensable to the study and when it is
not contrary to their individual best interests. Such research may not be approved unless it:
(i) Places the child at no more than minimal risk;681 or
(ii) Poses more than minimal risk but provides the child with direct benefit; or
(iii) Poses greater than minimal risk and does not hold out the prospect of direct
benefit, but has a high probability of generating generalised knowledge. In such a
case the risk must be justified by the knowledge ratio.682
677
S 72(6)(c) National Health Act (note 57 above).
678
NHREC Guidelines (note 56 above).
679
Andanda (note 166 above) 79–80. Andanda argues that in the light of this change in the law the MRC
guidelines are now subservient to the NHREC ones.
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Smit (note 34 above).
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The NHREC’s ethical guidelines define minimal risk as ‘the risk commensurate with daily life or routine




These provisions require RECs to pay special attention to protecting the welfare of children
by ensuring amongst others that they are not subjected to unacceptable levels of risk in the
study. In doing so an REC may require researchers to take additional measures to protect
children during the research process, such as ensuring that they report any abuse which may
be disclosed to researchers.683 Furthermore, the NHREC Guidelines provide that an REC may,
if it deems necessary, conduct post-research investigations to ascertain whether there was
compliance with the measures imposed.684
The provisions on children in the NHREC Guidelines are substantially similar to those in the
GCP Guidelines685 and those in the HSRC’s ethical guidelines dealing with the participation of
children in social science research.686 All three sets of guidelines provide that children must
be indispensable to the study, the consent of the parents, guardian or a custodian must be
obtained where possible, and the child must be free to withdraw at any time.687
Nevertheless, the obligations in these national ethical guidelines must be read with
institution-specific guidelines, where they exist.
In terms of its second core function, that of oversight over RECs, again the NHREC has taken
steps to fulfil this function, The NHA requires all RECs to be registered with and accredited by
the NHREC.688 Furthermore, the NHREC may audit RECs to ensure compliance with national
683




Stobie, Strode & Slack (note 59 above) 206–207 for a detailed comparison of the way in which these
guidelines approach risk standards and consent for research involving child participants.
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HSRC ethical guidelines and its Guidelines on the participation of children in research (note 541 above). The
HSRC’s Guidelines are premised on very similar principles as they provide that the ‘proposed research must
hold out no more than minimal risk of harm (defined as “the probability and magnitude of harm or discomfort
anticipated in the research will not be greater than those ordinarily encountered or to be expected in daily life,
including in routine medical, dental or psychological examinations and in social or education settings”). It must
not be possible to do the research with adult participants and the research must propose to investigate a
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norms and standards.689 This provides the NHREC with the opportunity to ensure that RECs
are administratively effective and acting in accordance with the national ethical guidelines.
To date the NHREC has issued a database of 34 RECs which have completed the registration
process with it.690 In 2009 it undertook an assessment of the extent to which all registered
RECs comply with (a) composition requirements set out in the national ethical guidelines and
(b) procedural obligations in such guidelines.691 Currently, this process is being repeated.692
The auditing of RECs addresses a significant gap in our ethical-legal framework. Moodley and
Landon argue that prior to 2007, no research had been conducted on whether RECs were
constituted in accordance with ethical guidelines.693 This meant that there was no
information on whether RECs, for example, included representatives of the community on
their committees as required by the national ethical guidelines.694 However, it does not
appear that the NHREC has undertaken an evaluation of the more complex issue of the
extent to which RECs comply with the substantive elements of its ethical guidelines.
The NHREC’s third core function is that of investigating and adjudicating on research
misconduct. In this regard it established a Complaints and Discipline Committee in 2007 to




The untitled database is available from http://www.nhrec.org.za/?page_id=21
[Accessed: 12 March 2012]. Report for the National Health Research Ethics Council, 2010/2011, (note 661
above) seems to imply that the database was developed in August 2009. It is not clear whether this database is
regularly updated.
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National Health Research Ethics Assessment/Evaluation Quantitative Report, available from
http://www.nhrec.org.za/wp-content/uploads/2012/recreport.pdf [Accessed: 12 March 2012]. See the section
below for more discussion on this assessment.
692
Personal communication, Professor Wassenaar, regarding the audit of the HSRC REC in June 2012, 25 August
2012.
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Moodley & Landon (note 451 above) 2.
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NHREC Guidelines (note 562 above).
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Report for the National Health Research Ethics Council, 2010/2011 (note 671 above). Regulation 7
Regulations relating to the National Health Research Ethics Council (note 649 above) gives the NHREC the
authority to set up working groups (sub-committees) to deal with special issues.
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and deals with all complaints by participants or researchers relating to research
misconduct.696 The NHA provides that the NHREC is empowered to adjudicate complaints
regarding the functioning of RECs697 as well as to investigate potential research misconduct
by ‘any person’.698 The Commission’s 2010/2011 Report indicates that during that one-year
reporting period, six complaints were received, four of which were resolved.699 The
Regulations provide that if a person is aggrieved by a decision of the NHREC they may appeal
to the Minister of Health.700 It is submitted that this would include a decision by the
Complaints and Discipline Committee.
The fourth and final core function of the NHREC is to advise government on issues relating to
research ethics. The latest report issued by the NHREC does not provide any detail on the
advice provided to the Ministry of Health on research ethics.701
4.2.4 Regulatory and review bodies: Research Ethics Committees
In the past there was no general statutory obligation to submit all health research for ethical
review702 even though several RECs had been in operation since 1966 and had institutional
ethical guidelines requiring ethical approval for health research.703 There were two








Report for the National Health Research Ethics Council, 2010/2011 (note 671 above).
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Regulation 7 Regulations relating to the National Health Research Ethics Council (note 640 above). The
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chairperson must be a person with knowledge of the law and two others should have knowledge of research
ethics. The Regulations are not clear on whether the members of the appeals committee must be members of
the NHREC.
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Report for the National Health Research Ethics Council, 2010/2011 (note 671 above). See Chapter Six for a
critique of this function by the NHREC.
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Strode, Slack & Mushariwa (note 94 above) 599.
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The first University to create an REC was the University of Witwatersrand. In 2007 there were approximately
34 RECs in South Africa: Moodley & Landen (note 451above) 1 and Van Oosten (note 104 above) 7.
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reviewed by an REC that the MRC recognised.704 Secondly, all clinical trials had to obtain
ethical approval before being submitted to the MCC for authorisation.705 Nevertheless,
beyond these instances, there was no legally binding obligation to submit health research to
an REC for approval.706 There was also no obligation on institutions conducting health
research to establish an REC. The NHA changed this position by creating a clear obligation for
all institutions, agencies or health establishments conducting health research to establish or
have access to a registered REC. Section 73 of the NHA provides:
(1) Every institution, health agency and health establishment at which health research is
conducted, must establish or have access to a health research ethics committee, which is
registered with the National Health Research Ethics Council.
(2) A health research ethics committee must –
(a) review research proposals and protocols in order to ensure that research conducted
by the relevant institution, agency or establishment will promote health, contribute to
the prevention of communicable or non-communicable diseases or disability or result in
cures for communicable or non-communicable diseases; and
(b) grant approval for research by the relevant institution, agency or establishment in
instances where research proposals and protocols meet the ethical standards of that
health research ethics committee.
Section 73(1) of the NHA creates an institutional obligation to establish an REC. Thus,
responsibility for failing to establish such an REC, to ensure that it is registered with the
NHREC or that staff/contractors have access to an accredited REC, must be borne by the
head or the governing structure of such an institution. It is not a direct obligation to submit
health research for ethical review as such, as that is merely an ethical obligation.707 However,
the draft Regulations make it clear that researchers are under an obligation to submit their
704
S 17(1) Medical Research Council Act (note 448 above).
705
Regulation 34(1)(e) General Regulations, Medicines and Relates Substances Act (note 164 above).
706
See Chapter Three for further discussion on this point.
707
Point 2.5 NHREC Guidelines (note 56 above).
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protocols for ‘independent review by an accredited registered health research ethics
committee’.708
Section 73(1) of the NHA defines two roles for RECs: (a) to review research and ensure that it
is relevant; and (b) grant approval when it is ethical.709 With regard to the first role, it is
assumed that RECs should assess relevance by referring to the principles established in the
South African Health Research Policy issued by the National Health Research Committee.
However, this policy applies only to research conducted within the public sector or which
utilises public funds.710 Nevertheless, it is argued that the obligation in section 73(1(a) means
that even research conducted by private agencies must be relevant as it ought to ‘promote
health’. It follows therefore that RECs must establish that the protocol promotes the health
of local communities.711
Regarding the second role, RECs must grant ethical approval if a protocol is found to be
ethical. Accordingly, RECs must make their own independent determination of whether a
protocol meets their ethical standards by drawing on internationally and nationally accepted
ethical guidelines.712
The roles for RECs as described in the NHA are very similar to those set out in the national
ethical guidelines. The NHREC Guidelines describe the roles of RECs as being: the review of
708
Regulation 2(h) draft Regulations on Human Subjects (note 13 above).
709
The determination on when health research is ethical must be made in the light of the ethical standards of
that REC: s 73(2)(b) National Health Act (note 57 above).
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National Health Policy (note 7 above).
711
This approach reflects the well-established ethical principle of justice: R Gillon ‘Medical ethics: Four
principles plus attention to scope’ (1994) Vol 309 British Medical Journal 1, 2–3, Tangwa (note 605 above) 56
and PL Knudsen ‘Ethical principles in human subjects study’ (2001) Vol 32 Archives of Medical Research 473,
474.
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Smit argues that this includes ensuring that the protocol is consistent with the ethical norms in the NHREC
Guidelines (note 34 above) 15. This indirectly makes the national ethical guidelines legally enforceable, an
approach which has been established by the courts in the past. For example, in Jansen van Vuuren and Another
NNO v Kruger (note 157 above).
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research protocols; ensuring that human subjects are treated with dignity and their well-
being is promoted; ensuring that the informed consent procedures are adequate; and
granting approval to protocols that meet the ethical standards of the committee.713 There is
a corresponding duty on the principal investigator of a study to submit the research for
ethical approval.714
Detailed guidance is also provided to RECs in ethical guidelines regarding, amongst others:
their functions; composition; appointment of members; procedures; the recording of
decisions; monitoring; dealing with complaints; suspending or discontinuing research; and
submitting compliance reports to the NHREC.715
Section 73 appears to be applicable to all forms of health research, and all institutions (public
and private), agencies and establishments conducting health research must either establish
or have access to an REC. This means that any research that falls within the ambit of ‘health
research’ as defined in section 1 of the NHA must be submitted to an REC for review, and
may proceed only if it is approved by the REC. Given the broad definition of health research
it is argued that even research which does not involve human participants, such as record
reviews, must be submitted for ethical approval.
4.2.5 Community liaison bodies: Community Advisory Groups (CAGs)
Currently, in some instances, Community Advisory Boards (CABs) or CAGS exist to act as a
liaison between researchers and communities even though there is no explicit legal








Reddy, Buchanan, Sifunda, James & Naidoo (note 345 above) 3. It appears that the terms CAG and CAB are
inter-changeable as the National Health Research Ethics Council (2012) Guidelines for Community Advisory
Groups available from http://www.nhrec.org.za/wp-content/uploads/2012/guideline_cag.pdf [Accessed: 28
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CAGs which set out the roles, structure and functions that such bodies could undertake
within community-based research.717 It is argued that the development of these Guidelines is
significant as, in particular, ‘poor communities, can only benefit from national policies being
established to specify types of representation, resourcing and legitimising authority, as the
clinical trial milieu develops within the fledgling South African democracy’.718 It is possible to
argue that these Guidelines are enforceable as they are norms and standards regulating the
conduct of research with human subjects issued by the NHREC in terms of section 72(6)(c) of
the NHA.719 Accordingly, researchers who fail to comply with them could be disciplined by
the NHREC.720
The NHREC Guidelines on CAGs provide that ‘community engagement may serve to increase
the relevance and quality of proposed research, and its acceptance by affected
communities’.721 Furthermore, the NHREC recommends that:
investigators attempt to engage the participating community and other stakeholders in a
relationship of mutual respect and collaboration because such engagement may add to the
quality and acceptability of research projects, particularly those that involve vulnerable
communities in complex research endeavours.722
August 2012] do not draw a clear distinction between the terms and refer to both as acceptable. These
Guidelines list the following CAGs as currently being in existence: Africa Centre CAB, Aurum Health KOSH CAB,
CAPRISA CAB, Chris Hani-Baragwanath Peri-Natal Health Research Unit Soweto CAB, Desmond Tutu HIV
Research Centre, Masiphulele and Nyanga CABs and the MEDUNSA CAB.
717
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The Guidelines suggest that determining when a CAG should be established rests with the
principal investigator in a study.723 Nevertheless, RECs ought to exercise oversight over such
decisions by raising the issue if they believe that a CAG is required in the circumstances.724
The NHREC Guidelines on CAGs state that the following should act as a guide as to when they
should be established:
(a) That the proposed research may hold distinct potential risks for participants and
participating communities, such as stigma and discrimination;
(b) That the populations to be recruited for the proposed research may have pre-existing
vulnerabilities that increase their susceptibility to research-related risks;
(c) That the proposed research may have a substantial impact on areas where it will be
conducted;
(d) The proposed research is particularly complex or lengthy;
(e) That similar studies elsewhere have historically included CABs as an additional safeguard;
(f) That investigators may need to harness the expertise of community representatives in
order to design and conduct the research more effectively; and
(g) That inequalities may exist between participating communities and investigators in terms
of power, education and resources.725
The NHREC Guidelines on CAGs identify six roles for such bodies. These are: one, to educate
researchers on community norms; two, to educate the community on the proposed
research; three, to advise the researchers on any matter relating to the study, such as
potential risks that may be faced by participants; four, providing inputs into the research
process; five, ensuring the community has a voice in the research process; six, assisting in










The HSRC Act does not require the establishment of CAGs in social science research.
However, it provides that when research is being conducted in areas under the jurisdiction of
traditional leaders, notice of intention to conduct research must be sent, in writing, to the
House of Traditional Leaders.727
4.3 Institutions and mechanisms to monitor or enforce health research rights
4.3.1 Monitoring health research
In the past, there were two key obligations regarding the monitoring of research. Firstly, the
Regulations issued under the Medicines Act provided that researchers must submit progress
reports to the MCC every six months.728 Secondly, ethical guidelines generally required that
RECs should monitor protocol compliance, study records, and progress with the research.729
The NHA has not significantly changed the monitoring framework. It has, however, firstly,
given RECs a legally defined role and indirectly requires all health research to be reviewed by
RECs.730 This new role for RECs means that research may not continue if ethical approval is
either not granted, or withdrawn, for a study due to non-compliance with ethical norms and
standards. Secondly, RECs themselves must be registered with and accredited by the NHREC.
This has created a new mechanism for ensuring that RECs act within the framework of both
ethical guidelines and the law.731 Thirdly, researchers are now obliged to comply with the
ethical standards issued by the NHREC and failure to do so may result in their being
disciplined.732
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S 14(6) HSRC Act (note 62 above).
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Ibid s 72(6)(f). The extent to which this new authority will enhance the ability of RECs to undertake their
monitoring function is discussed in Chapter Six.
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Currently the following monitoring obligations are placed on the various ethical-legal role-
players in terms of national ethical guidelines:
(a) Obligations on individuals: Principal investigators (PIs). The responsibilities of a PI include:
informing RECs of any amendments to the trial protocol which require REC approval,
reporting any serious or unexpected adverse events and reporting on the progress of the
trial at least annually, but more frequently if requested by the REC.733
(b) Obligations on the sponsors of research: Sponsors are required to appoint a trial monitor
in a clinical trial, who is responsible for overseeing and reporting on the progress of the
study.734 For example, during the course of the study, the designated person monitors
progress through maintaining personal contact with the PI, visiting the site and meeting
with staff, reviewing procedures, documents/source data, and discussing any problems
that have arisen or are foreseen. The monitor is obliged to evaluate and report to the
sponsor, ethics committee and MCC, on various aspects of the research, including: the
progress of the study; adherence to the protocol; conformity of the data presented in
reports with source data; whether there is accurate maintenance of essential
documentation; monitoring of the informed consent process and regular reporting to the
sponsor, ethics committee and regulatory authority.735 Sponsors are not obliged, but
they may elect, to appoint an independent auditor in a clinical trial to evaluate the
conduct of a trial and compliance with the trial protocol and applicable regulatory
requirements.736 In the event of the audit finding non-compliance, the sponsor is obliged
to: enforce compliance with the protocol or regulatory requirements; possibly terminate
the PI’s participation in the trial; or suspend or terminate the trial, where non-
compliance continues. The sponsor is also required to inform the investigators,
733








regulatory authority and the REC of the termination or suspension of the study, and the
reasons for this action.737
(c) Obligations on institutions: Ethics committees are required to undertake ongoing
monitoring of trials through reviewing reports provided by researchers, as well as by
establishing procedures for the continuing review and re-approval of each study, at least
once a year.738 The MCC is given statutory powers to ensure that researchers comply
with their ethical and legal obligations in clinical trials, as the Regulations provide that
they may:
request additional information, inspect a clinical trial or withdraw authorization to conduct a
clinical trial if the Council is of the opinion that the safety of the subjects of the trial is
compromised, or that the scientific reasons for conducting the trial have changed.739
There are no special procedural or other measures for monitoring research involving child
research participants.
4.3.2 Enforcing the rights of research participants
Currently, there are six ways in which research participants can enforce their legal rights and
ethical obligations.
Firstly, professional councils regulate the conduct of their members, and have powers of
discipline over their members. Section 2 of the Health Professions Act establishes a Health
Professions Council (HPC), with control over the training and registration of medical
practitioners, dentists, practitioners of supplementary health service professions, and
psychologists. 740 The Council has to determine strategic policy on matters such as ethics and
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manner in which registered professionals carry out their duties.741 The Council’s powers
include the authority to discipline practitioners for unprofessional conduct, that is, improper
or disgraceful conduct.742 Carstens and Pearmain argue that this includes the power to
discipline members who act improperly or disgracefully towards patients by failing to follow
ethical standards.743 Although the authors do not refer to whether similar powers exist in
order to discipline researchers, Van Oosten submits that unprofessional conduct by a
medical practitioner during health research may be reported to the HPC.744
Secondly, institutions employing researchers may discipline their employees who bring the
institution into disrepute for failing to comply with ethical, legal or regulatory standards.745 It
is argued that they could do this by bringing charges of misconduct against the researcher
(employee) for failing to comply with the ethical norms and standards of the institution or,
more generally, for failing to comply with legal and regulatory obligations. This could be
regarded as a form of misconduct in that they will have breached a workplace rule by failing
to comply with these obligations.
Thirdly, the NHREC has a wide range of functions, including powers to enforce good conduct
by health researchers or RECs reviewing research. It can:
(i) Adjudicate complaints regarding the functioning of an REC;746
(ii) Refer to the relevant statutory professional council matters involving the violation
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S 72(6)(d) National Health Act (note 57 above).
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(iii) Institute disciplinary action against any person found to be in violation of any
research-related norms and standards, or guidelines.748
Fourthly, it is submitted that researchers may be held criminally liable for their actions.749 For
example, if a researcher failed to obtain informed consent from a research participant, they
could be charged with the crime of assault. However, the criminal law can only be utilised if
it could be proved that the researcher intended to cause harm to the research participant.750
Fifthly, it is argued that if a researcher acted culpably or negligently towards a research
participant, delictual principles could be used to hold them accountable. The civil law
provides that a person who wrongfully and culpably harms another can be held responsible
for the harm and, accordingly, is obligated to pay compensation.751 For example, if
researchers acted negligently in failing to warn participants of the potential side effects of an
experimental drug used during pregnancy, participants could resort to the civil law to claim
compensation for loss suffered such as pain and suffering, or medical expenses. Carstens and
Pearmain submit that the failure to obtain informed consent is a figurative ‘assault’ on the
patient’s body in the sense that it wrongfully violates their right to bodily integrity and is
therefore actionable:
the lack of informed consent amounts to an assault (in the context of
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concept of assault should not be assessed in its strict literal sense, but as a violation of a
patient’s right to bodily or physical integrity.752
It is argued that it is also possible to enforce a research participant’s rights through contract
law. The informed consent document is in essence a contract between the researcher and
participant setting out the rights and obligations of both parties. Any breach of the terms of
a validly concluded informed consent agreement would be enforceable.753
Finally, the Constitution establishes various statutory bodies to support our constitutional
democracy.754 These include the South African Human Rights Commission (SAHRC), which is
tasked with promoting respect for human rights and developing a culture of human rights,
promoting the protection, development and attainment of human rights, and monitoring
and assessing the observance of human rights in the country.755 The SAHRC is also given the
power to investigate and report on the observance of human rights, to take steps to obtain
redress where human rights have been violated, to carry out research and to provide human
rights education.756Given this broad mandate, it is argued that the SAHRC could act on a
complaint regarding human rights abuses during research. This argument is supported by
recommendations issued by the Convention on the Rights of the Child Committee’s General
Comment Number Two, which highlights the important role that national human rights
institutions can play in protecting children’s rights.757
There are no child specific enforcement mechanisms.
4.4 Conclusions
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South Africa has a well-established institutional framework for regulating health research
established primarily by the NHA and the Medicines Act. Within the framework there are
three statutory institutions and two non-statutory bodies, RECs and CAGs. Collectively, these
institutions ensure that relevant research priorities are set, research is regulated
(scientifically and ethically), norms for the conduct of research are established, there is
community engagement and ethical norms and legal rights are enforced. The framework
places a number of procedural obligations on key stakeholders. These obligations vary
according to the nature and place of the health research being conducted.
Firstly, the conduct of health research places an obligation on all researchers who must:
(i) If the study is state-funded or carried out by the public sector, ensure that its aims
and objectives fit within the research priorities identified by the NHRC; and
(ii) Comply with all obligations set by the NHREC.
Furthermore all institutions undertaking health research must establish an REC or have
access to an REC.
Secondly, if the health research involves a living human participant then the following
additional procedural obligations exist:
(i) Compliance with the norms in sections 11 and 71 of the NHA;758
(ii) If the health research is undertaken by the HSRC and is in an area under the
control of the House of Traditional Leaders, they759 must be notified of the
intention to undertake the study; and
(iii) If the research is classified as a clinical trial, the study must be registered with the
MCC and the South African Clinical Trials Register (SANCTR).
758
See Chapter Five for a full description of these norms.
759
The House of Traditional Leaders, not the individual leaders in that area.
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Thirdly, if the health research enrols human participants and is by its nature a health service
which is experimental, then there are additional obligations to obtain consent from persons
within the health institution and not just the patient or research participant.
A key strength of the current institutional framework is that it creates a platform for both
procedural and substantive protections for research participants. This shifts the focus from
individuals having to protect themselves through the doctrine of informed consent, and
places the obligation on the institutions to ensure that health research is regulated in an
objective manner in line with the prevailing ethical and legal norms. The institutional
framework does not have a dedicated focus on child research participation. However, it is
contended that this is not a key institutional weakness. Nevertheless, the lack of a coherent
approach to the involvement of the community in research regulation, and the limited co-
ordination between the ethical-legal institutions remain key problems.760
760
This is addressed in detail in Chapter Six.
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Chapter Five:
The normative framework for regulating health research with
children
The preceding Chapter described the institutions that make up the current ethical-legal
framework. It examined the institutions which (a) create a policy framework, (b) establish a
national system for regulating research ethics, (c) undertake ethical review at an institutional
level, (d) engage with the community, and (e) implement monitoring and enforcement
mechanisms.
The Chapter began with a description of the parameters of the current ethical-legal
framework for regulating health research. This was followed by a description of the role and
functions of each institution, namely, the NHRC, the MCC, the NHREC, RECs and CAGs.
Monitoring and enforcement mechanisms were also individually described and discussed.
The Chapter concluded with a description of procedural obligations which institutions have
placed on key research stakeholders, such as the obligation to obtain ethical approval for
health research. It also made some comments on the strengths and weaknesses of the
current institutional framework for regulating health research in South Africa.
This Chapter describes the key legal norms that regulate health research with children in
South Africa. It sets out the rights of research participants to participate in research only with
informed consent, to be treated equally and to have their privacy and dignity protected. It
also describes the obligations on researchers to ensure that children are indispensable to the
study, that the research has an acceptable level of risk and that it fits within broad public
policy standards set for both so-called therapeutic and non-therapeutic research. Finally, the
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Chapter discusses mandatory reporting requirements which, in certain instances, impact on
the research relationship.
5.1 Introduction
Prior to the full implementation of the NHA legal provisions dealing with the protection of
research participants were contained in various enactments of our law, and no single piece
of legislation described the circumstances in which individuals could participate in health
research. Even the Children’s Act which describes in detail a child’s health rights did not
address the participation of children in health research.761 Furthermore, where protections
did exist, these were not research specific, resultantly, academic writers and RECs had in
many instances to apply general principles relating to medical treatment or the norms
established in ethical guidelines, to a research context.762
The position changed dramatically from 1 March 2012 with the implementation of sections
11 and 71 of the NHA.763 These sections contain norms which set out the rights of research
participants and how health research ought to be conducted. Draft Regulations on Research
with Human Subjects were also published for public comment on 23 February 2007 and
again in May 2013.764 However, to date they have not been finalised. It is uncertain when a
final version of these draft regulations will be promulgated. There are also some non-
research specific laws which contain norms that are relevant to the conduct of health
research with children. These are primarily laws which deal with other health rights of
children and those that place specific obligations on certain adults, such as the mandatory
reporting requirements.765
761
Strode, Slack & Essack (note 143 above) 247.
762
Strode, Slack & Mushariwa (note 94 above) 600.
763
Government Gazette No. 35081 (note 95 above).
764
Regulations relating to research on human subjects 2007 and 2013 (note 13 above). This thesis only refers to
the content of the 2013 draft regulations in the Addendum.
765
For example, s 134 of the Children’s Act which provides that a child may consent independently to
contraceptives and contraceptive advice from the age of 12 (note 4 above). This provision may be relevant in an
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Section 71 is the over-arching section setting norms for all health research involving human
participants. It comprises of three parts; firstly, section 71(1) which sets out general
provisions for health research on human participants. This part of the section also
establishes a platform for the development of a wide range of legal norms for research
involving human participants as it empowers the Minister of Health to issue regulations on
this issue.766 Secondly, sections 71(2) and (3) which deal with the circumstances in which
health research with minors may be conducted. These sections read:
71(2) Where research or experimentation is to be conducted on a minor for a therapeutic
purpose, the research or experimentation may only be conducted
(a) If it is in the best interests of the minor;
(b) In such manner and on such conditions as may be prescribed;
(c) With the consent of the parent or guardian of the child; and
(d) If the minor is capable of understanding, with the consent of the minor.
(3) (a) Where research or experimentation is to be conducted on a minor for a non-therapeutic
purpose, the research or experimentation may only be conducted
(i) In such manner and on such conditions as may be prescribed;
(ii) With the consent of the Minister;
(iii) With the consent of the parent or guardian of the minor; and
(iv) If the minor is capable of understanding, the consent of the minor.
(b) The Minister may not give consent in circumstances where
HIV prevention study as it would mean that even if parental consent was required for enrolment in the study, if
participants were provided with access to contraceptives during the trial they could consent to this intervention
independently and without the knowledge of their parents provided they were over the age of 12. Likewise the
mandatory obligation to report under-age sex, s 54 Criminal Law (Sexual Offences and Related Matters)
Amendment Act 32 of 2007 could mean that if an efficacy study into a vaginal microbicide enrolled girls
between the ages of 12–15 researchers would be obliged to report any sexual activity to the police where the
girl’s partners were over the age of 18 as their partners would be committing a sexual offence. See s 5.2.2 (vi)
below for more detail on this point.
766
Van Wyk (note 13 above) 47.
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(i) The objects of the research or experimentation can also be achieved if it is
conducted on an adult;
(ii) The research or experimentation is not likely to significantly improve scientific
understanding of the minor’s condition, disease or disorder to such an extent
that it will result in significant benefit to the minor or other minors;
(iii) The reasons for the consent to the research or experimentation by the parent or
guardian and, if applicable, the minor are contrary to public policy;
(iv) The research or experimentation poses a significant risk to the health of the
minor; or
(v) There is some risk to the health or well-being of the minor and the potential
benefit of the research or experimentation does not significantly outweigh that
risk.
Sections 11 and 16 of the NHA deal with instances when a health service is provided by a
health establishment for experimental or research purposes.767 In other words these two
provisions in the NHA deal with health research which is provided by or at a health
establishment.
These three sections in the NHA are significant for a number of reasons, but particularly as
they are the first legislative provisions to deal directly with the rights of all human
participants involved in health research.768 They also create a number of new norms in
relation to health research with minors. These are:
(i) Such research can only be conducted if the consent of a parent or guardian is
obtained. The NHA does not allow consent by care-givers even if they are acting
as de facto parents or guardians;
(ii) Minors who demonstrate ‘understanding’ will consent alongside the person
providing proxy consent and not merely assent to the study;
767
National Health Act (note 57 above).
768
Pope (note 93 above) 167.
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(iii) Therapeutic research must be in the best interests of the minor; and
(iv) Ministerial consent must be obtained for non-therapeutic research with minors.
The legislature has elected to provide additional protection to all ‘minors’ rather than just
children. The reason for this approach is unclear. Minority is based on the notion that only
persons with reasonable understanding and judgment should have the capacity to act.769
Accordingly, the law provides that individuals between birth and 18 have limited legal
capacity.770 Nevertheless, in certain defined circumstances minority may end before the age
of 18.771 Thus by using the word ‘minor’ as opposed to ‘child’ it is possible that the legislature
envisaged that certain children would have the legal capacity to consent to research before
the age of 18 because they are married or have been emancipated.772
It is submitted that these research-specific provisions read with the obligations or norms in
non-research laws create nine standards for research with children. These include both rights
for child research participants and obligations on researchers.773 These are described
individually below.
5.2 The rights of child research participants
5.2.1 Informed consent
769






A child who marries before the age of 18 becomes a legal major for all purposes. In this instance the child
remains a major even if the marriage ends due to death or divorce before the age of 18 ibid 114. A child may
also become a legal major before the age of 18 if they are emancipated by their parent or guardian.
Emancipation can occur when the minor acts without the assistance of their parent or guardian in juristic acts
ibid 115.
773
These are the rights to informed consent, privacy, dignity and equality. The obligations are to ensure that
therapeutic research is in the best interests of the child, ministerial consent is obtained for non-therapeutic
research with minors, mandatory reporting requirements are complied with, appropriate risk standards
adhered to and scientific justifications exist for the inclusion of children in health research.
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Informed consent to research participation is an accepted international law principle which
has its roots in the Nuremburg Code and the Helsinki Declaration.774 Prior to the full
implementation of the NHA in March 2012 only the Constitution referred to a participant’s
right to participate in research with their informed consent with section 12(2)(c) stating:
Everyone has the right to bodily and psychological integrity, which includes the right . . . not
to be subjected to medical or scientific experiments without their informed consent.775
This right includes protection against intrusions into a person’s physical body and a right to
autonomy in decision-making.776 This implies that there is a constitutional obligation on
researchers to obtain informed consent from research volunteers and research participants
have the right to make autonomous research-related decisions.777
In the past there were no express legal provisions dealing with when and how consent
should be obtained from children or their proxies for health research. Accordingly, it was
argued that given the lack of legal guidance the key legislative and common law principles
relating to informed consent to medical treatment and the principles established in ethical
guidelines should be used as a framework for describing when consent to health research
with children would be lawful.778
774
London et al (note 156 above) 288. See Chapter Two for a full description of the right to informed consent in
international law and ethical codes.
775
Constitution of the Republic of South Africa (note 2 above). This provision was inserted into the final
Constitution after the narrow wording in s 11 of the interim Constitution was criticised: Constitution of the
Republic of South Africa, Act 200 of 1993. The interim Constitution provided only that everyone ‘shall have the
right to freedom and security of the person, which shall include the right not to be detained without trial’.
Furthermore no one ‘shall be subject to torture of any kind, whether physical, mental or emotional, nor shall
any person be subject to cruel, inhuman or degrading treatment or punishment’ ibid.
776
I Currie & J de Waal The Bill of Rights Handbook 5 ed (2005) 308 and F Veriava ‘Ought the notion of informed
consent be cast in stone’? BRM v The Health Professions Council of South Africa’ (2004) Vol 20 South African




Smit (note 34 above) 15.
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Sections 11, 16 and 71 of the NHA clarify this situation by providing detail on the nature of
consent to health research and who may provide it when a child is to be enrolled in a study.
The draft Regulations also deal with consent by providing that research participants have the
right to bodily integrity.779 The draft Regulations provide further those participants must be
well-informed in order to facilitate appropriate decision-making and they outline the
minimum information that should be provided to research participants.780 The approach
taken towards consent from children/minors for health research in the NHA and the draft
Regulations is highly restrictive. It does not allow independent consent by children in any
circumstances and it limits the persons who may provide proxy consent. In this regard it is at
odds with the norms established in ethical guidelines.781 Both the NHA and the draft
Regulations on Human Subjects are silent on the issue of assent by child research
participants.
Consent is a defence to what would otherwise be an unlawful act. 782 It is reflected in the
common law principle of volenti non fit injuria (to one consenting no wrong is done).783 In
essence a person who willingly consents to a harmful act or an activity cannot claim that a
delict has been committed against them.784 It is argued that if the principle is to operate as a
defence the following must exist; the research participant should:
(i) Know the nature and extent of the harm or risk involved;785
(ii) Appreciate and understand the nature of the harm or risk;786 and
(iii) Voluntarily consent to the harm or assume the risk.787
779




See Chapter Six for further discussion on this point.
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C v Minister of Correctional Services (note 533 above) 301B.
787
Esterhuizen v Administrator, Transvaal (note 516 above) 722.
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Furthermore the act consented to must not be contra bonos mores788 and the person
consenting must have legal capacity.789
(i) Provide research participants with knowledge of the health research
Carstens and Permain argue that the standard of information that research participants are
entitled to is ‘full disclosure’ of all relevant facts.790 However, section 71 of the NHA simply
requires researchers to inform research participants of any possible negative or positive
consequences to their health.791 Section 11 of the NHA provides further that where research
is being conducted as part of a ‘health service’ or at a ‘health establishment’ the user must
be ‘informed’ that the health service is experimental.792 Regulation 2(d) of the draft
Regulations provides that research participants should be well informed and ‘able to make
appropriate choices’.793 Regulation 6 details the content of the information that ought to be
provided to participants:
(a) the purpose of the research; (b) treatments and possibility of random assignment of each
treatment (if the research involves treatment); (c) methods and procedures to be followed or
used during the research; (d) alternatives apart from participating in the research; (e)
potential harms and risks involved in participation; (f) expected benefits to the participant
and other persons in the research; (g) extent to which confidentiality and privacy will be
maintained; (h) available insurance in the event of research-related injury, for more than
minimal risk research; (i) details of the contact person in the event of a query or research-
related injury; (j) reimbursement and/or incentives given for participation; (k) in cases of
clinical trials, the availability of treatment beyond the duration of the trial; (l) details of the
sponsor and any potential conflict of interests; (m) their freedom to decline or withdraw from
788
Van Oosten (note 104 above) 29–30.
789
McQuoid-Mason (note 363 above) 8.
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Carstens & Permain (note 529 above) 894.
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S 71(1)(b) National Health Act (note 57 above).
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the research without prejudice; and (n) proof of ethics committee approval or MCC approval,
where relevant.794
These principles must be read with those established in the NHREC Guidelines which require
researchers to disclose additional information on the investigator’s qualifications, the
contact details of the REC and the procedures that will be followed if a participant is harmed
and is eligible for compensation related to a research-related injury.795
(ii) Appreciating and understanding the risks of the research
It is a well-established common law principle that a person providing consent must
appreciate the information on which they base their decision.796 In Christian Lawyers
Association v Minister of Health and Others (Reproductive Health Alliance as Amicus Curiae)
it was held that the ‘requirement of “appreciation” implies more than mere knowledge . . .
(the patient) must also comprehend and understand the nature and extent of the harm or
risk’.797
The NHA does not expressly require research participants to understand the information
presented in order to provide lawful consent except where the person is a minor and they
are giving consent alongside their parent or guardian.798 Nevertheless, the research
participant must understand the nature and extent of the research risks given the central
role understanding plays in the defence of volenti non fit injuria.




NHREC Guidelines (note 56 above) 4–5.
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McQuoid-Mason (note 363 above) 8.
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Christian Lawyers Association v Minister of Health and Others (Reproductive Health Alliance as Amicus
Curiae) 2005 (note 542 above) 515I–J.
798
Ss 71(2)–(3) National Health Act (note 57 above) states that ‘(i)f the minor is capable of understanding, with
the consent of the minor.’
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In essence this principle requires research participants to give express consent to the
research thus clearly indicating their intention to participate.799 The NHA provides that
participants must give written consent to research participation.800 Furthermore, section 11
of the NHA provides that if the study occurs at a health establishment, consent must be
obtained from the user, their health care provider, the head of the health care
establishment, the REC and any other person to whom this authority has been delegated.801
This section therefore requires both individual and institutional consent for research
participation. The only exception to written consent is set out in section 16(2) of the NHA
which provides that when record reviews are being done by health care providers for
research purposes and no personal identifiers are being obtained, consent is not required
from the patient, the health establishment or the REC.
The draft Regulations also provide that if a child elects not to participate in research they
cannot be compelled to enrol simply because their parents or guardians have provided
consent for their participation.802
(iv) Voluntariness
The NHA does not specifically require that consent to health research be voluntary.
However, it is argued that the common law principles would nevertheless apply, and
researchers would be obliged to take steps to both ensure that consent is always voluntarily
given and that they take steps to minimise factors that may limit voluntariness. The draft
Regulations on Human Subjects deal briefly with persons whose voluntariness may be
compromised under the category of persons in dependent relationships, stating that RECs
should give special attention to the vulnerability of persons who are in dependent
799
Van Oosten (note 104 above) 30.
800
S 71(1)(b) National Health Act (note 57 above).
801
National Health Act ibid.
802
Regulation 4(c) Draft Regulations on Human Subjects (note 13 above).
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relationships or comparable situations.803 The draft Regulations on Human Subjects also deal
with voluntariness in relation to prisoners.804
(v) The act must be lawful
It is a general principle of our common law that if consent is to be valid the act or conduct
consented to must be in accordance with public policy and not contra bonos mores.805 In
other words, the consent must be permitted or ought to be permitted by the legal order.806
This principle acts as a limit on individual autonomy.807 Generally, courts use an objective
test to establish whether consent to a particular act is considered contra bonos mores.808
This involves an assessment of the prevailing legal convictions of the community.809
It is argued that in the context of health research, the prevailing legal norms are set out in
the NHA. Accordingly, consent to health research would be valid if it was consistent with
what is considered lawful research in the NHA, the draft Regulations on Human Subjects and
the national ethical guidelines. For example, given that the NHA requires therapeutic
research with minors to be in their best interests, health research which was found to be
contrary to this standard could be considered contra bonos mores810
803
Regulation 4(3) ibid. The types of dependent relationships referred to in the draft Regulations include: (a)
older persons and their care-givers; (b) patients and health-care professionals;(c) students and teachers; (d)
persons with life-threatening diseases and their care-givers; (e) wards of the state and guardians or care-givers;
(f) employees and employers; (g) prisoners and the relevant prison authorities; and (h) members of the South
African National Defence Force.
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Regulation 5(4) ibid. This provides that ‘Research studies involving prisoners must: (a) be undertaken in
accordance with guidelines issued by the Department of Correctional Services; (b) present risks commensurate
with risks that would be accepted by non-prison volunteers; (c) ensure protection of the rights of prisoners,
including the right to dignity and humanity of the prisoners; and (d) facilitate the ability of prisoners, both
sentenced and awaiting trial, to make voluntary decisions about research participation’.
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See for example, S v Collett 1978 (3) SA 206 (RA) at 211D.
808




S 71(2)(a) National Health Act (note 56 above).
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(vi) Capacity
Research participants must have legal capacity to consent to research.811 The NHA stipulates
that consent must be obtained from parents or legal guardians and where minors have the
requisite understanding their consent must also be obtained. In other words, the NHA does
not give children the capacity to consent independently to research below the age of 18 but
it provides they may in certain circumstances provide dual consent alongside their parents.
This means that there are no circumstances in which persons who are legal minors can
provide independent consent.812 However, children who are no longer minors because they
are married or have been emancipated may have the capacity to consent to health research
before the age of 18.813 Children who are parents would also not have the legal capacity to
consent to health research on their own children even though they are ‘parents’ in terms of
the NHA.814 This is because as parents who are still under the age of 18 they would remain
legal minors and therefore unable to meet the legal capacity requirements set by the NHA.
5.2.2 Consent to certain therapeutic interventions that may be offered during a study
Within some forms of health research, such as clinical trials, children may be offered a range
of therapeutic services either as part of the study or as a benefit to participants. These are all
relevant to the setting of research-related norms.815 The age of consent to sex may also be
relevant in studies relating to a child’s sexual and reproductive rights.816
811
Strode, Slack & Essack (note 143 above) 248.
812
The only exception being children who have changed their legal status through marriage or emancipation.
813
Heaton (note 760 above) 115.
814
Strode & Slack (note 139 above) 56.
815
See Table 2 in Chapter One for a comparison of these ages of consent.
816
For example, Strode and Slack submit that the implications of the Sexual Offences Act for health research
are that ‘in many instances researchers may become aware through bio-medical or social science research that
an adolescent is involved in a sexual offences as they will have knowledge of a child’s sexual activity, this may
be because they ask adolescents questions about their sexual activity, identify sexually transmitted diseases,
provide HIV testing services or access to contraceptives. Many of these adolescents will be between the ages of
12–16. Through these interactions researchers may well gain knowledge of a sexual offence that has been
committed against or by a child’: Strode & Slack (note 143 above) 9.
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(i) Consent to medical treatment
The NHA provides that as a general principle a health service may not be ‘provided to a user
without the user’s informed consent’.817 The Children’s Act provides further that a child of 12
may consent independently to such a health service if it is considered to be a form of medical
treatment provided that they have ‘sufficient maturity’ and the ‘mental capacity to
understand the benefits, risks, social and other implications of the treatment’.818 If the child
is below the age of 12 or lacks capacity to consent, consent may be provided by amongst
others, the parent, guardian or care-giver.819 In certain circumstances when the parents,
guardian or care-giver are not able to consent, the superintendent of the hospital or the
Minister of Social Development may consent to the child’s medical treatment.820
(ii) Consent to HIV testing
The Children’s Act distinguishes HIV testing from medical treatment and creates four new
norms relating to such testing, including that the testing must be in the best interests of the
child, undertaken with informed consent, accompanied by pre- and post-test counselling and
results should be kept confidential.821 The Children’s Act also specifies when children will
have the capacity to consent to HIV testing. Children above the age of 12 may consent
independently to an HIV test. Unlike medical treatment parliament did not include a capacity
requirement for HIV testing where the child is over the age of 12. This means there will be a
general presumption that a child of 12 has sufficient capacity to consent to HIV testing,
817
S 7(1) National Health Act (note 57 above).
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S 129(2)(b) Children’s Act (note 4 above).
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S 129(4) ibid. If a child is over the age of 12 and has ‘sufficient maturity’ and the ‘mental capacity to
understand the benefits, risks, social and other implications of the treatment’ they will have the capacity to
consent to medical treatment on their own child as they are considered a ‘parent’ in terms of this section. For







children under 12 may also consent independently to HIV testing if they have ‘sufficient
maturity’.822
(iii) Consent to a termination of pregnancy
Girl children can consent to terminations of pregnancy at any age.823 However, in order to
ensure that they have support, section 5(3) of the Choice of Termination of Pregnancy Act
(hereafter referred to as the ‘Choice Act’) provides that ‘in the case of a pregnant minor, a
medical practitioner or a registered midwife, as the case may be, shall advise such minor to
consult with her parents, guardian, family members or friends before the pregnancy is
terminated: provided that the termination of the pregnancy shall not be denied because
such minor chooses not to consult them.’824 Although the Choice Act does not specify an age
at which a girl child may consent independently to a termination of pregnancy, in the
Christian Lawyers case it was held that consent may be given only by someone with the
intellectual and emotional capacity to understand the information provided, appreciate this
and provide consent.825 This means that young or immature girl children may not have the
capacity and will not qualify to consent on their own and would need the assistance of a
parent or guardian.826
822
Van Wyk (note 13 above ) 40. Nevertheless McQuoid-Mason submits that even though the Children’s Act is
silent on the issue of maturity with regard to HIV testing, children would have to have capacity in order to
consent: D McQuoid-Mason ‘The effect of the new Children’s Act on consent to HIV testing and access to
contraceptives by children’ (2007) Vol 97(12) SAMJ 1252, 1253.This is in line with the outcome of the Christian
Lawyers case (note 542 above).
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The Choice Act defines ‘woman’ in s 1 as ‘a female person of any age’. In s 5 it provides that a termination of
pregnancy may only be undertaken with ‘the informed consent of the pregnant woman’. S 5(2) provides further
that ‘notwithstanding any other law or the common law, but subject to the provisions of subsections (4) and
(5), no consent other than that of the pregnant woman shall be required for the termination of a pregnancy’:








(iv) Access to contraceptives and contraceptive advice.
Children aged 12 and above may consent to contraceptives and the obtaining of
contraceptive advice independently.827 This means that children may access information and
contraceptives within health research without the knowledge or consent of their parents if
they are over the age of 12.
(v) Consent to male circumcision
The Children’s Act limits the circumstances in which boys may be circumcised by prohibiting
circumcisions on boys below the age of 16 unless they are performed for cultural, religious or
medical reasons.828 Boys below this age require the assistance of an appropriate adult as
they cannot consent independently until they are 16.829 The Children’s Act does not describe
the adults who would have the capacity to consent to a circumcision on boys below the age
of 16. It is assumed that it would only be persons with full parental rights and
responsibilities.830 With boys above the age of 16, the Children’s Act provides that they must
(a) provide their own consent to the circumcision,831 (b) receive counselling prior to the
circumcision, and (c) the procedure must be carried out in the prescribed manner.832 Taking
into account a boy child’s ‘age, maturity and stage of development’ every boy has the right
to refuse to be circumcised.833
827
S 134 Children’s Act (note 4 above).
828
S 12(8) ibid. See DJ McQuoid-Mason ‘Is the mass circumcision drive in KwaZulu Natal involving neonates and
boys under 16 years of age legal? What should doctors do?’ (2013) Vol 103(5) South African Medical Journal
283–284 for further discussion on when male circumcision on boys is lawful.
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S 12(9) ibid. The Children’s Act is silent on which adults have the capacity to provide consent to a
circumcision on a boy under the age of 16.
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S 18(2) ibid provides that parental rights and responsibilities include: firstly, a duty to care for the child;
secondly, an obligation to maintain contact with the child; thirdly, to act as guardian of the child; and fourthly
to contribute to the maintenance of the child. Persons with partial parental rights and responsibilities are
required to safeguard the child’s health, well-being and development and protect the child from harm: s 32(1)
Children’s Act ibid. It is argued that given these duties decision-making regarding male circumcision clearly falls
within the obligations of persons with either full or partial parental rights and responsibilities.
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Consolidated Regulations Pertaining to the Children’s Act, 2005, Government Gazette No. 33076, 1 April 2010.
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(vi) Capacity to consent to sex
The Criminal Law (Sexual Offences and Related Matters) Amendment Act (hereafter referred
to as the Sexual Offences Act)834 describes a number of crimes against and involving children
that may impact on health research. The Sexual Offences Act provides that a male or female
under the age of 12 is incapable of consenting to a sexual act.835 The age of consent to sexual
penetration and other related sexual activities is 16. Until very recently, the Sexual Offences
Act provided that if a child between the ages of 12 and 15 engaged in consensual sexual
activity which included penetration, they would have been committing the crime of
consensual sexual penetration with a child, or statutory rape.836 If a child between the ages
of 12 and 15 engaged in consensual sexual activity which included non-penetrative direct or
indirect contact with the genital organs or mouth, they would have committed the crime of
consensual sexual violation with a child or statutory sexual assault.837
The situation changed with a decision by the Gauteng High Court in January 2013 in the
Teddy Bear Clinic for Abused Children and Prevention of Child Abuse and Neglect (RAPCAN) v
Minister of Justice and Constitutional Development case.838 In this matter the court found
that where sections 15 and 16 of the Sexual Offences Act criminalised consensual sex and
sexual activity between children of 12–15 or those of 12–15 with partners of 16 and 17
provided there was no more than a two-year age gap between them (if their partner was
834






S 16 ibid. A further complexity was that there was a mandatory reporting obligation on all persons aware of
a sexual offence against a child, this obligation included the reporting of consensual sexual activity to the police:
see D McQuoid-Mason ‘Mandatory Reporting of sexual abuse under the Sexual Offences Act and the best
interests of the child’ (2011) Vol 4(2) South African Journal of Bioethics and Law 74–78 for further discussion on
this issue. Also see Strode & Slack (note 143 above) where the authors look at the mandatory reporting of




over 15), these were inconsistent with the Constitution.839 This means that researchers
enrolling children engaged in consensual under-age sex will no longer have to report these
activities unless there is (a) a large age gap between the participants, or (b) one of the
partners is under 12 or over the age of 18.
Table 15: Consensual sexual offences by adolescents
Any person having
consensual sex with a





having sex with partners
of 16 or 17
Children between 12–15
having sex with partners
of 18 or older
All consensual sex is
illegal – child has no
capacity to consent to
sex
Consensual sex between
children who are both
between 12–15 is not
illegal
Consensual sex between
children who are 12–15 is
not illegal if their partner
is 16 or 17 and there is
no more than a two-year
age gap between them
Consensual sex between
children who are 12–15 is
illegal if their partner is
18 or older
Older person commits a
crime, the child under 12
is the ‘victim’




Person over 18 commits
a crime
5.2.3 Privacy840
Everyone has a right to privacy.841 The right extends to those aspects of a person’s life that
both the individual and society consider private.842 Private facts are information which if
disclosed ‘will cause mental distress and injury to anyone possessed of ordinary feelings and
intelligence in the same circumstances and in respect of which there is a will to keep them
private.’843 In terms of this approach the right to privacy will be infringed if an expectation of
839
Para 113 ibid. Also see DJ Mc Quoid Mason ‘Decriminalisation of consensual sexual conduct between
children: What should doctors do regarding the reporting of sexual offences under the Sexual Offences Act until
the Constitutional Court confirms the judgement of the Teddy Bear Clinic case? (2013) Vol 6(1) SAJBL 11 – 12
for a more in-depth discussion of the case.
840
This section is based substantially on an article provisionally accepted for publication to the Southern African
Journal of HIV Medicine in April 2013 namely, A Strode & C Slack ‘Adolescent privacy rights: A “Cinderella” issue
in health research?’ Strode was the first author in this publication. She prepared the initial draft setting out the
law on privacy. The application of these legal principles to research was developed collectively.
841
A Govindjee ‘The right to privacy’ in A Govindjee & P Vrancken (eds) Introduction to Human Rights (2009)
101, 101–102.
842
Currie & De Waal (note 776 above) 318.
843
National Media Ltd and Another v Jooste 1996 (3) SA 262 (A) quoted in NM and Others v Smith and Others
(Freedom of Expression Institute as Amicus Curiae) (note 357 above) para 34.
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privacy existed and that expectation was considered reasonable.844 Currie and De Waal argue
that the subjective expectation of privacy means anything considered private by the
individual themselves.845 The objective element requires that this expectation must be
reasonable.846 An assessment of whether the right to privacy has been infringed should be
based on an understanding of the value underpinning the right namely, the protection of an
individual’s autonomous identity and dignity.847 Invasions of privacy which infringe a
person’s dignity ought to be regarded as unreasonable.848
Constitutional and other rights apply in most instances to adults and children equally.849 Thus
by implication children are entitled to the right to privacy. In the recent Teddy Bear Clinic
case the court held that the Constitution recognises that children are the bearers of rights
and that they ‘are entitled to a realm of personal space and freedom in which to live their
own lives’.850 Nevertheless, applying these privacy principles to children is complex as they
do not always have the capacity to form a subjective expectation of privacy. Or they may
have less of an expectation of privacy in certain circumstances. Furthermore, the
reasonableness of such an expectation, if it exists, will depend on a range of factors including
whether a statutory limitation, such as a mandatory reporting obligation, limits the right.
It is argued that within the context of health research the right to privacy means that
research participants can expect that their participation in a study will remain confidential
unless they have agreed otherwise. Furthermore, any information disclosed or obtained
844
Ibid. This is also referred to as the ‘legitimate expectation’ test.
845
Ibid. This element of the test enables individuals to waive their right to privacy by expressly consenting to
an invasion of privacy. In such a case an individual cannot have a subjective expectation of privacy as they
have consented to the disclosure or to allow others access to the information.
846
Bernstein and Others v Bester NO 1996 (2) SA 751 (CC) para 67.
847






Teddy Bear Clinic and RAPCAN case (note 838 above) para 80.
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from participants during research will not be linked to their identity in any way unless
agreement is given for such a disclosure.851
There have not been any legislative provisions dealing with a research participant’s right to
privacy, and the NHA is silent on this issue.852 The NHREC Guidelines however describe the
ethical norm on privacy as being that the:
researcher must ensure that 'where personal information about research participants or a
community is collected, stored, used or destroyed, this is done in ways that respect the
privacy or confidentiality of the participants or the community and any agreements made
with the participants or community.853
The draft Regulations change this position by stating in Regulation 2(f) that research
involving human subjects must ‘ensure that participants’ rights are respected, including
their rights to dignity, privacy, bodily integrity and equality.’854 No further explanation is
given of how the right to privacy will apply to health research or of the nature of the duty
that this imposes on researchers. Although the NHA does not address privacy within
research, the Children’s and the Choice Acts specify how privacy rights apply in relation to
certain other health care services by stating:
851
The NHREC Guidelines define privacy as a ‘zone of exclusivity where individuals and collectivities are free
from scrutiny of others. It may also include control over the extent, timing and circumstances of sharing oneself
with others, whether physically, intellectually or in terms of behaviour’: Point 1.4 NHREC Guidelines (note 56
above). These Guidelines distinguish between privacy and confidentiality. They state that the right to privacy
deals with access to personal records whilst the right to confidentiality refers to the use of personal information
once it has been disclosed: 2.7 ibid.
852
The National Health Act (note 57 above) does however describe the right to privacy within the context of a
therapeutic relationship. S 14(1) provides that a user has the right to confidentiality of all health information.
Nevertheless s 14(2)(a)–(c) limits this right by stating that disclosures may be made if the user consents in
writing to these, if a court order or law requires the disclosure, or if non-disclosure presents a serious public
health threat. Furthermore, s 15(1) provides that a health care worker may disclose personal information about
a user provided it is within the ordinary scope of their duties, necessary for a legitimate purpose and is in the
interests of the user.
853
2.7 NHREC Guidelines (note 56 above).
854
Draft Regulations on Human Subjects (note 13 above).
201
(i) Children have the right to privacy regarding their ‘health status’ and access to
condoms, contraceptives and contraceptive advice;855
(ii) No person may disclose a child’s HIV status without the child or another
responsible adult’s consent;856
(iii) A child’s rights to privacy may be limited where this is in their best interests or
where this is required by other provisions in the Children’s Act such as mandatory
reporting obligations;857 and
(iv) The ‘identity of a woman who has requested or obtained a termination of
pregnancy shall remain confidential at all times unless she herself chooses to
disclose that information’.858
The Children’s Act also provides that a child has the capacity to consent independently to a
number of therapeutic interventions.859 Although it does not specify that children have a
right to privacy regarding such services, it is argued that as they do not need parental
assistance they would have an expectation of privacy which would be considered
reasonable.860
It has been submitted that based on the general principles relating to privacy described
above, the following norms can be extrapolated to guide health researchers. These are:
(i) Children do not have a right to privacy regarding their participation in health
research as parental or guardianship consent is always required in terms of
section 71 of the NHA;
855
S 13(1)(d) and s 134(3) Children’s Act (note 4 above).
856




S 7(5) Choice of Termination of Pregnancy Act (note 823 above). See the same note above regarding the
meaning of ‘woman’ in terms of the Choice Act.
859
These include for example, medical treatment and male circumcision. See Table 2 in Chapter One for a full
list of these interventions.
860
Strode & Slack (note 840 above).
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(ii) Children may have the right to privacy regarding certain therapeutic health
interventions in a study to which they will be consenting independently, such as
HIV testing or treatment for sexually transmitted infections (See Table 16 below);
and
(iii) A child’s right to privacy within research may be limited by both the concept of
the best interests of the child or specific statutory provisions such as those
relating to mandatory reporting.
Table 16: Therapeutic interventions in respect of which children have the right to privacy
within health research
Health intervention to which
children can expect privacy
Age at which children can expect






HIV testing 12 or below the age of 12 if the
child has ‘sufficient maturity’
Children’s Act
Termination of pregnancy No age of specified Choice of Termination of
Pregnancy Act
Medical treatment 12, provided the child has
‘sufficient maturity’
Children’s Act
Male circumcision 16 Children’s Act
Operations 12 and the child is of ‘sufficient
maturity and has the mental
capacity to understand the
benefits, risks, social and other
implications of the surgical
operation’. Child must be assisted
by his or her parent or guardian
Children’s Act
5.2.4 Dignity
The right to dignity is well established in international861 and domestic law, and is
increasingly being applied in the context of health research.862
861
Article 10, International Convention on Civil and Political Rights (note 9 above).
862
Kirchhoffer & Dierick (note 403 above) 75.
203
The Constitution provides in section 10 that everyone has inherent dignity and the right to
have their dignity respected and protected.863 This right requires a recognition of the intrinsic
worth of human beings. This is done through ensuring that everyone is regarded as being
worthy of equal respect and concern.864 The Constitutional Court has also recognised that
children have the right to have their dignity respected.865
Stone and Vrancken argue that as dignity is a highly personal right which is linked to one’s
own sense of inner value, to establish whether an infringement has occurred one must
assess the impact of the offending conduct or law on the person.866 The Constitutional Court
has on a number of occasions articulated the importance of this right:
[T]he Constitution asserts dignity to contradict our past in which human dignity for black
South Africans was routinely and cruelly denied. It asserts it too to inform the future, to
invest in our democracy respect for the intrinsic worth of all human beings. Human dignity
therefore informs constitutional adjudication and interpretation at a range of levels. It is a
value that informs the interpretation of many, possibly all, other rights. This Court has already
acknowledged the importance of the constitutional value of dignity in interpreting rights such
as the right to equality, the right not to be punished in a cruel, inhuman or degrading way,
and the right to life . . . In many cases, however, where the value of human dignity is
offended, the primary constitutional breach occasioned may be of a more specific right such
as the right to bodily integrity, the right to equality or the right not to be subjected to slavery,
servitude or forced labour.867
863
S 10 Constitution of the Republic of South Africa (note 2 above).
864
S v Makwanyane 1995 (3) SA 391 (CC) para 328. In S v Jordan the Constitutional Court held that this right
inheres in it various aspects of what it means to be a human being: 2002 (6) SA 642 (CC) para 74.
865
S v M (Centre for Child Law as Amicus Curiae) 2008 (3) SA 232 (CC) para 18.
866
L Stone & P Vrancken ‘Human dignity’ in Govindjee & Vrancken (note 823 above) 68.
867
Dawood v Minister of Home Affairs 2000 (3) SA 936 (CC) para 35.
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The NHA is silent on the rights of research participants to dignity. However the NHREC
Guidelines provide that all research participants have the right to have their dignity
respected:
Respect for the dignity, safety and well-being of participants should be the primary concern
in health research involving human participants. Culture, language, beliefs, perceptions, and
customs must all be considered.868
The draft Regulations change the current lack of legal reference to the right to dignity by
stating that research participants have the right to respect for their dignity.869 They do not
however set out the implications this has for the way in which research with human
participants is undertaken. Nevertheless, it is submitted that this requires research to be
conducted in a way which respects the inherent dignity of participants. In other words,
researchers would be required to ensure that participants are treated with respect and not
simply as a means to an end.
5.2.5 Equality
The right to equality is well established in international law.870 It is also recognised as being
an element of the ethical principle of justice.871
Everyone has the right to equality.872 This is the right to equal protection from the law, equal
access to all rights and freedoms and the right to not be unfairly discriminated against.873
Given our history equality has a central place in our constitutional framework:874
868
Point 2.1 NHREC Guidelines (note 56 above).
869
Regulation 2(f) draft Regulations on Human Subjects (note 13 above).
870
Article 3 International Convention on Civil and Political Rights (note 175 above).
871
Tangwa (note 597 above) 56.
872
S 9 Constitution of the Republic of South Africa (note 2 above) and s 6 Promotion of Equality Prevention of
Unfair Discrimination Act 4 of 2000.
873
Ibid and S Jagwanth ‘Expanding equality’ (2005) Acta Juridica 131, 131.
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The policy of apartheid, in law and in fact, systematically discriminated against black people
in all aspects of social life. Black people were prevented from becoming owners of property
or even residing in areas classified as 'white', which constituted nearly 90% of the land mass
of South Africa; senior jobs and access to established schools and universities were denied to
them; civic amenities, including transport systems, public parks, libraries and many shops
were also closed to black people. Instead, separate and inferior facilities were provided. The
deep scars of this appalling programme are still visible in our society. It is in the light of that
history and the enduring legacy that it bequeathed that the equality clause needs to be
interpreted.875
Nevertheless equality is a difficult and idealistic notion.876 It can be violated not only when
people are treated differently (formal equality)877 but also when there is a failure to treat
persons whose situations are different in a different manner, that is, the need for non-




Brink v Kitshoff NO 1996 (4) SA 197 (CC) para 40.
876
Currie & De Waal (note 776 above) 230.
877
Minister of Home Affairs and Another v Fourie and Another is an example of formal equality 2006 (3) BCLR
355 (CC). In this matter gay couples were being treated differently to heterosexual couples as they were
excluded from getting married by s 30(1) of the Marriage Act 25 of 1961 which provided that a marriage was
the union of a wife and husband. The Constitutional Court held that this was a discriminatory form of unequal
treatment on the grounds of ‘sexual orientation’: para 114.
878
Jagwanth (note 873 above) 132–133. The Constitutional Court has held that ‘equality should not be
confused with uniformity . . . Substantive equality means treating persons with equal concern and respect
across difference. It does not presuppose the elimination or suppression of difference’: National Coalition of
Gay and Lesbian Equality v Minister of Justice 1999 (1) SA 6 (CC) para 132. President of the RSA v Hugo 1997 (4)
SA 1 (CC) is an example of the Constitutional Court’s approach to substantive equality. In this matter President
Mandela, using powers granted to him in the Interim Constitution of the Republic of South Africa, granted a
remission of sentence to all mothers who were in prison on 10 May 1004 (provided they fell in certain
categories) and had minor children under the age of 12. Hugo, an incarcerated male, who met all the
requirements except that he was a father as opposed to a mother, argued that President Mandela had acted
unconstitutionally in unfairly discriminating against fathers on the grounds of ‘sex’ when granting a presidential
pardon to prisoners. The Constitutional Court held that the President’s actions did not infringe the equality
clause as to discriminate against fathers in this context was not unfair. Mothers had been a group facing
enormous burdens and this had disadvantaged them. Thus relative to mothers, fathers were not a
disadvantaged group and it was not unfair to discriminate against them. In other words the Constitutional Court
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policy or conduct is discriminatory is achieved through the test for unfair discrimination.879
The Promotion of Equality and Prevention of Unfair Discrimination Act provides that
discrimination will exist if there is an ‘act or omission, including a policy, law, practice,
condition or situation which directly or indirectly imposes burdens, obligations or
disadvantage on; or withholds benefits, opportunities or advantages from any person on one
or more grounds’.880 The test for whether such discrimination is unfair is set out in section 14
of the Equality Act. It requires a consideration of whether the alleged discrimination was fair
by reviewing the context of the complaint, a range of factors relating to the impact and
justifications for the discrimination and whether the discrimination was based on objectively
determinable criteria, intrinsic to the activity.881
The only laws which refer to the rights of research participants to be treated equally are (a)
the draft Regulations on Human Subjects which state that their rights to equality must be
respected.882 They do not give any further detail on how this principle would apply to health
research. (b) The Schedule of an Illustrative List of Unfair Practices in certain Sectors which is
attached to the Equality Act. This Schedule lists subjecting persons to research without their
consent as an example of a discriminatory practice.883
held that treating men differently to women was not unfair as giving women preferential treatment resulted in
an equal outcome, a society based on egalitarian principles.
879
Jagwanth (note 873 above) 133.
880
S 1 Promotion of Equality and Prevention of Unfair Discrimination Act (note 872 above). The listed grounds
include race, gender, sex, pregnancy, marital status, ethnic or social origin, colour, sexual orientation, age
disability, religion, conscience, belief, culture, language and birth.
881
Factors include, amongst others, whether the discrimination impairs or is likely to impair human dignity, the
impact or likely impact of the discrimination on the complainant, whether the discrimination has a legitimate
purpose, the nature of the discrimination and any steps that have been taken to address diversity. See also C
Albertyn, B Goldblatt & C Roederer (eds) Introduction to the Promotion of Equality and Prevention of Unfair
Discrimination Act, Act 4 of 2000 (2001) where the application of the test for unfair discrimination is discussed
in more detail, 32–48.
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Regulation 2(f) Draft Regulations on Human Subjects (note 13 above).
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Promotion of Equality and Prevention of Unfair Discrimination Act (note 872 above) illustrative list of unfair
practices in certain sectors.
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It is submitted that the right to equality in this context means that research participants may
not be unfairly excluded from research participation on arbitrary grounds such as race or
gender as it has a disparate impact on their benefiting from the outcomes of health research.
This is a particularly important issue for children as traditionally they have been excluded
from research and this has resulted, for example, in the undesirable off-label use of
medication with them.884 The populations being targeted for the recruitment of research
participants should also not unfairly focus on certain groups which have to then
disproportionately bear the burdens and risks of research.
5.3 Obligations on researchers to promote the welfare of child research participants
5.3.1 Therapeutic research is in the best interests of the child885
Section 71(2) of the NHA provides that therapeutic health research with minors may only be
conducted if ‘it is the best interests of the minor’.886 This new norm requires researchers to
demonstrate that the nature of the therapeutic health research is such that it is in the best
interests of the potential child participants.887 This provision adds to the norms in section 11
of the NHA which deal with research which takes place at a health establishment or forms
part of a health service.888 However, there is no further guidance provided in the draft
Regulations on Human Subjects regarding how this principle is to be applied within the
context of health research with minors.
884
See Chapter One for more detailed discussion on this point.
885
This section is based largely on the ideas articulated in earlier work done in Stobie, Strode & Slack (note 59
above). In this Chapter, Strode was the second author. She wrote the sections describing the legal framework,
including the description of the best interests principle. The analysis of these principles was developed
collectively.
886
National Health Act (note 57 above). Therapeutic research is not defined in the NHA or the draft Regulations
but it has been suggested that this is research that holds out the prospect of direct benefit to the participant.
887
Stobie, Strode & Slack (note 59 above) 198.
888
National Health Act (note 57 above).
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The concept of the best interests of the child has been recognised within our common law
for almost 100 years.889 Our courts have generally held that in applying this principle a wide
range of factors should be considered to establish if a decision is to promote a child’s
physical, moral, emotional and spiritual welfare.890 Essentially courts must evaluate, weigh
and balance these competing factors including a consideration of the child’s wishes.891
In the post-Apartheid era considering the best interests of the child has become a
constitutional imperative as section 28(2) of the Constitution states that a child’s best
interests are of paramount importance in every matter concerning the child.892 The
Constitutional Court has stated that the standard should be flexible, as individual
circumstances will determine which factors secure the best interests of a particular child.893
Section 7 of the Children’s Act codifies the factors that ought to be used when applying this
principle: 894
(1) Whenever a provision of this Act requires the best interests of the child standard to be
applied, the following factors must be taken into consideration where relevant, namely
889
Stobie, Strode & Slack (note 59 above).
890
McCall v McCall (note 68 above).
891
F v F [2006] 1 All SA 571 (SCA) 10.
892
Constitution of the Republic of South Africa (note 2 above). The Constitutional Court has emphasised the
importance of the use of this principle in interpretation in S v M (Centre for Child Law as Amicus Curiae) (note
865 above) para 15 where it stated that the ‘comprehensive and emphatic language of s 28 indicates that just
as law enforcement must always be gender-sensitive, so must it always be child-sensitive; that statutes must be
interpreted and the common law developed in a manner which favours protecting and advancing the interests
of children; and that courts must function in a manner which at all times shows due respect for children's
rights.’ The best interests of the child is therefore both a right and a guiding principle: Minister of Welfare and
Population Development v Fitzpatrick and Others 2000 (7) BCLR 713 (CC) para 17.
893
Ibid para 18. The best interests inquiry has subjective and objective elements. In the Australian case of In
the Marriage of Homan the court held that the ‘test of the welfare of the child has to be determined having
regard to contemporary social standards, that is, it cannot be a totally subjective test based upon the views or
standards of the individual parent [or child or other interested party] but objective at least in the sense of
falling within the wider range of existing social standards’ (1976) FLC 90–024 quoted in J Heaton ‘Some general
comments on the concept of the best interests of the child’ (1990) Vol 53 THRHR 97, 101.
894
Children’s Act (note 4 above).
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(a) the nature of the personal relationship between
(i) the child and the parents, or any specific parent; and
(ii) the child and any other care-giver or person relevant in those
circumstances;
(b) the attitude of the parents, or any specific parent, towards
(i) the child; and
(ii) the exercise of parental responsibilities and rights in respect of the child;
(c) the capacity of the parents, or any specific parent, or of any other care-giver or
person, to provide for the needs of the child, including emotional and intellectual
needs;
(d) the likely effect on the child of any change in the child’s circumstances,
including the likely effect on the child of any separation from
(i) both or either of the parents; or
(ii) any brother or sister or other child, or any other care-giver or person, with
whom the child has been living;
(e) the practical difficulty and expense of a child having contact with the parents, or any
specific parent, and whether that difficulty or expense will substantially affect the
child’s right to maintain personal relations and direct contact with the parents, or any
specific parent, on a regular basis;
(f) the need for the child
(i) to remain in the care of his or her parent, family and extended family; and
(ii) to maintain a connection with his or her family, extended family, culture or
tradition;
(g) the child’s:
(i) age, maturity and stage of development;
(ii) gender;
(iii) background; and
(iv) any other relevant characteristics of the child;
(h) the child’s physical and emotional security and his or her intellectual, emotional,
social and cultural development;
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(i) any disability that a child may have;
(j) any chronic illness from which a child may suffer;
(k) the need for a child to be brought up within a stable family environment and, where
this is not possible, in an environment resembling as closely as possible a caring
family environment;
(l) the need to protect the child from any physical or psychological harm that may be
caused by:
(i) subjecting the child to maltreatment, abuse, neglect, exploitation or
degradation or exposing the child to violence or exploitation or other harmful
behaviour; or
(ii) exposing the child to maltreatment, abuse, degradation, ill-treatment,
violence or harmful behaviour towards another person;
(m) any family violence involving the child or a family member of the child; and
(n) which action or decision would avoid or minimise further legal or administrative
proceedings in relation to the child.
(2) In this section parent includes any person who has parental responsibilities and rights in
respect of a child.
Nevertheless, applying this principle to health research is complex.895 It has been argued that
achieving a balance between promoting the best interests of children as a class and as
individual research participants is difficult, as allowing the involvement of children in
research so as to develop new health interventions which are in the best interests of all
children, is not always in the best interests of those who bear the individual burdens and
risks of research participation.896 This task is made even more difficult by (a) the limited legal
literature on what this obligation means in the context of health research, and the absence
895
Stobie, Strode & Slack (note 59 above) 201.
896
200–201 ibid. Given this complexity it has been argued by some that it is not possible for some forms of
health research to be in the best interests of the child, instead it can at most not be contrary to their best
interests: see Roscam Abbing (note 47 above) for a more detailed explanation of this argument.
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of research-specific case law,897 (b) the wording in the NHA which requires therapeutic study
to be in the best interests of individual child participants rather than children as a class, and
(c) the limited examples of how the principle has been used in other jurisdictions except in
English law, where it has been argued that subjecting a child to an unacceptable risk level is
contrary to their best interests.898
Stobie et al submit that the principle should be applied in the following way:
Firstly, the need to protect children must be balanced with an equal need to facilitate their
participation in research. Secondly, the need to protect the child from research-related risks
must be balanced against the potential health benefits of enrolment to child trial
participants, as well as children in broader society who will benefit from receiving an
efficacious vaccine. The criteria used in the best interests analysis are able to accommodate
these diverse considerations when carefully balanced. It is not dissimilar to a risk-benefit
analysis, as it requires a consideration of both what may be harmful to the child and what
may benefit a child.899
5.3.2 Ministerial approval is obtained for non-therapeutic research with minors900
Section 71(3) of the NHA creates an obligation to obtain consent from the Minister of Health
for all forms of non-therapeutic research with minors.901 This is a new layer of research




Kennedy & Grubb (note 51 above) 1729–1730.
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National Health Act (note 57 above). The term non-therapeutic research is not defined in the National
Health Act but the draft Regulations on Human Subjects define it as ‘any research not directed towards the
benefit of individual but rather towards improving scientific knowledge or technical application and developing
generalisable knowledge’: Regulation 1 Draft Regulations on Human Subjects (note 13 above).
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research with minors meets scientific, ethical and public policy justifications. Any research
which does not receive ministerial consent may not be undertaken.902 The NHA requires the
existence of four pre-conditions before ministerial consent may be granted for non-
therapeutic research with minors.
i. Children must be indispensable to the research
Section 71(3)(b) of the NHA provides that research may only be approved by the Minister of
Health if it can be shown that participation of minors is indispensable to the research. This
condition appears to refer to the ethical principle of ‘scientific necessity’. Currently, the
NHREC Guidelines require researchers to justify the inclusion of children in a study. In other
words, there is an ethical obligation to expressly set out why the study could not be done on
a less vulnerable population such as adults.903 Researchers will have to show that the study
relates to, for example, the health of children living in child-headed households and
therefore cannot be undertaken on any other population.
ii. The research will result in significant improvement in the understanding of the minor’s
condition or disorder
Section 71(3)(b) of the NHA requires researchers to demonstrate that the study will result in
a significant improvement in the understanding of the minor’s condition or disorder. It is
argued that this consideration also requires the scientific merits and its relevance to be
demonstrated. In other words, it appears that the Minister of Health may only grant consent
for the study to be undertaken if it can be shown that it will result in ‘significant’
improvements to our understanding of the condition or disorder.
The wording used in this instance is problematic as so-called non-therapeutic research
involves the enrolment of healthy individuals and not those with a condition or disorder.
902
Strode, Slack, Wassenaar & Singh (note 119 above) 202.
903
S 5.3.1 NHREC Guidelines (note 56 above) and Pope (note 93 above) 179.
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Accordingly, it has been argued that the use of the words ‘condition, disease or disorder;
should be interpreted broadly to include something a minor may be at risk of acquiring at
some point in the future. or a set of physical, psychological, neuro-developmental, or social
characteristics that has been shown to affect the health, well-being or risk of future health
problems for children’.904 This appears to be the only way in which so-called non-therapeutic
research which involves healthy children can be approved. This would mean, for example,
that an HIV vaccine study could be undertaken with children. In such a case, HIV negative
children would be enrolled and it would have to be argued that although they do not have
the ‘condition’ (HIV) they are at risk of acquiring it.
iii. Consent to the research will not be contrary to public policy
The third consideration that must be taken into account by the Minister of Health in terms of
s 71(3)(b) is whether consent to the research by the parents, legal guardian or the minor will
be contrary to public policy.905 It is a well-established common law principle that consent to
medical treatment must not be contra bonos mores.906 It has been argued that this requires
any consent to harm or the risk of harm to be in line with public policy and prevailing legal
norms.907 In determining the acceptability of the consent it is submitted that courts examine
prevailing legal norms within that particular area of the law, including those established by
the Constitution.908 For child research, the Minister of Health would have to examine the
legal norms underlying children’s law and research-related legislation. Key considerations
could be the emphasis in the Children’s Act on promoting child well-being and protecting
children from discrimination, exploitation and any other physical, emotional or moral
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presents acceptable standards of risk.910 The NHA sets a standard of acceptable risk by
stating that the non-therapeutic research with minor’s research must not pose a significant
risk to their health.911
iv. The research does not pose a significant risk to the minor, or if there is some risk this is
outweighed by the benefits to the minor
The final consideration for the Minister of Health when approving non-therapeutic research
with minors is that the health research must not be a significant risk and if there is some risk
it must be outweighed by the benefits to the minor.912 ‘Significant risk’ is a new term within
our ethical-legal framework. Currently, the highest acceptable level of risk for non-
therapeutic research set in most ethical guidelines is that of a minor increase over minimal
risk.913 It appears that a significant risk may represent a new upper level of risk as it appears
to be more than a minor increase over minimal risk.
Finally, the draft Regulations do not deal with how or when ministerial consent must be
obtained. Thus, although this provision became operational on 1 March 2012 it appears that
no applications for ministerial consent have been made as yet. How the provision will
operate in the future is unclear. It is possible that any regulations which are published in the
future will detail how researchers apply for ministerial consent after receiving ethical
approval (See Figure 3 below).
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Figure 3: The possible procedure that will have to be followed when undertaking non-
therapeutic health research with minors
5.3.3 Mandatory reporting of children in need of care and protection
There are a number of legal provisions which ensure that children in need of care or
protection are identified and steps taken to protect them from further harm. These
provisions place obligations on various people to report children who are being abused,
neglected or who are in need of care and protection.914 Children participating in research are
914
S 110 Children’s Act (note 4 above). The Children’s Act defines all three terms. Abuse is defined as ‘any form
of harm or ill-treatment deliberately inflicted on a child, and includes— (a) assaulting a child or inflicting any
other form of deliberate injury to a child; (b) sexually abusing a child or allowing a child to be sexually abused;
(c) bullying by another child; (d) a labour practice that exploits a child; or (e) exposing or subjecting a child to
behaviour that may harm the child psychologically or emotionally’. Neglect is described in the same section as
‘a failure in the exercise of parental responsibilities to provide for the child’s basic physical, intellectual,
emotional or social needs’: s 1 ibid. In contrast children in need of care and protection are defined according to
the vulnerable circumstances they may find themselves in. S 150(1) provides that a child will be in need of care
and protection if (a) they have been abandoned or orphaned and are without any visible means of support; (b)
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in a special relationship with researchers and in certain circumstances as a result of
information disclosed or discovered, mandatory reporting obligations may be triggered.
Furthermore, the draft Regulations on Human Subjects require researchers to comply with
mandatory reporting obligations by at a minimum providing that they must ‘refer
participants for professional assistance where necessary’.915
The Children’s Act requires reportable information to be submitted to the provincial
Department of Social Development, a designated child protection organisation or the police
for further investigation.916 Section 110(1) of the Children’s Act identifies the following
persons who are mandatorily required to report a child in need of care and protection, they
include:
Any correctional official, dentist, homeopath, immigration official, labour inspector, legal
practitioner, medical practitioner, midwife, minister of religion, nurse, occupational therapist,
physiotherapist, psychologists, religious leader, social service professional, social worker,
speech therapist, teacher, traditional health practitioner, traditional leader or member of
staff or volunteer worker at a partial care facility, drop-in centre or child and youth care
centre.
are displaying behaviour which cannot be controlled by the parent or care-giver; (c) lives or works on the
streets or begs for a living; (d) is addicted to a dependence-producing substance and is without any support to
obtain treatment for such dependency; (e) has been exploited or lives in circumstances that expose the child to
exploitation; (f) lives in or is exposed to circumstances which may seriously harm that child’s physical, mental or
social well-being; (g) may be at risk if returned to the custody of the parent, guardian or care-giver of the child
as there is reason to believe that he or she will live in or be exposed to circumstances which may seriously harm
the physical, mental or social well-being of the child; (h) is in a state of physical or mental neglect; or (i) is being
maltreated, abused, deliberately neglected or degraded by a parent, a care-giver, a person who has parental
responsibilities and rights or a family member of the child or by a person under whose control the child is living.
915
Regulation 3(f) draft Regulations on Human Subjects (note 13 above).
916
S 150(2) Children’s Act (note 4 above). The Children’s Act also refers specifically to children performing child
labour and those living in child-headed households as being in need of care and protection: s 150(2). The report
must be made in a standard way on Form 22, Regulation 33(1) Government Gazette Regulation Number
497/35476/3 29 June 2007.
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Although researchers are not specifically listed as a group of persons who must report, some
members of a research team may be obligated because they are medical practitioners,
nurses, psychologists or social workers. Furthermore, the Children’s Act also provides that
‘any person who on reasonable grounds believes that a child is in need of care and
protection’ may report such a belief to the provincial Department of Social Welfare, a
designated child protection agency or the police.917 The use of the word ‘may’ in this section
implies that such persons are not compelled by law to report a belief that a child is in need of
care or protection. Nevertheless, it could be argued that given the research relationship,
they may be ethically bound to protect the child by reporting their circumstances to the
authorities.
There are also provisions in other laws which place obligations on certain persons to take
steps to protect children, which may or may not be linked to reporting obligations. In some
forms of child research they may place obligations on researchers. Such provisions include
obligations to ensure that children are:
(i) Not required to work before the age of 15, and that those that are older than 15
do not undertake work that places their well-being, education, physical or mental
health, or spiritual, moral or social development at risk.918 Although there is no
legal obligation to report children in this situation in employment legislation, any
person may contact a labour inspector at the Department of Labour to inform
them of a child performing child labour or inappropriate work. Furthermore the
definition of abuse in the Children’s Act includes ‘a labour practice that exploits a
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(ii) Protected from sexual offences in terms of the Criminal Law, Sexual Offences and
Related Matters Amendment Act, such as rape, sexual assault, sex work, under-
age sex/sexual activity or sexual exploitation.920 Any person who is aware of a
sexual offence having been committed against a child must report this to the
police.921 These provisions place obligations on researchers to report any
knowledge of sexual offences against children. Researchers involved in research
on child sexuality, reproductive health or even broader issues may well become
aware of sexual offences, such as incest or abuse.922 They may also be faced with
the complexities of reporting consensual sex in for example, in HIV prevention
trial where participants under the age of 16 may be engaging in inter-generational
but consensual sex.923 Bhana et al suggest that in such situations researchers
should work with Childline who can act as an intermediary in the reporting
process:
. . . report the matter to Childline South Africa at toll-free number 0800 055 555.
Childline will then contact a registered social worker in the area who will investigate
and inform the South African Police Service (SAPS) accordingly. The interviewer will
record details of the child’s name, physical address and the school attended. As proof
of meeting the statutory reporting obligation, the interviewer must obtain a Childline
reference number as proof of reporting.924
920
Sexual Offences Act (note 765 above). The Act prohibits a wide range of sexual offences including amongst
others rape, s 3; sexual assault, s 5; and incest, s 12. The Act also contains a number of child specific sexual
offences such as consensual sexual penetration with certain children, s 15; consensual sexual violation of





A Bhana, S Swartz & A Davids ‘Standards for reporting of sex/sexual activity of minors in a research context’
2010) Vol 100(10) SAMJ 642, 642.
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See Strode & Slack (note 143 above) for a more detailed discussion of this issue. Also see s 5.2.2(vi) above for
more detail on this point.
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(iii) Able to attend school between the ages of seven and 15. All children between
seven and 15 must attend school in terms of the South African Schools Act.925
Although there is no reporting obligation, parents are required to ensure that
their children of school-going age attend school.926 This has implications for
researchers working with children between the ages of seven and 15 as they must
consider whether to inform parents if they are aware that children are not
attending school.
5.3.4 An appropriate risk standard
It is a well-accepted ethical principle that children may only participate in research if there is
an acceptable level of risk.927
Currently the law does not set a clear legal standard for acceptable levels of research-related
risk with children.928 Accordingly, some authors refer to ethical guidelines to fill this void929
as they provide that research interventions should pose acceptable levels of risk for child
participants.930 The draft Regulations on Human Subjects change the current position by
setting express risk standards that cannot be exceeded when undertaking research with
children:
925
S 3(1) South African Schools Act 84 of 1996.
926
Parents who fail to comply with the South African Schools Act are guilty of an offence: s 3(5) ibid.
927
Wendler & Grady (note 397) above) 203.
928
Strode, Slack, Grant & Mushariwa (note 114 above) 224.
929
Van Wyk (note 13 above) 48.
930
Points 2.9 and 5.2 NHREC Guidelines (note 56 above). These provide that where the research or research
interventions do not hold out the likelihood of direct health-related benefit for the child participants, the
allowable level of risk is a ‘slight’ increase over the risks children would normally face in their everyday lives,
and this is justified by a risk-knowledge ratio. In other words, there should be only a minor addition to life’s risk
as a result of the research intervention: s 5.2. Only MRC Book One (note 12 above) does not allow any increase
over everyday risk for non-therapeutic research. Where the research or interventions in the research do hold
out the prospect of direct benefit, then the allowable level of research risk is not specified but is justified by the
benefits to individual child participants, that is, a risk-benefit ratio ibid.
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4.(1) Children can only participate in research in instances where:
(a) the research poses a minimal risk to the child;
(a) the research poses a greater risk, but possibly be for the benefit of the child;
(b) the research can only be done on children; and
(c) the parent or legal guardian of the child gives consent for such a child to participate.
Always, refusal to participate by a child should precede the consent of the guardian..931
The draft Regulations conflict with the position in national ethical guidelines as they do not
allow a minor increase over minimal risk which prohibits most clinical trials from taking
place.
5.3.5 Children must be indispensable to the research
It is a well-established ethical principle that children should be indispensable to the
research.932
There is no current law which requires researchers to demonstrate that children are
indispensable to the study. It is however a criterion that the Minister of Health must consider
when giving consent for non-therapeutic research with minors.933 It is also a well-established
ethical guideline, with the NHREC Guidelines providing that ‘minors should participate in
research only where their participation is indispensable to the research’.934 A similar point is
made with regard to social science research in the ethical guidelines on research with
children issued by the HSRC.935 This means that RECs must find research with children to be
ethical only if researchers are able to demonstrate that it is not possible to do the research
with a less vulnerable group. For example, if researchers propose a study of low birth weight
931
Regulation 4(1) draft Regulations on Research with Human Subjects (note 133 above).
932
Andanda (note 166 above) 63 and Guidance Point 14 CIOMS (note 182 above).
933
S 71(3)(b) National Health Act (note 57 above).
934
S 5.1 of the NHREC Guidelines (note 56 above).
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HSRC Guidelines (note 541 above).
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babies, although these are frequently born to young mothers, they must justify why they
could not get the same data from mothers who are 18 and older.936
The draft Regulations change this position by providing that children must be indispensable
to the research.937 This transforms the ethical norm into a legal obligation and it becomes an
important protection ensuring that children are not used in health research unless scientific
indispensability can be demonstrated.
5.4 Conclusions
There is currently a normative framework which sets out the rights of research participants
and the circumstances in which health research may take place. This focuses primarily on
informed consent as the key mechanism for protecting research participants. However, the
rights to privacy, dignity and equality are also described in the draft Regulations. Many of the
norms created by the NHA are child-specific and there is a strong focus on ensuring that only
appropriate research with children is undertaken. This is done though the provisions in the
NHA which require therapeutic research to be in the best interests of the child and non-
therapeutic research to have ministerial consent. These are supplemented by provisions in
the draft Regulations which set appropriate risks standards and require researchers to
demonstrate that they are indispensable to the study. As a result of these norms, research
with children can only be undertaken if:
(i) Written consent is obtained from the child’s parent or legal guardian;
(ii) Written consent is obtained from the child if they have understanding;
(iii) Consent is obtained from the participant’s health care provider, the head of the
institution and its REC if the research takes place at a health facility or is an
experimental health service;
936
Personal communication, Professor Wassenaar, chair Bio-medical Research Ethics Committee, University of
KwaZulu-Natal, 18 November 2012.
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Regulation 4(1)(e) Regulations on research with Human Subjects (note 13 above).
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(iv) It has been demonstrated that therapeutic research is in the best interests of the
child;
(v) Ministerial consent has been obtained for non-therapeutic research; and
(vi) Mandatory reporting requirements are complied with.
When the draft Regulations are finalised, researchers will have to ensure:
(i) Research participants’ rights to privacy, dignity and equality are protected;
(ii) The study does not exceed the set risk standards; and
(iii) It has been demonstrated that children are indispensable to the study.
The current framework has dealt with a number of problems that existed before the NHA
was fully implemented. Firstly, it has clarified the issue of when and how children can
participate in non-therapeutic health research. The NHA recognises that children (minors)
can participate in all forms of so-called non-therapeutic research, including studies that
involve invasive procedures. In the past there were divergent approaches in ethical
guidelines regarding the types of non-beneficial research children could participate in.
Secondly, there was a lack of uniformity regarding the age at which children could consent
independently to health research. This has been settled by section 71 of the NHA which does
not allow independent consent to health research.
While this new framework strengthens the protections for child research participants,
cumulatively these new protections will reduce the pool of children eligible to participate in
health research, place additional administrative burdens on researchers and may result in
time delays.
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Using Nielsen’s models for classifying ethical-legal frameworks the normative framework can
be considered to fall within the prohibitive approach as the norms are highly restrictive.938
Even though children or minors are not excluded per se from participating in health research,
the over-emphasis on protection severely limits the circumstances in which they may
participate in health research. The emphasis in the normative framework is on substantive
protections for child research participants and accordingly there is less flexibility in the
standards and very little focus on child or parental autonomy.
In conclusion, the normative framework is now overly protective and does not facilitate
research; there is also a limited focus on child participation as there are no circumstances in
which children can consent independently to research and only a cursory reference to
children assenting to research participation.
938
Nielsen (note 42 above) 42. See Chapter Two for a more detailed discussion of this model.
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Chapter Six:
A critique of the ethical-legal framework for regulating health
research with children
In the preceding Chapter the normative framework for health research was set out. It
described the rights of research participants to participate in health research only with
informed consent, to be treated equally, to have their privacy respected and their dignity
protected. It also detailed the five obligations on researchers to promote the welfare of child
research participants including, firstly, to ensure that children are indispensable to the study.
Secondly, to demonstrate that the research has an acceptable risk standard. Thirdly, to show
that therapeutic research is in the best interests of minors. Fourthly, to obtain ministerial
approval for non-therapeutic research. And fifthly, when necessary, to comply with
mandatory reporting requirements.
Chapter Five concluded by stating that a well-developed normative framework exists in
South Africa, which describes the rights of research participants and the circumstances in
which health research may take place. Furthermore, it deals directly with when and how
children should participate in health research and, as a result, researchers must comply with
nine key norms. However, the framework is over-protective and in the future will hinder the
amount and nature of research that can be undertaken with children. As a result it can be
considered to fall within the prohibitive approach of the ethical-legal models described by
Nielsen.939
This Chapter uses the norms described in Chapter Two of this dissertation as benchmarks
against which the current South African ethical-legal framework is measured. It concludes
939
Nielsen (note 42 above) 42. See Chapter Two for a more detailed discussion of this model.
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with an assessment of the extent to which the framework protects child research
participants, facilitates their involvement in research-related decisions and facilitates
research.
6.1 Introduction
Chapters One and Two of this thesis argue that the regulation of research is important to
safeguard participants from harm940and ensure that the interests of society or science do not
outweigh the individual interests of research participants.941 At a micro-level, research
regulation creates a framework for the procedural and substantive regulation of individual
studies.942 Following the approach of Nielsen it is submitted that the regulation of research
ought to ensure that norms which declare certain interests as worthy of protection are
established.943 Furthermore, these norms ought to be carefully balanced so that the interests
of various stakeholders do not outweigh the rights of research participants. Finally, the
norms ought to be enforced though an institutional framework which can make declarations
on certain issues, thus clarifying the manner in which norms are applied in individual
situations.944 Accordingly, it is submitted that the key elements of an effective ethical-legal
framework are: it must require research to demonstrate scientific indispensability, ie that it
cannot be done without human participants; it carries an appropriate risk standard; it will
undergo scientific and ethical review; and there is the protection of research participants’
rights.945 Using these principles this thesis argues that to meet these standards, ethical-legal
frameworks require firstly, institutions which are able to (a) create policy guidance on the
most appropriate forms of research that ought to be undertaken, (b) review and regulate
research (scientifically and ethically), issue ethical norms and standards dealing with both
940
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procedural and substantive issues, (c) liaise with and involve the community, and (d)
implement effective enforcement mechanisms. Secondly, it requires legally established
norms which set minimum standards for the conduct of research.
6.2 Review of the extent to which South Africa’s current institutional framework meets key
international norms
It has been argued that an ethical-legal framework protects research participants by setting
procedural obligations enforced by institutions.946 Accordingly, these institutions play a
critical role in ensuring that children are protected, that they participate in research decision-
making, and that research with them is facilitated.
Currently South Africa has a good institutional framework which is created by, amongst
others, the NHA947 and the Medicines Act.948 This framework has established as statutory
bodies, the NHRC,949 the MCC,950 the NHREC,951 and institutionally based RECs.952 In some
circumstances Community Advisory Boards (CABs) exist even though currently there is no
direct legal obligation to establish such structures.953
6.2.1 Research policy body: NHRC
There is no international ethical-legal norm regarding the need for a policy-making body to
establish the priority research areas for a country. However, the well-established ethical
principle of justice requires ‘fairness in the treatment of individuals and communities and the
946
Glantz (note 90 above) 128.
947
National Health Act (note 57 above).
948
Medicines Act (note 164 above).
949
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227
equitable distribution of the burdens and benefits of research’.954 Accordingly, participants
should be invited to participate in research ‘for reasons directly related to the problem being
studied’ not because of their ‘easy availability, their compromised position, or their
manipulability’.955 This principle places an obligation on RECs to consider whether the
research will be relevant to the participants and their communities. It is submitted that the
establishment of institutions to establish such priorities facilitates the implementation of this
ethical principle. There are many examples in other jurisdictions of institutions which have
been established to set research priorities.956 More recently, some of the international
discussion on this issue has focused expressly on the mechanisms (institutional and other)
for public participation in setting the research agenda.957
Within the current framework, the NHA and its accompanying regulations create a statutory
body, the NHRC, to set research priorities for health research undertaken by or on behalf of
the public sector.958 This is a significant departure from the past in which (a) national
research priorities were established in two separate silos (social science and medical
research),959and (b) there were allegations of the research agenda being driven by political
ideology.960
954
Tangwa (note 597 above) 56.
955
K Moodley ‘HIV vaccine trial participation in South Africa’ (2002) Vol 27(2) Journal of Medicine and
Philosophy 197, 209.
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See Chapter Two for more discussion on this point.
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See for example, Bhan, Singh, Upshur, Singer & Daar (note 343 above) 0040272.
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See Chapter Four for a detailed discussion on the policy framework for setting research priorities.
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See Chapters Three and Four for a discussion on how the HSRC and the MRC advised their respective
ministers on research priorities.
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It has been submitted that during the Apartheid era health research aimed at achieving ‘two primary
considerations: (a) the desire to improve the health of white citizens; and (b) the desire to improve the health
of non-white citizens, but primarily only in so far as their health posed a threat to white citizens, or threatened
to undermine the national economy. As such, health research in the country was motivated by economic
considerations and not humanitarian ones’: Singh & Strode (note 45 above). See Chapter One for further
discussion on this issue.
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The strength of the approach taken by the NHA is that as a statutory body the NHRC has
defined roles and responsibilities and can be held accountable to the Ministry of Health.
Furthermore, the NHA has expressly identified children as a vulnerable group requiring
prioritisation in the research plans of the NHRC.961 This places a statutory obligation on the
NHRC to ensure that research benefiting children is prioritised. Although not required by the
NHA to act consultatively, the NHRC has held four national conferences with key research
stakeholders in developing and updating the research agenda.962 It is argued that this
consultative approach minimises the possibility of political interference in the development
of the research agenda.
It is submitted that there are two key weaknesses with the structure and functions of the
NHRC. Structurally, the NHA does not assert the independence of the NHRC. Given our
apartheid history in which the research agenda was motivated by political ideology, ensuring
that the NHRC is able to act independently is important. It was argued in Chapter Two that
finding the balance between oversight and interference in the research agenda is complex.
Furthermore, this must be done within the framework of the constitutional right to freedom
of expression which includes a right to ‘academic freedom and freedom of scientific
research’.963 Research priorities should be rational and not promote a particular political
ideology. If the statutory body mandated to set such priorities is independent it facilitates
such an approach. However, the NHA fails to state that the NHRC is an independent body.
Furthermore, the Regulations only refer to possible conflicts of interest in one instance,
requiring that members voluntarily recuse themselves if a potential conflict arises.964 Of even
greater concern is that in two instances the Regulations potentially undermine the
independence of the NHRC through:
961
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Regulation 7(7) Regulations on the Establishment of the NHRC (note 671 above).
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(i) Providing that the Minister of Health may make appointments to the NHRC if
there are no or ‘insufficient’ nominations for positions on the Committee.965
There is no process of calling for further nominations or for the soliciting of
nominations from experts in the field of health research. The circumstance in
which the Minister may declare that there are ‘insufficient’ nominations is not
specified. It is submitted that this gives the Minister the power to potentially
subvert the process of nominations to the NHRC and to appoint persons
sympathetic to a particular research agenda; and
(ii) The Minister of Health has the power to appoint the Chairperson and Deputy
Chairperson of the NHRC.966 It is submitted that this gives the Minister undue
control over the workings of the Committee, instead of allowing the members to
appoint their own chairperson and deputy.
Furthermore, the NHA and the Regulations are silent on who the Committee reports to on an
annual basis. However, given that the members of the Committee are appointed by the
Minister of Health, it is assumed that they report to him or her rather than to parliament. It
is argued that this further undermines the independence of the NHRC.
A further structural weakness of the NHRC is that neither the NHA nor its Regulations
provide any mechanism for the Committee to enforce its research agenda.967 Although
researchers are required to submit research to the provincial health research committees it
is not clear what such committees could do if institutions fail to comply. It is argued that the
Regulations ought to have established a link between the NHRC, the NHREC and RECs in






Ironically the Regulations allow researchers or research institutions to appeal against decisions made by the
NHRC but do not provide the Committee with any means to enforce its own decisions: Regulation 10(3) ibid.
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of national and provincial research priorities. This could also assist the NHRC in fulfilling one
of its core roles, that of co-ordinating health research.
A key gap in the statutory role created for the NHRC is the inadequate approach to public
participation in setting the research agenda. As set out in Chapter Two, Holman and Dutton
argue that the public ought to participate in the development of research policies as their
democratic right, thereby ensuring that public interests are reflected in research policies.968
The NHA does not create such a role for the NHRC. The Regulations accompanying the NHA
simply provide that the NHRC must have as one of its members a community
representative.969 However, neither the NHA nor its Regulations describes or creates any
other mechanism for engaging with the public on the development of research priorities. As
a result the NHRC appears to view stakeholder engagement as consultation with researchers
and research institutions. For example, at the most recent prioritisation conference, 271
delegates attended, none of these represented community groups, or even community
advisory boards.970 Most delegates came from either the Department of Health or RECs.971
6.2.2 National drug regulatory authority: MCC
The Helsinki Declaration provides that research must conform to scientific standards and
clinical trials should be registered with an appropriate regulatory authority.972
The national drug regulatory authority in South Africa is the MCC which is established in
terms of the Medicines Act.973 The strength of the approach is that the MCC has been
created as a statutory body with an obligation to ensure that drugs are safe, efficacious and
968
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their use is in the interests of the public.974 This includes a mandate to regulate clinical trials
which may precede the registration of a new drug.975 A further strength is that there is a
direct link between the MCC and the NHREC as a member of the MCC is required to sit on
the NHREC.976 This means that the legal framework requires some co-ordination in the
regulation of clinical trials between the national drug regulatory authority and the national
ethics structure. This is significant as the overlapping of roles between these two bodies has
been identified as a key complexity by the WHO.977
A key weakness in the way in which the Medicines Act has established the MCC is that it fails
to provide that the MCC is an independent body. Furthermore, following a recent change to
the Medicines Act the MCC is now no longer accountable to the legislature but directly to the
executive through the Minister of Health.978 Vawda submits that although the MCC has the
appearance of an independent institution being a juristic person, it is in terms of its new
structure simply one of the many line functions of the Department of Health.979 This lack of
clear statutory protection regarding the independence of the MCC as an institution
compounds pre-existing concerns with the MCC. For example, there were allegations that
the former Minister of Health, Dr Tshabala-Msimang interfered in its work and this new
structure will not prevent such interference in the future.980 Singh gives a further example of
the failure of the MCC to register an HIV prevention trial during a period in which the then
974
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President Thabo Mbeki denied the existence of HIV. 981 In this instance researchers had to
resort to a High Court action to compel the MCC to authorise the clinical trial.982 It has been
submitted that the lack of institutional separation from the Department of Health is thus a
flaw which has enabled political interference in its work.983 Furthermore, it impacts on the
reputation of the MCC as it no longer appears to be able to act as an independent body.984 A
further concern with the the lack of structural independence of the MCC is the issue of
‘regulatory capture.985 There are concerns in the literature that if drug regulatory authorities
are not structured in a way that ensures efficiency, accountability and transparency they can
inadvertently become ‘captured’ by the interests of drug companies and begin to serve their
priorities over the interests of the general public.986 In the current context, where the MCC
reports directly to the Minister of Health, it poses a risk that it may be captured by political
rather than private industry interests.
There are two key gaps in the structuring of the MCC. Firstly, the Medicines Act does not
create a mechanism for the engagement of the public in decisions regarding when to register
a new drug. Given that one of its roles is to ensure that the registration of a drug is in the
interests of the public it appears to be an anomaly not to have strong community
981
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representation on the MCC. Furthermore, while there is a structural link between the MCC
and the NHREC, the MCC does not have any formal relationship with the NHRC.987
Secondly, the Medicines Act does not deal in detail with the regulation of clinical trials. It
does however provide that the MCC may only register medicines if it is satisfied with the
application and this implies the application must be based on research.988 It is argued in
Chapter Four that this implies that the MCC’s role is to ensure that trials are scientifically
valid and will provide information on whether the product could be registered for use in
South Africa. However, this is not clearly specified. The concern with this approach is that it
means in reality that the national drug regulatory authority has a much greater focus on the
post-trial approval of drugs rather than the registration or supervision of clinical trials.989
6.2.3 National Research Ethics Structure: NHREC
Although there is no international norm on a national research ethics structure this thesis
argues in Chapter Two that RECs should operate within a national framework. This should
include affiliation to a national structure which monitors the composition, training, standards
of ethical review and the reporting requirements of RECs.
In South Africa, a national research ethics body exists, namely the NHREC,990 which is a
statutory body established by the NHA.991 This is significant as in the past there was no direct
regulation of RECs and they were not required to follow national ethical guidelines unless the
research was defined a clinical trial.992
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The strengths of the NHREC are that: one, it is a statutory body with defined roles and
responsibilities; and its structure as created by the NHA and the accompanying Regulations
enable it to fulfil its roles regarding the issuing of norms and standards, exercising oversight
over RECs and advising government. Two, its empowering legislation requires it to be made
up primarily of experts in the field of research ethics. 993 This ensures that it has the capacity
to carry out its mandate. Three, the NHREC has been able to ensure national uniformity in
research ethics by issuing national ethical guidelines,994 accrediting RECs and auditing
RECs.995 Four, the ethical guidelines issued by the NHREC are legally enforceable as section
73(2)(b) of the NHA provides that RECs must give ethical approval for health research which
meets ‘the ethical standards of that health research ethics committee’. It has been argued
that the ‘standards of that REC’ is a reference to the NHREC Guidelines.996 Five, the structure
of the NHREC as described by the NHA does to some extent address the lack of a national
body which co-ordinates all institutions within the ethical-legal framework997 as the
Regulations require that the NHREC be made up of, amongst others, a representative of the
MCC.998 Six, the NHREC is given the authority to discipline any person violating norms and
guidelines established by the NHA.999 This is significant as it has moved our framework away
from the professional control model in which the primary regulation of the conduct of
researchers was exercised by professional bodies such as the Health Professions Council of
South Africa.1000 The provisions in the NHA allow the NHREC to discipline ‘any person’ who
has violated norms set by the NHREC or those found in the NHA.1001 It is argued that this
993
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means that field workers, data capturers and other researchers who are not registered with
a professional body may be disciplined for an ethical-legal violation.
The weaknesses of the framework creating the NHREC are that firstly, its independence is
undermined to some extent by the powers given to the Minister of Health in the Regulations.
Although the Minister must call for nominations to the Council through a public process, if
none or ‘insufficient’ nominations are received, the Minister may simply appoint persons to
the NHREC.1002 Furthermore, just as in the case of the NHRC, the chair and vice-chair are
appointed by the Minister of Health.1003 Both these provisions undermine the independence
of the NHREC and its ability to perform its key functions.1004 Furthermore, the NHREC is
required to report to the Minister of Health rather than parliament, which again does not
facilitate the Council acting as an independent advisory and regulatory body on ethical
issues.1005
Secondly, although empowering the NHREC to discipline any person who violates ethical-
legal norms is an important innovation, the NHA has undermined this by only expressly
including one sanction, that of referring violations by health care workers to relevant
statutory bodies for disciplining.1006 Accordingly, it is unclear what other type of sanctions
1002
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could be applied to a member of a research team who cannot be defined as a health care
worker.
Finally, it is a key gap that the NHA does not provide a structural way of linking the work of
the NHREC and the NHRC.
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6.2.4 Research Ethics Committees
It is a well-established, international ethical-legal principle that health research should be
submitted for ethical review.1007The important role of RECs within ethical-legal frameworks
has been cemented by both the Helsinki Declaration and the WHO’s GCP Guidelines which
require researchers to develop a research protocol and submit this for ethical review.1008 In
essence this requires that an independent committee should provide third party assessment
of research protocols in order to minimise possible conflicts of interests, protect research
participants and avoid the exploitation of vulnerable individuals or communities.1009
South Africa has a well-established ethical-legal framework for RECs. Section 73 of the NHA
requires every institution, agency or health establishment conducting health research to
establish or have access to an REC.1010 The draft Regulations on Human Subjects provide
further that there is an obligation on health researchers to obtain ethical review of their
protocol.1011 This innovation in the NHA is significant as in the past there was no legal
obligation on institutions to establish RECs or on researchers to submit their protocols for
ethical review, unless they were undertaking research for the MRC or conducting a clinical
trial.1012
The strengths of the framework are: firstly, that institutions, agencies and health
establishments conducting health research are required by the NHA to establish RECs. This
places a legal obligation on institutions to ensure that ethical review of health research takes
place and a failure to create this infrastructure could result in the institution being
1007
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sanctioned by the NHREC.1013 Secondly, RECs operate within a national framework in terms
of which they are accountable not only to their institution but also the NHREC which
registers and accredits them.1014 This ensures that ethics review is of an acceptable standard
and operates in accordance with national norms and standards. It also assists with ensuring
that RECs are administratively competent as they may be audited by the NHREC.1015 Thirdly,
RECs are required to consider whether the proposed health research is relevant and will
‘promote health, contribute to the prevention of communicable or non-communicable
diseases or disability or result in cures for communicable or non-communicable diseases’.1016
It is argued that this places an obligation on RECs to consider the objectives of the proposed
study and whether they are relevant to the local context. Fourthly, section 73 of the NHA
applies to all health research1017 which creates a very broad obligation for all forms of health
research to be reviewed, even those that do not have human subjects, such as record
reviews.1018
It is argued that there are no structural weaknesses in the way in which the NHA and its
accompanying regulations deal with RECs except in relation to the role of community
participation in REC decision-making. Currently, the NHREC Guidelines require each REC to
appoint a community representative as a member of the committee. Nevertheless, who such
an individual should be and how they can reflect the voice of the community in ethical
decision-making is unclear. At an implementation level the NHREC also appears to have
1013
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weaknesses. It has noted that 23 per cent of all RECs are less than three years old.1019 It is
possible that such committees may be inexperienced and lack expertise. It is also probable
that this impacts on the quality of ethical review. Furthermore, there are no RECs registered
with the NHREC in three provinces, Mpumalanga, the North West and the Northern Cape.1020
This is of particular concern as there are a number of tertiary institutions in these provinces
and it may indicate that research is either being reviewed by unregistered RECs or not being
reviewed at all.
Finally, it is a shortcoming that the NHA does not expressly require ethical review of all
health research, as there is an inappropriate exception to ethical review provided for in
section 16(2) of the NHA. This allows record reviews to be done by health care providers
without ethical approval, provided no personal identifiers are obtained during the study. This
treats record reviews by health care providers differently to those being done by other
researchers, such as social scientists, and is out of step with international norms.
6.2.5 Community Advisory Groups
In Chapter Two it was argued that it is an emerging international ethical norm that in large
community-based studies, some type of structure must be established to facilitate
engagement between researchers and communities.1021
In South Africa, there is no statutory body within the ethical-legal framework to facilitate
public participation in research. However, the NHREC has issued Guidelines on the
establishment of CAGs (study or site-based committees which act as a liaison between
1019
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researchers and the community).1022 These guidelines are the first set of national guidelines
dealing with when and how CAGs should be set up.
One of the strengths of the South African system is that national guidelines on CAGs exist. It
is submitted in Chapter Four that these Guidelines are indirectly enforceable as they are
norms and standards regulating the conduct of research issued by the NHREC in terms of
section 72(6)(c) of the NHA.1023 The Guidelines are very broad and provide direction on when
a CAG ought to be established, its role and how it ought to function.1024 Although Principal
Investigators must determine whether a CAG should be established RECs are given the
responsibility of providing oversight on this decision. This is a flexible approach which
enables decisions as to when a CAG is required, to be made at local site level.
A weakness of the system is that oversight is to be provided by RECs, but they can only
intervene once an application for ethical approval for the study has been submitted. At this
stage, the study design, methodology and procedures have already been developed and
therefore, if ordered to establish a CAG at this point, communities may have missed the
opportunity for consultation on the conceptualisation of the study. It has been argued by
authors such as Mc Neil that ethical review is a political process in which various community
interests ought to be balanced.1025 Given the political nature of the decision-making he
submits that the majority of the members of the regulatory structures ought to represent
the community.1026
6.2.6 Monitoring and enforcement measures within the ethical-legal framework
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In Chapter Two it is argued that a range of monitoring and enforcement mechanisms need to
exist, including structures which are able to enforce ethical codes and a national regulatory
body to regulate research on new medical products.1027 Furthermore, the Helsinki
Declaration requires RECs to monitor ongoing studies.1028 It also places a corresponding
obligation on the researchers to provide monitoring information to their REC.1029
In South Africa, there are obligations to monitor research which have been included in
ethical guidelines.1030 There are also some legal obligations on researchers undertaking
clinical trials as they are required to report on their progress to the MCC.1031 The MCC can
request additional information from researchers, inspect a clinical trial site and withdraw
authorisation for a trial if it believes that the safety of trial participants is compromised or
the scientific reasons for conducting the trial have changed.1032 There are also a wide range
of enforcement mechanisms established by institutions within the ethical-legal framework,
the civil and criminal courts and institutions established by the Constitution.
The strengths of the monitoring measures are that they are indirectly legally enforceable as
these obligations are set out in ethical guidelines in terms of which RECs must act.1033
However Strode, Slack and Mushariwa argue that the weakness of these mechanisms is that
they tend to focus on formalistic compliance with the protocol rather than ‘on site processes
or dynamic interaction with trial participants’.1034 Furthermore, they submit that most RECs
1027
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do not always have the capacity to undertake a more active monitoring role in health
research.1035
There are six different ways in way research participants could enforce their rights in our
system.1036 They include a novel mechanism introduced by the NHA which provides the
NHREC with the power to adjudicate research-related complaints.1037
The strengths of the system are: firstly, there is a range of enforcement mechanisms which
can be used. Secondly, some of the mechanisms do not require the participants to have
financial resources, for example, complaints to the NHREC or the HPCSA do not require the
assistance of a lawyer or any other administrative cost. Thirdly, researchers are not the only
ones who can be held accountable; regulatory institutions within the ethical-legal framework
are also called to account. For example, the NHREC has the power to adjudicate complaints
regarding the functioning of an REC.1038 Fourthly, administrative law remedies can be used to
hold institutions accountable.1039 In other words, the courts can be used to hold institutions
accountable if they fail to fulfil their mandate.1040 Fifthly, it has been argued that our
enforcement mechanisms can also be a ‘useful mechanism to reverse irrational ideology-
driven science policy and decision-making’:1041
Admittedly, the courts are certainly not a panacea to all the challenges that bedevil
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scientific matters in all instances or be approached as a first recourse. However, as the South
African experience demonstrates, the judiciary can play a crucial role when authorities abuse
their power in the research arena.1042
Overall, the enforcement systems within the ethical-legal framework are weak and research
participants’ wishing to enforce their rights would face the following constraints:
(i) The general mechanisms are ‘constrained by cost, low levels of knowledge of
legal rights and limited access to legal services’;1043
(ii) Even enforcement mechanisms which should be cheap, speedy and easy to use
are fundamentally flawed. For example, Slack, Singh, Strode and Essack identify a
number of shortcomings with the GCP’s approach to compensation for research-
related harm in clinical trials, including that the GCP Guidelines limit claims for
harm to those of an ‘enduring’ nature. The authors argue that this is a narrow
approach as harms may be serious but not enduring. Furthermore, the GCP only
allows claims for bodily injury, thus excluding damages for psychological harm.
Finally, Slack et al argue that the procedural requirement that participants must
make their claim for compensation via the researchers is problematic as it
requires a party (the researcher) who has a direct interest in defending the matter
to assist in resolving the dispute.1044 Likewise there have been criticisms of the
effectiveness of reporting a health professional to the HPCSA. Some NGOs have
submitted that the complainant’s version is seldom accepted over that of the
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(iii) Using courts to settle such disputes has its limits, amongst others, the uncertainty
of the outcome, the time it takes to resolve the matter, remedies may or may not
be commensurate with the extent of the harm suffered and the outcome may not
offer a comprehensive solution to the problems associated with bio-
technology.1046
A gap in the framework is that the NHA has not created a clear set of sanctions that could
be imposed by the NHREC. It must, in terms of section 72(6) of the NHA, ‘refer to the
relevant statutory health professional council matters involving the violation or potential
violation of an ethical or professional rule by a health care provider’. This is a very narrow
remedy which can only be used against persons registered with a health professions
council. As articulated in Chapter Two this approach is premised on the professional
control model of an ethical-legal framework and has a number of limitations given that
research teams are often multi-disciplinary. Neither the NHA nor the Regulations relating
to the NHREC describes any other sanctions that it can impose.
6.3 Review of the extent to which South Africa’s current normative framework meets key
international norms
6.3.1 Overview
The norms regulating health research with human subjects (including specific norms
regarding children) are contained in sections 11, 16 and 71 of the NHA.1047 The Children’s Act
does not refer to the rights of a child regarding research participation. However, it does refer
to a child’s rights regarding other health interventions. Child research participants have
committee, and makes the proceedings more uncomfortable and stressful for complainants and their
witnesses’. Submission on the Health Profession’s Amendment Bill (B10–2005), AIDS Law Project available from
http://www.alp.org.za/pdf/Parliament/Health%20Professions%20Amendment%20Bill%20-%202006%20-
%20ALP.pdf [Accessed 1 July 2009].
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rights to informed consent, privacy, dignity and equality. There are also five legal obligations
on researchers to promote the welfare of child research participants.
6.3.2 The rights of research participants
It has been argued that effective ethical legal frameworks are those that protect the dignity
and rights of participants and promote their welfare.1048
(i) Informed consent to research participation
Informed consent is a well-established international ethical-legal norm which is based on the
principle of respect for a person’s autonomy and the right to bodily integrity.1049 Both the
Nuremburg Code and the Helsinki Declaration clearly articulate the fundamental nature of
consent to health research.1050
There is a clear but highly restrictive framework for informed consent to health research.
Sections 11, 16 and 71 of the NHA provide that written consent is required for all forms of
health research except record reviews by health care providers and health studies without
living human participants. The framework provides norms for obtaining consent in research
involving minors. Independent consent by children is prohibited and only parents or legal
guardians may provide proxy consent.1051 Ministerial consent is also required if the research
is classified as non-therapeutic.1052 The draft Regulations on Human Subjects provide further
that participants must be well informed accordingly, they outline the minimum information
that should be provided to research participants.1053 There is no express mention of the
1048
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voluntary nature of informed consent in the legislation but it is a well-established common
law principle.1054
The strengths of the system are that the NHA has established clear norms on informed
consent, which deal with the former problem of RECs taking differing approaches due to
inconsistencies in ethical guidelines.1055 The framework protects children by ensuring that
very stringent consent norms are in place. It also promotes child participation at one level as
minors must consent to health research alongside their parents or guardians, if they have
understanding.1056
The weakness of the approach in the NHA and its accompanying draft Regulations on Human
Subjects is that despite being overly protective, they fail to create a comprehensive
framework for informed consent to health research, as:
(i) Ensuring that research participants have a right to a basic level of information on
the study is not comprehensively established. It is a well-established international
ethical-legal principle that research participants must be given information in
order to make an informed choice to participate in research.1057 Both the ICH
Good Clinical Practice Guidelines and those issued by CIOMS stipulate that
participants must be told that they are being invited to volunteer to participate in
research.1058 It has been argued that these principles place an obligation on
researchers to inform participants or persons consenting, in layperson’s language,
of the nature, scope, consequences, risks, dangers, complications, benefits,
1054
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disadvantages and prognosis as well as any alternatives.1059 The NHA requires
researchers to inform research participants of any possible negative or positive
consequences to their health as well as (if applicable) being informed that the
‘health service’ they are receiving is experimental.1060 The draft Regulations
supplement this by listing the information that ought to be provided to research
participants.1061 However, neither the NHA nor the Draft Regulations on Human
Subjects emphasises the importance of advising research participants that they
are volunteering for research, except where that research is offered as part of a
health service;
(ii) Written consent is required for all forms of health research involving human
subjects. Obtaining written consent for health research is not a requirement in
the common law, and the new provisions in the NHA have serious implications for
certain types of research such as telephonic interviews, postal or electronic
studies in which the completion and voluntary return of the questionnaire is
commonly regarded as implied consent. Furthermore, requiring written consent
outlaws the obtaining of passive consent, a practice frequently used in social
science research with children.1062 This approach is out of step with the more
flexible one set out in the NHREC Guidelines which provide that consent may be
1059
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given verbally or in writing. It may also in certain circumstances be waived if prior
approval of the REC is obtained;1063
(iii) The authority to provide consent to health research involving minors has been
limited to parents or guardians. The NHA does not allow for consent by care-
givers even if they act as de facto parents or guardians and can consent to
medical treatment on the child in terms of the Children’s Act.1064 Nevertheless,
Pope argues that where children have no parents or guardian, for example,
children living in a child-headed household, the High Court could be approached
to provide consent as the upper guardian of all minors.1065 There have been
criticisms of this approach particularly as many children live away from their
parents or guardians.1066 Furthermore, there are a significant number of child-
headed households.1067 Strode and Slack argue that the approach should be less
rigid and re-focused around a graded standard which is dependent on risk levels.
Thus they submit that care-givers should be able to provide consent for research
which ‘would approximate decisions regarding children’s day-to-day care’.1068
Using this approach care-givers ought to be able to consent to minimal risk
research as this would be in line with the approach taken in the Children’s Act.1069
They also submit that this would ensure that children not living with their parents
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or guardians are not inappropriately excluded from potential benefits of being
research participants; and
(iv) There are no circumstances in which a child may consent independently to health
research. It has been argued that not allowing children to consent independently
to any form of health research is an overly restrictive approach which will prevent
some important health research from taking place.1070 Singh et al argue that some
forms of research, for example, studies on teenage drug use may place children at
risk if parental consent is required.1071 Likewise, it is clear that a study on why
teenagers are continuing to undergo backstreet abortions would struggle to
recruit girls if parental consent was required.1072 This is also out of step with the
approach taken in the Children’s Act where there is recognition of a child’s
evolving capacity to consent to a range of health interventions from the age of 12
onwards.1073 Finally, this approach inappropriately treats all health research alike
without recognising that research with some risk ought to be treated differently
to low or no risk studies.1074
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above) argue for a recognition of some children as ‘mature minors’, in other words capable of making
independent research-related decisions 182.
1074
Zuch, Mason-Jones, Mathews & Henley (note 121 above) 4.
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A key omission in the framework is that the law does not provide that participants must
appreciate or understand the information that they have been provided on the study. The
NHA and its draft Regulations are silent on the issue of appreciation. This is a gap as
establishing whether a research participant understands the risks of research is clearly a
complex issue which requires normative guidance.1075 This is particularly important given
that ‘understanding’ is now the benchmark for when a minor may consent rather than assent
to health research.1076
1075
Lindegger & Richter describe some of the key issues as being ‘understanding is an elusive concept, and it is
not a simple matter to gauge the nature and level of understanding that someone has of a concept, an event or
process. While it may be relatively easy to evaluate the adequacy of information disclosed (eg, showing
information on a videotape) it is far more difficult to assess how the information and its implications are truly
understood’: Lindegger & Richter (note 511 above) 315.
1076
S 71(2)–(3) National Health Act (note 57 above).
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(ii) Rights to privacy, dignity and equality in health research
Everyone has a right to privacy, dignity and equality in international law.1077 The right to
privacy within the context of research is also a well-established ethical principle.1078 The right
to dignity is also recognised in the international ethical-legal framework although applying
this right to research is not as well developed as the right to privacy.1079 The right to equality
is not recognised as a rights issue in the international ethical codes other than the Universal
Declaration of Human Rights and the Human Genome however, many of the values
underpinning the right to equality are recognised in the ethical concept of justice.1080
The NHA is silent on the issue of the rights to privacy, dignity and equality within research.
However, the NHREC Guidelines clearly provide that participants are entitled to privacy
regarding any personal information collected from them.1081 They also state that respect for
participants’ dignity must be a primary concern for all researchers.1082 They do not refer to
participants’ rights to equality. Nevertheless, there is a reference to inequalities in the
consent processes of research in the Schedule of an Illustrative List of Unfair Practices in
certain Sectors which is attached to the Equality Act.1083
The strength of the current system is that although the NHA is silent on these three rights
within the context of health research, the draft Regulations on Human Subjects require
studies to be respectful of participants’ rights to privacy, dignity, bodily integrity and
equality.
1077
Articles 17, 10, 2 and 3 International Convention on Civil and Political Rights (note 170 above).
1078
Tolich (note 391 above) 101, Guidance Point 6 Declaration of Helsinki (note 41 above) and Guidance Points
4 and 5 CIOMS (note 176 above).
1079
Guidance Point 2 Helsinki Declaration ibid and Guidance Point 4 CIOMS ibid.
1080
Tangwa (note 597 above) 56.
1081




Promotion of Equality and the Prevention of Unfair Discrimination Act (note 854 above).
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The weakness is that the draft Regulations do not provide any further detail on how these
rights apply within the context of research. This is particularly problematic in relation to the
privacy rights of children, where there is a lack of clarity regarding what information will be
disclosed to parents or guardians who are providing over-arching consent for research
participation. The failure of the NHA to address these rights also reflects a superficial
approach to the promotion of the well-being of research participants with the primary
protection being on the right to informed consent.
6.3.3 Obligations on researchers to protect child research participants
There are a number of specific obligations on health researchers who are undertaking
research with children to ensure that their rights and welfare are protected.
(i) Therapeutic research with minors must be in the best interests of the child
There is no international norm requiring therapeutic research to be in the best interests of
the child. Nevertheless, section 71(2) of the NHA requires researchers to demonstrate that
therapeutic research is in the best interests of minors.
The advantage of the approach taken in the NHA is that the concept of the best interests of
the child is well developed in our law.1084 It is a flexible standard which is well suited to being
applied with due consideration of the needs of the particular situation.1085 However, Stobie,
1084
Stobie, Strode & Slack (note 58 above) 198.
1085
S v M (Centre for Child law as Amicus Curiae) (note 847 above) para 24; Minister of Welfare and Population
Development v Fitzpatrick and Others (note 874 above) para 18; and Strode, Grant, Slack & Mushariwa (note 93
above) 266. Kopelman has defended the use of the concept of the best interests of the child as a standard for
establishing when health research is appropriate., She suggests that it is a useful benchmark for establishing
whether the study is reasonable, see L Kopelman ‘The Best-Interests Standard as threshold, ideal, and standard
of reasonableness’ (1997) Vol 22 (3) Journal of Medical Philosophy 271-289.
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supposedly guarantees non-discrimination – include the American
snowboarding gold medallist Seth Wescott, the Sochi-bound Canadian
biathlete Rosanna Crawford and the Australian four-man bobsled team.
Megan Rapinoe, who won gold in the women's football in London, said
she believed the IOC should have done more and made it clear that this
was not a political issue but a basic question of human rights. ‘I
understand and respect that the Olympics are not the time nor place for
political statements, but this is far beyond any kind of statement,’ the
report quotes her as saying.
Full report in The Guardian
Criminal: Niquab row woman admits witness intimidation
A Muslim woman who wore a full-face veil in court during her trial has
admitted witness intimidation. A report in The Guardian states that the
jury trying Rebekah Dawson (22), at Blackfriars Crown Court in London,
was discharged after failing to reach a verdict after deliberating for more
than 12 hours. But in a dramatic twist after a short delay, Dawson came
back into court and admitted the same charge of witness
intimidation that she had denied at her trial. The jury had also failed to
reach a verdict in the case of her brother Matthias Dawson (32), who
faced the same charge. Rebekah Dawson wore a niqab that showed just
her eyes during the seven-day trial. But she had waived her right to give
evidence in her defence during the trial after being told by Judge Peter
Murphy that she would have to show her face to the jury during her
testimony. She had argued it was against her religious views to show her
face to men. Judge Murphy released Dawson, of Hackney, east London,
on bail ahead of sentencing on a date to be fixed. She had intimidated
Daudi Yusuf, a security guard at the Finsbury Park mosque in north
London, last June, several weeks after he was involved in a row with her
husband, Royal Barnes, the report states.
Full report in The Guardian
TODAY'S BRIEFS
* Eduard Pretorius (33), accused of murdering and mutilating Maria
Mathe (25) last weekend, has appeared in the Swartruggens
Magistrate's Court, where the case was postponed to 7 February for a
formal bail application.
– IoL
* Ambiga Naidu (53), who pleaded guilty to defrauding former
Springbok flanker and Sharks captain Wayne Fyvie of R1.4m, has
been sentenced by Magistrate K Chamberlain of the Pinetown Regional
Court to eight years’ imprisonment.
– Daily News
* The case against a man (28), arrested in connection with acts of
terrorism against Sanral, has been struck off the roll in the Pretoria
Magistrate's Court. The man was the only one left in the holding cell when
Magistrate Maryke de la Rey was informed the case was nolle prosequi.
– IoL
* The Tshwane University of Technology has obtained a court order
stopping protests at it campuses. ‘In view of the on-going student
unrest, TUT ... obtained an interdict to prevent anyone from participating
in protest action on any of TUT's campuses, to disrupt TUT activities or
cause damage to TUT property,’ a spokesperson said.
– Mail & Guardian
© 2014 Juta and Company, Ltd
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Strode and Slack identify some key problems in using this concept as the standard for
assessing whether therapeutic research with children ought to be approved. Firstly, it is
unclear how the principle will apply, and limited literature exists on applying it to health
research with children.1086 Secondly, the norms for a best interests analysis articulated in
section 7 of the Children’s Act cannot be easily applied to health research. Thirdly, within the
context of research there will always be a tension between protecting individual child
participants and promoting the health of all children.1087
This is compounded by section 71(2) which is unclear as to whether the ‘best interests’
analysis relates to children as a group or as individuals. In other words, whether RECs may
only approve therapeutic research which is in the best interests of children as a class, or
whether parents, guardians and minors (if they have understanding) may only consent to
therapeutic research if it is in their individual best interests. It is submitted that using a
purposive approach to interpretation, the obligations in section 71(2) of the NHA ought to be
understood as imposing obligations on RECs to consider children as a class of research
participants during ethical approval, as in many instances it could be argued that requiring
therapeutic research to be in the best interests of individual children is not always possible
given that, for example, the efficacy or dosage of the experimental drug has not been
established with the age group under trial. Roscam-Abbing argues that it is only possible to
establish that the research is not contrary to a child’s best interests.1088On the other hand,
the obligations on parents, guardians or minors consenting to the research are to consider
the individual interests of the child participant.
(ii) Ministerial consent must be obtained for non-therapeutic research with minors
1086
Similar points are made in Slack, Strode, Grant & Milford (note 141 above) 683.
1087
Stobie, Strode & Slack (note 58 above) 200–201.
1088
Ros-cam-Abbing (note 50 above) 148.
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There is no international norm requiring executive approval for non-therapeutic research
with minors.1089 It is however an accepted ethical principle that there should be greater
scrutiny and protection in studies which do not offer a direct benefit to the child.1090 The
NHA provides that the Minister of Health must provide consent to all non-therapeutic health
research with minors.1091 The draft Regulations on Human Subjects do not provide any
guidance on how or when researchers must apply for ministerial consent.
The strength of the approach taken in the NHA is that it settles the debate on whether
children can participate only in certain limited forms of so-called non-therapeutic
research.1092 In the past ethical guidelines and academics took different approaches to the
nature of the studies and the level of risk to which a child could be exposed in so-called non-
therapeutic research.1093 It also creates a novel procedural protection for minors
participating altruistically in health research.1094 Furthermore, the NHA clearly sets out the
circumstances in which the Minister of Health may provide his or her consent to non-
therapeutic research, thus creating certainty.1095 This is in accordance with the Constitutional
Court jurisprudence which has found unconstrained discretionary powers given to the
executive are inconsistent with the Constitution.1096
1089
There is however an example in foreign law, the US Code of Federal Regulations provides research with
children which poses a risk of more than a minor increase over minimal risk mist be referred to the Secretary of
the Department of Health and Human Services for approval: Strode, Slack, Wassenaar & Singh (note 119 above)
201.
1090
Wendler & Grady (note 397) above) 203.
1091
S 71(3) National Health Act (note 57 above).
1092
Strode, Slack, Wassenaar & Singh (note 119 above) 201.
1093
See for example, the MRC’s Ethical Guidelines (Book One) (note 12 above), Van Wyk (note 13 above) 46,
Smit (note 34 above) 155 and Burchell (note 13 above) 193.
1094




Dawood v Minister of Home Affairs (note 849 above) paras 43–48. This case dealt with the circumstances in
which foreign spouses of South African residents were entitled to live in South Africa pending the outcome of
their application for an immigration permit. The Court held that when the legislature confers discretionary
powers on officials, in this case the discretionary power to issue temporary residence permits which allowed
foreign spouses to remain in South Africa whilst they applied for an immigration permit, the parameters of this
discretion should be clearly described in legislation, ‘(I)n a constitutional democracy such as ours the
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However, Strode, Slack, Wassenaar and Singh argue that the NHA has created new problems
by requiring ministerial consent for all forms of so-called non-therapeutic research with
minors.1097 They submit that section 71(3) is problematic as:
(a) The NHA inappropriately treats all forms of non-therapeutic research alike.1098 In
other words a low risk study into the amount of exercise teenagers undertake in a
week is treated in exactly the same manner as a study into a microbicide gel
which may pose a minor increase over minimal risk. This is a simplistic approach
which over-protects participants in low risk research;
(b) The need for the additional protection over and above ethical approval is
unclear;1099 and
(c) This is an example of the over ‘bureauicratision’ of ethics’ which may have many
unintended negative consequences such as; discouraging researchers from
conducting non-therapeutic research with minors or encouraging them to mis-
classify their research as therapeutic in nature.1100.
Slack et al argue further that (a) some of the factors that must be used by the Minister of
Health in approving non-therapeutic research in terms of the NHA are unclear and it is
uncertain as to how they will be applied in practice,1101 and (b) this new procedural
obligation may result in unnecessary delays.1102 Finally, given there are no regulations in
responsibility to protect constitutional rights in practice is imposed both on the legislature and on the executive
and its officials. The legislature must take care when legislation is drafted to limit the risk of an unconstitutional
exercise of the discretionary powers it confers’ para 48.
1097








Ibid. Slack, Strode, Grant & Milford (note 143 above) give the example of s 71(3)(b)(iii) of the National
Health Act (note 57 above) where the Minister of Health may only approve non-therapeutic research with
minors if the reasons they are consenting is contrary to public policy. The authors argue that there is a lack of




place setting out the nature of the application process,1103 it appears that since March 2012
when the provision became operational no applications have been made for ministerial
consent. Thus this is essentially a lame duck provision.
1103
Slack, Strode, Grant & Milford (note 143 above) 683.
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(iii) The mandatory reporting of abuse, neglect or children in need of care and protection
There is no international norm on the obligations on researchers to report abuse and
neglect. Currently, in South Africa there are a number of legal provisions which ensure that
children in need of care or protection are identified and steps taken to protect them from
further harm. In some instances these are mandatory obligations.1104 These obligations also
apply in most instances to researchers.1105
The strength of the current approach is that the provisions in the Children’s Act place duties
to report on a broader category of persons than was required previously in terms of the Child
Care Act.1106 Consequently a number of persons in the research team would be under an
obligation to report.1107 These provisions are supported by both criminal and civil liability if
the child suffers further harm as a result of the report not having being made.1108
There are however also a number of weaknesses in the legal approach to the reporting of
abuse or neglect of child research participants. Firstly, the NHA and the Children’s Act are
silent on how these obligations apply within the context of research. Secondly, there are no
ethical guidelines giving express guidance on this issue for researchers and RECs. This is
particularly problematic given the extent of research into the sexual and reproductive health
of adolescents. Thirdly, the mandatory reporting of consensual underage sex with an adult or
a much older partner in terms of the Sexual Offences Act may pose complexities for sexual
and reproductive health research with children. Although there has been a recent change in
the law, described above, and resultantly certain instances of consensual underage
1104
S 110 Children’s Act (note 4 above) and Sexual Offences Act (note 765 above).
1105
See Chapter Five for further discussion on this point.
1106
D McQuoid-Mason ‘The Children’s Amendment Act and the Criminal Law (Sexual Offences and Related
Matters) Amendment Act: Duty to report child abuse and sexual offences against children and mentally
disabled persons’ (2008) Vol 98 (12) SAMJ 929, 930.
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sex/activity are no longer illegal,1109 consensual inter-generational sex remains a sexual
offence. This means that where there is a large age gap between those in the sexual
relationship or one is an adult, the older person is committing a sexual offence and an
obligation to report the sexual activity continues to exist.1110 Given, that inter-generational
sex is often a norm in communities researchers will be faced with the dilemma of reporting
sexual partners who are not part of the study and this may impact on recruitment
strategies.1111
(iv) Appropriate risk standards
It is an internationally accepted ethical norm that the risks in health research ought to be
appropriate. This is a public policy consideration which is particularly important given that in
many instances participants altruistically accept research-related risks for the benefit not of
themselves but others.1112
The NHA does not set risk levels for children participating in research. There is however an
indirect risk standard in the NHA as the Minister of Health may not give consent for non-
therapeutic research if the study will pose a ‘significant risk’ to the minor.1113 Previously, this
lack of guidance was compensated by the principles set out in ethical guidelines.1114 The
draft Regulations change the current position by setting express risk standards that cannot
be exceeded when undertaking research with children.1115
1109
See Chapter Five where this issue is discussed in more detail.
1110
A Strode, J Toohey & C Slack ‘Brief memo on the Teddy Bear Clinic for Abused Children and Prevention of
Child Abuse and Neglect (RAPCAN) v Minister of Justice and Constitutional Development case (case number




Wendler & Grady (note 397 above) 203.
1113
S 71(3)(b)(iv) National Health Act (note 57 above).
1114
Stobie, Strode & Slack (note 59 above) 193–194.
1115
Regulation 4(1) draft Regulations on Research with Human Subjects (note 13 above).
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The strengths of the position in the draft Regulations on Human Subjects are that it is the
first time that clear legal guidelines have been issued on acceptable standards of research-
related risk. This is an important protection which ensures that children, who do not have
the legal capacity to consent to research, are protected from participating in studies that
may inappropriately place them at risk of harm. It has been argued that as the Minister of
Health may approve non-therapeutic research with minors if it does not pose a significant
risk to the participants, that this is recognition of a new upper level of risk.1116 Accordingly,
allowing the Minister of Health to approve such exceptional studies will facilitate research
which is not currently approvable by RECs.1117
The weakness of the approach in the NHA is that the term significant risk is not defined. It is
therefore not clear whether it is in fact a new upper level of risk. Furthermore, the risks
standards in the draft Regulations on Human Subjects are not in line with the well-
established principles in the ethical guidelines. The maximum level of risk to which a child
may be subjected is minimal risk. There may only be an increase in this level of risk if the
study is of direct benefit for the child.1118 Many non-therapeutic studies do not offer direct
benefits to the child participant and currently ethical guidelines allow children in such studies
to be subjected to a maximum of a minor increase over minimal risk.1119 This proposed new
approach therefore will prevent many clinical trials from taking place.
(v) Children must be scientifically indispensable to the research
It is an internationally accepted ethical norm that children must be indispensable to the
research.1120Currently, the NHA does not refer to this principle except narrowly with regard
to when the Minister of Health may give consent for non-therapeutic research with
1116




Regulation 4 draft Regulations on Human Subjects (note 13 above).
1119
See Chapter Four for a more detailed discussion of this issue.
1120
Guidance Point 14 CIOMS (note 182 above).
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minors.1121 It is however a well-established principle in the national ethical guidelines.1122
The draft Regulations on Human Subjects change this position by stating expressly that
children must be indispensable to the research.1123
The strength of the approach in the draft Regulations on Human Subjects is that it
transforms an ethical norm into a legal obligation which ensures that children are protected
from participating in studies which could be done with a less vulnerable population.
6.4 Key themes emerging from the critique of the ethical-legal framework
A review of the critique of the institutional and normative framework for regulating health
research, particularly research with children, reveals seven key themes which cut across all
elements of the ethical-legal framework.
6.4.1 The ethical-legal framework is premised solely on the principle of protecting child
research participants
In Chapter Two of this thesis the key norms that have been established in international law
and ethical codes were described. The key elements of effective ethical-legal frameworks
were also set out. It is argued that an ethical-legal framework which protects research
participants, promotes their active participation and facilitates research, should be based on
these three principles which are balanced against each other. Within the normative
framework for regulating health research with children in South Africa the only clear
principle that the system appears to be based on is that of protecting research participants.
This is done by restricting when and how children can participate in health research.1124
1121
S 71(3)(b) National Health Act (note 57 above).
1122
S 5.1 of the NHREC Guidelines (note 56 above).
1123
Regulation 4(1)(e) Regulations on research with Human Subjects (note 13 above).
1124
See Chapter Three where it is argued that there are no policy documents which reflect the principles that
underlie the ethical-legal framework. It is argued that the norms in s 71 National Health Act (note 57 above) are
all protective in nature, for example, this section does not allow minors to consent independently to any form
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A framework which is based solely on the principle of protecting child research participants is
problematic as firstly, it is out of step with the modern approach towards promoting the
involvement of children within research in order to improve their health and welfare.1125
Secondly, it ignores the constitutional imperative1126 to consider the best interests of the
child which requires the consideration of a range of factors in decisions which affect
children.1127 Protecting the child from harm is just one of the considerations within a best
interest analysis.1128 Thirdly, focusing on protection is contrary to the approach taken in the
national ethical guidelines which balance a range of factors in holistically promoting the
welfare of child research participants.
6.4.2 There is on-going uncertainty regarding ethical-legal norms as the system continues to
be in a state of flux
Although the NHA ushered in a new era by creating a comprehensive ethical-legal
framework, only parts of it were implemented in 2005.1129 This meant that between 2005–
2012 the institutional aspects of the new ethical-legal framework were in place but the
norms described in sections 11 and 71 of the NHA were not legal obligations.1130 As a result
RECs and other research stakeholders have had to operate in an uncertain environment with
of health research. This is clearly a protective measure as it requires proxy consent for all forms of health
research even low or no risk studies. See Chapter Five for further discussion on this point.
1125
See Chapter One for a more detailed discussion of the importance of involving children in health research
and the international shift towards ethical-legal systems which both facilitate research and protect child
research participants.
1126
S 28(2) Constitution of the Republic of South Africa (note 2 above).
1127
McCall v McCall (note 68 above).
1128
See for example, s 7 Children’s Act (note 4 above) which lists the factors that ought to be taken into
account in establishing the best interests of the child. Although the Act appears to indicate that this is a closed
list of factors the Constitutional Court in S v M (Centre for Child law as Amicus Curiae) (note 865 above) para 24
indicated that there should be an individual approach and not the use of a ‘predetermined formula’. It could be
argued that this implies that the list of factors in s 7 of the Children’s Act is not exhaustive.
1129
Government Gazette No. 27503 (note 94 above).
1130
See Chapters Three and Four for more detail on these points.
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disparate approaches to, amongst others, the age of consent to research.1131 In March 2012
sections 11 and 71 of the NHA were operationalised with almost no advance warning in the
Government Gazette1132 and as a result the final elements of the ethical-legal framework
were implemented. However, given that no regulations had been issued to accompany these
sections, some of the norms in section 71 remain in limbo. For example, there is no guidance
on the process and form an application for ministerial consent for non-therapeutic research
ought to take. As a result it appears that RECs are not requiring researchers to apply for this
form of authorisation.1133 Even the NHREC on its website has issued a statement indicating
that it is aware that clarity is needed on how RECs can meet the new norms in the NHA and
that section 71 conflicts with the position taken in the national ethical guidelines.1134 No
explanation has been issued by the Ministry of Health for its failure to finalise the draft
Regulations on Human Subjects.
This on-going uncertainty undermines the ethical-legal framework as it results in a lack of
clarity and its accompanying disparate approaches.1135 Furthermore, investigators, RECs and
other stakeholders face an uncertain ethical-legal future with no clear instruction on when
they will have to change current practices, such as allowing independent consent by children
in certain circumstances in accordance with the national ethical guidelines.1136 Ultimately,
this on-going state of flux could affect recruitment and informed consent processes.1137
1131
Slack, Strode, Grant & Milford (note 143 above) 682. For example, the authors describe how some RECs
during this period allowed children over the age of 14 to consent independently to therapeutic research on the
basis that children could consent to medical treatment from this age in terms of the Child Care Act 74 of 1983.
Ibid.
1132
Government Gazette No. 35081 (note 96 above).
1133
See for example, the approaches of UKZN and the HSRC (note 123 above).
1134
Statement from the Council on the Proclamation of s 71 of the National Health Act, undated, available from
http://www.nhrec.org.za/wp-content/uploads/2012/letter.pdf [Accessed: 28 December 2012].
1135
Slack, Strode, Grant & Milford (note 143 above) 682.
1136
See Chapters Three and Five for a discussion on when the ethical guidelines allow independent consent to
health research by children.
1137
Slack, Strode, Grant & Milford (note 143 above) 683.
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6.4.3 The protection of children within the ethical-legal framework is undermined by the lack
of institutional independence of some of the regulatory institutions
In Chapter Two the importance of ethical-institutions being independent was described. The
significance of this principle has been illustrated by the actions of both the apartheid and
post-apartheid governments. Under apartheid, research aimed to promote the prevailing
political ideology of white supremacy. Accordingly, funds were channelled towards research
to improve health services for whites1138 and in genomic research to ‘prove’ or provide a
rationale for white domination.1139 In the post-apartheid era, political interference in the
research agenda has continued. As described above there have been allegations of political
pressure being placed on the MCC1140 and Singh has argued that this same political influence
has resulted in for example, ‘ill-founded ideology-driven redundant and unreasonable
operational research’ by the Department of Health in relation to the prevention of mother-
to-child transmission of HIV.1141 Given this context, it is of concern that the independence of
three statutory bodies within the ethical-legal framework, the NHRC, the MCC and the
NHREC, has not been assured through their empowering legislation. Furthermore, their
independence has been actively undermined by (a) powers given to the Minister of Health to
appoint their members and chairpersons/deputies, and (b) their reporting structures which
require reporting directly to the Minister of Health rather than parliament. It is argued that
this inappropriately places power in the hands of the executive to control such bodies.
1138




Mail and Guardian (note 959 above).
1141
Singh (note 10 above) s 77. Heywood refers to this as the ‘sometimes hidden, sometimes open,
relationship . . . between the President and AIDS denialists’: M Heywood ‘Prevention of Mother to Child HIV
Transmission in South Africa: Background, strategies and outcomes of the Treatment Action Campaign case
against the Minister of Health’ (2003) Vol 19 South African Journal of Human Rights 278, 282.
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6.4.4 The ethical-legal framework has a superficial approach to community participation in
health research
The value of community participation in health research is well established.1142 In our ethical-
legal framework the principle of community engagement in research is reflected in a number
of different ways. Firstly, by ensuring that the ‘community’ as a key stakeholder in research is
represented by members appointed in this capacity on certain statutory bodies (the NHRC
and NHREC) as well as RECs.1143 Secondly, in some instances researchers are required to
establish a formal link with the community in which they are doing research though a
Community Advisory Board or Group.1144 This facilitates a broader community engagement
process relating to the research. Thirdly, in one instance community representatives (the
House of Traditional Leaders) must be informed of potential studies as the HSRC is required
to notify them of research it is undertaking in areas under their jurisdiction.1145
It is argued that nevertheless this approach to community engagement in health research is
superficial and haphazard as:
(a) The community is not required to be represented on all statutory bodies within the
ethical-legal framework, for example, the Medicines Act does not expressly require a
community representative on the Council. This is an uneven approach as they are
represented on the NHRC, NHREC and RECs;
(b) Community representatives are given nominal positions on regulatory structures and
would not be in a position to exert great influence over decisions;1146
(c) The role of community representatives or how they ought to be nominated / elected
onto statutory bodies and RECs is not described in any detail in policy documents.
1142
Point 1 National Health Research Ethics Council Guidelines for Community Advisory Groups (note 716
above). See Chapter Two for more detail on this point.
1143
See Chapter Four for a more detailed discussion on this point.
1144
National Health Research Ethics Council Guidelines for Community Advisory Groups (note 716 above).
1145
S 14(6) HSRC Act (note 62 above).
1146
See for example, the critique by Mc Neil (note 1025 above) in which he argues that ethics committees do
not have sufficient representation from the community.
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This makes it difficult to ensure that the broader community engagement in research
policy and regulation is meaningful. Key questions include for example, should the
community representative be someone from a democratically elected structure, a
person living in the area or a member of a non-governmental organisation? and
(d) Only the HSRC is required to ‘notify’ traditional leaders when researching in rural
areas. Although this is a form of community engagement it is very limited as it does
not require such leaders to input into the research process or to facilitate access to
community members living in those areas.
6.4.5 Ensuring there is consistency across the ethical-legal framework is hampered by a lack
of co-ordination across regulatory institutions
The current framework lacks cohesion and as a result although it is made up of a number of
institutions all playing a unique role in the broader spectrum of regulating research
regulation, there is no co-ordination between them. Co-ordination between the various
institutions within the ethical-legal framework is required ensure that research is regulated
in a holistic way through policy controls and ethical/scientific review. Prior to the
implementation of the NHA there was no mechanism for co-ordinating the work of the
limited institutions within the ethical-legal framework. This resulted in disjunctive
approaches and overlaps between the various institutions.1147 For example, the MCC issued
guidance on HIV vaccine trials which included a stipulation that participants must have a
matric in order to be eligible to volunteer as a participant.1148 This was criticised as it was
argued that the norms for informed consent are based on ethical obligations and should be
set by RECs and not the MCC.1149
1147






This lack of co-ordination has continued after the full implementation of the NHA since there
is still no express mechanism to ensure co-ordination between all the ethical-legal
institutions. The Regulations establishing the NHREC require that a member of the MCC sit
on the NHREC.1150 However, there is no reciprocal obligation. Nevertheless, the direct link
between the MCC and the NHREC does ensure a measure of co-ordination between these
two institutions. However, there is no link between the MCC, the NHREC, RECs and the NHRC
and this remains a gap. Furthermore, there is no direct link between the NHRC and any of
the other institutions in the ethical-legal framework.
6.4.6 The protections in the ethical-legal framework have been undermined by drafting errors
and inconsistencies between the approaches to child autonomy in the NHA and the Children’s
Act
The protections within the normative framework are undermined by a number of problems
in the way they have been drafted. Firstly, some of the drafting reflects outdated
approaches, for example, section 71 of the NHA distinguishes between so called therapeutic
and non-therapeutic research with minors. This is a contested approach which has been
criticised in the literature, with some academics arguing that studies cannot be neatly
categorised into one or the other group.1151 Furthermore, some international guidelines such
as the CIOMS guidelines have moved away from using these terms.1152 In our context, using
this approach is made even more complex as the NHA does not define either term and the
draft Regulations on Human Subjects only define non-therapeutic research.1153 Secondly, the
drafters of the NHA have failed to reconcile the sections on child research participants with
the principles underpinning the Children’s Act even though this is the most comprehensive
1150
Regulations relating to the National Health Research Ethics Council (note 667 above).
1151
Slack & Kruger (note 53 above) 269–270, Stobie, Strode and Slack (note 59 above) 197 and RJ Levine Ethics
and Regulation of Clinical Research (2nd ed) (1988) 122.
1152
Ibid and CIOMS Guidelines (note 182 above)..
1153
Slack, Strode, Grant & Milford (note 143 above) 683 and Regulation 1 draft Regulations on Human Subjects
(note 13 above).
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piece of legislation describing the rights of children. As a result, (a) different terminology is
used in the two acts, for example, the NHA in section 71 refers to minors rather than
following the Children’s Act and referring to children, and (b) there are different principles
underpinning each act which results in conflict. For example, the NHA does not recognise the
ability of children to consent independently to any form of health research.1154 This is in
direct contrast to the Children’s and Choice of Termination of Pregnancy Acts which
specifically allow persons under the age of 18 to consent to certain health interventions
without the assistance of their parent, guardian or care-giver.1155 No reason has been
advanced by the drafters of the NHA for restricting children from consenting independently
to any form of research.1156 Thirdly, poor drafting has resulted in inconsistencies and errors
within the NHA. For example, section 16 of the NHA reflects a highly permissive approach to
health research by not requiring any form of approval or consent for record reviews
undertaken at health establishments by health care providers.1157 This is inconsistent with
the rest of the highly restrictive framework created by sections 11 and 71.
6.4.7 The Minister of Health has an inappropriately large decision-making role in the ethical-
legal framework
The firm hand of the Minister of Health is felt throughout the ethical-legal framework in that
firstly, the Minister is required to appoint the members to three of the key statutory
regulatory institutions namely, the NHRC, the MCC and the NHREC.1158 Secondly, the
1154
S 71 National Health Act (note 57 above).
1155
Children’s Act (note 4 above) and Choice of Termination of Pregnancy Act (note 823 above). Also see Table
Two in Chapter One which sets out the ages of consent to various health interventions.
1156
Slack, Strode, Grant & Milford (note 143 above) 683.
1157
S 16(2) National Health Act (note 57 above). It should be noted that in many instances health care providers
would be required to obtain ethical approval despite this gap in the law as institutional policies would require
REC approval for all health research and journals will not accepted papers for publication without proof of
ethics review.
1158
Regulation 4 Regulations relating to the establishment of the National Health Research Committee (note
598 above), s 3–4 Medicines Act (note 430 above) and Regulation 3 Regulations relating to the National Health
Research Ethics Council (note 667 above).
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Minister appoints the chairperson and deputy of each of these bodies.1159 The Minister is
thus directly involved in the composition and leadership of all the regulatory bodies within
the ethical-legal framework except for RECs. Thirdly, the Minister is required to grant
consent to all non-therapeutic research with minors.1160 Thus the Minister is required to be
directly involved in decisions regarding what is or is not appropriate research with children. It
is submitted that the involvement of the executive in such research-related decisions
undermines the institutional framework for regulating research and adds little or no value to
the protection of human subjects.
6.5 Conclusions
In conclusion this critique has shown that although the ethical-legal framework has all of the
elements of an effective system, it fails child research participants for a number of reasons.
Firstly, the current normative framework is over-protective and as a result limits the number
of potential child research participants, as well as the types of research that may be
conducted with children. In essence the NHA has removed the flexibility that was in the
hands of RECs which flowed from the principles in ethical guidelines.
It is argued that this will have the unintended consequence of excluding important research
with children, thus retarding health gains for this sector of the population. Secondly, the
framework does not promote active community participation in research-related decisions.
There is even less focus on child participation given that unlike the approach in the Children’s
Act which recognises that children have evolving capacity the NHA does not allow
independent consent to any forms of health research by children. It is also silent on children
assenting to research participation. Thirdly, despite the well-established institutional
framework which ought to promote research with children, such studies will be tethered by
the restrictive normative framework. Thus the over-protective normative framework
1159
Regulation 5 ibid; s 2–3 ibid; and Regulation 4 ibid.
1160
S 71 National Health Act (note 57 above).
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dominates all aspects of the ethical-legal system resulting in more onerous procedures for
approving research with children, and complex and restrictive consent procedures all of
which act as barriers to the use of evidenced based approaches to promote children’s health.
271
Chapter Seven:
Using the principles of child protection, participation and research
facilitation to develop law and policy reform proposals
The previous Chapter was a critique of the current ethical-legal framework. It used the
international norms described in Chapter Two as benchmarks against which the South
African ethical-legal framework was measured. It concluded that it fails children as the
research norms in the NHA are over-protective thereby limiting the number of potential child
research participants as well as the types of research that may be conducted with children.
Furthermore, the framework does not promote the participation by children in research-
related decisions. For example, unlike the Children’s Act the NHA does not recognise the
evolving capacity of children, thus excluding them from active and independent participation
in any forms of health research. The Chapter concluded that the current ethical-legal
framework was strangling child research rather than facilitating it as the over-protective
normative framework was dominating all other aspects of the system. This has the
unintended consequence of excluding children from beneficial research and thus retarding
health development for them.
This Chapter establishes a theoretical framework for the proposed law and policy reforms by
setting out how the three principles underpinning this thesis ought to be used with children’s
rights and well-established ethical norms to establish when and how children should
participate in health research. An explanation is provided of how the proposed normative
reforms to the framework balance the three competing interests which underpin this thesis
namely, protection, participation and research facilitation. Detailed law reform proposals are
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included. The Chapter concludes with an explanation of how the proposed framework differs
from the current one.
7.1 Introduction
It has been argued that the regulation of research is important for two reasons. Firstly, in
order to safeguard participants from harm, ensure that their autonomy is protected, and
secondly, to ensure that the interests of society and of science do not outweigh the
individual interests of research participants.1161 This dissertation argues that where ethical-
legal frameworks regulate health research with children they should within this context
ensure that they not only protect child research participants but also promote their active
participation in research decision-making and facilitate appropriate health research.
Balancing these competing interests is complex and many frameworks either over-protect or
over-facilitate health research.1162
South Africa is no exception with the ethical-legal framework having moved from being
under-protective and overly facilitative of research to over-protective and highly
restrictive.1163 It is submitted that the vacillation between access and protection does not
serve the best interests of child health. Furthermore, in our current context the sudden
implementation of the new restrictive provisions in sections 11 and 71 of the NHA appears to
be undermining public confidence in research regulation with several universities and
research institutions publicly declaring that they will not comply with these sections in the
NHA until draft regulations are finalised.1164 They justify this position by arguing that they
have deep-rooted concerns about (a) the lack of clarity on how to implement the new norms
1161
Hope, Savulesen & Hendrick (note 165 above) 163.
1162
Friedman Ross (note 91 above) 2–3.
1163
A Strode ‘Law reform dealing with blood, tissues, organ transplants and health research: A lagging legal
framework that is strangling innovation’ (2012) Vol 102(9) South African Medical Journal 741, 741.
1164
Ibid. The universities include the University of KwaZulu-Natal, the University of the Witwatersrand and the
University of Cape Town. The HSRC has also adopted a similar position (see note 123 above).
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in the NHA without detailed regulations, and (b) the direct contradictions between the
approach taken in section 71 of the NHA and that contained in the NHREC ethical
guidelines.1165 Although these institutions submit that their refusal to comply with section 71
of the NHA in particular is justified in the circumstances, this approach nevertheless
undermines the principle of legality. Furthermore, it reflects deeper concerns regarding the
principled basis on which the NHA has based its norms. Given that there appears to be
limited stakeholder support for the new approach contained in section 71 of the NHA it is
unclear how child research will be regulated in the future without significant law and policy
reform.
7.2 Creating a theoretical framework for the protection and empowerment of child
research participants whilst facilitating appropriate health research with children
Based on the discussion in Chapter Three of this thesis which reflected on the way in which
the evolution of the ethical-legal framework had failed to find equipoise between child
protection, participation and research facilitation, and the critique in Chapter Six, this
Chapter argues that a new legal and policy framework is required which is clearly premised
on the three principles underpinning this thesis.
7.2.1 The principles underpinning children’s rights
It is submitted that children’s rights bring together two concepts. Firstly, the idea that every
person has human rights, and secondly, children are persons in their own right and are not
the property of their parents.1166 Within such a framework children are the bearers of rights




Human (note 132 above) 165.
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Ibid. This approach is also clearly reflected in South Africa’s Constitution where the drafters elected to
create a specific section in the Bill of Rights describing the rights of children: s 28 Constitution of the Republic of




CRC is based on an acceptance of this approach.1169 It describes the basic human rights of all
children through 54 articles and two Optional Protocols.1170 Its provisions include amongst
others: the right to survival; to develop to the fullest; to protection from harmful influences,
abuse and exploitation; and to participate fully in family, cultural and social aspects of
life.1171
The CRC has made children’s rights a core part of international law.1172 The Constitutional
Court in S v M held that ‘since its introduction the CRC has become the international
standard against which to measure legislation and policies, and has established a new
structure, modelled on children’s rights’.1173 Given that so many countries have acceded to
the CRC1174 it is clear that at one level its norms are broadly accepted and that there is now a
high level of consensus on the idea and content of children’s rights.1175 The Convention does
not specifically mention the rights of child research participants. However, many of its
provisions are broad enough to allow their application to health research with children.1176
Given the normative consensus on the content of children’s rights, it is argued that the
principles underpinning such rights are also almost universally accepted. Furthermore, as the
discourse around children’s rights has had to deal with the complexity of balancing the
protection and empowerment of children, it creates an appropriate theoretical framework
1169
Wolfson (note 237 above) 7.
1170
Convention on the Rights of the Child (note 48 above).
1171
Ibid. The CRC was the first international instrument to incorporate civil, political, cultural, economic,
political and social rights within a single convention.
1172
Sloth-Nielsen & Mezmur (note 229 above) 331.




Ibid. More countries have ratified the CRC than any other human rights treaty in history
http://www.unicef.org/crc/index_30229.html [Accessed 29 April 2013]. To date the United Nations reports that
it has been ratified by 193 countries http://treaties.un.org/Pages/ViewDetails.aspx?src=TREATY&mtdsg_no=IV-
11&chapter=4&lang=en [Accessed: 29 April 2013].
1176
The Committee on the Rights of the Child in General Comment No. 3 has issued guidance on HIV prevention
research (note 174 above). This guidance only applies narrowly to children participating in HIV-related studies
not health research generally. See Chapter Two for further discussion on this point.
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for developing principles that can form the foundation of health research norms for this
group.
7.2.2 Balancing key principles to inform the development of an ethical-legal framework for
health research with children
Throughout this thesis it has been argued that the three principles of child protection, child
participation and research facilitation ought to guide the development of ethical-legal norms
regulating research with children. Although these principles are inter-dependent and are all
equally important, they must be weighed and balanced against each other when developing
individual research norms.
At an over-arching level this thesis recognises that there is a right to ‘enjoy the benefits of
scientific progress and its applications’ in the ICESCRs.1177 However, there is no similar
provision in our Bill of Rights.1178 Nevertheless, this study submits that given that scientific
progress in this field requires research with human participants, the facilitation of health
research falls within the broad ambit of Article 15 of the ICESCRs. It is submitted that this
right to improved child health through evidence-based approaches must nevertheless be
balanced with two child-specific rights, ie child protection and child participation (See Table
17 below).
Table 17: Balancing research facilitation with child protection and participation
Right to benefit from scientific progress Child rights
Research facilitation Child protection and participation
It is submitted that there is always inherent tension between research facilitation on the one
hand and child protection and participation on the other. However, child protection and
1177
Article 15 International Convention on Economic, Social and Cultural Rights (note 10 above).
1178
Constitution of the Republic of South Africa (note 2 above).
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child participation rights may in different circumstances either complement each other or
compete for dominance. For example, even though the Children’s Act allows children to
consent to HIV testing unassisted at the age of 12, an approach which fosters child
participation in decision-making, the drafters of this Act tempered their approach and
promoted child protection by requiring most forms of HIV testing to be in a child’s best
interests.1179 This approach has ensured that both child protection and participation are
promoted without one principle dominating over the other. However, in some instances, the
rights may be in conflict and will require balancing, for example, whilst allowing very young
female children to consent unassisted to a termination of pregnancy may promote child
participation in sexual and reproductive decisions, it may nevertheless place their health at
risk given the potential physical and psychological implications of a termination.1180 In this
instance, the legislature had to balance these two rights and in the Choice of Termination of
Pregnancy Act it elected to place greater focus on autonomy and child participation rather
than protection.1181
7.2.3 Delineating the concepts of child protection, child participation and research facilitation
within an ethical-legal framework
It is argued that all three concepts, those of child protection, child participation the




Ss 130–133 Children’s Act (note 4 above). See Chapter Five for further discussion on a child’s rights
regarding HIV testing.
1180
For example, it was argued by the plaintiffs in the Christian Lawyers Association v Minister of Health and
Others (Reproductive Health alliance as Amicus Curiae) case that girls under the age of 18 did not have the
capacity to decide on a termination of pregnancy and accordingly, they should be protected by requirements of
mandatory counseling and parental consent (note 542 above) 512.
1181
S 5(2) Choice of Termination of Pregnancy Act (note 823 above). See Chapter Five for further discussion on
this Act and the protections developed by parliament to ensure that young girls’ rights to autonomy and
participation in the decision-making process were supported.
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This thesis uses the term child protection to refer to the obligations on certain adults and the
state to protect children from harm. It is argued that this is an obligation to ensure that
children do not suffer ‘physical or psychological injury or damage’.1182 The CRC views the
protection obligations of parents and the state as broadly requiring steps to be taken to,
amongst others, protect children from unfair discrimination,1183 physical or mental
violence1184 and protect them against economic,1185 sexual1186 or any other form of
exploitation.1187
Our Constitution provides that as an over-arching principle, children have a right to be
protected from amongst others, ‘maltreatment, neglect, abuse, or degradation’. It also
prohibits child labour.1188 The Children’s Act provides further details on child protection. For
example, section 6 sets out some general principles to guide the interpretation and
implementation of the Act. These principles include a strong focus on protection by
providing for the importance of respect for children’s rights, respect for a child’s dignity,
treating children fairly and equitably, and protection from unfair discrimination.1189 The
obligation to protect children also flows from the concept of parental responsibilities and
rights. These are duties owed by certain persons, such as parents to children, and include an
obligation to care for and to act as a guardian of the child.1190
1182
http://www.thefreedictionary.com/harm [Accessed: 19 January 2013]. Also see Chapter One for further
discussion on this point. S 28 of the Constitution provides that parents are primarily responsible for protecting
their children but if they cannot meet this obligation the duty falls to the state: Constitution of the Republic of
South Africa (note 2 above). Ss 18–21 of the Children’s Act (note 4 above) elaborate on this point by providing
that certain persons have parental responsibilities and rights towards a child. These include the obligation to
care, remain in contact with, maintain the child and act as their guardian: s 18(2) ibid.
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The Children’s Act also places special obligations on various individuals to act positively to
protect a child where there is a possibility that they are in need of care or protection. This
includes mandatory reporting obligations if, for example, they are being abused or
neglected.1191 These principles recognise the vulnerability of children and the need for
special measures to be taken to ensure that their best interests are promoted.
It is submitted that in the specific context of research, the term ‘child protection’ means
special obligations should be placed on researchers, sponsors and regulators to ensure that
children are not physically or psychologically harmed by participating in the study.1192 This
can be achieved through measures such as:
 Requiring parental, guardian or care-giver consent for research participation involving
children under the age of 12;
 Ensuring their rights to dignity, equality and privacy are not infringed;
 Obligating researchers to comply with mandatory reporting requirements;
 Setting upper limits on the risks that children may be subjected to in health research;
and
 Requiring researchers to demonstrate that children are indispensable to the study.
(ii) Child participation
The term ‘child participation’ refers to the active involvement of children in decision-making
according to their evolving capacity. As stated above, the principle is one of the four
fundamental pillars underlying the CRC1193 which recognises that children are the bearers of
rights and, as such, ought to participate in decisions that affect them in accordance with
their evolving capacity:1194
1191
S 110 Children’s Act ibid. See Chapter Five for the definitions of these terms.
1192
Abdool Karim et al (note 24 above)
1193
Human (note 132) above.
1194
Article 12 Convention on the Rights of the Child (note 48 above).
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‘States Parties shall assure to the child who is capable of forming his or her own views the
right to express those views freely in all matters affecting the child, the views of the child
being given due weight in accordance with the age and maturity of the child.’1195
This requires a consideration of how children can be involved in decision-making, both when
they have capacity and in circumstances where they require assistance.1196 Children’s right to
participate is defined broadly to include not only decision-making by the state and at
community level, but also the day-to-day decisions that adults make on children’s behalf. As
children grow and develop, they should take greater responsibility for decision-making in
matters that affect them.1197
The principle has been recognised in section 10 of the Children’s Act which provides that
every ‘child that is of such an age, maturity and stage of development as to be able to
participate in any matter concerning that child has the right to participate in an appropriate
way and views expressed by the child must be given due consideration’.1198 It has been
argued that this means that adults must at a minimum listen to the views expressed by
children, take them seriously, weight them according to the child’s evolving capacity and
advise children of the outcome of their decision, if it is being made on behalf of the child.1199
This thesis argues that child participation in research decision-making is particularly




McClure et al (note 78 above) 728 where the authors argue that in a research context children who have
capacity should participate through the consent process whilst those who do not should still be engaged
through giving their assent provided that they are over the age of seven.
1197
L Jamieson, R Bray, A Viviers, L Lake, S Pendlebury & C Smith South African Children’s Gauge 2010–2011
(2012) University of Cape Town 20, 23
1198
Children’s Act (note 4 above).
1199
South African Children’s Gauge 2010–2011 (note 1166 above) 27.
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patient autonomy.1200 In the context of research it is submitted that this means involving
children in deciding whether to participate in the study, obtaining their consent or assent,
and ensuring their wishes are respected should they wish to withdraw from the research at
any point. This can be achieved through measures such as:
 Involving children in consent and assent procedures;
 Allowing children of a certain age and capacity to consent independently to health
research;
 Providing that if a child does not wish to participate in research this opinion should be
respected;
 Allowing children to withdraw from a study at any point; and
 Encouraging child participation in research policy-making forums.
(iii) Benefiting from scientific progress – facilitating health research with children
The term ‘research facilitation’ refers to the steps that ought to be taken to ensure that laws,
policies and ethical guidelines do not unreasonably prevent health research from taking
place.1201 It is based on an acceptance that children have a right to benefit from scientific
progress. However, they can do so only if appropriate child research takes place. Thus, it is
argued that within the parameter of this right is an underlying acceptance that health
research has to meet certain standards if it is to be justifiable. In other words, it is submitted
that the promotion of appropriate health research with children is an inherent element of
their right to benefit from scientific progress. Although our Bill of Rights does not include a
positive right to benefit from scientific progress within the right to freedom of expression it
refers to the right to ‘academic freedom and freedom of scientific research’.1202 Following on
from the arguments above it is submitted that the freedom to undertake scientific research
implies a recognition of the importance of research as an activity. Furthermore, given that
1200
Castel v de Greef (note 138 above) 426B.
1201
Strode (note 1132 above) 742.
1202
S 16(1)(d) Constitution of the Republic of South Africa (note 2 above).
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children have the right to ‘basic health care services’1203 and everyone has the right to
‘access health care services’1204 it can be argued that realising these rights requires research
to promote the development of effective health prevention and treatment services. The
thesis argues that children thus have a right to participate in research and to benefit from its
outcomes. In other words, structures and norms are needed which do not exclude children
from research participation, but rather facilitate it in a protective and participatory
manner.1205 Nevertheless, it must be research which can be justified on objective, scientific
grounds. Furthermore, it must be demonstrated that children are indispensable to the study.
7.2.4 Using children’s rights intertwined with ethical principles to create a set of legal norms
to regulate health research
The principles underpinning children’s rights do not deal directly with issues relating to
health research. Accordingly, it is argued that the norms underpinning children’s rights ought
to be linked to well-established ethical norms in order to articulate appropriate legal
standards for the regulation of health research with children.1206
Table 18 below demonstrates how this approach could be used when the three interests of
protection of research participants, child participation and the facilitation of research need
to be continually balanced to ensure that the best interests of children are served.
Table 18: Using children’s rights and ethical norms to develop a legal framework for
regulating research with children
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Furthermore this thesis finds that legislation regulating research with children should also be
premised on the following more general principles:
 ‘Risky’ research must face greater ethical-legal scrutiny;1207
 The recognition of the evolving capacity of children;1208
1207
Points 2.9 and 5.2 NHREC Guidelines (note 56 above). See the law reform proposals below
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 Some flexibility should be available to RECs, which are aware of the local context;1209
and
 The development of broad norms consistent with those in the Children’s Act.1210
7.3 Proposals for law and policy reform based on the principles of protection, participation
and research promotion
It is argued that the approach described above needs to be applied to the following four
research-related rights and three obligations to create a framework which effectively
balances the competing interests of society, science and individual children:
(i) Informed consent
Informed consent is one of the most well-established rights of research participants. It has its
roots in the Nuremburg Code and the Helsinki Declaration.1211 It is based on the ethical
principle of respect for a person’s autonomy.1212 In South Africa, it is also a constitutional
right.1213 It is highly developed in both international and local ethical codes.1214
Protections should include ensuring that informed consent is obtained from participants and
that researchers are obligated to provide a minimum level of information to potential
participants. However, the doctrine of informed consent and assent also provides an
opportunity for children to participate in research-related decisions. A child’s refusal to
1208
The CRC is based on an acceptance of this principle and our Children’s Act (note 4 above) has followed suit
in recognising that children may have capacity to consent to certain health interventions before adulthood, see
Table Two in Chapter One.
1209
S 73(2)(b) National Health Act (note 57 above). RECs are simply required to determine whether the protocol
meets the ethical standards of that committee.
1210
It is submitted that as the Children’s Act is the primary piece of legislation dealing with the rights of children
there ought to be a synergy with the approaches, principles, norms and language in this Act so as to ensure that
there are not divergent approaches between this Act and the National Health Act.
1211
London et al (note 156 above) 288.
1212
Lee, Havens, Sato, Hoffman & Leuthner (note 381 above) 724.
1213
S 12 Constitution of the Republic of South Africa (note 2 above).
1214
Helsinki Declaration (note 41 above) and NHREC Guidelines (note 56 above).
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participate, or their decision to withdraw from a study should always be respected. Finally,
research can be facilitated through ensuring that consent norms provide:
(a) RECs with some flexibility and allowing them to authorise deviations from consent
norms where this is appropriate and in line with the NHREC Guidelines, for example,
allowing verbal consent in certain situations such as no or low risk telephone
interviews;
(b) Children over the age of 12 with the capacity to consent independently to minimal
risk research; and
(c) Care-givers with the authority to provide proxy consent to minimal risk research.
It is argued that balancing the three principles in this instance means that parental or
guardianship consent for all forms of health research is not always possible as, although this
creates a highly protective framework, it limits child participation and makes it difficult to
undertake certain studies such as low-risk, school-based adolescent sexuality studies.1215
These protections should therefore be tempered by allowing, in certain circumstances,
independent consent by children; care-givers to act as proxy consenters to minimal risk
research and RECs some flexibility to fulfil their obligations in terms of section 73(2)(b) of the
NHA which requires them to ‘grant approval for research . . . in instances where research
proposals and protocols meet the ethical standards of that health research ethics
committee’.
Table 19: Balancing the right to participate in health research with informed consent
Protection Participation Facilitation of research
Consent should be required for all
research involving the direct use of
human subjects, unless the REC
has provided an express waiver of
consent
Children over 12 with capacity
should be able to consent
independently to certain forms of
health research
Children under 12 who do not
have the capacity to consent
should be invited to assent to
Parents, guardians and care-givers
should be able to provide consent
1215
Zuch, Mason-Jones, Mathews & Henley (note 121 above) 4.
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health research
A child’s decision not to participate
in the study or to withdraw from it
should be respected
(ii) Privacy
The right to privacy is well established in international law.1216 A number of international
ethical codes apply this right to a research context and provide that research participants are
entitled to confidentiality when they participate in research.1217 Although not research-
specific there is also a constitutional right to privacy in South Africa.1218
The protection of the rights of research participants to privacy should be expressly provided
for in law. Child participation should also be encouraged by recognising a child’s right to
privacy regarding their research participation when they (a) have the capacity to consent
independently to the research, or (b) are able to consent on their own to certain therapeutic
intervention being offered as part of the study.
These norms of protection and participation can be balanced by protecting the privacy rights
of all child research participants as they have a right to confidentiality regarding their status
as research participants and for any information they disclose or provide to researchers. This
is a right accorded to all research participants, adults and children alike, and is not linked to
their capacity to consent. Although, if proxy consent is required, child participants will not
have the right to privacy regarding research participation. Participants who have provided
independent consent to research participation should be entitled to privacy regarding their
participation in the study, provided that their rights may be limited if this is not in the best
1216
Article 17 International Convention on Civil and Political Rights (note 170 above).
1217
Guidance Point 6 Declaration of Helsinki (note 41 above) and Guidance Points 4 and 5 CIOMS (note 182
above).
1218
S 14 Constitution of the Republic of South Africa (note 2 above) and NM and Others v Smith and Others
(Freedom of Expression Institute as Amicus Curiae) (note 357 above).
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interests of the child.1219 Child participation is promoted by allowing older children to keep
knowledge of their research participation private from their parents and if they so choose to
keep certain information regarding therapeutic interventions in the study from the person
providing proxy consent.
Table 20: Balancing the right to privacy in health research
Protection Participation Facilitation of research
All research participants have the
right to privacy regarding
information they provide to
researchers and regarding their
status as research participants
A child’s right to privacy may be
limited when it is in the best
interests of the child
Child research participants have
the right to privacy regarding
therapeutic interventions to which
they have consented
independently
Child research participants have
the right to privacy regarding their
participation in research if they
consent to such a study without
assistance
No specific issues regarding
research facilitation
1219
For example, it may not be in the best interests of the child to keep information on their HIV status private
in an HIV prevention trial. See Strode & Slack (note 822) above for further discussion on this issue.
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(iii) Dignity and Equality
The rights to dignity and equality are also well established in international law.1220 However,
fewer legal instruments link these rights to research.1221 In South Africa both dignity and
equality are rights entrenched in the Bill of Rights.1222 The right to dignity is also clearly
recognised in the national ethical guidelines.1223
The rights of all research participants to dignity and equality should be protected in law.
Acknowledging children’s right to participate in research-related decisions is a recognition of
their inherent dignity and entitlement to respect for their views. There is no balancing which
is required with these rights as research which undermines these rights, even though they be
in the public good, cannot outweigh children’s entitlement to these rights.
(iv) Appropriate risk standards
It is an international ethical norm that the risks in health research should be appropriate
given that in many instances participants will accept them altruistically for the benefit of
others.1224 In South Africa, risk standards are established in the national ethical guidelines.
1225 There are also references to risk standards in the draft Regulations on Human
Subjects.1226 It is argued that children should be protected from participating in research
with an unacceptable level of risk. Nevertheless, research should be facilitated by allowing
1220
Articles 10, 2 and 3 International Convention on Civil and Political Rights (note 172 above).
1221
The right to dignity is recognised in Guidance Point 2 Helsinki Declaration (note 41 above) and Guidance
Point 4 CIOMS (note 182 above). The right to equality has only recently been recognised in a research context
in the International Declaration on the Human Genome and Human Rights. See Chapter Two for more detail on
these points.
1222
Ss 10 and 9 Constitution of the Republic of South Africa (note 2 above).
1223
NHREC Guidelines (note 56 above).
1224
Wendler & Grady (note 397) above) 203.
1225
The NHREC Guidelines (note 56 above) 21 provide that the risks cannot place the child at more than
minimal risk; or if it poses more than minimal risk but provides the child with direct benefit; or if it poses
greater than minimal risk and does not hold out the prospect of direct benefit but has a high probability of
generating generalised knowledge. In such a case the risk must be justified by the knowledge ratio.
1226
Draft Regulations on Human Subjects (note 13 above).
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children to participate in studies which entail some risk, provided that this is not
disproportionate to the potential outcome.
It is submitted that the upper level of risk to which children can be subjected should be
specified in law. This should be premised on the standard of minimal risk, which is a well-
established ethical principle. In other words, the risks of the research should be equivalent to
the risks children ordinarily encounter in their ‘daily life or routine medical or psychological
examinations’.1227 It is submitted that given that ethical guidelines equate these risks to the
risks children encounter in routine medical care and not the general risks that they may face
in their daily lives, it is a clear indication that the drafters envisaged a relative risk
standard.1228Furthermore, the law should provide:
 Health research should not place children at more than a minimal risk of harm;
 If the study poses more than minimal risk of harm but provides the child with direct
benefit, it may nevertheless be approvable; or
 If the research poses greater than a minimal risk of harm and it does not hold out the
prospect of any direct benefit, it may be approved only if there is a high probability of
generating generalised knowledge.
In this instance, child protection must be balanced with research facilitation, as research will
generally carry some risks but the principle of child protection requires them to be lower
than set benchmarks.
Table 21 Balancing the risks that children can be exposed to in health research
Protection Participation Facilitation of research
Risk standards are set to an
appropriate level in law
- Children can participate in
research with some risk
1227
NHREC’s Ethical Guidelines (note 56 above) 21.




It is an international ethical principle that children should not be enrolled in research unless
it has been demonstrated that they are scientifically indispensable to the study.1229 In South
Africa this principle is established in the national ethical guidelines and the draft Regulations
on Human Subjects.1230
All child research participants should be protected by laws stating that RECs may not approve
research unless scientific indispensability has been shown. There is no balancing required
with this principle as protection ought to outweigh both child participation and research
facilitation in this instance.
(vi) Mandatory reporting of abuse
There is no international ethical-legal principle on the mandatory reporting of abuse in
health research with children. Nevertheless, there are a number of legal provisions in South
African law which ensure that children in need of care or protection are identified, and steps
taken to protect them from further harm. This is done primarily by requiring certain people,
particularly those in special relationships with children, such as medical practitioners to
report children who are being abused, neglected or who are in need of care and
protection.1231
This is an ethical principle which protects children and it is submitted that in this instance it
should outweigh the principles of child participation and research facilitation.
It is submitted that policy guidance is needed on how to apply this legal framework to health
research with children.
1229
Helsinki Declaration (note 41 above) and CIOMS Guidelines (note 182 above).
1230
NHREC Guidelines (note 56 above) and the draft Regulations on Human Subjects (note 573 above).
1231
S 110 Children’s Act (note 4 above). See Chapter Five for definitions of these terms.
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7.4 Recommendations for law reform
Based on the arguments for the development of a new normative framework founded on the
principles underpinning ethics and children’s rights which are set out above, a number of
recommendations are proposed below. In some instances, where possible, draft
amendments to the current legislation are described. The recommendations are as follows:
7.4.1 Strengthening the ethical-legal framework to enhance its capacity to regulate health
research with children
Recommendation One: It is recommended that the ethical-legal framework for regulating
health research with children be premised at a macro-level on the principle of the best
interests of the child. Furthermore, in order to promote the best interests of the child in
health research, three other principles ought to inform all other law and policy development:
that of ensuring that child research participants are protected, their ability to participate in
research-related decisions is promoted, and appropriate health research is facilitated. The
Department of Health in consultation with the NHREC should develop a health policy which
describes these fundamental principles and how they are to be used to guide the regulation
of health research with children.
Recommendation Two: It is recommended that the Minister of Health publish a revised
version of the draft Regulations on Human Subjects which were released for public comment
in 2007. The public should have an opportunity to comment on the new draft regulations
and thereafter, they should be finalised before the end of 2013. This revised draft should
take note of the proposals for reform made in Table 23 below.
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7.4.2 Strengthening the institutional aspects of the ethical-legal framework to enhance its
capacity to regulate research with children
Reforms of the institutional framework are required to (a) strengthen its independence from
the executive, (b) ensure that there is more effective co-operation between the various
institutions, (c) ensure that community participation in research-related decisions is
enhanced, and (d) establish better enforcement mechanisms.
Recommendation Three: Strengthening the independence of the ethical-legal institutions. It
is recommended that sections 69 and 72 of the NHA and sections 2 and 3 of the Medicines
Act be amended in order to guarantee the independence of the NHRC, the NHREC and the
MCC. It is proposed that the re-wording prohibit any person or organ of state from
interfering in the work of these statutory bodies, as well as requiring its members to act
independently and impartially. It should also expressly provide that the MCC is accountable
to parliament. Sanctions should be included to respond to conduct which undermines the
independence of these institutions (See Table 20 below reflecting the proposed amendments
underlined).1232
Table 22: Law reform to enhance the independence and accountability of the NHRC,
NHREC and the MCC
NHA: National Health Research Council
69. (1) The Minister must establish a committee to be known as the National Health Research
Committee.
(2) (a) The National Health Research Committee consists of not more than 15 persons, appointed
by the Minister after consultation with the National Health Council.
(b) A person appointed in terms of paragraph (a)–
(i) serves for a term of not more than three years and may be reappointed for one or
more terms; and
(ii) ceases to be a member on resignation or if requested by the Minister for good cause
1232
Deleted text is in square brackets and insertions are underlined.
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to resign;
(c) A vacancy in the National Health Research Committee must be filled by the appointment
of a person for the unexpired portion of the term of office of the member in whose place the
person is appointed, and in the same manner in which the member was appointed in terms of
paragraph (a).
(3) The National Health Research Committee must–
(a) determine the health research to be carried out by public health authorities;
(b) ensure that health research agendas and research resources focus on priority health
problems;
(c) develop and advise the Minister on the application and implementation of an integrated
national strategy for health research; and
(d) co-ordinate the research activities of public health authorities.
(4) The Minister must prescribe the manner in which the National Health Research Council must
conduct its affairs and the procedure to be followed at meetings of the Committee, including the
manner in which decisions must- be taken.
(5) A member of the National Health Research Committee who is not in the full-time employment
of the State must in respect his or her service as a member be paid such remuneration as the
Minister may determine with the concurrence of the Minister of Finance.
(6) A member of the National Health Research Committee shall serve impartially and
independently and exercise or perform his or her powers, duties and functions in good faith and
without fear, favour, bias or prejudice and subject only to the Constitution and the law.
(7) No organ of state and no member or employee of an organ of state nor any other person shall
interfere with, hinder or obstruct the National Health Research Committee in the exercise or
performance of its, his or her powers, duties and functions.
(8) Any conduct which interferes with or hinders the work of the National Health Research
Committee shall be punishable by law.
NHA: National Health Research Ethics Council
72. (1) A council to be known as the National Health Research Ethics Council is hereby
established.
(2) The Minister must–
(a) after consultation with the National Health Council, appoint as members the National
Health Research Ethics Council not more than 15 persons nominated by interested parties at
the invitation of the Minister by notice in the Gazette; and
(b) publish the list of appointees in the Gazette.
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(3) A member of the National Health Research Ethics Council is appointed for three years but may
be reappointed for one or more further terms of office.
(4) A member of the National Health Research Ethics Council must vacate his or her office if he or
she resigns or if requested by the Minister to resign for good cause;
(5) If a member of the National Health Research Ethics Council vacates office or dies, the Minister
may fill the vacancy by appointing a person in accordance with subsection (2) for the unexpired
portion of the term of office of his or her predecessor.
(6) A member of the National Health Research Ethics Council shall serve impartially and
independently and exercise or perform his or her powers, duties and functions in good faith and
without fear, favour, bias or prejudice and subject only to the Constitution and the law.
(7) No organ of state and no member or employee of an organ of state nor any other person shall
interfere with, hinder or obstruct the National Health Research Ethics Council in the exercise or
performance of its, his or her powers, duties and functions.
(8) Any conduct which interferes with or hinders the work of the National Health Research Ethics
Council shall be punishable by law.
[(6)] (9) The National Health Research Ethics Council must–
(a) determine guidelines for the functioning of health research ethics committees;
(b) register and audit health research ethics committees;
(c) set norms and standards for conducting research on humans and animals, including norms
and standards for conducting clinical trials;
(d) adjudicate complaints about the functioning of health research ethics committees and
hear any complaint by a researcher who believes that he or she has been discriminated
against by a health research ethics committee;
(e) refer to the relevant statutory health professional council matters involving the violation
or potential violation of an ethical or professional rule by a health care provider;
(f) institute such disciplinary action as may be prescribed against any person found to be in
violation of any norms and standards, or guidelines, set for the conducting of research in
terms of this Act. Impose an appropriate sanction where a member of a research team is
found to have committed a violation of ethical norms and standards including issuing a
reprimand, requesting an institution to take disciplinary action against an employee or order
an REC to take steps to either revoke ethical approval for a study or to place limitations on the
nature of the research being done;
(g) advise the national department and provincial departments on any ethical issues
concerning research.
[(7)] (10) For the purposes of subsection (6)(c), “clinical trials” means a systematic study,
involving human subjects that aims to answer specific questions about the safety or efficacy of a
medicine or method of treatment.
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Medicines Act: 2. Establishment, powers and functions of Medicines Control Council
(1) There is hereby established a council to be known as the Medicines Control Council, which
may exercise the powers and shall perform the functions conferred upon or assigned to the
council by this Act.
(2) The Council may advise the Minister or furnish a report to the Minister on any matter referred
to the council by the Minister for consideration and arising from the application of this Act.
(3) The council shall be a juristic person.
(4) No organ of state and no member or employee of an organ of state nor any other person shall
interfere with, hinder or obstruct the Medicines Control Council in the exercise or performance of
its, his or her powers, duties and functions.
(5) The Council is accountable to and shall report on an annual basis to parliament.
(6) Any conduct which interferes with or hinders the work of the National Health Research
Committee shall be punishable by law.
3. Constitution of council
(1) The council shall consist of so many members, but not more than 24, as the Minister may
from time to time determine and appoint.
(2) Not less than three of the members appointed to the council shall be persons representing
the community.
(3) The chair of the council shall designate one member to sit on the National Health Research
Committee and to act as a liaison person between these two bodies.
(4) The chair of the council shall designate one member to sit on the National Health Research
Ethics Council and to act as a liaison person between these two bodies.
(5) A member of the Medicines Control Council shall serve impartially and independently and
exercise or perform his or her powers, duties and functions in good faith and without fear,
favour, bias or prejudice and subject only to the Constitution and the law.
(6) Any conduct which interferes with or hinders the work of the Medicines Control Council
Committee shall be punishable by law.
Recommendation Four: Regulations 4 and 5 of the Regulations establishing the National
Health Research Committee should be amended so as to ensure that the powers given to the
Minister of Health to appoint members to the NHRC in the event of no or limited
nominations are removed. Likewise, the Minister’s powers to appoint the chairperson and
vice-chairperson of the NHRC should be replaced with provisions which enable the members
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of the Committee to elect from their own ranks persons into these two positions. Finally, a
new Regulation 6 should be inserted into the Regulations establishing the National Health
Research Committee which provides that the Committee is accountable to parliament (See
the proposed amendments, underlined, below).
Table 23: Law reform to enhance the independence and accountability of the NHRC
Regulations relating to the establishment of the National Health Research Committee
Constitution of the Committee
3.(1) The members of the Committee appointed by the Minister in terms of section 69(2) (a) of the
Act shall comprised the following:
(a) a person with extensive experience and knowledge in health research;
(b) a person representing the Department;
(c) a person representing the community;
(d) a person appointed on account of his/or her knowledge of the law;
(e) a person representing the Medicines Control Council; and
(f) a person representing the National Health Research Ethics Council.
Nomination and appointment of members of the Committee
4.(1) A notice relating to nominations of members of the Committee shall be published in the
Government Gazette and at least one newspaper enjoying circulation in the entire Republic for
appointment referred to in section 69(2) of the Act and shall include-
(a) the closing date and time for the receipt of nominations, and
(b) an address to which the nominations should be sent or delivered.
(2) A nomination of members of the Committee must be in a form substantially similar to
Annexure "A" and must be accompanied by a curriculum vitae signed by the nominated person.
(3) If the Minister receives no nomination or receives an insufficient number of nominations within
the period specified in the invitation, he or she must re-advertise the positions calling for further
nominations. [the Minister may appoint the required number of persons who qualify to be
appointed in terms of section 69(1) and such an appointment shall be deemed to have been
appropriately made.]
[(4) If the Minister receives no nomination, the Minister shall make the necessary nomination, and
any nomination so made by the Minister shall be deemed to have been properly made in terms of
the appropriate provisions of these regulations.]
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Appointment of the chairperson and the vice-chairperson
5.(1). For every newly constituted Committee members of the Committee shall at their first
meeting elect from among themselves a [the Minister shall appoint the] chairperson and a vice-
chairperson.
(2) The chairperson and vice-chairperson shall hold office during the term of office of the members
of the Committee unless the chairperson and the vice chairperson shall sooner resign or cease to
be a member of the Committee.
(3) The vice-chairperson may, if the chairperson is absent or for any reason unable to act as
chairperson, perform all the functions and exercise all the powers of the chairperson.
(4) If both the chairperson and vice-chairperson are absent from any meeting, the members
present shall elect one of their number to preside at that meeting and the person so presiding
may, during that meeting and until the chairperson resumes duty or vacates office.
(5) If both the chairperson and the vice-chairperson have been given leave of absence, the
[Minister shall appoint] members shall elect one of the members to act as chairperson until the
chairperson and the vice-chairperson resumes duty or vacates office.
(6) If the office of chairperson and the vice-chairperson become vacant, [the Minister shall appoint]
the members shall elect a new chairperson and the vice-chairperson, as the case may be, and the
member so elected shall hold office for the unexpired portion of the period for which his or her
predecessor was appointed.
Accountability of the Committee
(6)(1) The Committee shall be accountable to parliament.
(2) The Committee shall report on its activities to parliament on an annual basis.
Recommendation Five: Regulation 3 dealing with appointments and Regulation 4 setting out
the process for appointing the chairperson and vice-chairperson of the NHREC in the
Regulations Relating to the National Health Research Ethics Committee should be amended
to strengthen its independence from the executive. A new Regulation 5 should be inserted
into these Regulations providing that the NHREC is accountable to parliament (See the
proposed amendments, underlined, below).
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Table 24: Law reform to enhance the independence and accountability of the NHREC
Regulations relating to the National Health Research Ethics Council
Constitution of the Council
2. The members of the Council appointed by the Minister in terms of section 72(2)(a) are
constituted as follows:
(a) nine with extensive experience and knowledge in health research ethics;
(b) A representative from the community;
(c) A representative from the Department;
(d) A representative of the pharmaceutical industry;
(f) A representative from the Medicines Control Council;
(g) A representative of the National Health Research Committee;
(h) A person with extensive knowledge in animal health research ethics; and
(g) A person with extensive knowledge in law.
Nomination and appointment of members of the Council
3.(1) A notice relating to nominations of members of the Council shall be published in the
Government Gazette and at least one newspaper enjoying circulation in the entire Republic for
appointment referred to in section 72(l)(a) of the Act and shall include–
(a) the closing date and time for the receipt of nominations; and
(b) an address to which the nominations should be sent or delivered.
(2) A nomination of members of the Council must be in a form substantially similar to Annexure
“A” and must be accompanied by a curriculum vitae signed by the nominated person, and in the
case of a candidate referred to in regulation 2(b) above, signed by two other persons who are
members of a functioning Committee.
(3) If the Minister receives no nomination or receives an insufficient number of nominations within
the period specified in the invitation, he or she must re-advertise the positions calling for further
nominations. [the required number of persons who qualify to be appointed in terms of section
72(2) and such an appointment shall be deemed to have been appropriately made.]
Appointment of the chairperson and the vice-chairperson
4.(1). For every newly constituted Council the members of the Council shall at their first meeting
elect from among themselves a [Minister shall appoint the] chairperson and a vice-chairperson.
(2) The chairperson and vice-chairperson shall hold office during the term of office of the members
of the Council unless the chairperson and the vice-chairperson shall sooner resign or cease to be a
member of the Council.
(3) The vice-chairperson may, if the chairperson is absent or for any reason unable to act as
chairperson, perform all the functions and exercise all the powers of the chairperson.
(4) If both the chairperson and vice-chairperson are absent from any meeting, the members
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present shall elect one of their number to preside at that meeting and the person so residing may,
during that meeting and until the chairperson and the vice-chairperson resumes duty, perform all
the functions and exercise all the powers of the chairperson.
(5) If both the chairperson and the vice-chairperson have been given leave of absence, the
[Minister shall appoint] members shall elect one of the members to act as chairperson until the
chairperson and the vice-chairperson resumes duty or vacates office.
(6) If the office of chairperson and the vice-chairperson becomes vacant, the [Minister shall
appoint] members shall elect a new chairperson and the vice-chairperson, as the case may be, and
the member so elected shall hold office for the unexpired portion of the period for which his or her
predecessor was appointed.
Accountability of the Council
(5)(1) The Council shall be accountable to parliament.
(2) The Council shall report on its activities to parliament on an annual basis.
Recommendation Six: Enhancing co-operation between the institutions functioning within
the ethical-legal framework. In order to ensure co-ordination between the various
institutions within the ethical-legal framework, amendments will be required to (a)
Regulation 4 of the Regulations relating to the Establishment of the National Health Research
Committee,1233 (b) Regulation 2 of the Regulations relating to the National Health Research
Ethics Council, and (c) section 3 of the Medicines Act, in order to ensure that a
representative of each institution sits on the other structures. This will facilitate greater co-
operation between the various ethical-legal institutions (See the proposed amendments,
underlined, in Tables 20, 21 and 22 above).
Recommendation Seven: Facilitating greater community engagement on research-related
decisions. It is recommended that section 3 of the Medicines Act be amended to provide
expressly for a community representative on the MCC (See the proposed amendments which
are underlined where necessary in Table 20 above).
1233
Regulations relating to the establishment of the National Health Research Committee (note 599 above).
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Recommendation Eight: Enhancing the sanctions available to the NHREC in terms of section
72 of the NHA, as this will create a broader range of remedies that can be used by the NHREC
and will facilitate effective relief by research participants (See the proposed amendments
which have been underlined in Table 22 above).
7.4.3 Strengthening the normative aspects of the ethical-legal framework to enhance its
capacity to regulate health research with children
This thesis argues that given the fundamental flaws with section 71, described in Chapters
Five and Six, it would be very difficult to make proposals for amendments to the section.
Although it would be possible to minimise some of the negative impact of the section
through minor amendments1234 it would be very difficult to address the problems which flow
from the fact that the section is based on the flawed distinction between therapeutic and
non-therapeutic research.
Recommendation Nine: This thesis proposes that section 71 be replaced with a new section
which is based on the principles described above, rather than attempting to rectify the
current section in the NHA.1235 The revised section should:
(a) Expressly require informed consent from all research participants unless an express
waiver of consent is issued by an REC;1236
1234
For example, it would be possible to minimise the impact of ministerial consent by amending s 71(3)(a) as
follows: ‘Where research or experimentation is to be conducted on a minor for a non-therapeutic purpose, the
research or experimentation may only be conducted . . . (ii) With the consent of the Minister, if the risk of the
study exceeds a minor increase over minimal risk and is otherwise not approved by an REC’. This would narrow
the scope of ministerial consent to exceptional studies and would bring it in line with the Code of Federal
Regulations in the USA. See Strode, Slack, Wassenaar & Singh (note 119 above) 201 for more detail on the US
approach.
1235
Although it could be argued that law reform could also be inserted within the Children’s Act (note 4 above)
as that deals with a number of a child’s other health rights, this approach was rejected by this thesis as (a) it
could result in a divergent approach between the norms for health research with adults and children; (b) it
could result in a lack of clarity as stakeholders would have to consult both pieces of legislation with designing or
regulating studies; and (c) it may result in complexities when research involves both child and adult
participants.
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(b) Allow children from the age of 12 who have sufficient maturity and mental capacity
to understand the benefits, risks, social and other implications of minimal risk
research to consent independently to such a study. Children below this age or those
without capacity should, where possible, assent to research;1237
(c) Give parents, guardians or care-givers the authority to consent alongside their
children’s assent for all research which is classified as bearing more than minimal risk
or where the child is under the age of 12;1238
(d) Allow children who do not have the capacity to consent to assent to research;
(e) Ensure a child’s decision to decline to participate or withdraw from a study is
respected;1239
(f) Provide that research participants have the right to privacy regarding research
participation. Children who have consented independently to participation should
have the right to privacy regarding this choice. Children should also have the right to
privacy regarding therapeutic interventions within a study to which they have
consented independently. A child’s privacy rights may be limited when maintaining
confidentiality is not in their best interests;
(g) Stipulate that all research participants have the right to dignity and equality;
(h) Specify risk standards. Accordingly, the current risk standards in the draft Regulations
which conflict with the standards in the NHREC ethical guidelines should be deleted;
and
1236
This proposal is a deviation from the current approach in s 71 if the National Health Act (note 57 above) as
it does not require written consent but rather leaves the flexibility in the hands of the REC to determine the
nature of the informed consent process.
1237
This brings the circumstances in which children can consent to health research in line with other similar
health interventions in the Children’s Act (note 4 above). It requires that children reach the age of 12 and
demonstrate that they have capacity in order to consent to health research.
1238
This norm will enable children to provide independent consent to studies which are considered to pose no
more than minimal risk and to which an REC has waived the need for proxy consent. It will mean nevertheless
that proxy consent will still be required for, amongst others, clinical trials.
1239
This proposed norm promotes active child participation as the child’s decision regarding participation
trumps a choice made by their proxy consenter.
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(i) Ensure that research is not approved unless it is shown that the participation of
children is scientifically indispensable to the study.
See the proposed amendments in Table 23 below.
Table 25: Law reform to enhance the protection, participation of child research
participants in appropriate research (new section 71)
NHA Research on or experimentation with human subjects
71(1) Health research with human subjects shall only take place in the following circumstances:
(a) Informed consent has been obtained from all research participants unless an express waiver of
consent is issued by a Research Ethics Committee;
(b) The right of all research participants to privacy is respected;
(c) The right of all research participants to dignity and equality is respected;
(2) A Research Ethics Committee may only approve research with children in the following
circumstances:
(a) Where the research poses acceptable risk standards. No child may participate in research which
poses more than a minimal risk unless:
(i) The research poses more than minimal risk but provides the child with direct benefit; or
(ii) The research poses greater than minimal risk and does not hold out the prospect of direct
benefit but has a high probability of generating generalised knowledge. In such a case the risk
must be justified by the knowledge ratio;
(b) Consent has been obtained from the child for the minimal risk study. A child providing consent
must be over the age of 12 and have sufficient maturity and the mental capacity to understand the
benefits, risks, social and other implications of the research;
(c) Assent has been obtained from the child if it is a more than minimal risk study or they are under
the age of 12 and have sufficient understanding to assent, or they are over the age of 12 and lack
capacity to provide independent consent to minimal risk research;
(d) Consent for child research participation in a minimal risk study where the child is under the age
of 12, or is over the age of 12 and lacks capacity, has been obtained from the child’s parent, legal
guardian or care-giver;
(e) Consent for child participation in studies with more than a minor increase over minimal risk is
provided by the child’s parent or legal guardian;
(f) Where a child’s decision not to participate or to withdraw from a study will be respected;
(g) A child research participant’s right to privacy regarding participation in the study is respected if
they have given independent consent to the study;
(h) A child research participant’s right to privacy is respected regarding their accessing of or use of
therapeutic interventions offered during the study to which they have consented independently;
(i) A child research participant’s right to privacy may be limited when maintaining confidentiality is
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not in the best interests of the child; and
(j) It has been demonstrated that children are scientifically indispensable to the study.
Recommendation Ten: Section 16 of the NHA should be amended to provide that ethical
review is required for record reviews by health care providers (See Table 24 below which
contains the proposed revised wording (underlined) of section 16 of the NHA).
Table 26: Law reform to ensure that all forms of health research are submitted for ethical
review
NHA: Access to health records by health care providers or health researchers
16.(1) A health care provider may examine a user’s health records for the purposes of
(a) treatment with the authorisation of the user; and
(b) study, teaching or research with the authorisation of the user, head of the health
establishment concerned and the relevant health research ethics committee.
(2) If the study, teaching or research contemplated in subsection (1)(b) reflects or obtains no
information as to the identity of the user concerned, it is not necessary to obtain the
[authorisations contemplated in that subsection] consent of the user.
(3) A health researcher may examine a user’s health records for the purposes of study, teaching or
research with the authorisation of the user, head of the health establishment concerned and the
relevant health research ethics committee; and
(4) If the study, teaching or research contemplated in subsection (3) reflects or obtains no
information as to the identity of the user concerned, it is not necessary to obtain the authorisation
of the user.
Recommendation 11: The NHREC should issue policy guidance on the mandatory reporting
of abuse by health researchers.
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Table 27 below summarises the law and policy reform recommendations.
Table 27: Summary of Law and Policy Recommendations
Recommendation Number Policy reform Law reform





2 Revise and re-issue the draft
Regulation on Research with
Human Subjects
3 Amend sections 69 and 72 of
the NHA
4 Amend Regulations 3 and 4 of
the NHRC regulations
5 Amend Regulation 3 and 4 of
the NHREC Regulations
6 Amend Regulations 4 of the
NHRC regulations, Regulation 2
of the NHREC Regulations and s
2 of the MCC Act
7 Amend s 3 of the MCC Act
8 Amend s 72 of the NHA
9 Amend s 71 of the NHA
10 Amend s 16 of the NHA
11 NHREC issue a policy on
mandatory reporting in
research
7.5 Key differences between the proposed approaches based on children’s rights
intertwined with ethical principles and the current norms in the National Health Act
It is submitted that the proposed law and policy reforms described above reflect a new and
innovative approach to the regulation of research with children. They differ from the current
framework in that:
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(a) These proposals are based on a principled framework which attempts to balance child
protection, child participation and research facilitation. No one principle dominates
the framework;
(b) The language and approach have been synchronised with the Children’s Act and the
national ethical guidelines in order to ensure consistency. For example, the words
‘child’ and ‘children’ have been used rather than minor.1240 Likewise, children can
consent independently to minimal-risk health research if they are 12 years old and
meet the capacity requirement. This approach is substantially similar to the approach
the Children’s Act takes to children consenting to medical treatment.1241
Furthermore, the norms regarding consent and risk standards have been brought in
line with the NREC ethical guidelines;
(c) The outdated approach of distinguishing research as therapeutic and non-therapeutic
studies has been removed;
(d) Protections which had no ethical value, such as the need for ministerial consent for all
forms of non-therapeutic research with minors, have been removed;
(e) RECs have been given greater flexibility to decide whether a study is ethical in line
with section 73 of the NHA. For example, they are able to waive informed consent or
allow verbal consent;
(f) Research is facilitated, as highly restrictive provisions, such as the requiring of
mandatory written consent, the prohibition on independent consent by children and
ministerial consent for non-therapeutic research, have been removed. Research is
further facilitated through the broadening of the categories of adults who have the
capacity to provide proxy consent for child research participation;
(g) Research protections have been enhanced through, amongst others, amending the
NHA to provide that a child’s refusal to participate or their decision to withdraw from
1240
Child and children are the terms used in the Children’s Act (note 4 above) whilst the drafters of the NHA
elected to use the term minor in s 71 of the NHA (note 57 above).
1241
S 129 Children’s Act (note 4 above).
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a study must be respected; rights to privacy, dignity and equality have been added
from the draft Regulations to the NHA; and by placing an obligation on researchers to
show that children are scientifically indispensable to the study; and
(h) Child participation has been enhanced by enabling children to consent without
assistance in certain circumstances, obliging researchers to obtain assent and
respecting a child’s views regarding participation in the study.
Table 28 below shows changes to the existing law/policy position in respect of each
recommendation.
Table 28: Changes between the existing law and policy and the proposed reforms
Recommendation Number Current situation Proposed change








2 Draft regulations on human
subjects issued in 2007
Finalise regulations
3 Legislation does not expressly
protect the independence of
the NHRC, NHREC and the MCC
Strengthen the independence
of the NHRC, NHREC and the
MCC through amendments to
the NHA and the Medicines Act
4 Regulations establishing the
NHRC allow the Minister of
Health to appoint members to
the Committee
Amend regulations to prevent
the Minister of Health from
broad appointment powers
5 Regulations establishing the
NHREC allow the Minister of
Health to appoint members to
the Council
Amend regulations to prevent
the Minister of Health from
broad appointment powers
6 No mechanisms which enables
the members of the NHRC,
NHREC and the MCC to meet
and co-ordinate their work
Amend the NHRC and NREC
regulations and the Medicines
Act to facilitate co-operation
between the institutions in the
ethical-legal framework
7 No community representation Amend the Medicines Act to
ensure that a representative of
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on the MCC the community sits on the
Council
8 Limited sanctions for ethical
violations are described in the
NHA
Amend NHA to enhance the
powers of the NHREC to
discipline researchers
9 Section 71 of the NHA over
protects child research
participants
Amend s 71 of the NHA so that
it balances child protection and
participation with research
facilitation
10 Health researchers doing
record reviews do not need
ethical approval
Amend the NHA so that all
researchers must obtain ethical
approval for health research
11 No policy on when researchers
must report children in need of
care and protection
NHREC to issue a policy on
mandatory reporting in health
research
It is submitted that the proposed approach balances the three principles rather than allowing
protection to dominate. Table 29 shows at a macro level how the proposal works across the
three principles, in attempting to balance them in relation to each norm. The table also
shows the differences between the law and policy reform proposals and the current
situation.

































A child’s right to
privacy may be
limited when it is in
the best interests of
the child
Right to dignity and
equality
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The critique in Chapters One, Three and Six has shown that the current ethical-legal
framework cannot effectively regulate health research with children. As it has been stated,
albeit in a more general context:
The implementation of the final aspects of the National Health Act should be good news –
however, it isn’t, as the Minister of Health has ushered in a new legal framework that already
lags behind scientific developments, and is strangling much-needed innovation in health.
Political commitment is required to look to the future and ensure that there is synergy
between unfolding scientific developments, public health and human rights.1242
In conclusion this Chapter argues that law and policy reform is needed. Furthermore, it has
shown that a principled approach to law and policy reform is possible. Thus the regulation of
health research with children can balance both protection and participation with research
facilitation. This creates a framework which promotes child health at a macro-level without
compromising the need to take special measures to protect children and recognise their
evolving capacity.
The law and policy reform proposals described in this Chapter are far-reaching. They suggest
reforms to the intuitional and normative framework for regulating health research. Proposals
include changes to the NHA and its regulations, as well as the Medicines Act. It is submitted
that political commitment will be required tackle this issue, and will need to be coupled with
a commitment to ensure that the public and other key stakeholders are engaged in the
1242
Strode (note 1132 above) 741.
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The previous Chapter established a theoretical framework for the development of law and
policy reforms. It did so by describing the principles that underpin children’s rights, and
setting out how these could be balanced, particularly if they were linked to well-established
ethical norms. These principles were then used to inform the development of new South
African norms relating to informed consent, privacy, dignity, equality, risk standards,
ensuring children are scientifically indispensable to research and mandatory reporting of
abuse. The Chapter concluded with a range of law and policy reform proposals including
specific amendments to the NHA, its accompanying regulations, and the Medicines Act. An
elaboration was provided of how the proposed normative reforms to the framework
balances the three competing interests which underpin this thesis namely, protection,
participation and research facilitation, and how this approach differs from the current one.
This Chapter completes this thesis by drawing a number of conclusions on the extent to
which the South African ethical-legal framework protects child research participants,
promotes their participation in research-related decisions and facilitates appropriate
research. It also makes concluding comments on how a new approach to research regulation
could better serve the best interests of children.
8.1 Framing the issue: Walking the tightrope by balancing competing interests
This thesis has used the analogy of walking on a tightrope to describe the complexity of the
ethical-legal regulation of child research. It has submitted that there is an inherent tension
between facilitating health research with child participants and the need to both protect
children and facilitate their active engagement in research decision-making. Furthermore, if
a delicate balance is not struck between these three principles the tightrope walker will fall,
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resulting in either limited health research for children or inadequate protection and
involvement of children in decision-making. Accordingly, this thesis concludes that:
(i) As children are at high risk of childhood diseases, health research is required to develop
evidence-based interventions to promote their health and well-being
Many children are at risk of early childhood mortality and illness from preventable or
treatable diseases.1243 Poor child health outcomes have been compounded by a lack of child
specific data as historically children were excluded from health research in order to protect
them from harm.1244 Resultantly, they have been subjected to medication or interventions
tested only on adults even though they have different biokinetics, metabolism, physiology,
and immunological systems.1245
Recently, there has been a reversion to the active inclusion of children in research in order to
improve our understanding of issues that impact on their health and to develop appropriate
new prevention or treatment interventions.1246 This new approach is premised on an
acceptance that health research is critical to the development of drugs/health interventions
and to the monitoring and implementation of existing health services. Accordingly, this thesis
finds that realising a child’s constitutional right to both ‘basic health care services’ and
‘access to health care services’1247 requires health research involving children as research
participants.1248
1243
South Africa’s Children: A Review of Equality and Child Rights (note 21 above) 32. See Chapter One for more
detail on the health risks facing children. Also see Chapter Four where more detail is provided on the most
significant health risks facing South African children these include HIV and AIDS, TB, diarrhoeal disease, low
birth weight and protein energy malnutrition.
1244
Burns (note 6 above).
1245
Caldwell (note 16 above) 803. See Chapter One for definitions of these terms.
1246
http://www.who.int/childmedicines/questions/en/ [Accessed: 7 April 2009] and Jaspen, Cunningham,
Tucker et al (note 17 above) 87.
1247
S 28(1)(c) and s 71(1) Constitution of the Republic of South Africa (note 2 above).
1248
http://www.unbrussels.org/agencies/who.html [Accessed: 15 February 2012].
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(ii) There are competing interests in research and these must be regulated by an ethical-
legal framework
There are competing interests in health research as it frequently requires the use of human
volunteers who may bear some risk in order to generate new knowledge.1249 Given this
inherent tension, the regulation of health research should aim at ensuring that the interests
of society and of science do not override the individual interests of research participants.1250
(iii) Child research participants are vulnerable and their welfare must be ensured by an
ethical-legal framework which protects them, promotes their involvement in research-
related decision-making and facilitates appropriate research. Some key principles that
ought to underpin an ethical-legal framework can be found in international law and
ethical codes
This thesis concludes that the tensions between the interests of individuals and the interests
of science are heightened when children are to be enrolled as research participants due to
the constitutional obligation to act in the best interests of the child.1251 Nevertheless, in the
post-World War II period, an increasing number of research-related principles have been
established in international law and ethical codes which can be used to guide such decision-
making. These norms are found in, amongst others, the Geneva Conventions, the Nuremburg
Code, the ICCPRs, the ICESCRs, the Universal Declaration on the Human Genome and Human
Rights, the CRC, the EU Convention on Human Rights and Biomedicine, the Helsinki
Declaration, the CIOMS Guidelines, the WHO GCP and the ICH Guidelines1252 (See Table 28
1249
Fisher (note 40 above) 195. See Chapter One for further discussion on this point.
1250
Ibid and the Helsinki Declaration (note 41 above). See Chapter Two for a more detailed discussion on this
point.
1251
S 28(2) Constitution (note 2 above). This requires decision-making which affects children to consider a range
of factors in determining what is best for children both individually and as a group: Stobie, Strode & Slack (note
59 above) 198–204.
1252
See Chapter Two for a full description of these documents and the norms that they establish with regard to
research with human participants.
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below for an overview of these key norms which establish both procedural and substantive
protections).
Table 30: Key principles and rights from international law and ethical codes that ought to
underpin an ethical-legal framework regulating health research with children
Child protection Child participation Facilitating research with children
Right to participate in research
only if informed consent or assent
is provided
Proxy consent may be provided by
parents or guardians
Right to withdraw consent to
participation at any time
Right to participate in research
only if informed consent or assent
is provided
Proxy consent may be provided by
parents or guardians
Right to withdraw consent to
participation at any time
Clinical trials must be submitted
for regulatory approval
Right to dignity Right to benefit from scientific
progress
Vulnerable groups are entitled to
participate in research
Right to privacy Right to dignity
Research participants must be
informed of their rights
Protective measures must be
taken when vulnerable groups
participate in research
An appropriate balance of risks
and benefits must exist
The inclusion of children in
research must be scientifically
justified
All health research must be
submitted for ethical review
Promote and safeguard the health
of patients and research
participants
This dissertation finds that the norms established in international law and ethical codes are
not comprehensive, and there is a need for a convention dedicated to research participants’
rights. Nevertheless, these norms provide a basis for developing laws and policies for
protecting and facilitating child participation in national frameworks. Unfortunately, limited
315
international guidance exists on how these norms can be balanced with facilitating
appropriate child research.1253
8.2 A review of the extent to which the South African ethical-legal framework protects
research participants, enables child participation and facilitates health research
The first research question of this dissertation was: to what extent does the current ethical-
legal framework protect research participants, enable child participation in accordance with
their evolving capacity and facilitate appropriate health research? This question was
answered by firstly, by describing both the international ethical-legal norms for regulating
health research with children in Chapter Two and the South African ethical-legal framework
in Chapters Four and Five. Secondly, the ethical-legal framework was critiqued in Chapter Six.
The analytical framework used for the critique was based both on the extent to which the
ethical-legal framework met the international norms and its ability to balance the three
principles which underpin this thesis. Based on this approach this thesis concludes that:
(iv) South Africa has established institutions within its ethical-legal framework. The
institutional framework complies with some but not all international norms. Furthermore,
it protects child research participants but does not facilitate their active involvement in
research policy and regulation or effectively facilitate health research
It is submitted in Chapter Two that a key element of an ethical-legal framework is the need
to protect research participants by setting procedural obligations enforced by
institutions.1254
1253
See for example, the restrictive approach recommended by the Committee on the Rights of the Child
General Comment No. 3 (note 174 above) regarding the involvement of children in HIV prevention research.
This is in direct contrast with the proposals made by the WHO/UNAIDS/AAVP Expert Group (note 140 above).
This appears to reflect divergent approaches between the human rights obligations to protect children and
public health imperatives to develop HIV prevention products for at risk adolescents.
1254
Glantz (note 90 above) 128.
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This dissertation finds that the South African institutional framework for regulating health
research with children is well established. There are three statutory institutions and two
non-statutory bodies which collectively play key roles in the regulation of health research.1255
These institutions ensure that health research is appropriate by requiring studies to: fit
within a national research agenda; comply with scientific and ethical standards; and, in
certain circumstances, engage with the community. However, this institutional framework is
undermined by:
(a) The lack of defined institutional independence of the NHRC, the MCC and the
NHREC undermines their capacity to act impartially
This thesis finds that the institutional framework is undermined by the failure of the NHA and
the Medicines Act to (a) guarantee the independence of the NHRC, the NHREC and the MCC,
and (b) to ensure that powers given to the Minister of Health do not allow him or her to
interfere in the appointment of members or the workings of the these institutions. These
omissions mean that the relevant institutions are vulnerable to political pressure from the
executive. This in turn undermines their authority and ability to work independently.
(b) The participation of children and the community in the development of health
research policy and research regulation is limited as the legal framework has
adopted a superficial approach to community engagement
Based on the review of the institutions supporting the ethical-legal framework in Chapter
Four, this thesis finds that there is only a token involvement of the community in research
regulation. Although the community is represented on some statutory bodies this is not
linked to obligations on such institutions to engage in broader community consultation or
1255
The statutory bodies are the NHRC, the MCC and the NHREC. RECs and CAGs are not statutory bodies
however RECs have a specific statutory role described in s 73 of the National Health Act (note 57 above).
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debate and, as a result, research policy decisions are still largely in the hands of technical
experts.
The introduction of the research norms in section 71 is a good example of this lack of public
participation in the development of health research policy. In this instance, the new norms
reflect a significant policy shift which occurred silently and without public discourse on the
problems with the previous framework and on ways in which it could be strengthened.1256
The principles underpinning them were not set out in the White Paper on Transformation of
the Health System in South Africa1257 or in other policy documents issued by the Department
of Health. The rights of child research participants were also not an issue raised as part of the
extensive consultation process which informed the development of the Children’s Act.1258
Even the NHREC, a body with a statutory mandate to advise the government on research
ethics, appears to have been surprised by the implementation of sections 11 and 71 of the
NHA without the Regulations on Human Subjects being finalised.1259 Given that there have
been extensive criticisms of section 71 since it was adopted by Parliament; it is surprising
that, at the very least some of the issues of concern were not addressed in regulations.1260
This thesis finds that the high-handed manner in which the new research norms were
developed and implemented reflects the state’s non-commitment to consultations on health
research policy, its failure to act in a transparent fashion and the inability of the ethical-legal
institutions to impact on the normative framework.
(c) Monitoring and enforcement mechanism exists but research specific
enforcement mechanisms are generally weak
1256
This issue is discussed further in Chapter Six.
1257
White Paper for the Transformation of the Health System in South Africa (note 7 above).
1258
South African Law Reform Commission, 2002, Project 110: Review of the Child Care Act, available from
http://www.justice.gov.za/salrc/reports.htm [Accessed: 8 February 2012].
1259 Statement from the Council on Proclamation of s 71 of National Health Act (undated) available from
http://www.nhrec.org.za/wp-content/uploads/2012/letter.pdf [Accessed: 12 January 2013].
1260
See Chapter Six for an outline of these criticisms.
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It is submitted that although a comprehensive monitoring and enforcement framework
exists access to it is limited by structural factors such as costs and in some instances the need
for legal representation.1261 This thesis finds that there is a need for an amendment to the
NHA to ensure that the NHREC has broader powers that it can use to act against researchers
or institutions that infringe research participants’ rights.
(d) Appropriate health research is not facilitated due to the limited co-ordination
between regulatory institutions
This dissertation finds that there is only a formal institutional link between the MCC and the
NHREC. There is no other mechanism by which all the heads of the various institutions or the
institutions themselves can meet and co-ordinate their respective functions within the
ethical-legal framework. This is a significant gap which could lead to inconsistent and over-
lapping approaches.
(v) South Africa has a normative framework for regulating health research established
primarily in the NHA and ethical guidelines. To some extent this normative framework
meets the international standards however, it over protects children thus undermining
child participation in research-related decisions and hindering appropriate health
research
In Chapter Two of this thesis it is argued that ethical and legal norms are required in order to
regulate research. Accordingly, that chapter argued that an ideal legal framework should
have laws describing the rights of research participants, and the obligations on the state,




This thesis has described the South African normative framework for regulating health
research with children which is created primarily by the NHA in Chapter Five. There are
norms established both in law and ethical guidelines on the conduct of health research with
children. There are also a number of non-research specific laws which impact on the way in
which health research is conducted. Resultantly, there are four rights which set out when
and how children can participate in health research.1262 There are also four research-specific
obligations and one non-research specific obligation on researchers to promote the welfare
of child research participants.1263 These ensure that the vulnerability of children in health
research is expressly protected within the framework. However, this thesis concludes, these
ethical-legal norms are undermined because:
(a) The conflict between the norms in the NHA and those in the Children’s Act
result in health research with children being treated in an exceptional way which
is different from the approach taken to other health interventions. The norms in
the NHA are in many instances diametrically opposed to those in the NHREC
ethical guidelines.
There are a number of issues regarding the normative approach taken in the NHA. Firstly, the
norms in the NHA are also founded on principles which were rejected by the drafters of the
Children’s Act which is the primary source of law dealing with persons under the age of
18.1264 The Children’s Act is premised on, amongst others, the notion that children have
evolving capacity, they have a right to participate in decisions that affect them, and their
best interests must be considered.1265 Secondly, these norms are diametrically opposed to
the position adopted in the national ethical guidelines and the GCP. For example, ethical
1262
These rights are set out in ss 11, 16 and 71 National Health Act (note 57 above).
1263
See Chapter Five for a full description of these obligations.
1264
The drafters of the Children’s Act (note 4 above) accepted the principle that children have evolving capacity
and accordingly ought to be able to consent to certain health interventions without parental assistance: Strode,
Slack & Essack (note 143 above) 218.
1265
The preamble, ss 10 and 7 Children’s Act (note 4 above).
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guidelines treat research which may confer a direct benefit to the participants differently
from research without a direct benefit. For example, with research conferring the possibility
of a direct benefit the ethical guidelines allow for the approval of a higher risk level by an
REC. The NHA however, has inverted this principle and requires that this form of research
must receive greater scrutiny than research without a direct benefit.1266 Collectively, this
approach acts as a direct barrier to the conduct of certain forms of health research with
children which infringes other rights, such as those described in sections 27 and 28 of the
Constitution.1267
(b) The drafters of the NHA appear to have considered informed consent as one
of the primary mechanisms for protecting child research participants
This study finds that although the research norms in the NHA are protective they are
nevertheless limited by their focus on informed consent as the primary protection for child
research participants. The NHA is conspicuously silent on other rights such as the right to
privacy, dignity or equality.1268 Thus, although the normative framework is highly protective
for child research participants, ironically it prioritises a single right of child research
participants.
(c) The norms within the ethical-legal framework are based on a single principle,
that of child protection, and this has the unintended consequence of excluding
children from health research and consequently the benefits of scientific progress
in this field
1266
See Chapter Four for more discussion on this point.
1267
See for example, Zuch, Mason-Jones, Mathews & Henley (note 121 above) 4 where the authors describe the
impact that s 71 of the National Health Act will have on school-based adolescent health studies.
1268
These rights are referred to in the draft Regulations on Human Subjects however, given the uncertainty
around these draft Regulations there is no assurance that they will be in the final regulations.
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The critique of the ethical-legal framework in Chapter Six showed that the framework is
based on the over-arching premise of protecting child research participants. However, this
approach undermines children’s best interests by, amongst others, prohibiting them from
providing independent consent in any circumstances, limiting the categories of adults who
can provide proxy consent, mandatorily requiring written consent, requiring therapeutic
research to be in the best interests of children and obligating researchers to obtain
ministerial consent for non-therapeutic research. Cumulatively it could be argued that these
norms limit the pool of children eligible for enrolment in research, and thus prevent valuable
research from being undertaken. Accordingly, this thesis finds that the norms have the
unintended consequence of retarding the development of new health technology, medicine
and treatment for children.
(d) The rationale for a number of provisions is unclear and they offer limited
protection for child research participants
It is unclear for example, as to why the drafters of the NHA introduced a contested and
largely disregarded distinction between therapeutic and non-therapeutic research in the
NHA. Furthermore, there is no explanation as to why all forms of non-therapeutic research
with children required additional protection by obliging researchers to obtain ministerial
consent.
(vi) South Africa’s ethical-legal framework has grappled with the tension between
protection, participation and research facilitation. It has moved from a system based
largely on self-regulation to one which is highly regulated and restrictive, particularly
when the potential research participants are children
The current ethical-legal framework indicates a radical policy shift away from regulation
being vested in institutionally based RECs using ethical guidelines to decide when research
was ethical, to one in which there is greater emphasis on substantive and procedural
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protections for child research participants (See Table 29 below). Over the three phases of its
development, the protectiveness of the ethical-legal framework has been strengthened.
Resultantly, the protection of research participants is now the dominant principle underlying
the regulation of health research with children. Child participation has not evolved
significantly, as it remains focused on the consent and assent provisions within ethical
guidelines, although there is some reference to this principle in section 71 of the NHA.1269
Finally, research facilitation which was a strong element of the first and second phases of the
ethical-legal framework, has been undermined by the current system due to its focus on
child protection. This thesis finds that these disjunctive approaches reflect a lack of
coherence of the principles guiding health research, and do not serve the interests of
children or of science.
Table 29: The evolving nature of protection, participation and research facilitation with
children in the South African ethical-legal framework
Protection Child participation Research facilitation








Second phase Stronger Strong through assent
and consent processes
but undermined by a lack
of clarity on independent
consent
Strong




(vii) It is disconcerting that key legal problems with the first and second phases of the
ethical-legal framework have not been addressed in the very recent reforms implemented
in March 2012
1269
For example, s 71 requires children to participate alongside their parents/guardians in the consent process
if they are ‘capable of understanding’: National Health Act (note 57 above). This clearly reflects elements of a
child participation approach. See Chapters Five and Six for further discussion on this point.
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Chapters One and Three of this dissertation set out the key problems with first and second
phases of the ethical-legal framework. In the first phase there wasn’t a formal, legally
established ethical-legal framework. There were however, a limited number of institutions to
regulate research, and some legally binding norms and standards. This was addressed with
the introduction of the second stage of the ethical-legal framework which created a formal
system consisting of institutions to set the policy agenda, establish norms and standards, and
regulate health research. Enforceable ethical norms could also be established and research-
specific monitoring and enforcement mechanisms were established. The second phase of the
ethical-legal framework addressed (a) the focus on self-regulation by introducing a number
of statutory bodies, (b) the disjointed nature of many of the legal provisions by consolidating
most of the norms into the NHA, and (c) providing the NHREC with the authority to issue
national ethical guidelines binding all health researchers and institutions. However, there
were several problems with the second phase of the ethical-legal framework including that
the legally binding norms in the NHA were not implemented; there were differing
interpretations of the ethical guidelines; and some disharmony between the guidelines.
Overall, the previous ethical-legal frameworks failed as they did not adequately protect child
research participants or sufficiently promote child participation. They were however,
facilitative of health research.
The third or current stage of the ethical-legal framework came into being on 1 March 2012
with the implementation of sections 11 and 71 of the NHA. This completed the introduction
of a comprehensive ethical-legal framework by operationalising the legal norms in the NHA
on how and when research with human subjects may be conducted. This includes specific
provisions on research with minors. Although in the current phase there are now clear legal
norms regulating child research these norms tend to over-emphasise protection thereby
hindering research.
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(viii) Despite the full implementation of the NHA, the ethical-legal framework remains in a
state of limbo. It has been in this state for more than seven years. It is unclear as to when
the draft Regulations on Human Subjects will be finalised thus enabling the framework to
be fully implemented. This on-going state of limbo results in inconsistent approaches and
uncertainty for RECs, statutory institutions, researchers and participants
This dissertation finds that regulating health research with children is extremely complex due
to the on-going state of limbo in the ethical-legal framework.1270 Currently, although
required to do so by law, many RECs are not applying the norms described in section 71 of
the NHA because of, firstly, the uncertainty in the way in which the law was implemented
without accompanying regulations; and secondly, due to concerns regarding the way it
undermines well-established practices which have been developed on the basis of the
national ethical guidelines.1271 Once the regulations have been finalised and the framework is
in place, it is possible that compliance with the system may remain low due to this long
period of uncertainty and a lack of buy-in of the new norms by researchers, institutions and
RECs.
8.3 A review of the usefulness of the principles of protection, child participation and
research facilitation in developing new norms for the regulation of health research with
children
The second research question in this thesis was: can the three principles of protection,
participation and research promotion be used to establish the key legal norms that ought to
inform the development of laws regulating health research with children?
1270
Slack, Strode, Grant & Milford (note 143 above) 682.
1271
See the approaches taken by a range of research institutions (note 123 above).
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Chapter Seven of this dissertation sets out these three principles and develops a theoretical
model showing how they could be used to create ethical-legal norms for regulating research
with children. This thesis concludes:
(ix) In walking the tightrope towards better child health services and treatments, the
facilitation of health research must be carefully balanced with both child protection and
child participation
In Chapter Seven it is submitted that there is always an inherent tension between research
facilitation and child protection and participation. However, child protection and child
participation rights may in different circumstances either complement each other or
compete for dominance. It concludes that the right to access health services is premised on
health research and thus this must be balanced with child protection and child participation.
Furthermore, this approach could be used to develop norms for four research-related rights
(consent, privacy, dignity and equality) and three obligations (scientific indispensability,
appropriate risk standards and mandatory reporting) to create a framework which effectively
balances the competing interests of society, science and individual children.
(ix) The consideration of and the balancing of each principle can be an effective way of
developing research related norms for regulating child research participation
This dissertation concludes in Chapter Seven that these three principles do create an
effective framework for developing new norms provided they are linked to both the
principles underlying child rights and those contained in ethical norms. This dissertation
demonstrates the usefulness of such an approach by applying it to the current South African
ethical-legal framework and proposing new norms based on this principled approach.
326
8.4 Conclusion
In conclusion, this thesis has shown that children have a constitutional right to access ‘basic’
health services. This can most effectively be achieved if there is on-going health research to
improve services and treatments offered to children. In many instances, children will need to
participate in such studies. Given a history of abusive research practices it is acknowledged
that research ought to be regulated by an ethical-legal framework.
In this regard, the South African legislature has responded by moving from self-regulation to
a highly sophisticated system with three levels of controls. Firstly, policy controls which
ensure that appropriate and relevant research is undertaken; secondly, institutions which
regulate research; and thirdly, norms which describe enforceable rights and duties of key
stakeholders. These are created by amongst others the NHA and the Medicines Act.
On the face of it, the South African system appears to be an excellent case study of a
developing country that has effectively used the law to create a framework for regulating
health research, a framework which is comparable to any developed country. However, this
thesis has shown through its critique that, although the system has a solid institutional
foundation, norms have been haphazardly introduced into the system without any principled
basis. These norms are not relevant in that they do not address the key issues facing
research regulation and they are not coherent as they conflict with children’s rights and
ethical principles. Resultantly, the overly-restrictive new normative framework undermines
the institutional gains in the system. The over-focus on protection also has a disparate
impact on children as the framework severely limits when and how children can participate
in research. Consequently, it will be difficult to undertake both social science studies and
clinical trials with children in the future.
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This thesis has argued for law and policy reform to address the key weaknesses in the
institutional framework. It has also described three principles which when entwined with
ethical norms are able to develop a normative framework which will balance child
protection/participation with research facilitation. It has concluded with a description of
these proposals.
It is submitted that the key lessons that have emerged from the South African experience
and the proposed model for law reform could be applied in other jurisdictions as a
framework for developing locally relevant research norms for regulating research with
children. Children should not die or suffer needlessly of preventable health conditions, and
research should be employed strategically to improve health services and serve their best
interests. Nevertheless, such research should be regulated in a way that ensures their rights
are not infringed and their welfare is promoted. This can be achieved through carefully
balancing the three key principles of protection, participation and research facilitation, thus
effectively walking the tightrope.
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Addendum
The impact of the draft Regulations Relating to Research on Human
Subjects, published on 29 May 2013, on the regulation of health
research with children in South Africa
In 2007 the Minister of Health published draft Regulations relating to research on human
subjects for public comment (the 2007 draft Regulations).1272 A further set of regulations
presumably based on the public comments and dated 2009 (the 2009 revised Regulations) is
available on the NHREC website.1273 However, no further information was made available
regarding the status of these revised Regulations. Following the promulgation of section 71
of the NHA on 1 March 20121274 there was much speculation on whether the 2007 draft or
the 2009 revised Regulations would be gazetted, particularly as some aspects of section 71
are not implementable without more detailed guidance being provided. It was therefore not
unexpected that on 29 May 2013 a further set of draft Regulations titled ‘the Regulations
relating to Research with Human Subjects’ (the 2013 draft Regulations) was gazetted for
public comment. The closing date for submissions is 29 July 2013. These revised draft
regulations impact on the discussion on the current normative framework in Chapters One,
Three, Five, Six and Eight of this dissertation. Given, that they are still in draft form and it is
unclear as to whether (a) they will undergo significant revisions based on the public
comments, and (b) their deadline for completion, it was decided not to change the content
of this thesis but to add this explanatory addendum.
This addendum (a) sets out the sections of the 2013 draft Regulations which deal with or
impact on research with children and compare it with the approach taken in the 2007 draft
regulations; (b) discusses the implications that the 2013 draft Regulations will have for
1272
2007 draft Regulations relating to research on human subjects (note 13 above).
1273
2013 draft Regulations relating to research on human subjects (note 572 above).
1274
Government Gazette No. 35081 (note 96 above).
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research regulation with children including issues not addressed by them; and (c) conclude
with the implications they will have for the law reform proposals made in this thesis.
An overview of the content of the 2013 draft Regulations relating to Research with Human
Subjects
There are a number of areas in which the regulations may impact on the future regulation of
health research with children. The key content areas are each discussed in turn:
(i) Clarifying key terms used in the National Health Act through new or revised
definitions
The 2013 draft Regulations set out a number of key definitions in Regulation 1. Those that
will impact on research with children include:
The term ‘best interests’ of the child is a term used in section 71(2) of the NHA with regard to
therapeutic research with minors.1275 It was not defined in the NHA or the 2007 draft
Regulations. The 2013 draft Regulations provide some clarity by stating that it means
‘significant decisions affecting a minor’s life should aim to promote amongst others the
minor’s physical, mental, moral and emotional welfare’.1276
The 2013 draft Regulations also define the word ‘condition’ which is used in section 71 of the
NHA. The Act provides that the Minister of Health may not give his or her consent to non-
therapeutic research with minors unless, amongst others, it can be demonstrated that the
study will result in a significant improvement in the understanding of the minor’s condition
or disorder.1277 The term was not defined in either the NHA or the 2007 draft Regulations.
1275
National Health Act (note 56 above).
1276
Regulation 1 2013 draft Regulations relating to research on human subjects (note 13 above).
1277
S 71(3)(b) National Health Act (note 57 above).
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The 2013 draft Regulations state that in this context ‘condition’ means ‘physical and psycho-
social characteristics shown to affect health’.1278
The term ‘human subject’ has been defined as ‘a living person about whom an investigator
obtains data or specimens of identifiable private information through intervention or
interaction with that person’.1279 This is significant as the obligations in section 71 of the NHA
relate to ‘research or experimentation on a living person’1280 yet the term human subject
was not defined in the Act. This definition now clearly indicates that these norms only apply
to health research involving an actual interaction with a living research participant. This
definition also ensures synergy with the NHREC ethical guidelines which have a similar
definition. 1281
‘Minimal risk’ is not a term that is used in the NHA. However, the 2013 draft Regulations
have a specific section on risk standards in Regulation 4, and this term is important for
establishing the parameters of such risk standards. The term is defined as ‘the probability or
magnitude of harm or discomfort anticipated in the research is not greater in itself than that
ordinarily encountered in daily life including routine medical, dental or psychological tests or
examinations’. Again, this definition is in line with the approach to minimal risk as described
in the NHREC ethical guidelines.1282
The type of research which falls within the ambit of the term ‘non-therapeutic research’ is
important as there are a number of specific obligations set out in section 71 of the NHA if
such a study includes persons under the age of 18.1283 This term is not defined in the NHA
1278
Regulation 1 2013 draft Regulations relating to research on human subjects (note 13 above).
1278




National Health Act (note 56 above).
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National Health Act (note 57 above).
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but a similar definition was included in the 2007 draft Regulations which provided that it
entailed ‘any research not directed towards the benefit of individual but rather towards
improving scientific knowledge or technical application and developing generalisable
knowledge’.1284 The 2013 draft Regulations re-define this form of research so that there is
greater synchronicity with the NHREC ethical guidelines, stating that it is ‘research that does
not hold out the prospect of direct benefit to the participant but holds out the prospect of
generalisable knowledge’.1285
A definition of ‘significant risk’ is also provided in Regulation 1 of the 2013 draft Regulations.
This new risk standard introduced in section 71 of the NHA in relation to so-called non-
therapeutic research was not defined in either the NHA or the 2007 draft Regulations. The
2013 draft Regulations now define it as a ‘substantial risk of serious harm’.
The term ‘therapeutic research’ is also of importance as there are a number of obligations on
researchers who undertake this form of research with minors, in terms of section 71 of the
NHA. Neither the NHA nor the 2007 draft Regulations defined this term. The 2013 draft
Regulations state that it refers to ‘research that holds out the prospect of direct benefit to
the participant’.1286 Again, this definition is in line with the terminology used in the NHREC
ethical guidelines.1287
(ii) Describing key principles that must underpin the way in which health research is
conducted
Regulation 2 of the 2013 draft Regulations sets out 10 principles that should underpin the
way in which research is conducted. These are very similar to the principles contained in the
1284
Regulation 1 draft Regulations 2007 (note 13 above).
1285




NHREC ethical guidelines (note 56 above).
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2007 draft Regulations. They include, amongst others, that the research must be relevant, be
based on a valid scientific methodology, protect the rights of research participants to dignity,
equality, bodily integrity and privacy and be submitted for ethical review.1288
(iii) Setting out the obligations on researchers
Regulation 3 of the 2013 draft Regulations sets out seven obligations imposed on
researchers. Although the 2007 draft Regulations also included a number of obligations,
some changes have been made to those listed in the 2013 version. The obligations now
include responsibilities to meet procedural requirements such as ethical approval,
consultations with certain stakeholders, and ensuring that participants, if harmed, are
provided with assistance and compensation.1289
(iv) Setting additional norms for the participation of minors in research
Regulation 4 deals with the participation of special classes of persons in research including
minors. The approach in the 2013 draft Regulations is considerably different from that set
out in the 2007 draft Regulations. The current Regulation 4 sets maximum risk standards for
research involving children and requires researchers to demonstrate that children are
indispensable to the study.1290 Like the 2007 draft Regulations, the 2013 version also requires
an REC to pay special attention to persons in special relationships, such as those in a doctor-
patient or student-teacher relationship.1291 The new approach is now consistent with the
approach in the national ethical guidelines.1292
1288








NHREC Guidelines (note 56 above).
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(v) Describing the informational aspect of informed consent
Regulation 6 of the 2013 draft Regulations sets out 14 areas in which research participants
must be provided with information as part of the informed consent process.1293 The most
significant difference between the two sets of draft regulations is that the 2013 version now
requires participants to also be informed of ‘their freedom to decline or withdraw from the
research without prejudice’.1294
(vi) Providing guidance on applications for ethical approval
Regulation 7 requires researchers to obtain ethical approval from a registered REC, to satisfy
any requirements set by the Committee, and to ensure they comply with its obligations.1295
Similar provisions were set out in Regulation 8 of the 2007 draft Regulations.1296
(vii)Describing the manner and form in which an application must be made for ministerial
approval of non-therapeutic research with minors
The 2007 draft Regulations were silent on the process for applying for ministerial consent for
non-therapeutic research with minors. The 2013 draft Regulations deal with this issue in
Regulation 8. They provide that an application for ministerial approval must be made on a
standard form (Form A).1297 They also describe the process that must be followed in
obtaining ministerial consent. Researchers must obtain ethical approval and thereafter apply
to the Minister on the standard form.1298 The Minister, in making his or her decision, may








Regulation 7 draft Regulations 2007 (note 13 above).
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research ethics committees or relevant experts’.1299 The draft Regulations also provide that
researchers must be informed of the outcome of the Minister’s decision ‘in a timely
manner’.1300
Finally, the draft Regulations allude to the possible delegation of the Minister’s power to
another body which would then provide consent for non-therapeutic research when it states
that this decision may be made by the Minister or a ‘duly appointed delegated authority in
terms of s92(a) of the Act’.1301
The implications of the 2013 draft Regulations relating to Research with Human Subjects
on future studies involving children
It is argued that if the new 2013 draft Regulations are finalised in their current form they will
impact on the regulation of health research with children in a number of ways.
In many respects, the 2013 draft Regulations will enhance the regulation of research with
children in that they firstly, provide clarity on a number of key terms used in section 71 of
the NHA and this will assist in the implementation of these norms. For example, by providing
a definition of ‘significant risk’ there is now clarity on this term. This thesis had identified this
lacuna as a key concern as academics were divided on whether it implied minimal or a higher
level of approvable risk.1302 The definition provided in the 2013 draft Regulations makes it
clear that significant risk cannot be compared with minimal risk which is linked to the
concept of ‘everyday risks’. Instead the term refers to a higher level of risk through the use of








See Chapters Five and Six for further discussion on this point.
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Secondly, the 2013 draft Regulations address some of the concerns raised regarding
discordant approaches between the NHA and the national ethical guidelines.1303 The 2013
draft Regulations have addressed some of the issues relating to inconsistent terminology
between the NHA and ethical guidelines through a revision of some key terms. Furthermore,
the norms in the 2013 draft Regulations relating to risk standards and the informational
aspects of informed consent are now consistent with those in ethical guidelines.
Thirdly, the 2013 draft Regulations address some of the weaknesses in the current normative
framework by (a) providing that research participants have rights to dignity, equality and
privacy; (b) placing an obligation on researchers to inform research participants on 14 issues
which inform research decision-making; (c) setting maximum risk standards that children
may be subjected to in law; and (d) placing a legal obligation on researchers to demonstrate
that children are scientifically indispensable to a particular study.
Fourthly, the 2013 draft Regulations have provided clarity on the procedural aspects of
applying for ministerial consent in section 71 of the NHA. They describe the process that
must be followed and contain a form that must be used for this application.
There are, however, a number of weaknesses in the ethical-legal framework which are not
addressed by the draft Regulations. Resultantly, the most significant principled issues
plaguing the ethical-legal framework remain unaddressed. This was to be expected as
regulations are a form of delegated legislation, and accordingly the Minister of Health did
not have the statutory authority to establish new legal norms which are not provided for in
the empowering legislation. It could not therefore be expected that the draft Regulations
would change the principles which underpin our normative framework for research
regulation with children. Accordingly, this thesis has argued that law reform of the NHA is
1303
See Chapter Six for further discussion on this point.
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required to address these key issues. Irrespective of this limited opportunity offered by the
regulations for reform it is submitted that there were some issues which could have been
resolved in the regulations but which have remained unanswered. Outstanding issues
include:
(i) There is still no clarity on how to apply section 71(2)(a) of the NHA. This section
requires all therapeutic research with minors to be in the best interests of the minor.
Currently, it is unclear whether this principle must be used in an individual or
collective manner and both the NHA and the regulations are silent on this issue. In
other words, whether therapeutic research must promote the best interests of
children as a class or the best interests of individual child research participants is
open to debate. It is submitted that clarity could be provided in the regulations on
how to apply this principle.
(ii) The word ‘condition’ requires a broader meaning if it is to give effect to section 71(3)
of the NHA. The NHA provides that the Minister of Health may not give his or her
consent to non-therapeutic research with minors unless amongst others it can be
demonstrated that the study will result in a significant improvement in the
understanding of the minor’s condition or disorder. This term was not defined in the
NHA and some academics questioned whether this factor had any meaning as
participants in a so-called non-therapeutic study would be healthy and not generally
have the condition under study.1304 The 2013 draft Regulations attempt to rectify this
issue by defining the term as the ‘physical and psycho-social characteristics shown to
affect health’. Although defining this term does assist to some extent, it is submitted
that this particular definition fails to address the core issue – that of the need for the
term to be used broadly so that it includes conditions to which the participant may be
at risk of acquiring.
1304
Strode, Slack, Wassenaar & Singh (note 119 above).
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(iii) The lack of clarity between Regulation 2 (principles underpinning health research)
and Regulation 3 (obligations on researchers) should be addressed. There does not
appear to be any clear distinction between what is considered to be a principle which
underpins the way in which research is conducted and the obligations on researchers.
A principle has been defined as a ‘fundamental truth or proposition that serves as the
foundation for a system of belief or behaviour’.1305 Whilst an obligation has been
defined as an ‘act or course of action to which a person is morally or legally bound; a
duty or commitment’.1306 In this set of draft Regulations it is unclear how these terms
have been used since although Regulation 2 ought to set out the broad propositions
which give rise to various obligations in Regulation 3 this does not appear to be the
case. For example, a principle would be the need to respect the autonomy of
research participants and this could be translated into the dual obligations of
ensuring that participants are well informed and participate in health research only
after having provided consent. In the current draft or the regulations In Regulation 2
the language used seems to refer to obligations rather than ‘fundamental truths’
which guide the way health research is conducted. It is recommended that the
following provisions in Regulation 2 are principles and should be retained; the need
for research to be relevant, the importance of a valid methodology, effective
management of studies, the importance of individual autonomy, respect for rights. It
is recommended that firstly, all remaining principles should be phased as principles;
secondly, the principles which are in fact obligations such as the points on obtaining
informed consent, fair recruitment, risks, obtaining ethical approval and registering








ltPU [Accessed: 11 June 2013].
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synergy between the principles and obligations, in other words, there ought to be
obligations which correlate with each principle;
The implications of the 2013 draft Regulations relating to Research with Human Subjects
on the law reform recommendations made by this thesis
The 2013 draft Regulations do not have a significant impact on the proposed law reform
proposals made in this dissertation as most of the proposed normative changes were to the
text of the NHA itself. There are however, three instances in which the draft Regulations do
affect the recommendations made. These are firstly, that this thesis recommended that
research participants should have an express right to privacy, dignity and equality in the
NHA, and these rights are now included in the draft Regulations. Secondly, it was proposed
that the NHA provide that participants may withdraw from a study at any point and this is
now also provided for in the Regulations. Thirdly, the Regulations also require researchers to
demonstrate that children are scientifically indispensable to the study, and again this thesis
had proposed that such a principle be included in a revised section 71 of the NHA. In all three
cases it is arguable that reform of the NHA is now not required on these issues as they are
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